HLA-DQB1, HLA-DQA2, HLA-DQA1, C6orf10	Rheumatoid arthritis	3E-12	   2.10	[1.72-2.68] 	rs9275406	T	0.17	23918589
MYNN	Chronic lymphocytic leukemia	2E-9	   1.26	[1.17-1.35] 	rs10936599	C	NR	24292274
CAMK2D	Chronic lymphocytic leukemia	3E-9	   1.31	[1.20-1.44] 	rs6858698	C	NR	24292274
IPCEF1	Chronic lymphocytic leukemia	2E-10	   1.23	[1.15-1.30] 	rs2236256	C	NR	24292274
POT1	Chronic lymphocytic leukemia	3E-8	   1.22	[1.14-1.31] 	rs17246404	C	NR	24292274
ACOXL, BCL2L11	Chronic lymphocytic leukemia	5E-15	   1.37	[NR] 	rs1439287	A	0.48	24292274
SP110, SP140	Chronic lymphocytic leukemia	5E-13	   1.43	[NR] 	rs13397985	G	0.19	24292274
IRF4	Chronic lymphocytic leukemia	3E-16	   1.39	[NR] 	rs872071	G	0.51	24292274
HLA	Chronic lymphocytic leukemia	4E-8	   1.27	[NR] 	rs926070	A	NR	24292274
ACTA, FAS	Chronic lymphocytic leukemia	2E-8	   1.25	[NR] 	rs1800682	A	0.54	24292274
SCN3B, GRAMD1B	Chronic lymphocytic leukemia	4E-24	   1.64	[NR] 	rs735665	A	0.19	24292274
RPLP1	Chronic lymphocytic leukemia	8E-18	   1.42	[NR] 	rs7176508	A	0.38	24292274
IRF8	Chronic lymphocytic leukemia	1E-9	   1.29	[NR] 	rs1044873	C	0.61	24292274
HLA-DRB1, BTNL2, HLA-DRA, C6orf10	Hepatitis B vaccine response	3E-19	   2.05	[1.75-2.41] 	rs477515	T	0.442	24282030
SALM1	Amyotrophic lateral sclerosis (sporadic)	9E-9	   1.20	[1.12-1.29] 	rs34517613	T	NR	24256812
TRA	Narcolepsy	5E-49	   1.64	[1.53-1.75] 	rs1154155	G	0.148	24204295
ZNF365	Narcolepsy	1E-11	   1.23	[1.16-1.31] 	rs10995245	A	0.348	24204295
NR	Narcolepsy (age of onset)	2E-8	   1.82	 year decrease	rs9274477	G	0.292	24204295
NR	Narcolepsy (age of onset)	3E-8	   1.95	 year decrease	rs17212223	T	0.191	24204295
NR	Narcolepsy (age of onset)	8E-9	   1.90	 year decrease	rs7744020	A	0.272	24204295
BCO2, IL18, TEX12	Inflammatory biomarkers	2E-32	    .10	[0.08-0.12] unit increase	rs2250417	T	0.48	24182552
SRD5A2, DPY30, SPAST, SLC30A6, NLRC4	Inflammatory biomarkers	3E-19	    .08	[0.060-0.100] unit increase	rs7577696	G	0.41	24182552
IL1F10	Inflammatory biomarkers	2E-26	    .13	[0.11-0.15] unit increase	rs6743376	A	0.43	24182552
FBXL13	Blood pressure measurement (cold pressor test)	4E-9	   3.44	[2.30-4.58] mmHg decrease	rs17135875	C	0.01	24165912
TRPM8	Blood pressure measurement (cold pressor test)	3E-8	   1.71	[1.1-2.32] mmHg decrease	rs7577262	A	0.37	24165912
CDCA7	Blood pressure measurement (high sodium and potassium intervention)	4E-8	   3.20	[2.06-4.34] mmHg decrease	rs10930597	T	0.05	24165912
ARL4C	Blood pressure measurement (high sodium and potassium intervention)	2E-8	   3.28	[2.14-4.42] mmHg decrease	rs11887188	T	0.03	24165912
SALL1	Blood pressure measurement (high sodium and potassium intervention)	7E-13	   3.14	[2.28-4.00] mmHg decrease	rs2030114	A	0.01	24165912
CDCA7	Blood pressure measurement (high sodium and potassium intervention)	1E-8	   3.48	[2.28-4.68] mmHg decrease	rs10930597	T	0.05	24165912
IRAK1BP1	Blood pressure measurement (high sodium and potassium intervention)	1E-10	   5.38	[3.73-7.03] mmHg decrease	rs16890334	C	0.06	24165912
IRAK1BP1	Blood pressure measurement (high sodium intervention)	4E-9	   5.43	[3.63-7.23] mmHg decrease	rs16890334	C	0.06	24165912
PRMT6	Blood pressure measurement (low sodium intervention)	1E-8	   5.48	[3.60-7.36] mmHg decrease	rs1330225	C	0.01	24165912
PRMT6	Blood pressure measurement (low sodium intervention)	7E-9	   5.16	[3.42-6.90] mmHg decrease	rs1330225	C	0.01	24165912
CDCA7	Blood pressure measurement (low sodium intervention)	4E-8	   3.37	[2.17-4.57] mmHg decrease	rs10930597	T	0.05	24165912
PIBF1	Blood pressure measurement (low sodium intervention)	2E-9	   2.04	[1.37-2.71] mmHg increase	rs8002688	T	0.04	24165912
ISCA1L, HTR1A	Fasting insulin (interaction)	9E-10	NR	NR	rs16891077	A	0.209	24204828
LOC727960, NRG3	Fasting insulin (interaction)	5E-8	NR	NR	rs9787485	T	0.149	24204828
LOC100132037, LOC647077	Homeostasis model assessment of beta-cell function (interaction)	3E-9	NR	NR	rs2421332	C	0.24	24204828
EMX2, RAB11FIP2	Homeostasis model assessment of beta-cell function (interaction)	3E-8	NR	NR	rs7088969	T	0.312	24204828
ISCA1L, HTR1A	Homeostasis model assessment of insulin resistance (interaction)	1E-9	NR	NR	rs16891077	A	0.209	24204828
LOC727960, NRG3	Homeostasis model assessment of insulin resistance (interaction)	4E-8	NR	NR	rs9787485	T	0.149	24204828
CR1	Alzheimer's disease (late onset)	6E-24	   1.18	[1.14-1.22] 	rs6656401	A	0.197	24162737
BIN1	Alzheimer's disease (late onset)	7E-44	   1.22	[1.18-1.25] 	rs6733839	T	0.409	24162737
CD2AP	Alzheimer's disease (late onset)	5E-11	   1.10	[1.07-1.13] 	rs10948363	G	0.266	24162737
EPHA1	Alzheimer's disease (late onset)	1E-13	   1.11	[1.08-1.14] 	rs11771145	G	0.662	24162737
CLU	Alzheimer's disease (late onset)	3E-25	   1.16	[1.12-1.19] 	rs9331896	T	0.621	24162737
MS4A6A	Alzheimer's disease (late onset)	6E-16	   1.11	[1.09-1.15] 	rs983392	A	0.597	24162737
PICALM	Alzheimer's disease (late onset)	9E-26	   1.15	[1.12-1.18] 	rs10792832	G	0.642	24162737
ABCA7	Alzheimer's disease (late onset)	1E-15	   1.15	[1.11-1.19] 	rs4147929	A	0.19	24162737
INPP5D	Alzheimer's disease (late onset)	3E-8	   1.08	[1.05-1.11] 	rs35349669	T	0.488	24162737
MEF2C	Alzheimer's disease (late onset)	3E-8	   1.08	[1.05-1.11] 	rs190982	A	0.592	24162737
NME8	Alzheimer's disease (late onset)	5E-9	   1.08	[1.05-1.11] 	rs2718058	A	0.627	24162737
ZCWPW1	Alzheimer's disease (late onset)	6E-10	   1.10	[1.06-1.12] 	rs1476679	T	0.713	24162737
CELF1	Alzheimer's disease (late onset)	1E-8	   1.08	[1.05-1.11] 	rs10838725	C	0.316	24162737
FERMT2	Alzheimer's disease (late onset)	8E-9	   1.14	[1.09-1.19] 	rs17125944	C	0.092	24162737
CASS4	Alzheimer's disease (late onset)	3E-8	   1.14	[1.09-1.19] 	rs7274581	T	0.917	24162737
HLA-DRB5,HLA-DRB1	Alzheimer's disease (late onset)	3E-12	   1.11	[1.08-1.18] 	rs9271192	C	0.276	24162737
PTK2B	Alzheimer's disease (late onset)	7E-14	   1.10	[1.08-1.13] 	rs28834970	C	0.366	24162737
SORL1	Alzheimer's disease (late onset)	1E-14	   1.30	[1.22-1.39] 	rs11218343	T	0.961	24162737
SLC24A4, RIN3	Alzheimer's disease (late onset)	6E-9	   1.10	[1.06-1.14] 	rs10498633	G	0.783	24162737
HLA-DQB2	Hepatitis B	5E-37	   1.89	[1.69-2.08] 	rs7453920	G	0.87	24162738
HLA-C	Hepatitis B	9E-14	   1.33	[1.23-1.44] 	rs3130542	A	0.13	24162738
UBE2L3	Hepatitis B	2E-12	   1.22	[1.15-1.3] 	rs4821116	G	0.59	24162738
TERC, ACTRT3, MYNN, LRRC34	Bladder cancer	5E-9	   1.18	[1.11-1.23] 	rs10936599	C	0.76	24163127
LSP1	Bladder cancer	4E-8	   1.15	[1.09-1.21] 	rs907611	A	0.31	24163127
TP63	Bladder cancer	2E-11	   1.14	[1.10-1.19] 	rs710521	A	0.73	24163127
TMEM129, TACC3, FGFR3	Bladder cancer	7E-25	   1.22	[1.18-1.27] 	rs798766	T	0.19	24163127
TERT, CLPTML	Bladder cancer	4E-11	   1.12	[1.08-1.16] 	rs401681	C	0.54	24163127
NAT2	Bladder cancer	2E-10	   1.14	[1.09-1.18] 	rs1495741	A	0.8	24163127
PSCA	Bladder cancer	3E-15	   1.13	[1.10-1.16] 	rs2204008	T	0.46	24163127
Intergenic	Bladder cancer	4E-38	   1.24	[1.20-1.28] 	rs9642880	T	0.45	24163127
CCNE1	Bladder cancer	1E-11	   1.13	[1.09-1.17] 	rs8102137	C	0.33	24163127
CBX6, APOBEC3A	Bladder cancer	1E-11	   1.13	[1.09-1.17] 	rs1014971	T	0.62	24163127
DDAH1	Serum dimethylarginine levels (asymmetric)	1E-40	    .37	[0.32-0.42] unit increase	rs28489187	G	0.216	24159190
AGXT2	Serum dimethylarginine levels (asymmetric/symetric ratio)	2E-32	    .41	[0.34-0.48] unit decrease	rs37369	T	0.088	24159190
DDAH1	Serum dimethylarginine levels (asymmetric/symetric ratio)	1E-20	    .26	[0.20-0.31] unit increase	rs28489187	G	0.216	24159190
AGXT2	Serum dimethylarginine levels (symmetric)	1E-40	    .47	[0.4-0.54] unit increase	rs37369	T	0.088	24159190
DDAH1	Serum dimethylarginine levels (symmetric)	1E-18	    .18	[0.14-0.22] unit decrease	rs1884139	T	0.371	24159190
SLC25A45	Serum dimethylarginine levels (symmetric)	2E-10	    .36	[0.25-0.47] unit increase	rs34400381	A	0.043	24159190
EOMES	Hodgkin's lymphoma	1E-12	   1.26	[1.18-1.34] 	rs3806624	G	0.45	24149102
HBS1L, MYB	Hodgkin's lymphoma	3E-9	   1.21	[1.14-1.29] 	rs7745098	G	0.48	24149102
NR	Hodgkin's lymphoma	4E-10	   1.39	[NR] 	rs501764	C	0.19	24149102
NR	Hodgkin's lymphoma	6E-10	   1.37	[NR] 	rs2019960	G	0.23	24149102
NR	Hodgkin's lymphoma	5E-27	   1.62	[NR] 	rs6903608	G	0.27	24149102
FGFR2	Breast cancer	1E-12	   1.23	[1.158-1.296] 	rs2981578	C	0.514	24143190
LOC643714, TOX3	Breast cancer	4E-10	   1.23	[1.153-1.314] 	rs12922061	T	0.241	24143190
LOC643714, TOX3	Breast cancer	3E-11	   1.21	[1.146-1.284] 	rs3803662	T	0.522	24143190
WDR11, FGFR2	Adiponectin levels	3E-14	    .07	[0.050-0.090] unit increase	rs3943077	A	0.567	24105470
CDH13	Adiponectin levels	7E-165	    .33	[0.31-0.35] unit decrease	rs4783244	T	0.360	24105470
ADIPOQ	Adiponectin levels	2E-22	    .12	[0.10-0.14] unit increase	rs10937273	A	0.404	24105470
PEPD	Adiponectin levels	4E-12	    .08	[0.060-0.100] unit increase	rs889140	A	0.450	24105470
CMIP	Adiponectin levels	2E-10	    .08	[0.060-0.100] unit decrease	rs2925979	T	0.411	24105470
FOXP1	Digestive system disease (Barrett's esophagus and esophageal adenocarcinoma combined)	5E-9	   1.18	[1.12-1.25] 	rs2687201	T	0.303	24121790
BARX1	Digestive system disease (Barrett's esophagus and esophageal adenocarcinoma combined)	1E-9	   1.20	[1.14-1.27] 	rs11789015	A	0.717	24121790
CRTC1	Digestive system disease (Barrett's esophagus and esophageal adenocarcinoma combined)	4E-10	   1.18	[1.12-1.24] 	rs10419226	A	0.456	24121790
MC4R	Body mass index	8E-19	    .09	[0.070-0.110] kg/m2 increase	rs6567160	C	NR	24064335
FTO	Body mass index	2E-14	    .08	[0.060-0.100] kg/m2 increase	rs62033400	G	NR	24064335
MC4R	Fat body mass	3E-11	    .09	[0.07-0.11] unit increase	rs6567160	C	NR	24064335
CTSS	Fat body mass	4E-8	    .06	[0.040-0.080] unit decrease	rs2230061	A	NR	24064335
KCNQ1	Type 2 diabetes	5E-9	   1.30	[NR] 	rs8181588	A	0.48	24101674
GTF2I, GTF2IRD1	Sjögren's syndrome	1E-53	   2.20	[1.99-2.42] 	rs117026326	T	0.1501	24097066
STAT4	Sjögren's syndrome	2E-17	   1.44	[1.32-1.57] 	rs10168266	T	0.3357	24097066
TNFAIP3	Sjögren's syndrome	8E-9	   1.67	[1.40-1.99] 	rs5029939	G	0.0445	24097066
HLA-DRB1, HLA-DQA1	Sjögren's syndrome	9E-37	   1.75	[1.59-1.89] 	rs9271588	T	0.532	24097066
HLA-DPB1, COL11A2	Sjögren's syndrome	9E-25	   1.58	[1.45-1.72] 	rs4282438	G	0.3546	24097066
ABCA1	Cholesterol, total	6E-53	    .07	[NR] unit decrease	rs1883025	T	0.25	24097068
ABCB11	Cholesterol, total	4E-12	    .03	[NR] unit increase	rs2287623	G	0.41	24097068
ABCG5, ABCG8	Cholesterol, total	3E-73	    .08	[NR] unit increase	rs4299376	G	0.31	24097068
ABO	Cholesterol, total	3E-35	    .07	[NR] unit increase	rs9411489	T	0.21	24097068
ANGPTL3	Cholesterol, total	4E-80	    .08	[NR] unit decrease	rs2131925	G	0.34	24097068
APOA1	Cholesterol, total	3E-55	    .12	[NR] unit decrease	rs964184	C	0.84	24097068
APOB	Cholesterol, total	3E-139	    .10	[NR] unit increase	rs1367117	A	0.32	24097068
APOE	Cholesterol, total	1E-149	    .20	[NR] unit increase	rs4420638	G	0.19	24097068
ASAP3	Cholesterol, total	6E-9	    .03	[NR] unit decrease	rs1077514	C	0.15	24097068
BRAP	Cholesterol, total	2E-16	    .03	[NR] unit decrease	rs11065987	G	0.41	24097068
C6orf106	Cholesterol, total	4E-15	    .04	[NR] unit decrease	rs2814982	T	0.12	24097068
CETP	Cholesterol, total	4E-31	    .05	[NR] unit increase	rs3764261	A	0.32	24097068
CILP2	Cholesterol, total	4E-77	    .14	[NR] unit decrease	rs10401969	C	0.09	24097068
CMTM6	Cholesterol, total	2E-8	    .04	[NR] unit decrease	rs7640978	T	0.09	24097068
CSNK1G3	Cholesterol, total	2E-9	    .02	[NR] unit decrease	rs4530754	G	0.46	24097068
CYP7A1	Cholesterol, total	9E-12	    .04	[NR] unit increase	rs2081687	T	0.36	24097068
DLG4	Cholesterol, total	3E-10	    .02	[NR] unit decrease	rs314253	C	0.37	24097068
DNAH11	Cholesterol, total	1E-16	    .04	[NR] unit increase	rs12670798	C	0.25	24097068
ERGIC3	Cholesterol, total	5E-11	    .04	[NR] unit decrease	rs2277862	T	0.15	24097068
EVI5	Cholesterol, total	2E-8	    .04	[NR] unit decrease	rs7515577	C	0.23	24097068
FADS1, FADS2, FADS3	Cholesterol, total	3E-37	    .05	[NR] unit decrease	rs174546	T	0.36	24097068
FAM117B	Cholesterol, total	2E-9	    .03	[NR] unit increase	rs11694172	G	0.25	24097068
FLJ36070	Cholesterol, total	1E-16	    .03	[NR] unit increase	rs492602	G	0.47	24097068
FRK	Cholesterol, total	1E-9	    .03	[NR] unit increase	rs9488822	T	0.36	24097068
GCKR	Cholesterol, total	3E-42	    .05	[NR] unit increase	rs1260326	T	0.39	24097068
GPAM	Cholesterol, total	7E-16	    .03	[NR] unit increase	rs2255141	A	0.3	24097068
GPR146	Cholesterol, total	3E-10	    .03	[NR] unit increase	rs1997243	G	0.16	24097068
HBS1L	Cholesterol, total	3E-9	    .03	[NR] unit decrease	rs9376090	C	0.28	24097068
HFE	Cholesterol, total	2E-12	    .06	[NR] unit decrease	rs1800562	A	0.07	24097068
HLA	Cholesterol, total	1E-21	    .05	[NR] unit increase	rs3177928	A	0.17	24097068
HMGCR	Cholesterol, total	5E-74	    .68	[NR] unit increase	rs12916	C	0.4	24097068
HNF1A	Cholesterol, total	4E-17	    .03	[NR] unit increase	rs1169288	C	0.34	24097068
HNF4A	Cholesterol, total	1E-24	    .11	[NR] unit decrease	rs1800961	T	0.05	24097068
HPR	Cholesterol, total	7E-41	    .06	[NR] unit increase	rs2000999	A	0.2	24097068
INSIG2	Cholesterol, total	6E-9	    .04	[NR] unit increase	rs10490626, rs17526895	A	0.08	24097068
IRF2BP2	Cholesterol, total	5E-14	    .04	[NR] unit decrease	rs514230	A	0.48	24097068
KCNK17	Cholesterol, total	3E-8	    .02	[NR] unit increase	rs2758886	A	0.3	24097068
LDLR	Cholesterol, total	5E-202	    .19	[NR] unit decrease	rs6511720	T	0.12	24097068
LDLRAP1	Cholesterol, total	5E-12	    .03	[NR] unit decrease	rs12027135	A	0.46	24097068
LIPC	Cholesterol, total	7E-47	    .05	[NR] unit increase	rs1532085	A	0.40	24097068
LIPG	Cholesterol, total	4E-18	    .06	[NR] unit decrease	rs7241918	G	0.19	24097068
LPA	Cholesterol, total	3E-23	    .05	[NR] unit increase	rs1564348	C	0.18	24097068
LRPAP1	Cholesterol, total	1E-10	    .03	[NR] unit increase	rs6831256	G	0.42	24097068
MAFB	Cholesterol, total	9E-10	    .02	[NR] unit decrease	rs2902940	G	0.3	24097068
MARCH8, ALOX5	Cholesterol, total	8E-9	    .03	[NR] unit increase	rs970548	C	0.26	24097068
MIR148A	Cholesterol, total	7E-9	    .03	[NR] unit increase	rs4722551	C	0.2	24097068
MOSC1	Cholesterol, total	3E-11	    .04	[NR] unit decrease	rs2642442	C	0.33	24097068
MYLIP	Cholesterol, total	2E-15	    .04	[NR] unit decrease	rs3757354	T	0.24	24097068
NAT2	Cholesterol, total	3E-8	    .03	[NR] unit increase	rs1495741	G	0.26	24097068
NPC1L1	Cholesterol, total	4E-15	    .04	[NR] unit increase	rs2072183	C	0.29	24097068
PCSK9	Cholesterol, total	2E-39	    .05	[NR] unit increase	rs2479409	G	0.32	24097068
PHC1, A2ML1	Cholesterol, total	2E-9	    .04	[NR] unit decrease	rs4883201	G	0.12	24097068
PHLDB1	Cholesterol, total	1E-8	    .02	[NR] unit increase	rs11603023	T	0.42	24097068
PLEC1	Cholesterol, total	6E-9	    .04	[NR] unit increase	rs11136341	G	0.40	24097068
PPARA	Cholesterol, total	1E-8	    .03	[NR] unit increase	rs4253772	T	0.11	24097068
PPP1R3B	Cholesterol, total	2E-36	    .08	[NR] unit decrease	rs9987289	A	0.10	24097068
PXK	Cholesterol, total	4E-8	    .04	[NR] unit decrease	rs13315871	A	0.1	24097068
RAB3GAP1	Cholesterol, total	1E-13	    .03	[NR] unit increase	rs7570971	A	0.35	24097068
RAF1	Cholesterol, total	2E-9	    .04	[NR] unit decrease	rs2290159	C	0.23	24097068
SORT1	Cholesterol, total	2E-170	    .13	[NR] unit decrease	rs629301	G	0.24	24097068
SOX17	Cholesterol, total	5E-11	    .03	[NR] unit increase	rs10102164	A	0.21	24097068
SPTY2D1	Cholesterol, total	1E-11	    .03	[NR] unit decrease	rs10128711	T	0.3	24097068
ST3GAL4	Cholesterol, total	6E-15	    .05	[NR] unit increase	rs11220462	A	0.14	24097068
TIMD4	Cholesterol, total	5E-41	    .05	[NR] unit decrease	rs6882076	T	0.36	24097068
TOM1	Cholesterol, total	5E-8	    .02	[NR] unit increase	rs138777	A	0.36	24097068
TOP1	Cholesterol, total	1E-16	    .04	[NR] unit increase	rs6029526	A	0.47	24097068
TRIB1	Cholesterol, total	2E-65	    .06	[NR] unit decrease	rs2954029	T	0.47	24097068
TTC39B	Cholesterol, total	1E-13	    .04	[NR] unit decrease	rs581080	G	0.21	24097068
UBASH3B	Cholesterol, total	2E-14	    .03	[NR] unit increase	rs7941030	C	0.39	24097068
UGT1A1	Cholesterol, total	1E-9	    .04	[NR] unit increase	rs11563251	T	0.12	24097068
VIM, CUBN	Cholesterol, total	3E-11	    .03	[NR] unit increase	rs10904908	G	0.43	24097068
VLDLR	Cholesterol, total	7E-10	    .04	[NR] unit decrease	rs3780181	G	0.08	24097068
ABCA1	HDL cholesterol	2E-65	    .07	[NR] unit decrease	rs1883025	T	0.25	24097068
ABCA8	HDL cholesterol	1E-12	    .03	[NR] unit decrease	rs4148008	G	0.33	24097068
ACAD11	HDL cholesterol	5E-9	    .03	[NR] unit decrease	rs17404153	T	0.14	24097068
ADH5	HDL cholesterol	5E-8	    .02	[NR] unit increase	rs2602836	A	0.44	24097068
AMPD3	HDL cholesterol	5E-8	    .03	[NR] unit decrease	rs2923084	G	0.18	24097068
ANGPTL1	HDL cholesterol	7E-9	    .02	[NR] unit increase	rs4650994	G	0.49	24097068
ANGPTL4	HDL cholesterol	2E-8	    .03	[NR] unit decrease	rs7255436	C	0.47	24097068
ANGPTL8	HDL cholesterol	5E-17	    .06	[NR] unit decrease	rs737337	C	0.11	24097068
APOA1	HDL cholesterol	6E-48	    .11	[NR] unit increase	rs964184	C	0.84	24097068
APOE	HDL cholesterol	2E-21	    .07	[NR] unit decrease	rs4420638	G	0.19	24097068
ARL15	HDL cholesterol	7E-10	    .03	[NR] unit decrease	rs6450176	A	0.26	24097068
ATG7	HDL cholesterol	5E-8	    .03	[NR] unit increase	rs2606736	C	0.39	24097068
C4orf52	HDL cholesterol	5E-8	    .03	[NR] unit decrease	rs10019888	G	0.18	24097068
CETP	HDL cholesterol	1E-769	    .24	[NR] unit increase	rs3764261	A	0.32	24097068
CITED2	HDL cholesterol	3E-8	    .03	[NR] unit decrease	rs605066	C	0.42	24097068
CMIP	HDL cholesterol	1E-19	    .04	[NR] unit decrease	rs2925979	T	0.31	24097068
COBLL1	HDL cholesterol	2E-15	    .05	[NR] unit increase	rs12328675	C	0.13	24097068
CPS1	HDL cholesterol	9E-10	    .03	[NR] unit decrease	rs1047891	A	0.33	24097068
DAGLB	HDL cholesterol	6E-12	    .02	[NR] unit increase	rs702485	G	0.45	24097068
FADS1, FADS2, FADS3	HDL cholesterol	8E-28	    .04	[NR] unit decrease	rs174546	T	0.36	24097068
FAM13A	HDL cholesterol	4E-12	    .03	[NR] unit decrease	rs3822072	A	0.46	24097068
FTO	HDL cholesterol	7E-9	    .02	[NR] unit decrease	rs1121980	A	0.43	24097068
GALNT2	HDL cholesterol	4E-41	    .05	[NR] unit decrease	rs4846914	G	0.41	24097068
GSK3B	HDL cholesterol	1E-8	    .02	[NR] unit increase	rs6805251	T	0.39	24097068
HAS1	HDL cholesterol	2E-13	    .03	[NR] unit decrease	rs17695224	A	0.26	24097068
HDGF, PMVK	HDL cholesterol	2E-8	    .02	[NR] unit increase	rs12145743	G	0.34	24097068
HNF4A	HDL cholesterol	2E-34	    .13	[NR] unit decrease	rs1800961	T	0.05	24097068
IKZF1	HDL cholesterol	1E-8	    .02	[NR] unit increase	rs4917014	G	0.32	24097068
IRS1	HDL cholesterol	2E-17	    .03	[NR] unit increase	rs2972146	G	0.37	24097068
KAT5	HDL cholesterol	3E-8	    .02	[NR] unit increase	rs12801636	A	0.23	24097068
KLF14	HDL cholesterol	5E-17	    .03	[NR] unit increase	rs4731702	T	0.49	24097068
LACTB	HDL cholesterol	4E-11	    .03	[NR] unit decrease	rs2652834	A	0.21	24097068
LCAT	HDL cholesterol	8E-54	    .08	[NR] unit increase	rs16942887	A	0.14	24097068
LILRA3	HDL cholesterol	3E-23	    .05	[NR] unit increase	rs386000	C	0.26	24097068
LIPC	HDL cholesterol	1E-188	    .11	[NR] unit increase	rs1532085	A	0.4	24097068
LIPG	HDL cholesterol	1E-44	    .09	[NR] unit decrease	rs7241918	G	0.19	24097068
LPL	HDL cholesterol	1E-149	    .16	[NR] unit increase	rs12678919	G	0.13	24097068
LRP1	HDL cholesterol	2E-13	    .03	[NR] unit increase	rs11613352	T	0.26	24097068
LRP4	HDL cholesterol	7E-29	    .05	[NR] unit increase	rs3136441	C	0.18	24097068
LRP4	HDL cholesterol	7E-29	    .05	[NR] unit increase	rs3136441	C	0.18	24097068
MARCH8, ALOX5	HDL cholesterol	2E-10	    .03	[NR] unit increase	rs970548	C	0.26	24097068
MC4R	HDL cholesterol	4E-8	    .03	[NR] unit decrease	rs12967135	A	0.25	24097068
MLXIPL	HDL cholesterol	5E-13	    .04	[NR] unit increase	rs17145738	T	0.13	24097068
MOGAT2, DGAT2	HDL cholesterol	1E-8	    .03	[NR] unit decrease	rs499974	A	0.19	24097068
MVK	HDL cholesterol	2E-13	    .04	[NR] unit decrease	rs7134594	C	0.48	24097068
OR4C46	HDL cholesterol	2E-10	    .03	[NR] unit increase	rs11246602	C	0.15	24097068
PABPC4	HDL cholesterol	3E-18	    .04	[NR] unit decrease	rs4660293	G	0.24	24097068
PDE3A	HDL cholesterol	1E-8	    .02	[NR] unit increase	rs7134375	A	0.43	24097068
PEPD	HDL cholesterol	3E-9	    .02	[NR] unit decrease	rs731839	G	0.35	24097068
PGS1	HDL cholesterol	2E-11	    .02	[NR] unit decrease	rs4129767	G	0.48	24097068
PIGV, NR0B2	HDL cholesterol	1E-15	    .05	[NR] unit decrease	rs12748152	T	0.09	24097068
PLTP	HDL cholesterol	5E-40	    .06	[NR] unit decrease	rs6065906	C	0.19	24097068
PPP1R3B	HDL cholesterol	2E-41	    .08	[NR] unit decrease	rs9987289	A	0.1	24097068
RBM5	HDL cholesterol	9E-12	    .03	[NR] unit increase	rs2013208	T	0.5	24097068
RSPO3	HDL cholesterol	3E-10	    .02	[NR] unit increase	rs1936800	C	0.49	24097068
SBNO1	HDL cholesterol	3E-8	    .06	[NR] unit increase	rs4759375	T	0.08	24097068
SCARB1	HDL cholesterol	6E-32	    .05	[NR] unit increase	rs838880	C	0.34	24097068
SETD2	HDL cholesterol	4E-9	    .03	[NR] unit decrease	rs2290547	A	0.2	24097068
SLC39A8	HDL cholesterol	1E-15	    .07	[NR] unit decrease	rs13107325	T	0.08	24097068
SNX13	HDL cholesterol	9E-12	    .03	[NR] unit decrease	rs4142995	T	0.38	24097068
STAB1	HDL cholesterol	9E-11	    .03	[NR] unit increase	rs13326165	A	0.21	24097068
STARD3	HDL cholesterol	3E-17	    .03	[NR] unit decrease	rs11869286	G	0.35	24097068
TMEM176A	HDL cholesterol	2E-8	    .04	[NR] unit decrease	rs17173637	C	0.12	24097068
TRIB1	HDL cholesterol	3E-29	    .04	[NR] unit increase	rs2954029	T	0.47	24097068
TRPS1	HDL cholesterol	4E-17	    .03	[NR] unit decrease	rs2293889	T	0.41	24097068
TTC39B	HDL cholesterol	1E-19	    .04	[NR] unit decrease	rs581080	G	0.21	24097068
UBASH3B	HDL cholesterol	1E-14	    .03	[NR] unit increase	rs7941030	C	0.39	24097068
UBE2L3	HDL cholesterol	4E-18	    .04	[NR] unit decrease	rs181362	T	0.23	24097068
VEGFA	HDL cholesterol	2E-11	    .03	[NR] unit decrease	rs998584	A	0.49	24097068
ZBTB42, AKT1	HDL cholesterol	1E-8	    .02	[NR] unit increase	rs4983559	G	0.4	24097068
ZNF648	HDL cholesterol	5E-20	    .03	[NR] unit decrease	rs1689800	G	0.35	24097068
ZNF664	HDL cholesterol	8E-10	    .03	[NR] unit increase	rs4765127	T	0.35	24097068
ABCG5, ABCG58	LDL cholesterol	4E-72	    .08	[NR] unit increase	rs4299376	G	0.31	24097068
ABO	LDL cholesterol	2E-41	    .08	[NR] unit increase	rs9411489	T	0.21	24097068
ACAD11	LDL cholesterol	2E-9	    .03	[NR] unit decrease	rs17404153	T	0.14	24097068
ANGPTL3	LDL cholesterol	3E-32	    .05	[NR] unit decrease	rs2131925	G	0.34	24097068
ANXA9, CERS2	LDL cholesterol	5E-9	    .03	[NR] unit decrease	rs267733	G	0.16	24097068
APOA1	LDL cholesterol	2E-26	    .09	[NR] unit decrease	rs964184	C	0.84	24097068
APOB	LDL cholesterol	1E-182	    .12	[NR] unit increase	rs1367117	A	0.32	24097068
APOE	LDL cholesterol	2E-178	    .23	[NR] unit increase	rs4420638	G	0.19	24097068
APOH, PRXCA	LDL cholesterol	1E-11	    .10	[NR] unit increase	rs1801689	C	0.04	24097068
BRAP	LDL cholesterol	1E-11	    .03	[NR] unit decrease	rs11065987	G	0.41	24097068
BRCA2	LDL cholesterol	2E-11	    .02	[NR] unit increase	rs4942486	T	0.48	24097068
CETP	LDL cholesterol	2E-34	    .05	[NR] unit decrease	rs3764261	A	0.32	24097068
CILP2	LDL cholesterol	3E-54	    .12	[NR] unit decrease	rs10401969	C	0.09	24097068
CMTM6	LDL cholesterol	1E-8	    .04	[NR] unit decrease	rs7640978	T	0.09	24097068
CSNK1G3	LDL cholesterol	4E-12	    .03	[NR] unit decrease	rs4530754	G	0.46	24097068
DLG4	LDL cholesterol	3E-10	    .02	[NR] unit decrease	rs314253	C	0.37	24097068
DNAH11	LDL cholesterol	5E-14	    .03	[NR] unit increase	rs12670798	C	0.25	24097068
EHBP1	LDL cholesterol	6E-9	    .02	[NR] unit decrease	rs2710642	G	0.35	24097068
FADS1, FADS2, FADS3	LDL cholesterol	2E-39	    .05	[NR] unit decrease	rs174546	T	0.36	24097068
FN1	LDL cholesterol	3E-8	    .02	[NR] unit decrease	rs1250229	T	0.27	24097068
GPAM	LDL cholesterol	1E-13	    .03	[NR] unit increase	rs2255141	A	0.30	24097068
HFE	LDL cholesterol	8E-14	    .06	[NR] unit decrease	rs1800562	A	0.07	24097068
HLA	LDL cholesterol	3E-17	    .05	[NR] unit increase	rs3177928	A	0.17	24097068
HMGCR	LDL cholesterol	8E-78	    .07	[NR] unit increase	rs12916	C	0.40	24097068
HNF1A	LDL cholesterol	6E-21	    .04	[NR] unit increase	rs1169288	C	0.34	24097068
HPR	LDL cholesterol	4E-41	    .07	[NR] unit increase	rs2000999	A	0.20	24097068
INSIG2	LDL cholesterol	2E-12	    .05	[NR] unit decrease	rs10490626	A	0.08	24097068
IRF2BP2	LDL cholesterol	9E-12	    .04	[NR] unit decrease	rs514230	A	0.48	24097068
LDLR	LDL cholesterol	4E-262	    .22	[NR] unit decrease	rs6511720	T	0.12	24097068
LDLRAP1	LDL cholesterol	2E-14	    .03	[NR] unit decrease	rs12027135	A	0.46	24097068
LOC84931	LDL cholesterol	9E-9	    .02	[NR] unit increase	rs2030746	T	0.4	24097068
LPA	LDL cholesterol	3E-21	    .05	[NR] unit increase	rs1564348	C	0.18	24097068
LRPAP1	LDL cholesterol	2E-8	    .02	[NR] unit increase	rs6831256	G	0.42	24097068
MAFB	LDL cholesterol	2E-11	    .03	[NR] unit decrease	rs2902940	G	0.30	24097068
MIR148A	LDL cholesterol	4E-14	    .04	[NR] unit increase	rs4722551	C	0.2	24097068
MOSC1	LDL cholesterol	5E-11	    .04	[NR] unit decrease	rs2642442	C	0.33	24097068
MTMR3	LDL cholesterol	1E-8	    .08	[NR] unit increase	rs5763662	T	0.04	24097068
MYLIP	LDL cholesterol	2E-17	    .04	[NR] unit decrease	rs3757354	T	0.24	24097068
NPC1L1	LDL cholesterol	7E-16	    .04	[NR] unit increase	rs2072183	C	0.29	24097068
NYNRIN	LDL cholesterol	3E-15	    .03	[NR] unit increase	rs8017377	A	0.46	24097068
PCSK9	LDL cholesterol	3E-50	    .06	[NR] unit increase	rs2479409	G	0.32	24097068
PIGV, NR0B2	LDL cholesterol	3E-12	    .05	[NR] unit increase	rs12748152	T	0.09	24097068
PLEC1	LDL cholesterol	7E-12	    .05	[NR] unit increase	rs11136341	G	0.4	24097068
PPARA	LDL cholesterol	3E-8	    .03	[NR] unit increase	rs4253772, rs4253776	T	0.11	24097068
PPP1R3B	LDL cholesterol	9E-24	    .07	[NR] unit decrease	rs9987289	A	0.10	24097068
SNX5	LDL cholesterol	6E-9	    .03	[NR] unit increase	rs2328223	C	0.21	24097068
SORT1	LDL cholesterol	5E-241	    .17	[NR] unit decrease	rs629301	G	0.24	24097068
SOX17	LDL cholesterol	4E-11	    .03	[NR] unit increase	rs10102164	A	0.21	24097068
SPTLC3	LDL cholesterol	4E-10	    .03	[NR] unit decrease	rs364585	A	0.38	24097068
ST3GAL4	LDL cholesterol	7E-21	    .06	[NR] unit increase	rs11220462	A	0.14	24097068
TIMD4	LDL cholesterol	3E-31	    .05	[NR] unit decrease	rs6882076	T	0.36	24097068
TOP1	LDL cholesterol	5E-18	    .04	[NR] unit increase	rs6029526	A	0.47	24097068
TRIB1	LDL cholesterol	2E-50	    .06	[NR] unit decrease	rs2954029	T	0.47	24097068
UGT1A1	LDL cholesterol	5E-8	    .03	[NR] unit increase	rs11563251	T	0.12	24097068
VLDLR	LDL cholesterol	2E-9	    .04	[NR] unit decrease	rs3780181	G	0.08	24097068
AKR1C4	Triglycerides	2E-12	    .03	[NR] mg/dL decrease	rs1832007	G	0.18	24097068
ANGPTL3	Triglycerides	3E-74	    .07	[NR] mg/dL decrease	rs2131925	G	0.34	24097068
APOA1	Triglycerides	7E-224	    .23	[NR] mg/dL decrease	rs964184	C	0.84	24097068
CAPN3	Triglycerides	2E-11	    .10	[NR] mg/dL increase	rs2412710	A	0.04	24097068
CETP	Triglycerides	2E-25	    .04	[NR] mg/dL decrease	rs3764261	A	0.32	24097068
CILP2	Triglycerides	1E-69	    .12	[NR] mg/dL decrease	rs10401969	C	0.09	24097068
CYP26A1	Triglycerides	2E-11	    .02	[NR] mg/dL decrease	rs2068888	A	0.45	24097068
FADS1, FADS2, FADS3	Triglycerides	7E-38	    .05	[NR] mg/dL increase	rs174546	T	0.36	24097068
FRMD5	Triglycerides	2E-9	    .07	[NR] mg/dL increase	rs2929282	T	0.07	24097068
FTO	Triglycerides	3E-8	    .02	[NR] mg/dL increase	rs1121980, rs9930333	A	0.43	24097068
GALNT2	Triglycerides	7E-31	    .04	[NR] mg/dL increase	rs4846914	G	0.41	24097068
GCKR	Triglycerides	2E-239	    .12	[NR] mg/dL increase	rs1260326	T	0.39	24097068
INSR	Triglycerides	5E-10	    .02	[NR] mg/dL decrease	rs7248104	A	0.42	24097068
IRS1	Triglycerides	3E-15	    .03	[NR] mg/dL decrease	rs2972146	G	0.37	24097068
JMJD1C	Triglycerides	8E-12	    .03	[NR] mg/dL decrease	rs10761731	T	0.44	24097068
KLHL8	Triglycerides	1E-18	    .03	[NR] mg/dL decrease	rs442177	G	0.42	24097068
LIPC	Triglycerides	2E-18	    .03	[NR] mg/dL increase	rs1532085	A	0.40	24097068
LPL	Triglycerides	2E-199	    .17	[NR] mg/dL decrease	rs12678919	G	0.13	24097068
LRP1	Triglycerides	9E-14	    .03	[NR] mg/dL decrease	rs11613352	T	0.26	24097068
LRPAP1	Triglycerides	2E-12	    .03	[NR] mg/dL increase	rs6831256	G	0.42	24097068
MAP3K1	Triglycerides	3E-16	    .04	[NR] mg/dL increase	rs9686661	T	0.2	24097068
MET	Triglycerides	2E-8	    .02	[NR] mg/dL decrease	rs38855	G	0.47	24097068
MIR148A	Triglycerides	9E-11	    .02	[NR] mg/dL increase	rs4722551	C	0.2	24097068
MLXIPL	Triglycerides	9E-99	    .12	[NR] mg/dL decrease	rs17145738	T	0.13	24097068
MPP3	Triglycerides	1E-8	    .03	[NR] mg/dL increase	rs8077889	C	0.22	24097068
MSL2L1	Triglycerides	2E-12	    .03	[NR] mg/dL decrease	rs645040	G	0.23	24097068
NAT2	Triglycerides	3E-12	    .04	[NR] mg/dL increase	rs1495741	G	0.26	24097068
PDXDC1	Triglycerides	2E-8	    .02	[NR] mg/dL decrease	rs3198697	T	0.43	24097068
PEPD	Triglycerides	3E-9	    .02	[NR] mg/dL increase	rs731839	G	0.35	24097068
PIGV, NR0B2	Triglycerides	1E-9	    .04	[NR] mg/dL increase	rs12748152	T	0.09	24097068
PINX1	Triglycerides	3E-11	    .02	[NR] mg/dL increase	rs11776767	C	0.37	24097068
PLA2G6	Triglycerides	3E-8	    .02	[NR] mg/dL decrease	rs5756931	C	0.40	24097068
PLTP	Triglycerides	2E-34	    .05	[NR] mg/dL increase	rs6065906	C	0.19	24097068
RSPO3	Triglycerides	3E-8	    .02	[NR] mg/dL decrease	rs1936800, rs719726	C	0.49	24097068
TIMD4	Triglycerides	2E-15	    .03	[NR] mg/dL decrease	rs6882076	T	0.36	24097068
TRIB1	Triglycerides	1E-107	    .08	[NR] mg/dL decrease	rs2954029	T	0.47	24097068
VEGFA	Triglycerides	3E-15	    .49	[NR] mg/dL increase	rs998584	A	0.49	24097068
ZNF664	Triglycerides	2E-8	    .03	[NR] mg/dL decrease	rs4765127	T	0.35	24097068
SURF6, ABO	Serum alkaline phosphatase levels	1E-56	    .08	[0.069-0.089] U/L decrease	rs651007	A	0.226	24094242
ABO	Serum alkaline phosphatase levels	3E-21	    .04	[0.033-0.049] U/L increase	rs8176720	C	0.452	24094242
SURF6, ABO	Serum alkaline phosphatase levels	3E-27	    .05	[0.039-0.055] U/L decrease	rs7025162	A	0.384	24094242
ABO	Serum alkaline phosphatase levels	4E-8	    .06	[NR] U/L decrease	rs657152	T	0.46	24094242
CTNNA2	Orthostatic hypotension	5E-8	   1.38	[NR] mmHg decrease	rs6736587	C	0.16	24124408
CASR	Calcium levels	9E-86	    .07	[0.063-0.079] unit increase	rs1801725	T	0.15	24068962
DGKD	Calcium levels	8E-11	    .02	[0.012-0.024] unit increase	rs1550532	C	0.31	24068962
GCKR	Calcium levels	1E-10	    .02	[0.016-0.018] unit increase	rs780094	T	0.42	24068962
GATA3	Calcium levels	5E-9	    .03	[0.017-0.037] unit increase	rs10491003	T	0.09	24068962
CARS	Calcium levels	1E-10	    .02	[0.012-0.024] unit decrease	rs7481584	A	0.3	24068962
DGKH, KIAA0564	Calcium levels	9E-10	    .02	[0.014-0.03] unit decrease	rs7336933	A	0.15	24068962
CYP24A1	Calcium levels	9E-12	    .02	[0.012-0.024] unit decrease	rs1570669	A	0.66	24068962
VKORC1L1	Calcium levels	8E-9	    .02	[0.0091-0.0209] unit increase	rs17711722	T	0.47	24068962
CYP19A1	Follicule stimulating hormone	2E-16	    .11	[0.090-0.130] unit increase	rs2414095	A	0.31	24049095
NR	Follicule stimulating hormone	4E-8	NR	NR	rs3764618	G	0.08	24049095
SHBG	Hormone measurements	1E-8	    .28	[0.18-0.38] unit decrease	rs2075230	G	0.29	24049095
SHBG	Hormone measurements	5E-19	    .09	[0.070-0.110] unit decrease	rs2075230	G	0.29	24049095
CYP19A1	Hormone measurements	7E-31	    .08	[0.060-0.100] unit decrease	rs2414095	A	0.31	24049095
CYP19A1	Hormone measurements	8E-28	    .11	[0.090-0.130] unit increase	rs2445762	C	0.28	24049095
SMOC1	Tuberculosis	9E-9	   7.14	[NR] 	rs17175227	G	0.98	24057671
GATM	Homoarginine levels	1E-45	    .27	[NR] unit decrease	rs1153858	C	0.72	24047826
RENBP, ARHGAP4, MECP2	Schizophrenia	4E-8	   1.31	[NR] 	rs2269372	A	NR	24043878
PCSK6, VIMP, LOC100507472, CHSY1, SNRPA1	Relative hand skill in reading disability	9E-9	    .37	[0.24-0.50] unit decrease	rs7182874	T	0.71	24068947
SP3, CDCA7	End-stage renal disease in Type 1 diabetics	4E-8	   1.81	[1.47-2.24] 	rs4972593	A	0.14	24029427
COPZ1, NFE2	Mean platelet volume	2E-9	    .09	[NR] unit decrease	rs10506328	C	0.64	24026423
DNM3	Mean platelet volume	2E-8	    .11	[NR] unit increase	rs10914144	T	NR	24026423
TMCC2, CNTN2, RBBP5, RIPK5	Mean platelet volume	3E-13	    .11	[NR] unit increase	rs9660992	A	0.57	24026423
ARHGEF3	Mean platelet volume	9E-34	    .19	[NR] unit decrease	rs1354034	C	0.61	24026423
FLJ36031, PIK3CG	Mean platelet volume	5E-22	    .15	[NR] unit decrease	rs342293	A	0.56	24026423
JMJD1C, NRBF2, REEP3	Mean platelet volume	3E-18	    .13	[NR] unit increase	rs7075195	A	NR	24026423
WDR66, TMEM120B, SETD1B, PSMD9, BCL7A	Mean platelet volume	6E-38	    .31	[NR] unit decrease	rs7961894	T	0.89	24026423
TAOK1	Mean platelet volume	1E-10	    .10	[NR] unit increase	rs9900280	G	0.52	24026423
RCL1	Platelet counts	1E-9	   4.94	[NR] unit increase	rs423955	G	0.66	24026423
ARHGEF3	Platelet counts	6E-24	   7.97	[NR] unit increase	rs1354034	T	0.61	24026423
SH2B3, ATXN2	Platelet counts	5E-11	   5.33	[NR] unit decrease	rs3184504	T	0.5	24026423
HBS1L, MYB	Platelet counts	8E-10	   5.51	[NR] unit decrease	rs9399137	T	NR	24026423
BET1L, PSMD13, SIRT3, RIC8A, ODF3, SCGB1C1	Platelet counts	5E-12	   6.46	[NR] unit decrease	rs11602954	A	0.78	24026423
CACNB4	Adverse response to chemotherapy in breast cancer (alopecia)	2E-9	   2.38	[1.44-3.93] 	rs3820706	G	0.57	24025145
STAM2	Adverse response to chemotherapy in breast cancer (alopecia)	3E-8	   3.61	[2.17-5.98] 	rs16830728	T	0.59	24025145
CETP	Lipid traits	5E-11	   6.57	 unit decrease	rs9989419	A	0.42	24023261
APOC1	Lipid traits	1E-14	    .25	 unit increase	rs4420638	G	0.17	24023261
LPL	Lipid traits	6E-10	   -.24	 unit decrease	rs17482753	T	0.09	24023261
APOE	Lipid traits	3E-53	    .48	[0.42-0.54] unit decrease	rs7412	T	0.12	24023260
APOE	Lipid traits	2E-30	    .09	[0.070-0.110] unit decrease	rs7412	T	0.12	24023260
APOA5	Lipid traits	6E-24	    .14	[0.12-0.16] unit decrease	rs662799	A	0.76	24023260
GCKR	Lipid traits	2E-9	    .08	[0.060-0.100] unit increase	rs780092	A	0.68	24023260
CETP	Lipid traits	3E-9	    .04	[0.020-0.060] unit increase	rs1800775	A	0.4	24023260
SCN1A	Mesial temporal lobe epilepsy with hippocampal sclerosis	4E-8	   1.24	[1.15-1.34] 	rs7587026	A	0.263	24014518
SCN1A	Mesial temporal lobe epilepsy with hippocampal sclerosis	3E-9	   1.42	[1.26-1.59] 	rs7587026	A	0.263	24014518
SOX9, KCNJ2	Adolescent idiopathic scoliosis (severe)	6E-12	   2.21	[1.76-2.77] 	rs12946942	T	0.213	24023777
IL1RL1	Serum protein levels (sST2)	7E-94	    .18	[0.16-0.20] unit decrease	rs950880	A	0.39	23999434
IL1RL1	Serum protein levels (sST2)	2E-39	    .29	[0.25-0.33] unit decrease	rs13029918	G	0.05	23999434
IL1RL1	Serum protein levels (sST2)	1E-35	    .13	[0.11-0.15] unit increase	rs1420103	A	0.23	23999434
SLC9A4	Serum protein levels (sST2)	3E-33	    .11	[0.09-0.13] unit increase	rs1014286	G	0.36	23999434
IL1RL1	Serum protein levels (sST2)	2E-30	    .15	[0.13-0.17] unit increase	rs17639215	A	0.13	23999434
IL1RL1	Serum protein levels (sST2)	2E-27	    .15	[0.13-0.17] unit decrease	rs12999542	C	0.11	23999434
IL1R1	Serum protein levels (sST2)	6E-20	    .14	[0.1-0.18] unit decrease	rs13019803	T	0.11	23999434
IL1RL2	Serum protein levels (sST2)	4E-16	    .13	[0.091-0.169] unit decrease	rs1558648	G	0.12	23999434
IL1RL2	Serum protein levels (sST2)	2E-11	    .08	[0.06-0.1] unit decrease	rs2302612	C	0.17	23999434
IL1RL1	Serum protein levels (sST2)	7E-11	    .08	[0.06-0.1] unit decrease	rs11693697	C	0.22	23999434
IL18RAP	Serum protein levels (sST2)	2E-8	    .14	[0.1-0.18] unit increase	rs11465699	A	0.06	23999434
ATP2B1	Blood pressure	7E-15	    .80	[0.6-1] mm of mercury decrease	rs17249754	A	0.35	24001895
HLA-DPB1, HLA-DPB2, HSD17B8, RING1, COL11A2, RXRB, HLA-DOA, HLA-DPB1*04	Wegener's granulomatosis	2E-50	   4.17	[3.33-5.00] 	rs9277554	C	0.708	23740775
SEMA6A	Wegener's granulomatosis	2E-8	   1.35	[1.22-1.49] 	rs26595	T	0.56	23740775
PIP4K2A	Acute lymphoblastic leukemia (B-cell precursor)	2E-9	   1.23	[1.15-1.32] 	rs10828317	T	0.68	23996088
GATA3	Acute lymphoblastic leukemia (B-cell precursor)	9E-12	   1.31	[1.21-1.41] 	rs3824662	T	0.17	23996088
NCOA3	Osteoarthritis (hip)	2E-10	   1.28	[1.18-1.39] 	rs6094710	A	0.04	23989986
CAMK2B	Osteoarthritis (hip)	8E-10	   1.27	[1.15-1.41] 	rs3757837	C	0.06	23989986
ZNF648, GLUL	Cardiovascular heart disease in diabetics	2E-8	   1.36	[1.22-1.51] 	rs10911021	C	0.679	23982368
HLA-DRB9	Schizophrenia	9E-14	   1.67	[1.63-1.71] 	rs114002140	A	0.763	23974872
C10orf32, AS3MT, CALHM1, CALHM2, CALHM3,CNNM2, CYP17A1, INA, MIR1307, NT5C2, PCGF6, PDCD11, SFXN2, ST13P13, TAF5, USMG5, WBP1L	Schizophrenia	4E-13	   1.11	[1.08-1.14] 	rs7085104	A	0.645	23974872
MAD1L1, FTSJ2, NUDT1, SNX8	Schizophrenia	6E-13	   1.11	[1.08-1.13] 	rs6461049	T	0.571	23974872
MIR137, DPYD	Schizophrenia	2E-12	   1.12	[1.09-1.16] 	rs1198588	T	0.786	23974872
CACNA1C	Schizophrenia	5E-12	   1.10	[1.08-1.13] 	rs1006737	A	0.332	23974872
CACNB2, NSUN6	Schizophrenia	1E-10	   1.16	[1.11-1.21] 	rs17691888	G	0.886	23974872
TSNARE1	Schizophrenia	2E-10	   1.09	[1.06-1.12] 	rs4129585	A	0.439	23974872
Intergenic	Schizophrenia	4E-10	   1.10	[1.07-1.12] 	rs10789369	A	0.383	23974872
SNX19	Schizophrenia	2E-9	   1.09	[1.06-1.12] 	rs7940866	T	0.487	23974872
GRIA1	Schizophrenia	3E-9	   1.24	[1.17-1.31] 	rs17504622	T	0.05	23974872
MAU2, CILP2, GATAD2A, GMIP, HAPLN4, LPAR2, MIR640, NCAN, NDUFA13, PBX4, SUGP1, TM6SF2, TSSK6, YJEFN3	Schizophrenia	3E-9	   1.09	[1.06-1.12] 	rs2905424	T	0.348	23974872
QPCT, C2orf56, CEBPZ, PRKD3, SULT6B1	Schizophrenia	7E-9	   1.09	[1.06-1.11] 	rs2373000	T	0.402	23974872
SLCO6A1	Schizophrenia	9E-9	   1.09	[1.06-1.12] 	rs6878284	C	0.363	23974872
ITIH3, ALAS1, ALDOAP1, BAP1, C3orf78, DNAH1, GLT8D1, GLYCTK, GNL3, ITIH1, ITIH4, MIR135A1, MIRLET7G, MUSTN1, NEK4, NISCH, NT5DC2, PBRM1, PHF7, PPM1M, RFT1, SEMA3G, SFMBT1, SPCS1, STAB1, TLR9, TMEM110, TNNC1, TWF2, WDR82	Schizophrenia	1E-8	   1.09	[1.06-1.11] 	rs4687552	T	0.641	23974872
ZEB2	Schizophrenia	1E-8	   1.08	[1.05-1.11] 	rs12991836	C	0.348	23974872
FONG, C2orf47, C2orf69, SPATS2L, TYW5	Schizophrenia	1E-8	   1.10	[1.07-1.14] 	rs2949006	T	0.192	23974872
TCF4	Schizophrenia	1E-8	   1.08	[1.05-1.11] 	rs4801131	C	0.582	23974872
C2orf82, GIGYF2, KCNJ13, NGEF	Schizophrenia	2E-8	   1.09	[1.06-1.12] 	rs778371	G	0.281	23974872
AKT3, CEP170	Schizophrenia	2E-8	   1.10	[1.07-1.13] 	rs14403	C	0.773	23974872
C12orf65, ABCB9, ARL6IP4, CDK2AP1, MIR4304, MPHOSPH9, OGFOD2, PITPNM2, RILPL2, SBNO1, SETD8	Schizophrenia	2E-8	   1.09	[1.06-1.13] 	rs11532322	A	0.318	23974872
MMP16	Schizophrenia	3E-8	   1.12	[1.08-1.16] 	rs11995572	T	0.135	23974872
ZSWIM6, C5orf43	Schizophrenia	4E-8	   1.08	[1.05-1.11] 	rs171748	A	0.471	23974872
SDCCAG8	Schizophrenia	3E-8	   1.09	[1.06-1.12] 	rs1538774	G	0.74	23974872
Intergenic	Schizophrenia	4E-8	   1.08	[1.05-1.11] 	rs2910032	C	0.469	23974872
CDCA7, SP3	Otitis media (chronic/recurrent)	2E-8	   1.51	[1.30-1.70] 	rs10497394	G	0.637	23974705
ACTN1	Fibrinogen	1E-8	    .01	[0.005-0.009] unit increase	rs434943	A	0.31	23969696
C5orf56, IRF1	Fibrinogen	2E-21	    .02	[0.019-0.027] unit increase	rs11242111	A	0.05	23969696
CD300LF	Fibrinogen	1E-8	    .01	[0.006-0.01] unit decrease	rs10512597	T	0.18	23969696
CHD9	Fibrinogen	1E-10	    .01	[0.006-0.01] unit increase	rs7204230	T	0.7	23969696
CPS1	Fibrinogen	2E-11	    .01	[0.007-0.011] unit increase	rs715	T	0.68	23969696
DIP2B	Fibrinogen	3E-8	    .01	[0.004-0.008] unit increase	rs7968440	A	0.64	23969696
FARP2	Fibrinogen	2E-9	    .01	[0.005-0.009] unit increase	rs1476698	A	0.65	23969696
FGB	Fibrinogen	2E-127	    .03	[0.029-0.033] unit increase	rs1800789, rs4463047, rs4508864	A	0.21	23969696
HGFAC, LRPAP1	Fibrinogen	2E-8	    .02	[0.0091-0.0209] unit increase	rs16844401	A	0.08	23969696
IL1F10, IL1RN	Fibrinogen	6E-19	    .01	[0.007-0.011] unit decrease	rs6734238	A	0.58	23969696
IL1R1, IL1R2	Fibrinogen	3E-8	    .01	[0.004-0.008] unit increase	rs12712127	A	0.41	23969696
IL6R	Fibrinogen	6E-27	    .01	[0.009-0.013] unit decrease	rs4129267	T	0.39	23969696
JMJD1C	Fibrinogen	9E-22	    .01	[0.008-0.012] unit decrease	rs7896783	A	0.48	23969696
LEPR	Fibrinogen	5E-14	    .01	[0.006-0.01] unit increase	rs1938492	A	0.62	23969696
MS4A6A	Fibrinogen	4E-9	    .01	[0.005-0.009] unit decrease	rs1019670	A	0.36	23969696
MSL2,PCCB	Fibrinogen	1E-16	    .01	[0.008-0.012] unit decrease	rs1154988	A	0.78	23969696
NLRP3	Fibrinogen	1E-19	    .01	[0.008-0.012] unit increase	rs10157379	T	0.62	23969696
PLEC1	Fibrinogen	1E-9	    .01	[0.005-0.009] unit decrease	rs7464572	C	0.6	23969696
PSMG1	Fibrinogen	2E-11	    .01	[0.006-0.01] unit decrease	rs4817986	T	0.28	23969696
SHANK3, ARSA, CPT1B	Fibrinogen	3E-8	    .01	[0.006-0.01] unit decrease	rs6010044	A	0.8	23969696
SNx13, PRPS1L1	Fibrinogen	5E-10	    .01	[0.005-0.009] unit decrease	rs10226084	T	0.52	23969696
SPPL2A	Fibrinogen	7E-10	    .01	[0.005-0.009] unit decrease	rs12915708	C	0.3	23969696
TOMM7, IL6	Fibrinogen	7E-9	    .01	[0.004-0.008] unit decrease	rs2286503	T	0.36	23969696
C5orf56, IRF1	Fibrinogen	2E-48	    .02	[0.017-0.021] unit decrease	rs2106854	T	0.21	23969696
APOA1	Infantile hypertrophic pyloric stenosis	2E-10	   1.59	[1.38-1.83] 	rs12721025	A	0.0569	23989729
Intergenic	Infantile hypertrophic pyloric stenosis	3E-21	   1.55	[1.42-1.70] 	rs11712066	A	0.7484	23989729
Intergenic	Infantile hypertrophic pyloric stenosis	5E-14	   1.37	[1.26-1.48] 	rs573872	G	0.2282	23989729
Intergenic	Infantile hypertrophic pyloric stenosis	8E-18	   1.36	[1.27-1.46] 	rs29784	T	0.4504	23989729
RSPO3	Blood pressure	3E-10	    .85	[0.44-1.26] unit increase	rs13209747	T	0.19	23972371
RSPO3	Blood pressure	2E-11	    .56	[0.32-0.80] unit increase	rs13209747	T	0.19	23972371
PLEKHG1	Blood pressure	5E-8	   1.02	[0.53-1.51] unit decrease	rs17080102	C	0.1	23972371
PLEKHG1	Blood pressure	2E-11	    .74	[0.45-1.03] unit decrease	rs17080102	C	0.1	23972371
EVX1, HOXA	Blood pressure	2E-12	   1.20	[0.73-1.67] unit increase	rs17428471	T	0.14	23972371
EVX1, HOXA	Blood pressure	2E-9	    .61	[0.34-0.88] unit increase	rs17428471	T	0.14	23972371
ULK4	Blood pressure	5E-13	    .49	[0.29-0.69] unit increase	rs1717027	T	0.64	23972371
SOX6	Blood pressure	5E-10	    .45	[0.25-0.65] unit increase	rs1401454	T	0.46	23972371
MYNN, TERC	Multiple myeloma	9E-14	   1.26	[1.18-1.33] 	rs10936599	G	0.8	23955597
PSORS1C1, CCHCR1, CDSN, TCF19, POU5F1	Multiple myeloma	1E-10	   1.19	[1.13-1.26] 	rs2285803	A	0.32	23955597
TNFRSF13B	Multiple myeloma	8E-9	   1.26	[1.16-1.36] 	rs4273077	G	0.12	23955597
CBX7	Multiple myeloma	8E-16	   1.23	[1.17-1.29] 	rs877529	A	0.51	23955597
LHX2, DENND1A	Waist circumference	2E-8	    .07	[0.05-0.09] unit decrease	rs2075064	T	0.13	23966867
RREB1	Waist-hip ratio	3E-8	    .06	[0.04-0.08] unit increase	rs6931262	T	0.25	23966867
MIR129, LEP	Type 2 diabetes	3E-13	   1.17	[1.12-1.22] 	rs791595	A	0.08	23945395
GPSM1	Type 2 diabetes	2E-10	   1.15	[1.10-1.20] 	rs11787792	A	0.874	23945395
SLC16A13	Type 2 diabetes	8E-13	   1.20	[1.14-1.26] 	rs312457	G	0.078	23945395
IGF2BP2	Type 2 diabetes	5E-14	   1.19	[1.14-1.24] 	rs1470579	C	0.34	23945395
CDKAL1	Type 2 diabetes	2E-13	   1.18	[1.13-1.23] 	rs7754840	C	0.42	23945395
CDKN2A, CDKN2B	Type 2 diabetes	1E-18	   1.23	[1.18-1.29] 	rs10811661	T	0.55	23945395
TCF7L2	Type 2 diabetes	2E-15	   1.48	[1.34-1.63] 	rs7903146	T	0.04	23945395
HHEX	Type 2 diabetes	2E-8	   1.14	[1.09-1.20] 	rs1111875	C	0.29	23945395
KCNQ1	Type 2 diabetes	4E-29	   1.30	[1.24-1.36] 	rs2237892	C	0.61	23945395
DUSP9	Type 2 diabetes	2E-12	   1.14	[1.10-1.18] 	rs5945326	A	0.68	23945395
CRYGS	Illicit drug use	5E-8	  15.68	[NR]  unit increase	rs1868152	A	0.124	23942779
NAT8	Metabolite levels  (X-11787)	2E-23	    .09	[0.07-0.10] unit increase	rs13538	A	NR	23934736
ALMS1	Metabolite levels  (X-11787)	1E-23	    .09	[0.07-0.10] unit increase	rs6546857	A	0.477	23934736
LOC402233	Metabolite levels (Pyroglutamine)	2E-10	    .14	[0.10-0.18] unit increase	rs10463316	A	0.642	23934736
CTNNA3	Metabolite levels (Pyroglutamine)	5E-8	    .17	[0.11-0.23] unit decrease	rs12251332	C	NR	23934736
ZFHX1B	Myopia (severe)	6E-10	   1.26	[NR] 	rs13382811	T	0.275	23933737
SNTB1	Myopia (severe)	2E-9	   1.27	[NR] 	rs6469937	A	0.764	23933737
RSPO1, SNIP1, RSPO1, GNL2, EPHA10, DNALI1, CDCA8, C1orf109	Axial length	4E-13	    .07	[0.053-0.092] unit increase	rs4074961	T	0.4361	24144296
ZC3H11B, LOC388739, LOC728518	Axial length	1E-11	    .07	[0.051-0.092] unit decrease	rs994767	A	0.4085	24144296
MGC4308, LOC648640, DOC1, C3ORF26, TBC1D23, FILIP1L, COL8A1	Axial length	5E-11	    .08	[0.056-0.104] unit increase	rs9811920	A	0.3975	24144296
LAMA2, ARHGAP18	Axial length	1E-8	    .12	[0.08-0.164] unit increase	rs12193446	A	0.9092	24144296
GJD2, ACTC1	Axial length	4E-11	    .07	[0.047-0.086] unit increase	rs11073058	T	0.4532	24144296
HLA	Celiac disease	5E-21	NR	NR	rs424232	C	NR	23936387
PTPRD	Personality dimensions	3E-8	    .06	[-0.0184-0.1384] unit decrease	rs2146180	G	NR	23903073
GCKR	Glycemic traits (pregnancy)	6E-13	    .00	[NR] unit decrease	rs1260326	T	0.409	23903356
GCKR	Glycemic traits (pregnancy)	6E-11	    .01	[NR] unit decrease	rs1260326	T	0.409	23903356
HKDC1, SUPV3L1, SRGN, VPS26A, HK1	Glycemic traits (pregnancy)	1E-22	    .28	[NR] unit increase	rs4746822	T	0.675	23903356
BACE2, PLAC4, C21orf130, FAM3B	Glycemic traits (pregnancy)	6E-16	    .04	[NR] unit increase	rs6517656	G	0.839	23903356
G6PC2	Glycemic traits (pregnancy)	2E-16	    .01	[NR] unit decrease	rs560887	T	0.291	23903356
PCSK1	Glycemic traits (pregnancy)	5E-15	    .01	[NR] unit decrease	rs6235	G	0.272	23903356
PPP1R3B	Glycemic traits (pregnancy)	5E-15	    .03	[NR] unit decrease	rs4841132	G	0.91	23903356
PPP1R3B	Glycemic traits (pregnancy)	3E-13	    .01	[NR] unit decrease	rs4841132	G	0.91	23903356
MTNR1B	Glycemic traits (pregnancy)	3E-16	    .22	[NR] unit increase	rs7936247	T	0.361	23903356
MTNR1B	Glycemic traits (pregnancy)	2E-12	    .00	[NR] unit increase	rs7936247	T	0.361	23903356
DIRC3	Thyroid cancer	6E-10	   1.25	[1.16-1.34] 	rs6759952	T	0.43	23894154
FOXE1	Thyroid cancer	3E-10	   1.78	[NR] 	rs965513	A	NR	23894154
HLA-B, HLA-C	HIV-1 susceptibility	4E-11	   1.52	 	rs4418214	C	NR	23935489
IL13, RAD50	Atopic dermatitis	2E-17	   1.38	[1.283-1.49] 	rs1295686	A	NR	23886662
CREBL1, TNXB, 	Atopic dermatitis	3E-14	   1.58	[1.405-1.779] 	rs12153855	T	NR	23886662
C11orf30,LRRC32	Atopic dermatitis	4E-13	   1.29	[1.2-1.38] 	rs7130588	G	NR	23886662
FLG	Atopic dermatitis	9E-11	    .34	[0.24-0.44] unit increase	rs6661961	T	NR	23886662
SCN5A	Brugada syndrome	1E-14	   1.73	[1.51-1.99] 	rs11708996	C	0.15	23872634
SCN10A	Brugada syndrome	1E-68	   2.55	[2.30-2.84] 	rs10428132	T	0.41	23872634
HEY2, NCOA7	Brugada syndrome	5E-17	   1.58	[1.42-1.75] 	rs9388451	C	0.50	23872634
IL23R	Crohn's disease	2E-10	   2.06	[1.64-2.58] 	rs76418789	G	0.931	23850713
TBC1D1,KLF3	Crohn's disease	4E-14	   1.43	[1.31-1.57] 	rs6856616	C	0.23	23850713
HLA-DRB5,HLA-DQA1,HLA-DRB1,HLA-DRA,BTNL2	Crohn's disease	3E-12	   1.36	[1.25-1.49] 	rs10947261	T	0.294	23850713
ITPR3, MIF1, IP6K3, LEMD2, MLN	Crohn's disease	1E-8	   1.32	[1.20-1.45] 	rs751728	T	0.733	23850713
RNASET2, FGFR1OP, CCR6, MIR3939	Crohn's disease	8E-12	   1.34	[1.23-1.45] 	rs2149085	T	0.379	23850713
SMNDC1,DUSP5,RP11-525A16.1	Crohn's disease	2E-10	   1.42	[1.28-1.58] 	rs11195128	T	0.152	23850713
STARD10, ATG16L2, FCHSD2	Crohn's disease	7E-9	   1.46	[1.28-1.65] 	rs11235667	G	0.096	23850713
HLA-DRB5,HLA-DQA1,HLA-DRB1,HLA-DRA,BTNL2	Crohn's disease	5E-12	   1.66	[1.44-1.92] 	rs9271366	A	0.888	23850713
ICA1, GLCCI1	Intraocular pressure	1E-8	    .45	[0.29-0.61] unit increase	rs59072263	G	0.88	23836780
MTHFR	Homocysteine levels	4E-104	    .16	[0.14-0.17] unit increase	rs1801133	A	0.34	23824729
MTR	Homocysteine levels	2E-10	    .05	[0.037-0.072] unit decrease	rs2275565	T	0.21	23824729
CPS1	Homocysteine levels	5E-27	    .09	[0.071-0.102] unit increase	rs7422339	A	0.33	23824729
MUT	Homocysteine levels	2E-10	    .04	[0.031-0.059] unit increase	rs9369898	A	0.62	23824729
NOX4	Homocysteine levels	2E-20	    .12	[0.099-0.15] unit decrease	rs7130284	T	0.07	23824729
DPEP1	Homocysteine levels	2E-43	    .10	[0.083-0.11] unit increase	rs154657	A	0.47	23824729
CBS	Homocysteine levels	4E-24	    .07	[0.058-0.086] unit decrease	rs234709	T	0.45	23824729
MMACHC	Homocysteine levels	2E-9	    .04	[0.03-0.057] unit increase	rs4660306	T	0.33	23824729
SLC17A3	Homocysteine levels	1E-8	    .06	[0.04-0.079] unit increase	rs548987	C	0.13	23824729
GTPB10	Homocysteine levels	2E-8	    .04	[0.026-0.053] unit decrease	rs42648	A	0.4	23824729
CUBN	Homocysteine levels	8E-10	    .05	[0.032-0.059] unit increase	rs1801222	A	0.34	23824729
HNF1A	Homocysteine levels	1E-12	    .05	[0.037-0.065] unit decrease	rs2251468	A	0.65	23824729
FUT2	Homocysteine levels	7E-9	    .04	[0.028-0.056] unit increase	rs838133	A	0.45	23824729
MTHFR	Homocysteine levels	3E-21	    .10	[0.079-0.123] unit decrease	rs12134663	A	0.8	23824729
CUBN	Homocysteine levels	8E-10	    .05	[0.035-0.071] unit increase	rs12780845	A	0.65	23824729
NOX4	Homocysteine levels	2E-8	    .05	[0.029-0.061] unit decrease	rs957140	A	0.45	23824729
DPEP1, FANCA	Homocysteine levels	8E-11	    .09	[0.063-0.117] unit decrease	rs12921383	T	0.87	23824729
CBS	Homocysteine levels	2E-12	    .06	[0.04-0.072] unit increase	rs2851391	T	0.47	23824729
APOE	C-reactive protein	2E-21	    .12	[NR] unit increase	rs2075650	G	0.122	23844046
CRP	C-reactive protein	4E-21	    .11	[NR] unit increase	rs16842559	T	0.887	23844046
HNF1A	C-reactive protein	4E-12	    .05	[NR] unit increase	rs1183910	G	0.709	23844046
LEPR	C-reactive protein	9E-9	    .05	[NR] unit increase	rs10889569	T	0.778	23844046
C11orf30, LRRC32	Allergic sensitization	1E-18	   1.18	[1.13-1.22] 	rs2155219	T	0.47	23817571
STAT6	Allergic sensitization	1E-14	   1.30	[1.21-1.39] 	rs1059513	T	0.9	23817571
SLC25A46, TSLP, WDR36, CAMK4	Allergic sensitization	5E-14	   1.20	[1.15-1.28] 	rs10056340	G	0.17	23817571
HLA-DQB1, HLA-DQA1, 	Allergic sensitization	2E-12	   1.15	[1.11-1.2] 	rs6906021	C	0.45	23817571
IL1RL1, IL18R1, IL18RAP	Allergic sensitization	5E-11	   1.20	[1.14-1.28] 	rs3771175	T	0.86	23817571
TLR1,TLR6, TLR10, MIR574, FAM114A1	Allergic sensitization	5E-11	   1.23	[1.18-1.29] 	rs17616434	T	0.78	23817571
LPP, BCL6	Allergic sensitization	3E-10	   1.12	[1.09-1.16] 	rs9865818	G	0.41	23817571
MYC, PVT1	Allergic sensitization	5E-10	   1.14	[1.09-1.19] 	rs4410871	T	0.28	23817571
IL2, ADAD1, KIAA1109, IL21	Allergic sensitization	6E-10	   1.15	[1.1-1.2] 	rs17454584	G	0.26	23817571
HLA-B, MICA, HLA-C, MICB	Allergic sensitization	4E-8	   1.14	[1.09-1.20] 	rs6932730	T	0.82	23817571
IL1RL2, IL1RL1	Self-reported allergy	2E-16	    .14	[0.11-0.18] unit decrease	rs10189629	A	0.1450	23817569
PLCL1	Self-reported allergy	6E-10	    .07	[0.050-0.097] unit increase	rs10497813	G	0.4825	23817569
LPP, BCL6	Self-reported allergy	1E-9	    .07	[0.050-0.098] unit increase	rs9860547	A	0.4629	23817569
TLR1,TLR6,TLR10	Self-reported allergy	5E-21	    .14	[0.11-0.17] unit decrease	rs2101521	A	0.2384	23817569
ADAD1	Self-reported allergy	4E-8	    .07	[0.047-0.099] unit increase	rs17388568	A	0.2748	23817569
DAB2, PTGER4	Self-reported allergy	8E-11	    .08	[0.055-0.102] unit decrease	rs7720838	G	0.4254	23817569
WDR36, CAMK4, TSLP	Self-reported allergy	2E-20	    .11	[0.087-0.134] unit increase	rs1438673	C	0.4951	23817569
HLA-C, MICA	Self-reported allergy	3E-12	    .10	[0.075-0.133] unit increase	rs9266772	C	0.1882	23817569
HLA-DQA1, HLA-DQB1	Self-reported allergy	7E-15	    .09	[0.071-0.118] unit increase	rs6906021	C	0.4749	23817569
RANBP6, IL33	Self-reported allergy	2E-9	    .11	[0.077-0.15] unit increase	rs7032572	G	0.1665	23817569
C11orf30, LRRC32	Self-reported allergy	2E-19	    .11	[0.085-0.132] unit increase	rs2155219	T	0.5146	23817569
SMAD3	Self-reported allergy	1E-8	    .08	[0.052-0.106] unit increase	rs17228058	G	0.2353	23817569
GSDMB, IKZF3	Self-reported allergy	9E-9	    .07	[0.045-0.092] unit decrease	rs9303280	T	0.4805	23817569
NFATC2	Self-reported allergy	7E-9	    .15	[0.10-0.20] unit decrease	rs6021270	C	0.0576	23817569
GATA3	Self-reported allergy	2E-8	    .07	[0.046-0.095] unit decrease	rs962993	T	0.4292	23817569
FOXA1, TTC6	Self-reported allergy	5E-8	    .08	[0.052-0.110] unit increase	rs1998359	G	0.2491	23817569
EXOC1	Cervical cancer	3E-10	   1.28	[1.19-1.38] 	rs13117307	T	0.10	23817570
GSDMB	Cervical cancer	9E-10	   1.19	[1.13-1.26] 	rs8067378	G	0.22	23817570
PRDM16	Migraine	4E-14	   1.09	[1.07-1.11] 	rs2651899	C	0.41	23793025
TSPAN2	Migraine	5E-14	   1.14	[1.10-1.18] 	rs12134493	A	0.12	23793025
MEF2D, APOA1BP	Migraine	1E-8	   1.07	[1.05-1.10] 	rs2274316	C	0.36	23793025
FHL5	Migraine	1E-11	   1.10	[1.07-1.13] 	rs11759769	A	0.22	23793025
c7orf10	Migraine	1E-9	   1.11	[1.08-1.15] 	rs4379368	T	0.11	23793025
TGFBR2	Migraine - clinic-based	2E-8	   1.15	[1.10-1.21] 	rs6790925	T	0.38	23793025
ASTN2	Migraine - clinic-based	1E-9	   1.16	[1.11-1.22] 	rs6478241	A	0.38	23793025
TSPAN2	Migraine without aura	5E-8	   1.18	[1.11-1.26] 	rs12134493	A	0.12	23793025
FHL5	Migraine without aura	2E-12	   1.18	[1.13-1.24] 	rs11759769	A	0.22	23793025
ACTA2, FAS	Chronic lymphocytic leukemia	1E-14	   1.27	[1.19-1.33] 	rs4406737	G	0.57	23770605
BCL2	Chronic lymphocytic leukemia	3E-12	   1.47	[1.32-1.61] 	rs4987855	G	0.91	23770605
TSPAN32	Chronic lymphocytic leukemia	2E-10	   1.20	[1.13-1.27] 	rs7944004	T	0.49	23770605
LEF1	Chronic lymphocytic leukemia	4E-10	   1.20	[1.14-1.27] 	rs898518	A	0.59	23770605
CASP10, CASP8	Chronic lymphocytic leukemia	3E-9	   1.19	[1.12-1.25] 	rs3769825	T	0.45	23770605
CDKN2B, AS1	Chronic lymphocytic leukemia	1E-8	   1.19	[1.12-1.27] 	rs1679013	C	0.52	23770605
PMAIP1	Chronic lymphocytic leukemia	3E-8	   1.19	[1.12-1.27] 	rs4368253	C	0.69	23770605
ACOXL, BCL2L11	Chronic lymphocytic leukemia	2E-18	   1.41	[1.30-1.52] 	rs13401811	G	0.81	23770605
ODF1, KLF10	Chronic lymphocytic leukemia	5E-8	   1.19	[1.12-1.27] 	rs2511714	G	0.41	23770605
ACOXL	Chronic lymphocytic leukemia	4E-17	   1.37	[NR] 	rs17483466	G	0.2	23770605
SP140	Chronic lymphocytic leukemia	1E-22	   1.45	[NR] 	rs13397985	G	0.18	23770605
IRF4	Chronic lymphocytic leukemia	6E-20	   1.33	[NR] 	rs872071	G	0.51	23770605
HLA	Chronic lymphocytic leukemia	2E-10	   1.24	[NR] 	rs9273363, rs674313, rs9273012	A	0.27	23770605
BAK1	Chronic lymphocytic leukemia	5E-8	   1.22	[NR] 	rs210142	C	0.72	23770605
MYC	Chronic lymphocytic leukemia	2E-8	   1.21	[NR] 	rs2466035, rs2456449, rs2466032	C	0.31	23770605
SCN3B	Chronic lymphocytic leukemia	4E-39	   1.62	[NR] 	rs735665	A	0.19	23770605
MNS1, RFXDC2	Chronic lymphocytic leukemia	2E-13	   1.41	[NR] 	rs11636802, rs7169431	G	0.11	23770605
RPLP1	Chronic lymphocytic leukemia	1E-17	   1.32	[NR] 	rs7176508	A	0.39	23770605
IRF8	Chronic lymphocytic leukemia	5E-17	   1.33	[NR] 	rs391023, rs2292982, rs305061	G	0.63	23770605
TMEM161B, MEF2C	Retinal arteriolar caliber	2E-12	   1.60	[1.15-2.05] unit decrease	rs2194025	G	0.91	23776548
SFRS2,MFSD11,JMJD6,MXRA7	Retinal arteriolar caliber	2E-10	    .86	[0.61-1.11] unit decrease	rs3744061	G	0.44	23776548
BCL6, LPP	B cell non-Hodgkin lymphoma	3E-13	   1.44	[1.31-1.59] 	rs6773854	C	0.21	23749188
VEGFA	Sexual dimorphism in anthropometric traits	2E-11	NR	NR	rs1358980	T	NR	23754948
COBLL1, SNORA70F, GRB14	Sexual dimorphism in anthropometric traits	6E-16	NR	NR	rs6717858	T	NR	23754948
LYPLAL1, SLC30A10, ZC3H11B	Sexual dimorphism in anthropometric traits	7E-16	NR	NR	rs2820443	T	NR	23754948
H19, MIR675	DNA methylation (parent-of-origin)	5E-16	NR	NR	rs4930103	A	0.49	23725790
TERF1P3	DNA methylation (parent-of-origin)	2E-8	NR	NR	rs10012307	T	0.06	23725790
RPL26P31	DNA methylation (parent-of-origin)	2E-9	NR	NR	rs7931462	G	0.02	23725790
Intergenic	DNA methylation (parent-of-origin)	2E-9	NR	NR	rs10497324	A	0.04	23725790
Intergenic	DNA methylation (parent-of-origin)	5E-8	NR	NR	rs13135284	C	0.26	23725790
Intergenic	DNA methylation (parent-of-origin)	1E-9	NR	NR	rs10934011	G	0.21	23725790
H19	DNA methylation (variation)	1E-14	NR	NR	rs4930103	G	0.397	23725790
FAM190A	DNA methylation (variation)	3E-8	NR	NR	rs11933531	A	0.04	23725790
GNAS, GNAS-AS1	DNA methylation (variation)	5E-9	NR	NR	rs965808	G	0.22	23725790
GRM4	Osteosarcoma	8E-9	   1.57	[1.35-1.83] 	rs1906953	A	NR	23727862
Intergenic	Osteosarcoma	1E-8	   1.39	[1.23-1.54] 	rs7591996	C	NR	23727862
LOC100129158	Educational attainment	4E-10	    .10	[NR] unit increase	rs9320913	A	0.483	23722424
LOC150577	Educational attainment	5E-11	   1.05	[NR] 	rs4851266	T	0.396	23722424
BTN1A1	Educational attainment	2E-8	    .09	[NR] unit increase	rs1056667	T	0.538	23722424
GBX2	Educational attainment	3E-8	    .11	[NR] unit increase	rs11687170	T	0.770	23722424
TANK	Educational attainment	4E-8	    .09	[NR] unit decrease	rs7309	A	0.476	23722424
CD36	HDL cholesterol	6E-10	    .03	[NR] unit increase	rs2366858	C	0.173	23726366
PPP1R3B	HDL cholesterol	7E-9	    .04	[NR] unit decrease	rs1461729	T	0.116	23726366
LPL	HDL cholesterol	1E-8	    .02	[NR] unit increase	rs326	T	0.469	23726366
CETP	HDL cholesterol	1E-44	    .06	[NR] unit increase	rs247617	A	0.262	23726366
LOC55908	HDL cholesterol	2E-9	    .02	[NR] unit decrease	rs12979813	T	0.495	23726366
APOA,APOC	HDL cholesterol	3E-12	    .05	[NR] unit decrease	rs964184	G	0.248	23726366
CETP	HDL cholesterol	3E-16	    .05	[NR] unit increase	rs247617	C	0.298	23726366
APOA, APOC	HDL cholesterol	1E-12	    .41	[NR] unit increase	SNP11-116799496	1	.0016	23726366
PCSK9	LDL cholesterol	2E-17	   9.01	[NR] unit decrease	rs17111684	A	0.12	23726366
APOB	LDL cholesterol	4E-8	   4.86	[NR] unit decrease	rs12713956	G	0.183	23726366
ABCG8	LDL cholesterol	1E-9	   5.97	[NR] unit increase	rs4245791	G	0.143	23726366
LDLR	LDL cholesterol	2E-17	  32.93	[NR] unit decrease	rs17249141	T	0.0126	23726366
APOE	LDL cholesterol	2E-21	   6.77	[NR] unit increase	rs1160985	C	0.365	23726366
GCKR	Triglycerides	1E-8	    .07	[NR] unit increase	rs4665972	T	0.123	23726366
LPL	Triglycerides	1E-8	    .04	[NR] unit decrease	rs326	T	0.469	23726366
APOA,APOC	Triglycerides	5E-14	    .21	[NR] unit increase	rs6589566	C	0.0176	23726366
APOC1	Triglycerides	3E-19	    .10	[NR] unit decrease	rs12721054	G	0.1137	23726366
GCKR	Triglycerides	7E-9	    .07	[NR] unit increase	rs780094	C	0.358	23726366
LPL	Triglycerides	7E-9	    .11	[NR] unit decrease	rs17410962	G	0.112	23726366
APOA, APOC	Triglycerides	4E-33	    .16	[NR] unit increase	rs964184	G	0.248	23726366
CCDC27, LOC388588, LRRC47, KIAA0562, DFFB	Blood trace element (Cu levels)	5E-10	    .20	[0.14-0.26] unit decrease	rs1175550	A	NR	23720494
SELENBP1, PSMB4, POGZ	Blood trace element (Cu levels)	3E-20	    .31	[0.25-0.38] unit increase	rs2769264	G	NR	23720494
DMGDH, BHMT2, BHMT	Blood trace element (Se levels)	9E-28	    .25	[0.20-0.29] unit increase	rs921943	T	NR	23720494
CA1, CA2, CA3, CA13	Blood trace element (Zn levels)	6E-12	    .18	[0.13-0.23] unit increase	rs1532423	A	NR	23720494
SCAMP5, PPCDC	Blood trace element (Zn levels)	2E-18	    .29	[0.22-0.35] unit decrease	rs2120019	C	NR	23720494
KLF8, ZXDA, ZXDB	Blood trace element (Zn levels)	1E-12	    .21	[0.15-0.27] unit increase	rs4826508	T	NR	23720494
STX18, MSX1, LOC100507266	Congenital heart disease	3E-10	   1.46	[NR] 	rs870142	A	0.228	23708191
TBX15, SPAG17	Congenital heart malformation	8E-10	   1.40	[1.26-1.56] 	rs2474937	C	0.08	23708190
MAML3	Congenital heart malformation	5E-12	   1.40	[1.27-1.54] 	rs1531070	A	0.11	23708190
ABO	Malaria	9E-10	   1.28	[1.19-1.39] 	rs8176722	A	NR	23717212
HBB	Malaria	2E-16	   2.15	[1.79-2.59] 	rs12788102	A	NR	23717212
NA	Primary tooth development (number of teeth)	3E-8	    .14	[0.092-0.194] unit increase	rs10932688	G	NR	23704328
CALU, OPN1SW	Primary tooth development (number of teeth)	4E-9	    .14	[0.097-0.191] unit increase	rs1799922	T	NR	23704328
CACNB2	Primary tooth development (number of teeth)	2E-9	    .14	[0.096-0.186] unit increase	rs10740993	C	NR	23704328
ADK, VCL, AP3M1	Primary tooth development (number of teeth)	8E-16	    .19	[0.15-0.24] unit increase	rs7924176	A	NR	23704328
MSRB3	Primary tooth development (number of teeth)	2E-9	    .15	[0.1-0.198] unit increase	rs12229918	C	NR	23704328
HMGA2	Primary tooth development (number of teeth)	1E-10	    .18	[0.13-0.24] unit increase	rs17101923	G	NR	23704328
DLEU7	Primary tooth development (number of teeth)	3E-8	    .13	[0.086-0.18] unit increase	rs9316505	A	NR	23704328
AJUBA, C14orf93	Primary tooth development (number of teeth)	3E-8	    .15	[0.097-0.203] unit increase	rs997154	G	NR	23704328
IGF2BP1	Primary tooth development (number of teeth)	7E-16	    .19	[0.14-0.24] unit increase	rs1994969	T	NR	23704328
KCNJ2, KCNJ16	Primary tooth development (number of teeth)	2E-19	    .22	[0.17-0.27] unit increase	rs8080944	A	NR	23704328
FAM155E, EDA	Primary tooth development (number of teeth)	7E-19	    .20	[0.16-0.24] unit increase	rs11796357	G	NR	23704328
NA	Primary tooth development (time to first tooth eruption)	2E-10	    .19	[0.13-0.25] unit decrease	rs6568401	C	NR	23704328
ADK, VCL, AP3M1	Primary tooth development (time to first tooth eruption)	2E-8	    .17	[0.11-0.22] unit decrease	rs7924176	A	NR	23704328
CDON	Primary tooth development (time to first tooth eruption)	4E-8	    .15	[0.097-0.203] unit decrease	rs4937076	A	NR	23704328
MSRB3	Primary tooth development (time to first tooth eruption)	7E-14	    .22	[0.16-0.27] unit decrease	rs12229918	C	NR	23704328
HMGA2	Primary tooth development (time to first tooth eruption)	6E-11	    .21	[0.15-0.28] unit decrease	rs17101923	G	NR	23704328
BMP4	Primary tooth development (time to first tooth eruption)	9E-17	    .24	[0.18-0.3] unit decrease	rs17563	G	NR	23704328
IGF2BP1	Primary tooth development (time to first tooth eruption)	2E-14	    .03	[-0.02592-0.07992] unit decrease	rs1994969	T	NR	23704328
TEX14, RAD51C	Primary tooth development (time to first tooth eruption)	2E-9	    .16	[0.11-0.22] unit decrease	rs412000	C	NR	23704328
KCNJ2, KCNJ16	Primary tooth development (time to first tooth eruption)	8E-34	    .34	[0.29-0.4] unit decrease	rs8080944	A	NR	23704328
FAM155E, EDA	Primary tooth development (time to first tooth eruption)	3E-22	    .25	[0.2-0.3] unit decrease	rs11796357	G	NR	23704328
NA	Red blood cell traits	5E-9	    .30	[0.20-0.40] unit increase	rs7120391	C	0.12	23696099
ITFG3	Red blood cell traits	5E-29	   3.57	[2.94-4.20] fL decrease	rs9924561	T	0.10	23696099
ITFG3	Red blood cell traits	8E-36	   1.56	[1.32-1.80] pg decrease	rs9924561	T	0.10	23696099
ITFG3	Red blood cell traits	9E-17	    .47	[0.35-0.59] unit decrease	rs9924561	T	0.10	23696099
G6PD	Red blood cell traits	4E-13	    .20	[0.14-0.26] x10^12/L decrease	rs1050828	A	0.12	23696099
G6PD	Red blood cell traits	1E-14	   2.46	[1.83-3.09] fL increase	rs1050828	A	0.12	23696099
G6PD	Red blood cell traits	9E-9	    .72	[0.48-0.96] pg increase	rs1050828	A	0.12	23696099
KCNN2	Coronary arterial lesions in patients with Kawasaki disease	2E-8	  12.60	[4.13-38.5] 	rs17136627	A	0.008	23677057
SLC26A9	Cystic fibrosis-related diabetes	1E-9	   1.39	[1.25-1.54] 	rs4077468	A	0.58	23670970
C17orf47,TEX14, PPM1E, RAD51C, SEPT4, TRIM37, SKA2	Testicular germ cell tumor	4E-13	   1.27	[1.18-1.33] 	rs9905704	T	0.68	23666239
MAD1L1	Testicular germ cell tumor	6E-9	   1.21	[1.14-1.29] 	rs12699477	C	0.38	23666239
RFWD3, GLG1, MLKL	Testicular germ cell tumor	5E-12	   1.26	[1.18-1.34] 	rs4888262	C	0.458	23666239
HPGDS, SMARCAD1	Testicular germ cell tumor	1E-8	   1.19	[1.12-1.26] 	rs17021463	T	0.42	23666239
SPRY4	Testicular germ cell tumor	8E-10	   1.64	[1.39-1.89] 	rs4624820	G	NR	23666239
KITLG	Testicular germ cell tumor	3E-13	   2.33	[1.85-2.94] 	rs995030	A	NR	23666239
TMEM18	Body mass index	3E-17	    .10	[0.076-0.124] unit decrease	rs12463617	A	0.15	23669352
POMC	Body mass index	5E-8	    .06	[0.035-0.075] unit decrease	rs1561288	T	0.22	23669352
GNPDA2	Body mass index	6E-9	    .05	[0.032-0.068] unit increase	rs13130484	T	0.43	23669352
FTO	Body mass index	4E-23	    .08	[0.067-0.099] unit increase	rs9940128	A	0.44	23669352
TNNI3K	Body mass index	3E-11	    .06	[0.042-0.078] unit increase	rs1514175	A	0.43	23669352
SEC16B	Body mass index	4E-11	    .08	[0.059-0.103] unit increase	rs543874	G	0.19	23669352
PMAIP1, MC4R	Body mass index	4E-17	    .08	[0.061-0.101] unit increase	rs7234864	T	0.26	23669352
SLC25A44	Testicular germ cell tumor	3E-8	   1.19	[1.08-1.30] 	rs2072499	G	0.35	23666240
UCK2	Testicular germ cell tumor	2E-8	   1.20	[1.09-1.33] 	rs3790672	C	0.28	23666240
DAZL	Testicular germ cell tumor	1E-8	   1.24	[1.12-1.37] 	rs10510452	A	0.69	23666240
CENPE	Testicular germ cell tumor	2E-10	   1.24	[1.12-1.36] 	rs2720460	A	0.61	23666240
CATSPER3,PITX1	Testicular germ cell tumor	2E-8	   1.25	[1.13-1.38] 	rs3805663	T	0.63	23666240
PRDM14	Testicular germ cell tumor	5E-8	   1.22	[1.11-1.34] 	rs7010162	G	0.61	23666240
HEATR3	Testicular germ cell tumor	4E-9	   1.32	[1.17-1.48] 	rs8046148	G	0.79	23666240
RAD51C,TEX14	Testicular germ cell tumor	3E-9	   1.21	[1.10-1.34] 	rs9905704	T	0.67	23666240
MCM3AP	Testicular germ cell tumor	1E-9	   1.26	[1.15-1.38] 	rs2839186	T	0.46	23666240
TERT,CLPTM1L	Testicular germ cell tumor	5E-24	   1.39	[1.25-1.54] 	rs4635969	T	0.2	23666240
SPRY4	Testicular germ cell tumor	3E-31	   1.52	[1.38-1.67] 	rs4624820	A	0.54	23666240
BAK1	Testicular germ cell tumor	2E-24	   1.44	[1.30-1.61] 	rs210138	G	0.19	23666240
DMRT1	Testicular germ cell tumor	2E-26	   1.38	[1.25-1.52] 	rs755383	T	0.63	23666240
ATF7IP	Testicular germ cell tumor	1E-13	   1.32	[1.20-1.46] 	rs2900333	C	0.62	23666240
KITLG	Testicular germ cell tumor	2E-50	   2.26	[1.95-2.61] 	rs995030	G	0.8	23666240
TLR10,TLR1,FAM114A1,TLR6,KLF3	Helicobacter pylori serologic status	1E-18	   1.43	[1.32-1.54] 	rs10004195	A	0.75	23652523
FCGR2A,HSPA6	Helicobacter pylori serologic status	2E-8	   1.37	[1.23-1.54] 	rs368433	C	0.84	23652523
F5	Venous thromboembolism	4E-51	   2.07	[1.89-2.28] 	rs6427196	C	0.93	23650146
ABO	Venous thromboembolism	2E-52	   1.55	[1.47-1.64] 	rs687621	G	0.65	23650146
F11	Venous thromboembolism	3E-14	   1.24	[1.17-1.31] 	rs4253399	G	0.61	23650146
FGG	Venous thromboembolism	2E-13	   1.25	[1.18-1.32] 	rs6536024	C	0.42	23650146
SLC39A6	Esophageal squamous cell cancer (length of survival)	4E-8	   1.30	[1.19-1.43] 	rs1050631	T	0.18	23644492
KIAA1005	Vitiligo (non-segmental)	6E-11	   2.77	[2.04-3.76] 	rs3213758	A	.497	23678272
ARMS2, HTRA, PLEKHA1, BTBD16,	Age-related macular degeneration	8E-27	   2.28	[1.96-2.65] 	rs10490924	A	0.35	23577725
ARMS2,HTRA1,PLEKHA1,BTBD16	Age-related macular degeneration (extreme sampling)	3E-29	   3.12	[2.55-3.80] 	rs3750848	C	0.37	23577725
FGF21	Dietary macronutrient intake	4E-10	    .22	[0.14-0.3] % decrease	rs838145	G	0.46	23636237
FTO	Dietary macronutrient intake	1E-9	    .10	[0.061-0.139] % increase	rs1421085	C	0.42	23636237
PKHD1	Weight loss (gastric bypass surgery)	5E-8	  10.90	 unit decrease	rs728996, rs2894788, rs6458777, rs4715233, rs9296661, rs1326589	S	0.39	23633212
SLAMF6	Graves' disease	2E-18	   1.34	[1.25-1.43] 	rs1265883	C	0.1	23612905
TG,WISP1,SLA	Graves' disease	8E-9	   1.16	[1.10-1.22] 	rs2294025	T	0.19	23612905
CAMK1G	Amyotrophic lateral sclerosis	3E-8	   1.31	[NR] 	rs6703183	A	0.3416	23624525
CABIN1, SUSD2, GGT5	Amyotrophic lateral sclerosis	2E-9	   1.52	[NR] 	rs8141797	G	0.1026	23624525
C17orf71	Circulating myeloperoxidase levels (plasma)	3E-12	    .06	[0.040-0.080] unit decrease	rs6503905	A	0.37	23620142
MPO, RNF43, PPM1E	Circulating myeloperoxidase levels (plasma)	4E-9	    .07	[0.050-0.090] unit decrease	rs12940923	A	0.84	23620142
CFH	Circulating myeloperoxidase levels (serum) 	5E-41	    .15	[0.13-0.17] unit decrease	rs800292	A	0.23	23620142
NOTCH4,C2,HLA	Circulating myeloperoxidase levels (serum) 	1E-8	    .05	[0.030-0.070] unit decrease	rs3134931	T	0.73	23620142
SIRPB2	Circulating myeloperoxidase levels (serum) 	4E-8	    .09	[0.051-0.129] unit decrease	rs6042507	A	0.11	23620142
UGT1A	Bilirubin levels	9E-20	NR	NR	rs887829	T	0.312	23642732
ZNF483	Menarche (age at onset)	4E-15	   2.78	[4.31-5.94] unit decrease	rs10441737	T	.64	23599027
LRRC34	Interstitial lung disease 	8E-13	   1.30	[1.19-1.42] 	rs6793295	C	0.26	23583980
FAM13A	Interstitial lung disease 	2E-11	   1.29	[1.18-1.42] 	rs2609255	G	0.21	23583980
TERT	Interstitial lung disease 	2E-19	   1.37	[1.27-1.49] 	rs2736100	A	0.49	23583980
DSP	Interstitial lung disease 	1E-19	   1.43	[1.32-1.55] 	rs2076295	G	0.44	23583980
Intergenic	Interstitial lung disease 	1E-8	   1.30	[1.20-1.41] 	rs4727443	C	0.39	23583980
OBFC1	Interstitial lung disease 	2E-8	   1.25	[1.15-1.35] 	rs11191865	A	0.49	23583980
MUC2	Interstitial lung disease 	7E-34	   1.52	[1.40-1.65] 	rs7934606	T	0.42	23583980
ATP11A	Interstitial lung disease 	7E-9	   1.27	[1.14-1.39] 	rs1278769	G	0.76	23583980
Intergenic	Interstitial lung disease 	1E-11	   1.30	[1.19-1.41] 	rs2034650	A	0.51	23583980
MAPT	Interstitial lung disease 	9E-14	   1.41	[1.28-1.56] 	rs1981997	G	0.77	23583980
DPP9	Interstitial lung disease 	2E-12	   1.29	[1.18-1.41] 	rs12610495	G	0.29	23583980
SEC16B	Body mass index	2E-13	    .06	[0.044-0.076] unit increase	rs543874	G	0.25	23583978
ADCY3	Body mass index	4E-8	    .05	[0.029-0.065] unit increase	rs7586879	T	0.34	23583978
GNPDA2	Body mass index	2E-10	    .05	[0.035-0.067] unit increase	rs348495	G	0.34	23583978
FTO	Body mass index	1E-10	    .07	[0.051-0.095] unit increase	rs17817964	T	0.12	23583978
GALNT10	Body mass index	5E-14	    .02	[0.012-0.030] unit increase	rs7708584	A	0.42	23583978
MIR148A, NFE2L3	Body mass index	1E-10	    .03	[0.022-0.042] unit increase	rs10261878	C	0.94	23583978
MYH6	Heart rate	5E-45	    .56	[0.47-0.66] unit increase	rs365990	G	0.353	23583979
GJA1	Heart rate	1E-33	    .71	[0.57-0.85] unit increase	rs1015451	C	0.102	23583979
ACHE	Heart rate	8E-27	    .45	[0.34-0.55] unit increase	rs13245899	G	0.195	23583979
CD46	Heart rate	4E-26	    .61	[0.48-0.75] unit increase	rs11118555	A	0.124	23583979
FADS1	Heart rate	1E-22	    .36	[0.27-0.45] unit increase	rs174549	A	0.31	23583979
SLC35F1	Heart rate	8E-21	    .38	[0.29-0.47] unit increase	rs11153730	T	0.509	23583979
LINC00477,C12orf67	Heart rate	3E-20	    .44	[0.32-0.57] unit increase	rs17287293	A	0.85	23583979
KIAA1755	Heart rate	5E-29	    .43	[0.34-0.52] unit increase	rs6127471	C	0.54	23583979
CCDC141	Heart rate	4E-26	    .74	[0.59-0.89] unit increase	rs17362588	A	0.114	23583979
SYT10	Heart rate	6E-24	    .38	[0.29-0.47] unit increase	rs7980799	A	0.401	23583979
HCN4	Heart rate	4E-20	    .51	[0.40-0.63] unit increase	rs4489968	T	0.843	23583979
GNB4	Heart rate	2E-14	    .36	[0.24-0.48] unit increase	rs7612445	G	0.816	23583979
FLRT2	Heart rate	3E-13	    .33	[0.24-0.43] unit increase	rs17796783	T	0.716	23583979
CHRM2	Heart rate	1E-12	    .51	[0.35-0.66] unit increase	rs2350782	C	0.116	23583979
NKX2-5	Heart rate	2E-12	    .30	[0.20-0.40] unit increase	rs6882776	G	0.68	23583979
GNG11	Heart rate	7E-12	    .32	[0.21-0.42] unit increase	rs180242	T	0.333	23583979
B3GNT7	Heart rate	1E-10	    .30	[0.20-0.40] unit increase	rs13030174	A	0.733	23583979
FNDC3B	Heart rate	1E-9	    .21	[0.11-0.30] unit increase	rs9647379	C	0.4	23583979
RFX4	Heart rate	2E-9	    .28	[0.19-0.36] unit increase	rs2067615	A	0.49	23583979
CPNE8	Heart rate	4E-9	    .23	[0.15-0.32] unit increase	rs826838	C	0.443	23583979
TFPI	Heart rate	5E-8	    .22	[0.12-0.31] unit increase	rs4140885	A	0.317	23583979
GJA1	Heart rate	7E-12	    .32	[0.22-0.42] unit increase	rs11154027	C	0.567	23583979
GJA1	Heart rate	1E-8	    .74	[0.49-0.99] unit increase	rs17083533	A	0.077	23583979
CD34	Heart rate	4E-10	    .51	[0.39-0.63] unit increase	rs11578508	A	0.665	23583979
GCK	Glycemic traits	5E-18	    .06	[0.049-0.077] mmol-1 increase	rs1799884	A	NR	23575436
MTNR1B	Glycemic traits	5E-13	    .04	[0.029-0.053] mmol-1 increase	rs10830962	C	NR	23575436
C12orf51	Glycemic traits	6E-14	    .06	[0.045-0.077] mmol-1 decrease	rs2074356	T	NR	23575436
CDKAL1	Glycemic traits	3E-19	    .25	[0.19-0.30] mmol-1 increase	rs9348440	A	NR	23575436
GCK	Glycemic traits	3E-9	    .21	[0.14-0.28] mmol-1 increase	rs1799884	A	NR	23575436
MTNR1B	Glycemic traits	3E-12	    .19	[0.14-0.24] mmol-1 increase	rs10830962	C	NR	23575436
MYL2	Glycemic traits	9E-13	    .28	[0.20-0.35] mmol-1 decrease	rs12229654	G	NR	23575436
C12orf51	Glycemic traits	1E-16	    .32	[0.24-0.40] mmol-1 decrease	rs2074356	T	NR	23575436
OAS1	Glycemic traits	5E-9	    .24	[0.16-0.32] mmol-1 decrease	rs11066453	G	NR	23575436
GCK	Glycemic traits	3E-10	    .16	[0.11-0.21] mmol-1 increase	rs1799884	A	NR	23575436
C12orf51	Glycemic traits	6E-9	    .17	[0.11-0.22] mmol-1 decrease	rs2074356	T	NR	23575436
ABCA7, HMHA1, GRIN3B	Alzheimer's disease (late onset)	2E-9	   1.79	[1.47-2.12] 	rs115550680	G	0.07	23571587
LEKR1, CCNL1	Adiposity in newborns	6E-21	    .06	[0.036-0.076] mm increase	rs1482853	C	0.620	23575227
LEKR1, CCNL1	Adiposity in newborns	3E-13	    .47	[0.28-0.66] % increase	rs1482853	C	0.620	23575227
MEF2C	Bone mineral density	9E-9	    .20	[0.12-0.28] unit decrease	rs11951031	T	0.06	23572186
FTO	Body mass index	2E-51	   1.35	[NR] 	rs11075990	G	0.4	23563607
MC4R	Body mass index	4E-21	   1.24	[NR] 	rs8089364	C	0.27	23563607
TMEM18	Body mass index	6E-15	   1.26	[NR] 	rs2903492	A	0.83	23563607
NEGR1	Body mass index	2E-14	   1.16	[NR] 	rs2568958	A	0.6	23563607
GNPDA2	Body mass index	2E-13	   1.16	[NR] 	rs10938397	G	0.43	23563607
SEC16B	Body mass index	5E-12	   1.21	[NR] 	rs633715	C	0.19	23563607
TFAP2B	Body mass index	2E-11	   1.20	[NR] 	rs987237	G	0.18	23563607
BDNF	Body mass index	6E-10	   1.18	[NR] 	rs2030323	C	0.79	23563607
LOC144233	Body mass index	2E-9	   1.13	[NR] 	rs7138803	A	0.38	23563607
ETV5	Body mass index	4E-8	   1.21	[NR] 	rs1516725	C	0.86	23563607
IGFBP4	Height	5E-12	   1.18	[NR] 	rs584438	C	0.62	23563607
H6PD	Height	3E-10	   1.23	[NR] 	rs6662509	T	0.15	23563607
RSRC1,SHOX2	Height	2E-9	   1.12	[NR] 	rs2362965	T	0.5	23563607
PPP2R2A	Height	4E-8	   1.15	[NR] 	rs1594829	C	0.77	23563607
ZBTB38	Height	4E-47	   1.33	[NR] 	rs1991431	A	0.44	23563607
GDF5	Height	8E-37	   1.31	[NR] 	rs224333	A	0.36	23563607
HMGA2	Height	7E-32	   1.26	[NR] 	rs1351394	T	0.49	23563607
CDK6	Height	1E-28	   1.28	[NR] 	rs42235	T	0.3	23563607
HIST1H2BF	Height	1E-25	   1.26	[NR] 	rs806794	A	0.7	23563607
DLEU7	Height	2E-24	   1.26	[NR] 	rs3118906	G	0.72	23563607
MTMR11	Height	4E-23	   1.25	[NR] 	rs11205303	C	0.38	23563607
AMZ1	Height	4E-23	   1.24	[NR] 	rs798554	C	0.68	23563607
LCORL	Height	3E-22	   1.38	[NR] 	rs6845078	C	0.85	23563607
HHIP	Height	4E-21	   1.33	[NR] 	rs7689420	C	0.84	23563607
GPR126	Height	1E-20	   1.24	[NR] 	rs7741741	T	0.72	23563607
ADAMTSL3	Height	1E-19	   1.19	[NR] 	rs11259933	A	0.51	23563607
C17orf82	Height	1E-18	   1.20	[NR] 	rs2079795	T	0.32	23563607
PRKG2	Height	4E-18	   1.20	[NR] 	rs1878528	G	0.33	23563607
BMP2	Height	5E-18	   1.20	[NR] 	rs2145270	C	0.37	23563607
BMP6	Height	5E-17	   1.18	[NR] 	rs1885486	A	0.48	23563607
C6orf173	Height	1E-16	   1.18	[NR] 	rs1490384	T	0.49	23563607
C5orf23	Height	2E-16	   1.18	[NR] 	rs9292468	T	0.4	23563607
SPAG17	Height	2E-16	   1.22	[NR] 	rs7534091	A	0.74	23563607
PCSK5	Height	4E-16	   1.48	[NR] 	rs11144688	G	0.89	23563607
FNDC3B	Height	4E-16	   1.18	[NR] 	rs4535251	T	0.5	23563607
EFEMP1	Height	8E-16	   1.22	[NR] 	rs3791679	A	0.77	23563607
PROCR	Height	1E-15	   1.17	[NR] 	rs8114671	C	0.56	23563607
ACAN	Height	1E-15	   1.18	[NR] 	rs2280470	A	0.33	23563607
CABLES1	Height	5E-15	   1.18	[NR] 	rs11082304	T	0.5	23563607
HMGA1	Height	5E-15	   1.29	[NR] 	rs1759645	C	0.16	23563607
MFAP2	Height	5E-15	   1.17	[NR] 	rs2284746	G	0.52	23563607
FRS2	Height	7E-15	   1.19	[NR] 	rs10748128	T	0.35	23563607
PXMP4	Height	1E-14	   1.21	[NR] 	rs1074683	C	0.76	23563607
CSH1	Height	3E-14	   1.19	[NR] 	rs2941551	G	0.27	23563607
JAZF1	Height	8E-14	   1.18	[NR] 	rs1029534	T	0.31	23563607
ATAD5	Height	9E-14	   1.16	[NR] 	rs3764419	C	0.61	23563607
CENPO,ADCY3,POMC	Height	1E-13	   1.19	[NR] 	rs11895026	A	0.24	23563607
GLT25D2	Height	2E-13	   1.17	[NR] 	rs3814333	T	0.33	23563607
RYBP	Height	5E-13	   1.15	[NR] 	rs9832740	G	0.49	23563607
L3MBTL3	Height	5E-13	   1.19	[NR] 	rs1415701	G	0.73	23563607
C14orf39	Height	8E-13	   1.16	[NR] 	rs2093210	C	0.42	23563607
C6orf106	Height	8E-13	   1.26	[NR] 	rs2744971	G	0.15	23563607
GHSR	Height	1E-12	   1.17	[NR] 	rs572169	T	0.31	23563607
DOT1L	Height	2E-12	   1.15	[NR] 	rs11880992	A	0.39	23563607
RFT1	Height	2E-12	   1.15	[NR] 	rs2564921	T	0.43	23563607
ZNF367	Height	2E-12	   1.22	[NR] 	rs2025151	G	0.18	23563607
HLA-C, HLA-B	Height	4E-12	   1.18	[NR] 	rs2247056	T	0.27	23563607
FLJ44796	Height	4E-12	   1.15	[NR] 	rs10058074	A	0.45	23563607
LIN28B	Height	5E-12	   1.16	[NR] 	rs9391253	T	0.32	23563607
EPB41L1	Height	6E-12	   1.21	[NR] 	rs6141600	C	0.28	23563607
CCDC91	Height	6E-12	   1.16	[NR] 	rs10843164	T	0.68	23563607
POMC	Height	6E-12	   1.17	[NR] 	rs13428823	G	0.37	23563607
DNM3	Height	7E-12	   1.20	[NR] 	rs12075079	G	0.21	23563607
PTPRJ	Height	7E-12	   1.16	[NR] 	rs10838798	T	0.31	23563607
ANKS1A	Height	8E-12	   1.17	[NR] 	rs13210323	A	0.73	23563607
NFATC4	Height	1E-11	   1.16	[NR] 	rs1950500	T	0.3	23563607
ETV6	Height	3E-11	   1.14	[NR] 	rs2856321	G	0.37	23563607
SUPT3H	Height	5E-11	   1.15	[NR] 	rs10948222	C	0.6	23563607
SOCS2	Height	7E-11	   1.26	[NR] 	rs10492321	A	0.21	23563607
FAM46A	Height	1E-10	   1.14	[NR] 	rs310405	A	0.52	23563607
NPR3	Height	1E-10	   1.20	[NR] 	rs6450922	C	0.75	23563607
FUBP3	Height	2E-10	   1.14	[NR] 	rs7466269	A	0.64	23563607
LTBP1	Height	2E-10	   1.15	[NR] 	rs1545552	G	0.72	23563607
APRIN	Height	2E-10	   1.14	[NR] 	rs718444	T	0.37	23563607
AIF1	Height	3E-10	   1.14	[NR] 	rs2844479	A	0.66	23563607
FBXW11	Height	3E-10	   1.16	[NR] 	rs153750	G	0.62	23563607
ESR1	Height	4E-10	   1.17	[NR] 	rs2982712	C	0.47	23563607
IGF2BP3	Height	5E-10	   1.14	[NR] 	rs6957923	G	0.63	23563607
ADAMTS17	Height	7E-10	   1.15	[NR] 	rs4965593	C	0.32	23563607
PITX1	Height	9E-10	   1.15	[NR] 	rs526896	T	0.72	23563607
TRIM13	Height	1E-9	   1.16	[NR] 	rs9596219	T	0.25	23563607
PSMC3	Height	2E-9	   1.15	[NR] 	rs10838708	G	0.53	23563607
ZMIZ1	Height	2E-9	   1.13	[NR] 	rs780151	G	0.57	23563607
RDHE2	Height	3E-9	   1.29	[NR] 	rs4075154	A	0.87	23563607
BCKDHB	Height	3E-9	   1.12	[NR] 	rs2322633	T	0.5	23563607
SCMH1	Height	3E-9	   1.12	[NR] 	rs11209718	T	0.44	23563607
TMEM176A	Height	4E-9	   1.15	[NR] 	rs10231759	C	0.28	23563607
PPM1B	Height	4E-9	   1.15	[NR] 	rs4953076	G	0.25	23563607
DYM	Height	5E-9	   1.13	[NR] 	rs9967417	G	0.42	23563607
LOXL1	Height	7E-9	   1.14	[NR] 	rs4337252	C	0.5	23563607
DCBLD1	Height	2E-8	   1.14	[NR] 	rs9285425	G	0.5	23563607
C2orf52	Height	2E-8	   1.12	[NR] 	rs6750795	T	0.44	23563607
KIAA1546	Height	2E-8	   1.14	[NR] 	rs6855629	G	0.63	23563607
CDC42EP3	Height	2E-8	   1.40	[NR] 	rs17511102	T	0.09	23563607
LYPLAL1	Height	3E-8	   1.12	[NR] 	rs7552186	C	0.62	23563607
DIS3L2	Height	3E-8	   1.16	[NR] 	rs3103267	C	0.72	23563607
HS6ST3	Obesity	1E-8	   1.10	[NR] 	rs7989336	A	0.47	23563607
ZZZ3	Obesity	3E-8	   1.09	[NR] 	rs17381664	C	0.39	23563607
GNAT2	Obesity	9E-12	   1.25	[NR] 	rs17024258	T	0.04	23563607
HNF4G	Obesity	2E-9	   1.06	[NR] 	rs4735692	A	0.58	23563607
MRPS33P4	Obesity	2E-8	   1.06	[NR] 	rs13041126	T	0.72	23563607
ADCY9	Obesity	4E-8	   1.07	[NR] 	rs2531995	T	0.61	23563607
FTO	Obesity	5E-110	   1.23	[NR] 	rs8043757	T	0.4	23563607
TMEM18	Obesity	3E-40	   1.18	[NR] 	rs6711012	C	0.82	23563607
MC4R	Obesity	2E-36	   1.15	[NR] 	rs538656	T	0.24	23563607
GNPDA2	Obesity	3E-34	   1.12	[NR] 	rs10938397	G	0.43	23563607
SEC16B	Obesity	9E-23	   1.12	[NR] 	rs633715	C	0.19	23563607
BDNF	Obesity	3E-22	   1.12	[NR] 	rs2030323	C	0.79	23563607
TFAP2B	Obesity	5E-22	   1.12	[NR] 	rs2206277	T	0.18	23563607
LOC144233	Obesity	1E-20	   1.09	[NR] 	rs7138803	A	0.38	23563607
ADCY3,POMC	Obesity	1E-17	   1.08	[NR] 	rs10182181	G	0.46	23563607
NRXN3	Obesity	1E-17	   1.08	[NR] 	rs7141420	T	0.52	23563607
NEGR1	Obesity	2E-17	   1.08	[NR] 	rs7531118	C	0.56	23563607
GIPR	Obesity	3E-14	   1.10	[NR] 	rs1800437	G	0.78	23563607
ETV5	Obesity	2E-13	   1.10	[NR] 	rs9816226	T	0.82	23563607
SH2B1	Obesity	3E-13	   1.07	[NR] 	rs7498665	G	0.4	23563607
MAP2K5	Obesity	6E-13	   1.08	[NR] 	rs8028313	C	0.78	23563607
C5orf37	Obesity	3E-12	   1.07	[NR] 	rs2307111	T	0.6	23563607
RPL27A	Obesity	1E-11	   1.07	[NR] 	rs11042023	C	0.65	23563607
FANCL	Obesity	1E-10	   1.07	[NR] 	rs887912	T	0.28	23563607
GPRC5B	Obesity	2E-10	   1.09	[NR] 	rs12446632	G	0.86	23563607
TNNI3K	Obesity	5E-9	   1.06	[NR] 	rs1514177	C	0.43	23563607
LINGO2	Obesity	3E-8	   1.07	[NR] 	rs10968576	G	0.32	23563607
FTO	Obesity	1E-79	   1.33	[NR] 	rs7185735	G	0.4	23563607
TMEM18	Obesity	6E-24	   1.24	[NR] 	rs10189761	A	0.82	23563607
MC4R	Obesity	3E-22	   1.19	[NR] 	rs11152213	C	0.24	23563607
TFAP2B	Obesity	3E-19	   1.20	[NR] 	rs2207139	G	0.18	23563607
SEC16B	Obesity	4E-19	   1.19	[NR] 	rs633715	C	0.19	23563607
GNPDA2	Obesity	3E-18	   1.14	[NR] 	rs13130484	T	0.43	23563607
LOC144233	Obesity	1E-16	   1.14	[NR] 	rs7138803	A	0.38	23563607
NEGR1	Obesity	1E-13	   1.12	[NR] 	rs3101336	C	0.61	23563607
GIPR	Obesity	4E-13	   1.16	[NR] 	rs10423928	T	0.77	23563607
BDNF	Obesity	6E-11	   1.13	[NR] 	rs2030323	C	0.79	23563607
LINGO2	Obesity	2E-10	   1.11	[NR] 	rs1412239	G	0.32	23563607
OLFM4	Obesity	2E-9	   1.15	[NR] 	rs9568867	A	0.13	23563607
ETV5	Obesity	3E-9	   1.15	[NR] 	rs1516725	C	0.86	23563607
C5orf37	Obesity	4E-9	   1.09	[NR] 	rs2112347	T	0.63	23563607
GPRC5B	Obesity	4E-9	   1.15	[NR] 	rs11639988	A	0.86	23563607
FANCL	Obesity	6E-9	   1.10	[NR] 	rs887912	T	0.28	23563607
RABEP2,SH2B1	Obesity	7E-9	   1.10	[NR] 	rs7184597	T	0.33	23563607
FTO	Obesity	6E-39	   1.45	[NR] 	rs1421085	C	0.41	23563607
HNF4G	Obesity	4E-10	   1.04	[NR] 	rs4735692	A	0.58	23563607
RPTOR	Obesity	2E-8	   1.04	[NR] 	rs7503807	A	0.57	23563607
FTO	Obesity	2E-81	   1.14	[NR] 	rs1558902	A	0.41	23563607
TMEM18	Obesity	6E-35	   1.11	[NR] 	rs6711012	C	0.82	23563607
GNPDA2	Obesity	4E-28	   1.08	[NR] 	rs13130484	T	0.43	23563607
MC4R	Obesity	2E-27	   1.10	[NR] 	rs10871777	G	0.24	23563607
SEC16B	Obesity	7E-20	   1.08	[NR] 	rs633715	C	0.2	23563607
BDNF	Obesity	5E-17	   1.07	[NR] 	rs2030323	C	0.79	23563607
NEGR1	Obesity	4E-16	   1.06	[NR] 	rs2568958	A	0.61	23563607
TFAP2B	Obesity	7E-16	   1.07	[NR] 	rs2206277	T	0.18	23563607
ETV5	Obesity	2E-14	   1.07	[NR] 	rs9816226	T	0.82	23563607
ADCY3,POMC	Obesity	3E-14	   1.05	[NR] 	rs10182181	G	0.46	23563607
GPRC5B	Obesity	4E-12	   1.07	[NR] 	rs12446554	G	0.86	23563607
SH2B1	Obesity	5E-12	   1.05	[NR] 	rs7498665	G	0.4	23563607
MAP2K5	Obesity	1E-11	   1.06	[NR] 	rs8028313	C	0.79	23563607
CADM2	Obesity	3E-11	   1.06	[NR] 	rs13078807	G	0.2	23563607
LOC144233	Obesity	2E-10	   1.04	[NR] 	rs10875976	A	0.49	23563607
FANCL	Obesity	2E-9	   1.04	[NR] 	rs6731302	A	0.44	23563607
NRXN3	Obesity	3E-9	   1.04	[NR] 	rs2370983	A	0.62	23563607
TNNI3K	Obesity	1E-8	   1.04	[NR] 	rs1514174	C	0.44	23563607
C5orf37	Obesity	1E-8	   1.04	[NR] 	rs2112347	T	0.63	23563607
LY86	Waist-hip ratio	2E-10	   1.16	[NR] 	rs1294421	G	0.62	23563607
RSPO3	Waist-hip ratio	9E-10	   1.15	[NR] 	rs7745274	A	0.55	23563607
LYPLAL1	Waist-hip ratio	7E-9	   1.16	[NR] 	rs2820464	G	0.66	23563607
COBLL1	Waist-hip ratio	3E-8	   1.13	[NR] 	rs13389219	C	0.57	23563607
FTO	Obesity (early onset extreme)	3E-28	   1.44	[1.35-1.54] 	rs1421085	C	0.41	23563609
MC4R	Obesity (early onset extreme)	9E-14	   1.33	[1.23-1.43] 	rs476828	C	0.24	23563609
TMEM18	Obesity (early onset extreme)	2E-13	   1.42	[1.29-1.56] 	rs12463617	C	0.85	23563609
NEGR1	Obesity (early onset extreme)	5E-13	   1.38	[1.26-1.50] 	rs1993709	G	0.81	23563609
PRKCH	Obesity (early onset extreme)	3E-10	   1.50	[1.32-1.70] 	rs1957894	T	0.06	23563609
LEPR	Obesity (early onset extreme)	2E-9	   1.42	[1.27-1.59] 	rs11208659	C	0.08	23563609
PACS1	Obesity (early onset extreme)	2E-9	   1.22	[1.15-1.31] 	rs564343	A	0.41	23563609
RMST	Obesity (early onset extreme)	4E-9	   1.67	[1.41-1.99] 	rs11109072	A	0.03	23563609
NEGR1	Obesity (early onset extreme)	2E-8	   1.21	[1.13-1.29] 	rs3101336	C	0.60	23563609
APOE, TOMM40	Alzheimer's disease biomarkers	2E-16	    .08	[NR] unit increase	rs769449	A	NR	23562540
APOE, TOMM40	Alzheimer's disease biomarkers	2E-18	    .09	[NR] unit increase	rs769449	A	NR	23562540
SNAR-I, GEMC1, OSTNIL1-RAP, UTS2D, CCDC50	Alzheimer's disease biomarkers	5E-9	    .05	[NR] unit increase	rs9877502	A	NR	23562540
GLIS3	Alzheimer's disease biomarkers	1E-8	    .07	[NR] unit decrease	rs514716	G	NR	23562540
GLIS3	Alzheimer's disease biomarkers	3E-9	    .07	[NR] unit decrease	rs514716	G	NR	23562540
NCR2, TREM	Alzheimer's disease biomarkers	4E-8	    .09	[NR] unit decrease	rs6922617	A	NR	23562540
APOE, CEACAM16, BCL3, PVRL2, TOMM40, PPP1R37	Alzheimer's disease (late onset)	5E-39	   2.09	[1.87-2.34] 	rs519113	G	0.29	23565137
MSMB	PCA3 expression level	1E-9	   1.25	[1.18-1.32] unit increase	rs10993994	T	0.41	23555189
KLK2, KLK3	PCA3 expression level	1E-8	   1.24	[1.17-1.31] unit increase	rs10424878	A	0.40	23555189
TERC	Telomere length	3E-31	    .10	[0.081-0.113] unit decrease	rs10936599	T	0.252	23535734
OBFC1	Telomere length	7E-11	    .07	[0.049-0.089] unit decrease	rs9420907	A	0.865	23535734
ADAM15, ADAR, CKS1B, DCST1, DCST2, DPM3, EFNA1, EFNA3,EFNA4, FLAD1, KCNN3, LENEP, LOC10050, LOC100505666,MIR4258, PBXIP1, PMVK, PYGO2, SHC1, SLC50A1, ZBTB7B	Prostate cancer	2E-8	   1.06	[1.03-1.09] 	rs1218582	G	0.45	23535732
LOC127841, LRRN2, MDM4, PIK3C2B, PLEKHA6, PPP1R15B	Prostate cancer	2E-11	   1.10	[1.05-1.14] 	rs4245739	A	0.75	23535732
C2orf48, CYS1, GRHL1, KLF11, MIR4261, RRM2, TAF1B	Prostate cancer	3E-8	   1.07	[1.03-1.10] 	rs11902236	A	0.27	23535732
ANO7, ATG4B, BOK, BOK-AS1, DTYMK, FARP2, HDLBP, SEP2,STK25, THAP4	Prostate cancer	5E-9	   1.12	[1.08-1.17] 	rs3771570	A	0.15	23535732
ATP6V1A, BOC, KIAA2018, MIR4446, NAA50, SIDT1, SPICE1,WDR52, WDR52-AS, WDR52-AS1	Prostate cancer	4E-13	   1.10	[1.08-1.14] 	rs7611694	A	0.59	23535732
AFM, RASSF6, AFP, ALB, ANKRD17, COX18, LOC72804, LOC728040	Prostate cancer	5E-13	   1.10	[1.06-1.12] 	rs1894292	G	0.52	23535732
BOD1, FAM44B, LOC285593, STC2	Prostate cancer	5E-8	   1.07	[1.04-1.11] 	rs6869841	A	0.21	23535732
AGER, AGPAT1, ATF6B, BTNL2, C2, C4A, C4B, C6orf10, CFB,CYP21A1P, CYP21A2, DOM3Z, EGFL8, FKBPL, GPSM3,HCG23, HLA-DQA1, HLA-DQB1, HLA-DRA, HLA-DRB1, HLA-DRB5,HLA-DRB6, LOC10029, LOC100293534, LOC10050,LOC100507547, MIR1236, NOTCH4, PBX2, PPT2, PPT2-EGF,PPT2-EGFL8, PRRT1, RDBP, RNF5, RNF5P1, SKIV2L, STK19,TNXA, TNXB	Prostate cancer	5E-9	   1.07	[1.04-1.10] 	rs3096702	A	0.4	23535732
ARMC2, SESN1, CEP57L1, FOXO3, LACE1, LINC0022, LINC00222	Prostate cancer	8E-9	   1.07	[1.03-1.11] 	rs2273669	G	0.15	23535732
RGS17, FBXO5, MTRF1L	Prostate cancer	4E-18	   1.12	[1.09-1.15] 	rs1933488	A	0.59	23535732
SP8, ABCB5, RPL23P8	Prostate cancer	5E-13	   1.11	[1.07-1.15] 	rs12155172	A	0.23	23535732
EBF2	Prostate cancer	8E-11	   1.11	[1.07-1.16] 	rs11135910	A	0.16	23535732
ACTR1A, ARL3, AS3MT, C10orf32, C10orf32-AS3MT, C10orf95,CNNM2, CUEDC2, CYP17A1, FBXL15, LOC100505761,MIR146B, PSD, SFXN2, SUFU, TMEM180, TRIM8, WBP1L	Prostate cancer	5E-10	   1.10	[1.06-1.12] 	rs3850699	A	0.71	23535732
BIRC2, BIRC3, MMP10, MMP20, MMP27, MMP7, MMP8,TMEM123, YAP1	Prostate cancer	2E-11	   1.10	[1.06-1.14] 	rs11568818	A	0.56	23535732
TBX5, LOC255480	Prostate cancer	7E-11	   1.07	[1.04-1.10] 	rs1270884	A	0.49	23535732
DDHD1, ERO1L, FERMT2, GNPNAT1, GPR137C, PSMC6, STYX,TXNDC16	Prostate cancer	2E-14	   1.12	[1.08-1.16] 	rs8008270	G	0.82	23535732
ACTN1, RAD51B, ZFP36L1	Prostate cancer	3E-10	   1.09	[1.06-1.12] 	rs7141529	G	0.5	23535732
DBIL5P, FAM57A, GEMIN4, GLOD4, NXN, RNMTL1, VPS53	Prostate cancer	5E-15	   1.10	[1.07-1.14] 	rs684232	G	0.36	23535732
HOXB13, PRAC, SPOP, ZNF652, ABI3, B4GALNT2, FLJ40194, GNGT2, IGF2BP1, NGFR, PHB, PHOSPHO1	Prostate cancer	2E-9	   1.15	[1.09-1.22] 	rs11650494	A	0.08	23535732
SALL3, ATP9B	Prostate cancer	2E-9	   1.09	[1.05-1.12] 	rs7241993	G	0.7	23535732
ADRM1, C20orf15, C20orf151, C20orf166, C20orf166-AS1,CABLES2, GATA5, GTPBP5, HRH3, LAMA5, MIR1-1,MIR133A2, MIR4758, OSBPL2, RPS21	Prostate cancer	4E-8	   1.06	[1.03-1.1] 	rs2427345	G	0.63	23535732
ABHD16B, ARFRP1, C20orf195, DNAJC5, EEF1A2, GMEB2,LIME1, LOC100505815, MIR1914, MIR647, MIR941-1,MIR941-2, MIR941-3, MIR941-4, PPDPF, PRIC285, PRPF6,PTK6, RTEL1, RTEL1-TN, RTEL1-TNFRSF6B, SAMD10,SLC2A4RG, SRMS, STMN3, TNFRSF6B, TPD52L2, UCKL1,UCKL1-AS1, ZBTB46, ZGPAT, ZNF512B	Prostate cancer	4E-16	   1.12	[1.09-1.16] 	rs6062509	A	0.7	23535732
GPR143, LOC100288814, SHROOM2, TBL1X, WWC3	Prostate cancer	2E-10	   1.14	[1.09-1.2] 	rs2405942	A	0.79	23535732
TERT	Breast cancer	5E-12	   1.15	[1.11-1.20] 	rs10069690	T	0.321	23535733
ESR1	Breast cancer	5E-16	   1.15	[1.11-1.19] 	rs2046210	A	0.423	23535733
PTHLH	Breast cancer	2E-12	   1.20	[1.15-1.27] 	rs10771399	T	0.895	23535733
TOX3	Breast cancer	6E-13	   1.14	[1.10-1.18] 	rs3803662	T	0.267	23535733
MERIT40	Breast cancer	9E-13	   1.15	[1.11-1.20] 	rs8170	A	0.191	23535733
PEX14	Breast cancer	1E-8	   1.10	[1.06-1.14] 	rs616488	A	0.665	23535733
LPIN2	Body mass index (asthmatics)	8E-9	NR	NR	rs643507	C	0.01	23517042
PEX14	Breast cancer	2E-10	   1.06	[1.04-1.09] 	rs616488	A	0.67	23535729
PTPN22, BCL2L15, AP4B1, DCLRE1B, HIPK1	Breast cancer	2E-8	   1.07	[1.04-1.09] 	rs11552449	T	0.17	23535729
Intergenic	Breast cancer	4E-11	   1.10	[1.06-1.14] 	rs4849887	C	0.902	23535729
METAP1D, DLX1, DLX2	Breast cancer	1E-8	   1.05	[1.03-1.08] 	rs2016394	G	0.52	23535729
DIRC3	Breast cancer	1E-15	   1.08	[1.06-1.10] 	rs16857609	T	0.26	23535729
ITPR1, EGOT	Breast cancer	2E-12	   1.07	[1.04-1.09] 	rs6762644	G	0.4	23535729
TGFBR2	Breast cancer	2E-8	   1.06	[1.03-1.08] 	rs12493607	C	0.35	23535729
TET2	Breast cancer	4E-8	   1.05	[1.03-1.08] 	rs9790517	T	0.23	23535729
ADAM29	Breast cancer	4E-16	   1.11	[1.09-1.15] 	rs6828523	C	0.87	23535729
RAB3C	Breast cancer	3E-8	   1.05	[1.03-1.07] 	rs10472076	C	0.38	23535729
EBF1	Breast cancer	2E-14	   1.07	[1.05-1.09] 	rs1432679	C	0.43	23535729
FOXQ1	Breast cancer	7E-9	   1.06	[1.04-1.09] 	rs11242675	T	0.61	23535729
RANBP9	Breast cancer	8E-9	   1.05	[1.03-1.07] 	rs204247	G	0.43	23535729
ARHGEF5, NOBOX	Breast cancer	7E-11	   1.06	[1.04-1.09] 	rs720475	G	0.75	23535729
Intergenic	Breast cancer	9E-14	   1.07	[1.05-1.09] 	rs9693444	A	0.32	23535729
Intergenic	Breast cancer	2E-17	   1.10	[1.08-1.12] 	rs6472903	T	0.82	23535729
MIR1208, MYC	Breast cancer	3E-11	   1.07	[1.04-1.10] 	rs11780156	T	0.16	23535729
Intergenic	Breast cancer	1E-8	   1.06	[1.03-1.08] 	rs10759243	A	0.39	23535729
MLLT10, DNAJC1	Breast cancer	4E-14	   1.07	[1.05-1.09] 	rs7072776	A	0.29	23535729
TCF7L2	Breast cancer	3E-8	   1.06	[1.04-1.08] 	rs7904519	G	0.46	23535729
Intergenic	Breast cancer	2E-8	   1.05	[1.03-1.08] 	rs11199914	C	0.68	23535729
DKFZp761E198, OVOL1, SNX32, CFL1, MUS81	Breast cancer	9E-12	   1.05	[1.04-1.08] 	rs3903072	G	0.53	23535729
Intergenic	Breast cancer	1E-9	   1.05	[1.03-1.08] 	rs11820646	C	0.59	23535729
Intergenic	Breast cancer	4E-8	   1.05	[1.03-1.07] 	rs12422552	C	0.26	23535729
NTN4	Breast cancer	2E-22	   1.10	[1.08-1.12] 	rs17356907	A	0.7	23535729
BRCA2, N4BP2L1, N4BP2L2	Breast cancer	5E-8	   1.26	[1.14-1.39] 	rs11571833	T	0.0080	23535729
PAX9, SLC25A21	Breast cancer	2E-13	   1.08	[1.05-1.1] 	rs2236007	G	0.79	23535729
RAD51L1	Breast cancer	1E-10	   1.08	[1.05-1.11] 	rs2588809	T	0.16	23535729
CCDC88C	Breast cancer	4E-10	   1.06	[1.04-1.09] 	rs941764	G	0.34	23535729
MIR1972-2, FTO	Breast cancer	6E-14	   1.08	[1.05-1.1] 	rs17817449	T	0.6	23535729
CDYL2	Breast cancer	2E-16	   1.08	[1.05-1.10] 	rs13329835	G	0.22	23535729
Intergenic	Breast cancer	2E-10	   1.05	[1.03-1.08] 	rs527616	G	0.62	23535729
SSBP4, ISYNA1, ELL	Breast cancer	5E-15	   1.08	[1.05-1.1] 	rs4808801	A	0.65	23535729
C19orf61, KCNN4, LYPD5, ZNF283	Breast cancer	2E-10	   1.06	[1.04-1.08] 	rs3760982	A	0.46	23535729
EMID1, RHBDD3, EWSR1, CHEK2	Breast cancer	3E-9	   1.12	[1.07-1.18] 	rs132390	C	0.036	23535729
MKL1	Breast cancer	9E-19	   1.12	[1.09-1.16] 	rs6001930	C	0.11	23535729
Intergenic	Breast cancer	2E-26	   1.09	[1.07-1.11] 	rs11249433	G	0.4	23535729
Intergenic	Breast cancer	2E-57	   1.14	[1.11-1.16] 	rs13387042	A	0.51	23535729
SLC4A7	Breast cancer	2E-30	   1.10	[1.08-1.12] 	rs4973768	T	0.47	23535729
TERT	Breast cancer	7E-9	   1.06	[1.04-1.09] 	rs10069690	T	0.26	23535729
Intergenic	Breast cancer	2E-37	   1.13	[1.10-1.15] 	rs10941679	G	0.25	23535729
MAP3K1	Breast cancer	3E-36	   1.12	[1.10-1.15] 	rs889312	C	0.28	23535729
Intergenic	Breast cancer	8E-9	   1.05	[1.03-1.08] 	rs17530068	G	0.22	23535729
ESR1	Breast cancer	2E-21	   1.16	[1.12-1.21] 	rs3757318	A	0.07	23535729
Intergenic	Breast cancer	1E-27	   1.09	[1.07-1.12] 	rs13281615	G	0.41	23535729
Intergenic	Breast cancer	1E-34	   1.12	[1.1-1.14] 	rs865686	T	0.62	23535729
ZNF365	Breast cancer	1E-36	   1.16	[1.14-1.19] 	rs10995190	G	0.84	23535729
ZMIZ1	Breast cancer	7E-22	   1.08	[1.06-1.10] 	rs704010	T	0.38	23535729
FGFR2	Breast cancer	2E-170	   1.27	[1.24-1.29] 	rs2981579	A	0.4	23535729
LSP1	Breast cancer	2E-11	   1.07	[1.05-1.09] 	rs3817198	C	0.31	23535729
Intergenic	Breast cancer	2E-63	   1.21	[1.18-1.24] 	rs614367	T	0.15	23535729
PTHLH	Breast cancer	8E-31	   1.16	[1.14-1.2] 	rs10771399	A	0.88	23535729
Intergenic	Breast cancer	9E-22	   1.09	[1.06-1.11] 	rs1292011	A	0.58	23535729
RAD51L1	Breast cancer	3E-19	   1.09	[1.06-1.11] 	rs999737	C	0.77	23535729
TOX3	Breast cancer	2E-114	   1.24	[1.21-1.27] 	rs3803662	A	0.26	23535729
COX11	Breast cancer	2E-13	   1.06	[1.04-1.09] 	rs6504950	G	0.72	23535729
NRIP1	Breast cancer	7E-16	   1.09	[1.06-1.11] 	rs2823093	G	0.73	23535729
CDCA7	Breast cancer	3E-8	   1.06	[1.03-1.09] 	rs1550623	A	0.84	23535729
PDE4D	Breast cancer	3E-8	   1.09	[1.05-1.12] 	rs1353747	T	0.905	23535729
HNF4G	Breast cancer	6E-15	   1.13	[1.09-1.17 	rs2943559	G	0.07	23535729
DNAJC1	Breast cancer	9E-16	   1.26	[1.18-1.35] 	rs11814448	C	0.02	23535729
CHST9	Breast cancer	3E-8	   1.04	[1.02-1.06] 	rs1436904	T	0.6	23535729
CHMP4C, FABP5, PMP2, FABP4, FABP12, IMPA1, SLC10A5, ZFAND1, SNX16	Ovarian cancer	6E-9	   1.19	[1.12-1.26] 	rs11782652	A	0.07	23535730
CHMP4C, FABP5, PMP2, FABP4, FABP12, IMPA1, SLC10A5, ZFAND1, SNX16	Ovarian cancer	7E-10	   1.24	[1.16-1.33] 	rs11782652	A	0.07	23535730
MLLT10, NEBL, C10orf113, C10orf114, SKIDA1, DNAJC1	Ovarian cancer	2E-8	   1.10	[1.06-1.13] 	rs1243180	T	0.31	23535730
HNF1B, ACACA, C17orf78, TADA2A, DUSP14, SYNRG, DDX52, TBC1D3F, TBC1D3, MRPL45, GPR179, SOCS7, ARHGAP23	Ovarian cancer	8E-10	   1.12	[1.08-1.17] 	rs757210	G	0.37	23535730
HLA-DRB1, HLA-DQA1	Ulcerative colitis	1E-18	   2.10	[1.78-2.48] 	rs9271366	G	0.11	23511034
IRF8	Ulcerative colitis	4E-10	   1.56	[1.36-1.80] 	rs16940186	G	0.21	23511034
Intergenic	Ulcerative colitis	3E-9	   1.52	[1.32-1.74] 	rs16940202	C	0.22	23511034
HERC2	Eye color	1E-177	   2.82	[2.62-3.02] unit increase	rs12913832	A	NR	23548203
SLC24A4	Eye color	4E-11	    .33	[0.23-0.43] unit increase	rs12896399	G	NR	23548203
HERC2	Eye color	1E-158	   2.84	[2.62-3.06] unit decrease	rs12913832	G	NR	23548203
EDNRB	Hair color	2E-14	    .08	[0.060-0.100] unit increase	rs975739	G	NR	23548203
IRF4	Hair color	1E-28	    .35	[0.29-0.41] unit increase	rs12203592	C	NR	23548203
KITLG	Hair color	7E-19	    .18	[0.14-0.22] unit increase	rs12821256	C	NR	23548203
SLC24A4	Hair color	2E-36	    .16	[0.14-0.18] unit decrease	rs12896399	G	NR	23548203
HERC2	Hair color	1E-167	    .39	[0.37-0.41] unit increase	rs12913832	G	NR	23548203
MC1R	Hair color	3E-9	    .16	[0.10-0.22] unit decrease	rs1805007	C	NR	23548203
IRF4	Non-melanoma skin cancer	7E-14	    .21	[0.15-0.27] unit increase	rs12203592	T	NR	23548203
IRF4, EXOC2	Non-melanoma skin cancer	5E-8	    .15	[0.091-0.209] unit increase	rs12202284	A	NR	23548203
MC1R	Non-melanoma skin cancer	3E-10	    .34	[0.24-0.44] unit increase	rs1805007	C	NR	23548203
TYR	Sunburns	2E-8	    .60	[0.38-0.82] unit increase	rs1126809	G	NR	23548203
MC1R	Sunburns	2E-19	   1.66	[1.31-2.01] unit increase	rs1805007	C	NR	23548203
IRF4	Tanning	3E-23	    .35	[0.29-0.41] unit decrease	rs12203592	C	NR	23548203
TYR	Tanning	5E-21	    .12	[0.10-0.14] unit decrease	rs1126809	G	NR	23548203
HERC2	Tanning	1E-22	    .14	[0.12-0.16] unit increase	rs12913832	G	NR	23548203
MC1R	Tanning	1E-65	    .39	[0.35-0.43] unit decrease	rs1805007	C	NR	23548203
ASIP	Tanning	4E-9	    .07	[0.050-0.090] unit decrease	rs4911414	G	NR	23548203
PNPLA3, SAMM50, PARVB	Non-alcoholic fatty liver disease	2E-20	   2.02	[1.60-2.56] 	rs2896019	G	0.45	23535911
NAT8	Glomerular filtration rate	4E-8	   1.17	[0.76-1.58] unit increase	rs10206899	C	0.23	23535967
NAT8	Glomerular filtration rate	6E-9	   1.10	[0.73-1.47] unit increase	rs10206899	C	0.23	23535967
SHROOM3	Glomerular filtration rate	1E-8	    .93	[0.62-1.24] unit increase	rs10032549	A	0.47	23535967
SPATA5L1	Glomerular filtration rate	8E-10	   1.13	[0.78-1.48] unit decrease	rs17536527	C	0.47	23535967
NAT8	Glomerular filtration rate	2E-9	   1.10	[0.75-1.45] unit increase	rs10206899	C	0.23	23535967
SHROOM3	Glomerular filtration rate	2E-9	    .96	[0.65-1.27] unit decrease	rs4859682	A	0.45	23535967
Intergenic	Breast Cancer in BRCA1 mutation carriers	4E-13	   1.19	[1.14-1.25] 	rs8170	G	0.48	23544013
Intergenic	Breast Cancer in BRCA1 mutation carriers	5E-9	   1.28	[1.18-1.39] 	rs2046210	C	0.08	23544013
Intergenic	Ovarian cancer in BRCA1 mutation carriers 	1E-8	   1.27	[1.17-1.38] 	rs17631303	G	0.19	23544013
Intergenic	Ovarian cancer in BRCA1 mutation carriers 	3E-8	   1.25	[1.16-1.35] 	rs183211	A	0.23	23544013
Intergenic	Ovarian cancer in BRCA1 mutation carriers 	3E-8	   1.20	[1.17-1.38] 	rs4691139	G	0.48	23544013
Intergenic	Ovarian cancer in BRCA1 mutation carriers 	6E-11	   1.30	[1.2-1.41] 	rs3814113	A	0.66	23544013
ARF5, PAX4, SND1	Type 2 diabetes	2E-10	   1.14	[1.09-1.19] 	rs10229583	G	0.825	23532257
NR	Venous thromboembolism (gene x gene interaction)	6E-11	   1.64	[NR] 	rs493014:rs886090	G	NR	23509962
NR	Venous thromboembolism (gene x gene interaction)	4E-10	   1.54	[NR] 	rs1336472:rs4715555	A	NR	23509962
NR	Venous thromboembolism (gene x gene interaction)	5E-10	   1.67	[NR] 	rs380904:rs8086028	A	NR	23509962
NR	Venous thromboembolism (gene x gene interaction)	7E-10	   2.10	[NR] 	rs6815916:rs6092326	G	NR	23509962
NR	Venous thromboembolism (gene x gene interaction)	8E-10	   1.50	[NR] 	rs2282015:rs13050454	G	NR	23509962
NR	Venous thromboembolism (gene x gene interaction)	1E-9	   1.56	[NR] 	rs7648704:rs4868644	G	NR	23509962
NR	Venous thromboembolism (gene x gene interaction)	1E-9	   2.05	[NR] 	rs315122:rs884483	G	NR	23509962
NR	Venous thromboembolism (gene x gene interaction)	2E-9	   1.73	[NR] 	rs1423386:rs6491679	G	NR	23509962
NR	Venous thromboembolism (gene x gene interaction)	2E-9	   1.52	[NR] 	rs7714670:rs12880735	C	NR	23509962
NR	Venous thromboembolism (gene x gene interaction)	2E-9	   1.74	[NR] 	rs9392653:rs7780976	T	NR	23509962
NR	Venous thromboembolism (gene x gene interaction)	2E-9	   1.71	[NR] 	rs9804128:rs4784379	G	NR	23509962
NR	Venous thromboembolism (gene x gene interaction)	2E-9	   1.80	[NR] 	rs1364505:rs1204660	A	NR	23509962
NR	Venous thromboembolism (gene x gene interaction)	2E-9	   1.60	[NR] 	rs2288073:rs10771022	G	NR	23509962
NR	Venous thromboembolism (gene x gene interaction)	2E-9	   1.49	[NR] 	rs1367228:rs3905075	A	NR	23509962
NR	Venous thromboembolism (gene x gene interaction)	3E-9	   1.65	[NR] 	rs12541254:rs305009	A	NR	23509962
NR	Venous thromboembolism (gene x gene interaction)	4E-9	   1.88	[NR] 	rs10504130:rs2847351	A	NR	23509962
NR	Venous thromboembolism (gene x gene interaction)	5E-9	   1.86	[NR] 	rs6695223:rs1763510	C	NR	23509962
NR	Venous thromboembolism (gene x gene interaction)	5E-9	   2.13	[NR] 	rs6771316:rs10986432	A	NR	23509962
NR	Venous thromboembolism (gene x gene interaction)	7E-9	   1.50	[NR] 	rs664910:rs877228	G	NR	23509962
NR	Venous thromboembolism (gene x gene interaction)	7E-9	   2.03	[NR] 	rs1910358:rs9981595	C	NR	23509962
NR	Venous thromboembolism (gene x gene interaction)	9E-9	   2.22	[NR] 	rs6771725:rs10507246	T	NR	23509962
NR	Venous thromboembolism (gene x gene interaction)	9E-9	   1.56	[NR] 	rs16865717:rs2009579	T	NR	23509962
NR	Venous thromboembolism (gene x gene interaction)	9E-9	   1.69	[NR] 	rs2028385:rs2038227	G	NR	23509962
NR	Venous thromboembolism (gene x gene interaction)	1E-8	   1.62	[NR] 	rs6858430:rs4800250	T	NR	23509962
IKZF1,DDC,GRB10	Acute lymphoblastic leukemia (childhood)	2E-29	   1.67	[1.53-1.83] 	rs6964969	C	0.28	23512250
ARID5B	Acute lymphoblastic leukemia (childhood)	6E-46	   1.86	[1.71-2.03] 	rs10821936	C	0.33	23512250
CEBPE	Acute lymphoblastic leukemia (childhood)	9E-12	   1.36	[1.24-1.48] 	rs4982731	C	0.28	23512250
BCHE	Aspirin hydrolysis (plasma)	9E-17	NR	NR	rs6445035	A	NR	23508960
CBLN2	Pulmonary arterial hypertension (without BMPR2 mutations)	7E-10	   1.97	[1.59-2.45] 	rs2217560	G	0.069	23502781
CCND1	Multiple myeloma (IgH translocation)	8E-11	   1.82	[1.52-2.19] 	rs603965	G	0.56	23502783
CCND1	Multiple myeloma (IgH translocation)	2E-11	   1.95	[1.61-2.38] 	rs603965	G	0.55	23502783
NR	Multiple myeloma (hyperdiploidy)	1E-9	   1.48	[1.30-1.68] 	rs6599175	G	0.16	23502783
NR	Multiple myeloma (hyperdiploidy)	1E-9	   1.43	[1.27-1.60] 	rs4487645	C	0.65	23502783
NR	Multiple myeloma (hyperdiploidy)	2E-9	   1.37	[1.24-1.52] 	rs139371	A	0.46	23502783
NR	Multiple myeloma (hyperdiploidy)	2E-9	   1.47	[1.30-1.67] 	rs2272007	A	0.16	23502783
LIPC	HDL cholesterol	2E-14	    .17	[0.13-0.21] unit decrease	rs1077835	A	0.38	23505323
SLC12A3,NLRC5,HERPUD1,CETP	HDL cholesterol	1E-24	    .23	[0.19-0.27] unit increase	rs1532624	A	0.43	23505323
NIPSNAP3A,NIPSNAP3B,ABCA1	HDL cholesterol	6E-26	    .37	[0.29-0.45] unit decrease	rs9282541	A	0.11	23505323
LOC100506532,RXRA,COL5A1	Central corneal thickness	8E-10	    .23	[NR] unit decrease	rs3118515	A	0.262	23493294
CDKN2A,CDKN2B	Coronary artery calcification	2E-11	    .53	[0.38-0.69] unit increase	rs1537370	T	0.46	23561647
HLA	Cervical cancer	9E-10	   2.13	[1.67-2.70] 	DRB1*1301-DQA1*0103-DQB1*0603	D	NR	23482656
KCNT2, CFH, CFHR3, CFHR1P, CFHR4, CFHR2, CFHR5, F13B, ASPM, ZBTB41	Age-related macular degeneration	1E-16	   3.75	[2.91-4.82] 	SNP_A-2171106	2	0.39	23536807
PLEKHA1, ARMS2, HTRA1	Age-related macular degeneration	1E-16	   3.14	[2.49-3.97] 	SNP_A-1841655	1	0.20	23536807
WNT4,LOC100289113,ZBTB40	Endometriosis	3E-9	   1.30	[1.19-1.41] 	rs2235529	A	0.153	23472165
WNT4	Endometriosis	7E-9	   1.28	[NR] 	rs10917151, rs4654783, rs2235529	S	0.152	23472165
SPON1	Brain connectivity	6E-10	    .00	[NR] unit increase	rs2618516	T	0.36	23471985
SCN5A	Electrocardiographic conduction measures	3E-20	    .66	[NR] msec decrease	rs1805126	A	0.655	23463857
C6orf204	Electrocardiographic conduction measures	6E-16	    .54	[NR] msec increase	rs6906287	C	0.451	23463857
CDKN1A	Electrocardiographic conduction measures	5E-25	    .81	[NR] msec decrease	rs1321313	C	0.742	23463857
NFIA	Electrocardiographic conduction measures	6E-18	    .60	[NR] msec decrease	rs2207790	A	0.461	23463857
SCN10A	Electrocardiographic conduction measures	5E-27	    .75	[NR] msec increase	rs6795970	A	0.396	23463857
ITGA4	Monocyte count	5E-17	    .22	[NR] unit decrease	rs2124440	G	0.45	23314186
RPN1	Monocyte count	2E-16	    .23	 unit decrease	rs2712381	A	0.40	23314186
IRF8	Monocyte count	3E-16	    .22	 unit decrease	rs424971	G	0.47	23314186
ARMS2, HTRA1	Age-related macular degeneration	4E-540	   2.76	[2.72-2.80] 	rs10490924	T	0.3	23455636
CFH	Age-related macular degeneration	1E-434	   2.43	[2.39-2.47] 	rs10737680	A	0.64	23455636
C2, CFB	Age-related macular degeneration	4E-89	   1.74	[1.68-1.79] 	rs429608	G	0.86	23455636
C3	Age-related macular degeneration	1E-41	   1.42	[1.37-1.47] 	rs2230199	C	0.2	23455636
TIMP3	Age-related macular degeneration	2E-26	   1.31	[1.26-1.36] 	rs5749482	G	0.74	23455636
APOE	Age-related macular degeneration	2E-20	   1.30	[1.24-1.36] 	rs4420638	A	0.83	23455636
CETP	Age-related macular degeneration	7E-16	   1.22	[1.17-1.27] 	rs1864163	G	0.76	23455636
VEGFA	Age-related macular degeneration	9E-16	   1.15	[1.12-1.18] 	rs943080	T	0.51	23455636
TNFRSF10A	Age-related macular degeneration	3E-15	   1.15	[1.12-1.19] 	rs13278062	T	0.48	23455636
LIPC	Age-related macular degeneration	3E-11	   1.13	[1.09-1.17] 	rs920915	C	0.48	23455636
CFI	Age-related macular degeneration	7E-11	   1.14	[1.10-1.17] 	rs4698775	G	0.31	23455636
COL10A1	Age-related macular degeneration	2E-8	   1.10	[1.07-1.14] 	rs3812111	T	0.64	23455636
COL8A1, FILIP1L	Age-related macular degeneration	4E-13	   1.23	[1.17-1.29] 	rs13081855	T	0.1	23455636
IER3, DDR1	Age-related macular degeneration	2E-11	   1.16	[1.11-1.20] 	rs3130783	A	0.79	23455636
SLC16A8	Age-related macular degeneration	2E-11	   1.15	[1.11-1.19] 	rs8135665	T	0.21	23455636
TGFBR1	Age-related macular degeneration	3E-11	   1.13	[1.10-1.17] 	rs334353	T	0.73	23455636
RAD51B	Age-related macular degeneration	9E-11	   1.11	[1.08-1.14] 	rs8017304	A	0.61	23455636
ADAMTS9	Age-related macular degeneration	5E-9	   1.10	[1.07-1.14] 	rs6795735	T	0.46	23455636
B3GALTL	Age-related macular degeneration	2E-8	   1.10	[1.07-1.14] 	rs9542236	C	0.44	23455636
ZNF638	Height	2E-10	    .10	[0.069-0.131] unit increase	rs12612930	C	0.6	23456168
MAML2	Height	8E-9	    .08	[0.054-0.112] unit increase	rs11021504	A	0.51	23456168
CS, STAT2	Height	3E-9	    .12	[0.082-0.164] unit increase	rs3816804	C	0.77	23456168
CYP19A1	Height	5E-10	    .19	[0.13-0.25] unit increase	rs3751599	G	0.93	23456168
C18orf12	Height	2E-8	    .11	[0.07-0.144] unit increase	rs11082671	G	0.79	23456168
FTO	Melanoma	4E-12	   1.16	[1.11-1.20] 	rs16953002	A	0.17	23455637
PYROXD2	Metabolite levels	2E-91	NR	NR	rs4345897	G	NR	23281178
FADS1	Metabolite levels	2E-30	NR	NR	rs174549	G	NR	23281178
ACADL	Metabolite levels	4E-29	NR	NR	rs3764913	T	NR	23281178
CYP4F2	Metabolite levels	9E-24	NR	NR	rs2108622	T	NR	23281178
UGT1A8	Metabolite levels	9E-25	NR	NR	rs887829	T	NR	23281178
PON1	Metabolite levels	7E-15	NR	NR	rs2057681	G	NR	23281178
LIPC	Metabolite levels	9E-13	NR	NR	rs261342	C	NR	23281178
SLCO1B1	Metabolite levels	5E-15	NR	NR	rs11045879	C	NR	23281178
ACE	Metabolite levels	9E-13	NR	NR	rs4351	A	NR	23281178
NCK2	Addiction	1E-11	  13.87	NR unit increase	rs2377339	G	.0159	23533358
NCK2	Addiction	2E-11	NR	NR	rs12043259, rs6747023, rs7589342, rs12995333, rs4851870, rs1465641, rs1465639, rs6741172, rs12995849, rs2163350, rs7589561, rs4851095, rs2377339, rs2163349	S	NR	23533358
NCK2	Addiction	2E-8	NR	NR	rs2377339	G	.0159	23533358
VIPR2	Myopia (pathological)	9E-14	   1.33	[1.23-1.44] 	rs2730260	C	0.238	23406873
SNTB1	Myopia (pathological)	2E-11	   1.32	[1.22-1.43] 	rs7839488	A	0.765	23406873
SNTB1	Myopia (pathological)	8E-12	   1.31	[1.22-1.42] 	rs7839488, rs4395927, rs4455882	S	0.728	23406873
SNTB1	Myopia (pathological)	4E-10	   1.30	[1.2-1.41] 	rs7839488, rs4395927, 4455882	S	0.235	23406873
MAPK3	Pubertal anthropometrics	9E-11	    .07	[0.048-0.092] unit increase	rs4788196	G	0.44	23449627
MAMSTR	Pubertal anthropometrics	5E-8	    .07	[0.043-0.097] unit increase	rs281379	G	0.52	23449627
ADCY3,DNAJC27,POMC	Pubertal anthropometrics	1E-8	    .08	[0.053-0.107] unit decrease	rs1172294	G	0.45	23449627
VGLL3	Pubertal anthropometrics	3E-9	    .11	[0.073-0.147] unit decrease	rs7628864	G	0.38	23449627
LIN28B	Pubertal anthropometrics	4E-9	    .11	[0.079-0.141] unit increase	rs7759938	C	0.32	23449627
ANK3	Autism spectrum disorder, attention deficit-hyperactivity disorder, bipolar disorder, major depressive disorder, and schizophrenia (combined)	3E-9	   1.08	[1.03-1.13] 	rs10994359	C	NR	23453885
NKAIN1, SNRNP40, ZCCHC17, FABP3, SERINC2	Alcohol dependence	3E-8	   1.26	 	rs4478858	G	NR	23455491
G6PD, TKTL1, MECP2, MPP1	Red blood cell traits	2E-16	    .45	[0.34-0.56] % decrease	rs762516	T	0.148	23446634
PRKCE	Red blood cell traits	4E-9	    .28	[0.18-0.37] % decrease	rs13008603	A	0.163	23446634
ITFG3, LUCL7, NPRL3, POLR3K, RPL2B, MPG	Red blood cell traits	3E-23	    .19	[0.15-0.23] g/dL decrease	rs13335629	A	0.12	23446634
G6PD, TKTL1, MECP2, MPP1	Red blood cell traits	4E-18	    .16	[0.12-0.2] g/dL decrease	rs762516	T	0.146	23446634
ITFG3, LUCL7, NPRL3, POLR3K, RPL2B, MPG, NME4, DECR	Red blood cell traits	9E-48	    .33	[0.29-0.37] g/dL decrease	rs13335629	A	0.117	23446634
ITFG3, LUCL7, NPRL3, POLR3K, RPL2B, MPG, NME4, DECR	Red blood cell traits	2E-34	    .68	[0.58-0.79] pg decrease	rs13339636	G	0.132	23446634
CD164	Red blood cell traits	1E-8	    .23	[0.15-0.31] pg decrease	rs9386791	C	0.416	23446634
ITFG3, LUCL7, NPRL3, POLR3K, RPL2B, MPG, NME4, DECR, RHOT2, LMF1,WDR90	Red blood cell traits	4E-22	    .65	[0.52-0.78] fL decrease	rs13335629	A	0.134	23446634
G6PD, FAM3A, F8, MPP1	Red blood cell traits	4E-14	   1.58	[1.17-1.99] fL increase	rs762516	T	0.137	23446634
ITFG3, LUCL7	Red blood cell traits	7E-24	    .17	[0.14-0.20] x10^6/uL, increase	rs13335629	A	0.12	23446634
G6PD, F8, MPP1, MECP2, CTAG2	Red blood cell traits	4E-19	    .11	[0.0063-0.2097] x10^6/uL, decrease	rs1050828	T	0.108	23446634
G6PD	Red blood cell traits	2E-11	    .03	[0.023-0.042] % decrease	rs1050828	T	0.116	23446634
ITFG3	Red blood cell traits	1E-8	    .16	[0.10-0.22] d/dL increase	rs1122794	A	0.1984	23446634
ZNF516	Renal transplant outcome	4E-8	    .29	[NR] unit increase	rs6565887	G	NR	23432519
TNFSF11	Bone mineral density	4E-14	    .15	[0.11-0.19] unit decrease	rs1021188	C	0.17	23437003
LOC285735	Bone mineral density	3E-12	    .11	[0.071-0.149] unit decrease	rs271170	T	0.33	23437003
TNFRSF11B	Bone mineral density	1E-10	    .10	[0.061-0.139] unit decrease	rs7839059	A	0.34	23437003
C6orf97, ESR1	Bone mineral density	1E-9	    .09	[0.070-0.110] unit decrease	rs6909279	G	0.40	23437003
FMN2	Bone mineral density	2E-9	    .19	[0.13-0.25] unit increase	rs9287237	T	0.15	23437003
BCHE	Alzheimer's disease biomarkers	3E-8	NR	NR	rs509208	G	0.16	23419831
APOE	Alzheimer's disease biomarkers	5E-14	NR	NR	rs429358	C	0.28	23419831
APOC1	Alzheimer's disease biomarkers	4E-12	NR	NR	rs56131196	A	0.29	23419831
PVRL2	Alzheimer's disease biomarkers	1E-10	NR	NR	rs6857	T	0.28	23419831
TOMM40	Alzheimer's disease biomarkers	7E-9	NR	NR	rs59007384	T	0.32	23419831
LPA	Aortic-valve calcification	3E-11	   2.05	[1.66-2.53] 	rs10455872	G	0.07	23388002
HLA-A	Beta-2 microglubulin plasma levels	2E-22	    .04	[0.032-0.048] unit decrease	rs9260489	G	0.58	23417110
HLA-A	Beta-2 microglubulin plasma levels	9E-10	    .03	[0.020-0.040] unit decrease	HLA-A*02:01	A	0.27	23417110
SH2B3, ATXN2	Beta-2 microglubulin plasma levels	3E-8	    .02	[0.012-0.028] unit decrease	rs3184504	C	0.49	23417110
HLA-A	Beta-2 microglubulin plasma levels	1E-8	    .03	[0.018-0.042] unit increase	HLA-A*01:01	A	0.17	23417110
HLA-B	Beta-2 microglubulin plasma levels	2E-20	    .06	[0.046-0.074] unit increase	HLA-B*08:01	B	0.13	23417110
HLA-B	Beta-2 microglubulin plasma levels	2E-10	    .05	[0.034-0.066] unit decrease	HLA-B*15:01	B	0.07	23417110
HLA-C	Beta-2 microglubulin plasma levels	1E-18	    .05	[0.042-0.066] unit increase	HLA-C*07:01	C	0.16	23417110
TRIM31	Beta-2 microglubulin plasma levels	3E-15	    .03	[0.022-0.038] unit increase	rs2023472	A	0.38	23417110
HLA-C	Beta-2 microglubulin plasma levels	2E-23	    .04	[0.032-0.048] unit decrease	rs9264638	A	0.58	23417110
HLA-B	Beta-2 microglubulin plasma levels	9E-9	    .02	[0.012-0.028] unit increase	rs2523608	A	0.59	23417110
HLA-B	Beta-2 microglubulin plasma levels	1E-8	    .04	[0.026-0.054] unit increase	rs16899524	C	0.93	23417110
MICA	Beta-2 microglubulin plasma levels	2E-12	    .05	[0.034-0.066] unit decrease	rs2596466	C	0.07	23417110
NPRL3	Sickle cell anemia (haemolysis)	2E-9	    .44	[0.30-0.58] unit decrease	rs7203560	C	0.07	23406172
OR51L1	Sickle cell anemia (haemolysis)	1E-29	    .82	[0.68-0.96] unit decrease	rs2445284	G	0.05	23406172
OR51I1, OR51I2	Sickle cell anemia (haemolysis)	3E-10	    .26	[0.18-0.34] unit decrease	rs7948471	A	.21	23406172
NELL-1	Thiazide-induced adverse metabolic effects in hypertensive patients	7E-9	  28.20	[18.67-37.73] mg/dL increase	rs12279250	C	0.15	23400010
CHRNG, PRSS56	Refractive error	5E-11	    .14	[0.098-0.18] unit decrease	rs1881492	T	0.22	23396134
CACNA1D	Refractive error	2E-8	    .10	[0.063-0.129] unit increase	rs14165	A	0.32	23396134
LAMA2	Refractive error	2E-12	    .24	[0.17-0.3] unit increase	rs12205363	C	0.1	23396134
CHD7, TOX	Refractive error	4E-12	    .11	[0.077-0.135] unit increase	rs7837791	T	0.49	23396134
ZMAT4	Refractive error	4E-10	    .12	[0.081-0.151] unit increase	rs7829127	G	0.25	23396134
RORB	Refractive error	4E-8	    .10	[0.061-0.131] unit decrease	rs7042950	G	0.24	23396134
CYP26A1	Refractive error	1E-11	    .11	[0.076-0.138] unit decrease	rs10882165	T	0.42	23396134
BICC1	Refractive error	2E-13	    .11	[0.079-0.137] unit decrease	rs7084402	G	0.48	23396134
GRIA4	Refractive error	6E-9	    .10	[0.064-0.126] unit decrease	rs11601239	C	0.46	23396134
RDH5	Refractive error	4E-12	    .12	[0.086-0.152] unit increase	rs3138144	C	0.48	23396134
PCCA, ZIC2	Refractive error	2E-8	    .09	[0.056-0.114] unit increase	rs2184971	G	0.44	23396134
GJD2	Refractive error	1E-15	    .16	[0.12-0.2] unit decrease	rs524952	A	0.48	23396134
RASGRF1	Refractive error	4E-11	    .10	[0.073-0.131] unit decrease	rs4778879	G	0.44	23396134
MYO1D	Refractive error	1E-10	    .13	[0.092-0.17] unit decrease	rs17183295	T	0.23	23396134
KCNJ2	Refractive error	3E-8	    .08	[0.053-0.107] unit increase	rs4793501	C	0.42	23396134
LOC100506035	Refractive error	1E-8	    .10	[0.066-0.132] unit decrease	rs9307551	A	0.25	23396134
KCNQ5	Refractive error	4E-9	    .11	[0.075-0.149] unit increase	rs7744813	C	0.41	23396134
TJP2	Refractive error	7E-9	    .12	[0.083-0.165] unit decrease	rs11145465	A	0.25	23396134
PTPRR	Refractive error	5E-9	    .10	[0.066-0.132] unit increase	rs12229663	G	0.27	23396134
SIX6	Refractive error	1E-8	    .09	[0.059-0.117] unit decrease	rs1254319	A	0.32	23396134
RBFOX1	Refractive error	6E-10	    .12	[0.081-0.155] unit decrease	rs17648524	C	0.36	23396134
SHISA6	Refractive error	7E-11	    .10	[0.072-0.13] unit decrease	rs2969180	A	0.36	23396134
BMP2	Refractive error	2E-8	    .09	[0.058-0.12] unit decrease	rs235770	T	0.39	23396134
PRSS56	Refractive error	8E-11	    .15	[0.11-0.20] unit decrease	rs1656404	A	0.21	23396134
PDE8B	Thyroid hormone levels	2E-26	    .14	[0.12-0.16] unit decrease	rs6885099	A	0.594	23408906
PDE10A	Thyroid hormone levels	1E-24	    .10	[0.08-0.12] unit increase	rs753760	C	0.691	23408906
CAPZB	Thyroid hormone levels	4E-21	    .11	[0.089-0.137] unit decrease	rs10799824	A	0.161	23408906
MAF,LOC440389	Thyroid hormone levels	8E-18	    .08	[0.062-0.102] unit increase	rs3813582	T	0.674	23408906
VEGFA	Thyroid hormone levels	7E-16	    .08	[0.059-0.099] unit decrease	rs9472138	T	0.285	23408906
VEGFA	Thyroid hormone levels	2E-10	    .07	[0.045-0.085] unit decrease	rs11755845 	T	0.266	23408906
NR3C2	Thyroid hormone levels	9E-16	    .09	[0.065-0.109] unit increase	rs10032216	T	0.781	23408906
IGFBP5	Thyroid hormone levels	3E-15	    .08	[0.058-0.098] unit increase	rs13015993	A	0.736	23408906
SOX9	Thyroid hormone levels	8E-13	    .06	[0.046-0.082] unit decrease	rs9915657	T	0.541	23408906
NFIA	Thyroid hormone levels	5E-12	    .14	[0.1-0.182] unit decrease	rs334699	A	0.052	23408906
FGF7	Thyroid hormone levels	1E-11	    .07	[0.05-0.094] unit decrease	rs10519227	A	0.245	23408906
PRDM11	Thyroid hormone levels	9E-11	    .07	[0.045-0.085] unit decrease	rs17723470	T	0.279	23408906
MIR1179  	Thyroid hormone levels	3E-10	    .06	[0.04-0.08] unit decrease	rs17776563	A	0.322	23408906
INSR	Thyroid hormone levels	3E-10	    .06	[0.039-0.075] unit decrease	rs4804416	T	0.569	23408906
ABO	Thyroid hormone levels	4E-10	    .06	[0.04-0.076] unit increase	rs657152	A	0.343	23408906
ITPK1	Thyroid hormone levels	2E-9	    .06	[0.042-0.086] unit decrease	rs11624776	A	0.66	23408906
NRG1	Thyroid hormone levels	3E-9	    .07	[0.044-0.088] unit decrease	rs7825175	A	0.21	23408906
MBIP	Thyroid hormone levels	1E-8	    .05	[0.034-0.07] unit decrease	rs1537424	T	0.608	23408906
SASH1 	Thyroid hormone levels	2E-8	    .05	[0.033-0.069] unit increase	rs9497965	T	0.415	23408906
GLIS3 	Thyroid hormone levels	3E-8	    .06	[0.037-0.077] unit increase	rs1571583	A	0.249	23408906
DIO1	Thyroid hormone levels	8E-32	    .14	[0.11-0.16] unit increase	rs2235544	A	0.51	23408906
LHX3 	Thyroid hormone levels	2E-14	    .10	[0.077-0.127] unit increase	rs7860634	A	0.53	23408906
FOXE1	Thyroid hormone levels	2E-11	    .10	[0.069-0.127] unit increase	rs7045138	T	0.553	23408906
AADAT 	Thyroid hormone levels	5E-9	    .11	[0.074-0.148] unit increase	rs11726248	A	0.106	23408906
PDE8B	Thyroid hormone levels	6E-24	    .12	[0.096-0.144] unit decrease	rs6885099	A	0.594	23408906
PDE8B	Thyroid hormone levels	3E-38	    .17	[0.14-0.19] unit decrease	rs6885099	A	0.594	23408906
PDE10A	Thyroid hormone levels	5E-9	    .08	[0.051-0.101] unit increase	rs753760	C	0.691	23408906
PDE10A	Thyroid hormone levels	6E-20	    .13	[0.1-0.16] unit increase	rs753760	C	0.691	23408906
CAPZB	Thyroid hormone levels	3E-14	    .12	[0.092-0.154] unit decrease	rs10799824	A	0.161	23408906
CAPZB	Thyroid hormone levels	1E-8	    .10	[0.066-0.132] unit decrease	rs10799824	A	0.161	23408906
MAF,LOC440389	Thyroid hormone levels	6E-17	    .12	[0.088-0.142] unit increase	rs3813582	T	0.674	23408906
VEGFA	Thyroid hormone levels	6E-12	    .09	[0.065-0.115] unit decrease	rs9472138	T	0.285	23408906
NR3C2	Thyroid hormone levels	2E-13	    .11	[0.079-0.133] unit increase	rs10032216	T	0.781	23408906
IGFBP5	Thyroid hormone levels	8E-11	    .10	[0.066-0.124] unit increase	rs13015993	A	0.736	23408906
FGF7	Thyroid hormone levels	6E-10	    .10	[0.066-0.124] unit decrease	rs10519227	A	0.245	23408906
NRG1	Thyroid hormone levels	2E-8	    .08	[0.055-0.113] unit decrease	rs7825175	A	0.21	23408906
SASH1 	Thyroid hormone levels	3E-8	    .07	[0.043-0.091] unit increase	rs9497965	T	0.415	23408906
DIO1	Thyroid hormone levels	3E-18	    .13	[0.1-0.16] unit increase	rs2235544	A	0.51	23408906
DIO1	Thyroid hormone levels	5E-15	    .14	[0.11-0.18] unit increase	rs2235544	A	0.51	23408906
LHX3 	Thyroid hormone levels	5E-8	    .10	[0.063-0.133] unit increase	rs7860634	A	0.53	23408906
LHX3 	Thyroid hormone levels	2E-8	    .11	[0.071-0.145] unit increase	rs7860634	A	0.53	23408906
LPCAT2,CAPNS2	Thyroid hormone levels	5E-8	    .10	[0.064-0.134] unit increase	rs6499766	A	0.478	23408906
NETO1,FBXO15	Thyroid hormone levels	3E-8	    .08	[0.054-0.112] unit decrease	rs7240777	A	0.5632	23408906
KLKB1	Circulating vasoactive peptide levels 	4E-52	    .03	[0.027-0.035] nmol/l increase	rs4253238	C	0.46	23381795
KLKB1	Circulating vasoactive peptide levels 	1E-122	   5.14	[4.71-5.56] pmol/l increase	rs4253238	C	0.46	23381795
F12	Circulating vasoactive peptide levels 	6E-24	    .02	[0.018-0.026] nmol/l increase	rs2731672	T	0.24	23381795
F12	Circulating vasoactive peptide levels 	1E-67	   4.61	[4.09-5.13] pmol/l increase	rs2731672	T	0.24	23381795
EDN1	Circulating vasoactive peptide levels 	1E-27	   2.96	[2.42-3.49] pmol/l increase	rs5370	T	0.22	23381795
ADM	Circulating vasoactive peptide levels 	1E-12	    .02	[0.011-0.019] nmol/l decrease	rs2957692	G	0.40	23381795
TCF4	Schizophrenia	3E-10	   1.60	[NR] 	rs1261117	T	0.06	23894747
MYO10	Major depressive disorder	2E-8	   3.18	[2.77-3.59] 	rs17651119	C	0.99	23377640
Intergenic	Major depressive disorder	5E-8	   1.47	[1.33-1.61] 	rs10065906	C	0.308	23377640
Intergenic	Major depressive disorder	3E-8	    .24	[0.16-0.33] unit increase	rs12054895	T	0.275456	23377640
PHGDH	Metabolite levels	2E-14	NR	NR	rs478093	G	0.71	23378610
CPS1	Metabolite levels	3E-50	    .61	[0.53-0.69] unit decrease	rs715	T	0.68	23378610
BHMT, BHMT2	Metabolite levels	2E-9	    .38	[0.26-0.51] unit increase	rs17823642	C	0.89	23378610
SLC6A12, SLC6A13	Metabolite levels	2E-10	    .36	[0.25-0.46] unit decrease	rs499368	A	0.51	23378610
FADS1, FADS2, FADS3, FEN1	Metabolite levels	3E-9	    .28	[0.19-0.37] unit increase	rs174541	T	0.65	23378610
B4GALT1	IgG glycosylation	5E-8	    .05	[0.032-0.068] unit increase	rs12342831	T	0.73755	23382691
SYNGR1, TAB1, MGAT3, CACNA1I	IgG glycosylation	3E-8	    .08	[0.054-0.112] unit increase	rs909674	C	0.29096	23382691
SYNGR1, TAB1, MGAT3, CACNA1I	IgG glycosylation	2E-10	    .07	[0.050-0.094] unit increase	rs909674	C	0.29096	23382691
SUV420H1	IgG glycosylation	1E-8	    .17	[0.11-0.23] unit increase	rs4930561	G	0.510670339237057	23382691
SMARCB1,DERL3	IgG glycosylation	9E-10	    .26	[0.17-0.34] unit decrease	rs2186369	G	0.189377544642857	23382691
FUT8	IgG glycosylation	7E-14	    .24	[0.18-0.3] unit increase	rs11847263	G	0.391757509628303	23382691
NR	IgG glycosylation	5E-8	    .20	[0.13-0.27] unit increase	rs10813957	G	0.738414638629283	23382691
IL6ST,ANKRD55	IgG glycosylation	1E-10	    .29	[0.2-0.38] unit increase	rs17348299	C	0.836731980863373	23382691
SMARCB1,DERL3	IgG glycosylation	3E-8	    .23	[0.15-0.31] unit decrease	rs2186369	G	0.189496820649755	23382691
NR	IgG glycosylation	4E-8	    .80	[0.52-1.09] unit decrease	rs278541	C	0.97906300623053	23382691
ST6GAL1	IgG glycosylation	2E-45	    .50	[0.43-0.57] unit increase	rs11710456	G	0.699014551202137	23382691
ST6GAL1	IgG glycosylation	5E-19	    .39	[0.31-0.48] unit increase	rs7652995	G	0.176763000890472	23382691
ST6GAL1	IgG glycosylation	1E-8	    .20	[0.13-0.27] unit increase	rs11710456	G	0.698919993324432	23382691
B4GALT1	IgG glycosylation	3E-11	    .24	[0.17-0.31] unit decrease	rs12342831	C	0.262623398308856	23382691
RECK	IgG glycosylation	4E-8	    .20	[0.13-0.27] unit decrease	rs4878639	C	0.263725273253227	23382691
HLA-DQA2, HLA-DQB2	IgG glycosylation	4E-8	    .19	[0.12-0.25] unit increase	rs1049110	C	0.34601888034188	23382691
ABCF2,SMARCD3	IgG glycosylation	2E-10	    .31	[0.22-0.41] unit increase	rs1122979	G	0.875182808816914	23382691
FUT8	IgG glycosylation	8E-20	    .29	[0.23-0.35] unit increase	rs11847263	G	0.390847885290148	23382691
NR	IgG glycosylation	2E-9	    .19	[0.13-0.26] unit increase	rs6583437	G	0.63670095951417	23382691
SYNGR1,TAB1,MGAT3,CACNA1I	IgG glycosylation	5E-10	    .21	[0.14-0.28] unit decrease	rs909674	C	0.298923567230632	23382691
ST6GAL1	IgG glycosylation	6E-11	    .23	[0.16-0.3] unit increase	rs11710456	G	0.699064071907101	23382691
PRRT1	IgG glycosylation	4E-8	    .21	[0.14-0.29] unit decrease	rs9296009	T	0.196432337204109	23382691
ST6GAL1	IgG glycosylation	4E-31	    .40	[0.34-0.47] unit increase	rs11710456	G	0.698883767483296	23382691
B4GALT1	IgG glycosylation	3E-10	    .22	[0.15-0.29] unit decrease	rs12342831	C	0.262634642316258	23382691
ST6GAL1	IgG glycosylation	4E-16	    .35	[0.27-0.44] unit increase	rs7652995	G	0.176834709131403	23382691
ST6GAL1	IgG glycosylation	2E-13	    .26	[0.19-0.32] unit increase	rs11710456	G	0.698789225734639	23382691
B4GALT1	IgG glycosylation	3E-11	    .24	[0.17-0.31] unit decrease	rs12342831	C	0.262517754229742	23382691
ST6GAL1	IgG glycosylation	9E-37	    .44	[0.37-0.51] unit increase	rs11710456	G	0.69898246345811	23382691
ST6GAL1	IgG glycosylation	2E-20	    .40	[0.32-0.49] unit increase	rs7652995	G	0.176683507130125	23382691
ST6GAL1	IgG glycosylation	6E-75	    .64	[0.57-0.71] unit increase	rs11710456	G	0.699317446770601	23382691
ST6GAL1	IgG glycosylation	3E-40	    .58	[0.49-0.67] unit increase	rs7652995	G	0.17684106013363	23382691
IL6ST,ANKRD55	IgG glycosylation	2E-9	    .27	[0.18-0.35] unit decrease	rs17348299	C	0.836659126892253	23382691
ST6GAL1	IgG glycosylation	6E-17	    .29	[0.22-0.36] unit decrease	rs11710456	G	0.699014551202137	23382691
SLC38A10	IgG glycosylation	3E-8	    .17	[0.11-0.23] unit increase	rs7224668	C	0.524575415405165	23382691
ST6GAL1	IgG glycosylation	3E-37	    .45	[0.38-0.52] unit increase	rs11710456	G	0.699319077951002	23382691
ST6GAL1	IgG glycosylation	9E-15	    .34	[0.25-0.42] unit increase	rs7652995	G	0.176843186191537	23382691
SYNGR1,TAB1,MGAT3,CACNA1I	IgG glycosylation	2E-10	    .21	[0.15-0.28] unit increase	rs909674	C	0.298878222915738	23382691
ST6GAL1	IgG glycosylation	5E-44	    .49	[0.42-0.56] unit decrease	rs11710456	G	0.699243829246545	23382691
ST6GAL1	IgG glycosylation	7E-17	    .37	[0.28-0.45] unit decrease	rs7652995	G	0.176986749442711	23382691
B4GALT1	IgG glycosylation	1E-10	    .23	[0.16-0.3] unit increase	rs12342831	C	0.2625544125	23382691
ST6GAL1	IgG glycosylation	8E-17	    .29	[0.22-0.36] unit decrease	rs11710456	G	0.698797577867024	23382691
NR	IgG glycosylation	9E-11	    .23	[0.16-0.3] unit decrease	rs3780486	C	0.737437251227131	23382691
ST6GAL1	IgG glycosylation	5E-8	    .24	[0.15-0.33] unit decrease	rs7652995	G	0.176702207496653	23382691
ST6GAL1	IgG glycosylation	5E-17	    .29	[0.23-0.36] unit decrease	rs11710456	G	0.698840198840838	23382691
NR	IgG glycosylation	5E-11	    .23	[0.16-0.3] unit decrease	rs3780486	C	0.737450810521623	23382691
ST6GAL1	IgG glycosylation	5E-8	    .24	[0.15-0.33] unit decrease	rs7652995	G	0.176770524297815	23382691
NR	IgG glycosylation	1E-9	    .22	[0.15-0.29] unit increase	rs10813951	G	0.262554376171352	23382691
NR	IgG glycosylation	1E-11	    .25	[0.18-0.33] unit increase	rs137686	C	0.24173856626506	23382691
SMARCB1,DERL3	IgG glycosylation	1E-10	    .27	[0.19-0.35] unit decrease	rs2186369	G	0.189518247657296	23382691
NR	IgG glycosylation	5E-8	    .18	[0.12-0.24] unit increase	rs3788556	C	0.56038034270415	23382691
SYNGR1,TAB1,MGAT3,CACNA1I	IgG glycosylation	9E-24	    .34	[0.27-0.4] unit increase	rs909674	C	0.298476014725569	23382691
NR	IgG glycosylation	5E-10	    .22	[0.15-0.29] unit increase	rs10813951	G	0.262743396083667	23382691
SMARCB1,DERL3	IgG glycosylation	1E-10	    .27	[0.18-0.35] unit decrease	rs2186369	G	0.189496820649755	23382691
SYNGR1,TAB1,MGAT3,CACNA1I	IgG glycosylation	1E-24	    .34	[0.28-0.41] unit increase	rs909674	C	0.299013119715176	23382691
SUV420H1	IgG glycosylation	9E-10	    .19	[0.13-0.24] unit increase	rs4930561	G	0.511382618397086	23382691
NR	IgG glycosylation	4E-8	    .18	[0.11-0.24] unit increase	rs7973719	C	0.487491611566485	23382691
HLA-DQA2, HLA-DQB2	IgG glycosylation	2E-8	    .19	[0.12-0.26] unit increase	rs1049110	C	0.346381764494382	23382691
ABCF2,SMARCD3	IgG glycosylation	1E-9	    .30	[0.2-0.39] unit increase	rs1122979	G	0.874862054831461	23382691
FUT8	IgG glycosylation	3E-21	    .30	[0.24-0.37] unit increase	rs11847263	G	0.391170597752809	23382691
NR	IgG glycosylation	7E-10	    .20	[0.13-0.26] unit increase	rs6583437	G	0.636802753258427	23382691
IL6ST,ANKRD55	IgG glycosylation	3E-10	    .28	[0.19-0.37] unit decrease	rs17348299	C	0.836731980863373	23382691
ABCF2,SMARCD3	IgG glycosylation	6E-10	    .30	[0.21-0.4] unit increase	rs1122979	G	0.875396395193591	23382691
SYNGR1,TAB1,MGAT3,CACNA1I	IgG glycosylation	3E-13	    .25	[0.18-0.31] unit increase	rs909674	C	0.299013119715176	23382691
NR	IgG glycosylation	2E-13	    .23	[0.17-0.29] unit increase	rs11847263	G	0.393307344254937	23382691
NR	IgG glycosylation	4E-8	    .17	[0.11-0.24] unit increase	rs6583437	G	0.637533007630161	23382691
SMARCB1,DERL3	IgG glycosylation	7E-16	    .34	[0.25-0.42] unit decrease	rs2186369	G	0.189660889532294	23382691
SYNGR1,TAB1,MGAT3,CACNA1I	IgG glycosylation	3E-9	    .20	[0.13-0.27] unit increase	rs909674	C	0.299056983073497	23382691
ABCF2,SMARCD3	IgG glycosylation	2E-9	    .29	[0.2-0.39] unit increase	rs1122979	G	0.875342207034728	23382691
SYNGR1,TAB1,MGAT3,CACNA1I	IgG glycosylation	1E-10	    .22	[0.15-0.28] unit increase	rs909674	C	0.298923567230632	23382691
SMARCB1,DERL3	IgG glycosylation	5E-10	    .26	[0.18-0.34] unit decrease	rs2186369	G	0.189640669950739	23382691
FUT8	IgG glycosylation	2E-13	    .23	[0.17-0.29] unit increase	rs11847263	G	0.392332365307037	23382691
NR	IgG glycosylation	2E-9	    .22	[0.15-0.29] unit increase	rs10813957	G	0.738414638629283	23382691
IL6ST,ANKRD55	IgG glycosylation	7E-11	    .29	[0.2-0.38] unit increase	rs17348299	C	0.836731980863373	23382691
NR	IgG glycosylation	4E-8	    .81	[0.52-1.09] unit decrease	rs278541	C	0.97906300623053	23382691
IL6ST,ANKRD55	IgG glycosylation	1E-10	    .29	[0.2-0.37] unit decrease	rs17348299	C	0.836731980863373	23382691
NR	IgG glycosylation	3E-9	    .21	[0.14-0.28] unit increase	rs10813957	G	0.738414638629283	23382691
IL6ST,ANKRD55	IgG glycosylation	1E-10	    .29	[0.2-0.37] unit increase	rs17348299	C	0.836731980863373	23382691
FUT8	IgG glycosylation	2E-19	    .29	[0.22-0.35] unit decrease	rs11847263	G	0.39336899642538	23382691
NR	IgG glycosylation	3E-8	    .18	[0.11-0.24] unit decrease	rs6583437	G	0.636915159517426	23382691
FUT8	IgG glycosylation	1E-22	    .31	[0.25-0.37] unit decrease	rs11847263	G	0.393000049217002	23382691
NR	IgG glycosylation	1E-9	    .19	[0.13-0.26] unit decrease	rs6583437	G	0.636650594183445	23382691
FUT8	IgG glycosylation	5E-15	    .25	[0.19-0.31] unit increase	rs11847263	G	0.394040135631155	23382691
NR	IgG glycosylation	1E-8	    .18	[0.12-0.24] unit increase	rs6583437	G	0.637609347358997	23382691
FUT8	IgG glycosylation	3E-14	    .24	[0.18-0.3] unit decrease	rs11847263	G	0.393211372416891	23382691
NR	IgG glycosylation	5E-9	    .19	[0.12-0.25] unit decrease	rs6583437	G	0.637881567834681	23382691
FUT8	IgG glycosylation	3E-17	    .27	[0.21-0.33] unit decrease	rs11847263	G	0.393162371823451	23382691
SMARCB1,DERL3	IgG glycosylation	1E-12	    .29	[0.21-0.38] unit increase	rs2186369	G	0.189579642030276	23382691
IKZF1	IgG glycosylation	8E-12	    .22	[0.16-0.28] unit increase	rs6421315	C	0.368343116206589	23382691
SYNGR1,TAB1,MGAT3,CACNA1I	IgG glycosylation	2E-10	    .21	[0.15-0.28] unit decrease	rs909674	C	0.299146468388246	23382691
FUT8	IgG glycosylation	3E-8	    .17	[0.11-0.24] unit decrease	rs11847263	G	0.393668566146993	23382691
SMARCB1,DERL3	IgG glycosylation	4E-9	    .24	[0.16-0.33] unit increase	rs2186369	G	0.189663332739421	23382691
NR	IgG glycosylation	3E-12	    .24	[0.17-0.31] unit increase	rs4821897	G	0.707128727839644	23382691
IKZF1	IgG glycosylation	2E-13	    .24	[0.17-0.3] unit increase	rs6421315	C	0.368316756347439	23382691
SMARCB1,DERL3	IgG glycosylation	2E-14	    .32	[0.24-0.4] unit increase	rs2186369	G	0.189496820649755	23382691
SYNGR1,TAB1,MGAT3,CACNA1I	IgG glycosylation	3E-8	    .19	[0.12-0.25] unit decrease	rs909674	C	0.299013119715176	23382691
FUT8	IgG glycosylation	1E-10	    .20	[0.14-0.26] unit decrease	rs11847263	G	0.393717723953695	23382691
NR	IgG glycosylation	9E-17	    .35	[0.27-0.43] unit decrease	rs2186369	G	0.189496820649755	23382691
SYNGR1,TAB1,MGAT3,CACNA1I	IgG glycosylation	1E-16	    .28	[0.21-0.35] unit increase	rs909674	C	0.299013119715176	23382691
SMARCB1,DERL3	IgG glycosylation	1E-12	    .29	[0.21-0.38] unit decrease	rs2186369	G	0.189496820649755	23382691
NR	IgG glycosylation	4E-18	    .30	[0.23-0.36] unit decrease	rs4821897	G	0.707166482866044	23382691
IKZF1	IgG glycosylation	7E-11	    .21	[0.15-0.27] unit decrease	rs6421315	C	0.368179075211393	23382691
SMARCB1,DERL3	IgG glycosylation	8E-15	    .32	[0.24-0.41] unit decrease	rs2186369	G	0.189580990204809	23382691
SYNGR1,TAB1,MGAT3,CACNA1I	IgG glycosylation	6E-10	    .21	[0.14-0.28] unit increase	rs909674	C	0.298923976402493	23382691
LAMB1	IgG glycosylation	1E-8	    .37	[0.25-0.5] unit decrease	rs2072209	G	0.0582759206419973	23382691
SMARCB1,DERL3	IgG glycosylation	2E-8	    .23	[0.15-0.32] unit decrease	rs2186369	G	0.189823636647347	23382691
BACH2	IgG glycosylation	7E-9	    .21	[0.14-0.28] unit decrease	rs404256	C	0.559129675122385	23382691
SMARCB1,DERL3	IgG glycosylation	1E-16	    .35	[0.26-0.43] unit decrease	rs2186369	G	0.189496820649755	23382691
NR	IgG glycosylation	1E-8	    .20	[0.13-0.27] unit increase	rs4917017	G	0.70576580729862	23382691
NR	IgG glycosylation	4E-16	    .28	[0.21-0.34] unit increase	rs909674	C	0.299013119715176	23382691
SMARCB1,DERL3	IgG glycosylation	9E-17	    .35	[0.27-0.43] unit decrease	rs2186369	G	0.189496820649755	23382691
IKZF1	IgG glycosylation	1E-8	    .18	[0.12-0.25] unit decrease	rs6421315	C	0.368179075211393	23382691
SYNGR1,TAB1,MGAT3,CACNA1I	IgG glycosylation	6E-16	    .27	[0.21-0.34] unit increase	rs909674	C	0.299013119715176	23382691
SMARCB1,DERL3	IgG glycosylation	9E-17	    .35	[0.27-0.43] unit increase	rs2186369	G	0.189358691006233	23382691
IKZF1	IgG glycosylation	8E-9	    .19	[0.12-0.25] unit increase	rs6421315	C	0.368120581032947	23382691
SYNGR1,TAB1,MGAT3,CACNA1I	IgG glycosylation	2E-15	    .27	[0.2-0.34] unit decrease	rs909674	C	0.299146275601069	23382691
SMARCB1,DERL3	IgG glycosylation	2E-8	    .24	[0.15-0.32] unit decrease	rs2186369	G	0.190211496872207	23382691
SMARCB1,DERL3	IgG glycosylation	4E-9	    .25	[0.16-0.33] unit decrease	rs2186369	G	0.189826451627285	23382691
SMARCB1,DERL3	IgG glycosylation	2E-8	    .23	[0.15-0.31] unit increase	rs2186369	G	0.189496820649755	23382691
SMARCB1,DERL3	IgG glycosylation	3E-13	    .30	[0.22-0.39] unit decrease	rs2186369	G	0.189660889532294	23382691
SYNGR1,TAB1,MGAT3,CACNA1I	IgG glycosylation	3E-9	    .20	[0.13-0.27] unit increase	rs909674	C	0.299056983073497	23382691
MYL2	Coronary heart disease	4E-14	   1.26	[1.19-1.34] 	rs3782889	C	0.21	23364394
ACAD10, ALDH2, C12orf51, RPL6-PTPN11	Coronary heart disease	5E-11	   1.41	[1.27-1.56] 	rs11066015	A	NR	23364394
FGF21, FUT1, FUT2, IZUMO1, RASIP1	Dietary macronutrient intake	8E-9	    .11	[0.071-0.149] percent decrease	rs838133	A	0.45	23372041
C12orf51, CCDC63, MYL2, ALDH2	Drinking behavior	3E-215	   3.33	[3.23-3.45] 	rs11066280	T	0.84	23364009
C11orf10, C11orf9, FADS1, FADS2, FADS3, FEN1, RAB3IL1	Oleic acid (18:1n-9) plasma levels	2E-32	    .23	[0.192-0.268]  unit increase 	rs102275 	C	0.328	23362303
ALG14, RWDD3, CNN3, TMEM56 	Palmitic acid (16:0) plasma levels	3E-11	    .18	[0.125-0.23]  unit incease 	rs2391388 	C	0.451	23362303
GCKR, C2orf16, ZNF512, XAB1 	Palmitoleic acid (16:1n-7) plasma levels	1E-9	    .02	[0.014-0.027]  unit increase 	rs780093 	T	0.41	23362303
HIF1AN, SEC31B, NDUFB8, WNT8B, SCD 	Palmitoleic acid (16:1n-7) plasma levels	6E-9	    .02	 unit decrease 	rs11190604 	A	0.782	23362303
NAP5 	Palmitoleic acid (16:1n-7) plasma levels	4E-8	    .05	[0.031-0.065]  unit decrease 	rs6722456 	A	0.023	23362303
PKD2L1	Palmitoleic acid (16:1n-7) plasma levels	6E-15	    .03	[0.024-0.041] unit decrease	rs603424	A	0.193	23362303
C11orf0, C11orf9, FADS1, FADS2, FEN1 	Palmitoleic acid (16:1n-7) plasma levels	7E-13	    .02	[0.017-0.03]  unit increase 	rs102275 	T	0.329	23362303
C11orf10, FADS1, FADS2, FEN1, FADS3	Stearic acid (18:0) plasma levels	1E-20	    .18	[0.142-0.218] unit decrease	rs102275	C	0.322	23362303
ALG14, TMEM56	Stearic acid (18:0) plasma levels	2E-18	    .17	[0.128-0.202] unit decrease	rs6675668	T	0.49	23362303
RWDD3 	Stearic acid (18:0) plasma levels	2E-15	    .25	  unit decrease 	rs6671200 	A	NR 	23362303
CNN3 	Stearic acid (18:0) plasma levels	2E-14	    .15	  unit increase 	rs860873 	A	NR 	23362303
LPGAT1 	Stearic acid (18:0) plasma levels	3E-9	    .17	[0.113-0.223]  unit decrease 	rs11119805 	A	0.123	23362303
MECOM	Osteoporosis	4E-8	   1.39	[1.24-1.56] 	rs784288	A	0.23	23349225
SLC17A8, NR1H4, SCYL2, GAS2L3	Squamous cell carcinoma	1E-10	   1.28	[1.19-1.39] 	rs12296850	A	0.744	23341777
HLA-DRB5, HLA-DQA1	Lymphoma	2E-8	   1.37	[1.23-1.54] 	rs4530903	T	NR	23349640
LPXN	Lymphoma	4E-8	   1.29	[1.17-1.40] 	rs12289961	T	NR	23349640
HLA-DRB5, HLA-DQA1	Lymphoma	3E-12	   1.93	[NR] 	rs4530903	T	NR	23349640
HLA-DRA, HLA-DRB5, HLA-DRB1, BTLN2 	Lymphoma	2E-10	   1.56	[NR] 	rs9268853	C	NR	23349640
HLA-DQB2, TAP2	Lymphoma	2E-9	   1.57	[NR] 	rs2621416	G	NR	23349640
PTGDS	Beta-trace protein levels	1E-23	    .05	[0.040-0.060] unit increase	rs57024841	A	0.58	23328707
SSTR1, CLEC14A	Metabolite levels (5-HIAA/ MHPG Ratio)	5E-8	    .32	 unit increase	rs11622412	T	NR	23319000
C6orf10	Hepatitis C induced liver cirrhosis	9E-11	   1.46	[1.28-1.62] 	rs910049	A	0.142	23321320
BTNL2	Hepatitis C induced liver cirrhosis	1E-8	   1.30	[1.18-1.42] 	rs3817963	A	0.315	23321320
Intergenic	Hepatitis C induced liver cirrhosis	1E-10	   1.37	[1.24-1.51] 	rs9405098	A	0.253	23321320
Intergenic	Hepatitis C induced liver cirrhosis	1E-10	   1.37	[1.24-1.51] 	rs3135363	C	0.702	23321320
Intergenic	Hepatitis C induced liver cirrhosis	1E-9	   1.36	[1.22-1.49] 	rs3129860	A	0.231	23321320
CFH	Age-related macular degeneration	2E-31	   1.41	[1.33-1.49] 	rs1329424	T	0.38	23326517
CFH	Age-related macular degeneration	7E-32	   1.40	[1.32-1.48] 	rs1061147	A	0.37	23326517
FADS1	Hematology traits	4E-8	    .02	[0.011-0.023] unit increase	rs174548	G	0.319	23303382
TNFRSF13B	Hematology traits	8E-24	    .03	[0.025-0.037] unit increase	rs4561508	T	0.335	23303382
HLA-DRB1	Epstein-Barr virus immune response (EBNA-1)	3E-13	    .28	[NR] unit decrease	rs477515	T	0.32	23326239
HLA-DQB1, C6orf15, PSORS1C1, HLA-B, BAT2, BAT4, EHMT2, PRRT1, NOTCH4, 	Epstein-Barr virus immune response (EBNA-1)	2E-10	    .45	[NR] unit decrease	rs2854275	T	0.064	23326239
NR	Menopause (age at onset)	5E-26	    .30	[0.25-0.36] years decrease	rs11668344	A	0.636	23307926
NR	Menopause (age at onset)	5E-12	    .46	[0.33-0.59] years decrease	rs16991615	A	0.0785	23307926
NR	Menopause (age at onset)	4E-11	    .19	[0.13-0.25] years increase	rs1046089	A	0.3492	23307926
NR	Menopause (age at onset)	5E-8	    .16	[0.10-0.21] years increase	rs10852344	T	0.5835	23307926
TCF7L2	Type 2 diabetes	3E-19	   1.44	[1.33 - 1.56] 	rs7903146	T	0.31	23300278
SGCG, SACS	Type 2 diabetes	2E-8	   1.49	[1.3-1.72] 	rs9552911	G	0.93	23300278
TCF7L2	Type 2 diabetes	6E-22	   1.30	[1.23 - 1.37] 	rs7903146	T	0.31	23300278
TCF7L2	Type 2 diabetes	3E-35	   1.15	[1.13 - 1.18] 	rs7903146	T	0.3	23300278
IGF2BP2	Type 2 diabetes	4E-9	   1.06	[1.04-1.09] 	rs1470579	C	0.45	23300278
TCF7L2	Type 2 diabetes	2E-38	   1.15	[1.12 - 1.17] 	rs7903146	T	0.3	23300278
IGF2BP2	Type 2 diabetes	2E-13	   1.06	[1.04-1.08] 	rs1470579	C	0.45	23300278
TCF7L2	Type 2 diabetes	9E-75	   1.19	[1.17 - 1.21] 	rs7903146	T	0.5	23300278
IGF2BP2	Type 2 diabetes	2E-19	   1.08	[1.05-1.09] 	rs1470579	C	0.5	23300278
GPC5	Tetralogy of Fallot	3E-9	   1.29	[1.152-1.441] 	rs7982677	A	0.281	23297363
PTPN11	Tetralogy of Fallot	8E-11	   1.34	[1.208-1.496] 	rs11065987	G	0.418	23297363
B3GNT3	Tumor biomarkers	1E-13	    .07	[0.029-0.115] U/ml decrease	rs265548	C	0.26	23300138
ABO	Tumor biomarkers	7E-105	    .21	[0.18-0.23] ng/ml increase	rs8176749	T	0.18	23300138
FUT6	Tumor biomarkers	1E-35	    .07	[0.048-0.098] ng/ml increase	rs3760775	T	0.33	23300138
FUT2	Tumor biomarkers	6E-209	    .24	[0.21-0.26] ng/ml increase	rs1047781	T	0.46	23300138
FAM3B	Tumor biomarkers	3E-22	    .07	[0.040-0.098] ng/ml increase	rs441810	G	0.24	23300138
AFP	Tumor biomarkers	3E-18	    .07	[0.032-0.098] ng/ml decrease	rs12506899	G	0.32	23300138
HISPPD2A	Tumor biomarkers	1E-14	    .09	[0.056-0.118] ng/ml increase	rs2251844	C	0.42	23300138
FUT6	Tumor biomarkers	3E-290	    .48	[0.44-0.52] U/ml decrease	rs3760775	T	0.33	23300138
FUT2, CA11	Tumor biomarkers	8E-176	    .44	[0.41-0.48] U/ml increase	rs1047781	T	0.46	23300138
FUT6	Tumor biomarkers	5E-132	    .28	[0.20-0.37] U/ml increase	rs17271883	G	0.38	23300138
FUT6	Tumor biomarkers	2E-56	    .17	[0.11-0.22] U/ml decrease	rs3760776	T	0.20	23300138
HLA-DRB1, HLA-DQA1, HLA	Leishmaniasis (visceral)	3E-17	   1.41	[1.30-1.52] 	rs9271858	G	0.39	23291585
CCR1, CCR3	Behcet's disease	4E-13	   1.39	[1.27-1.52] 	rs7616215	C	0.654	23291587
STAT4	Behcet's disease	1E-9	   1.27	[1.17-1.37] 	rs7574070	A	0.421	23291587
KLRC4	Behcet's disease	1E-9	   1.28	[1.18-1.39] 	rs2617170	T	0.63	23291587
ERAP1	Behcet's disease	5E-11	   4.56	[2.88-7.22] 	rs17482078	T	0.02	23291587
ERAP1	Behcet's disease	4E-8	   3.08	[2.04-4.65] 	rs17482078	T	0.02	23291587
COL8A2	Corneal structure	3E-11	    .03	[-0.0092-0.0692] unit increase	rs96067	A	0.8	23291589
COL4A3	Corneal structure	1E-9	    .07	[0.05-0.09] unit decrease	rs7606754	A	0.35	23291589
FNDC3B	Corneal structure	5E-12	    .10	[0.061-0.139] unit decrease	rs4894535	T	0.17	23291589
TBL1XR1, KCNMB2	Corneal structure	1E-8	    .06	[0.04-0.08] unit decrease	rs7620503	T	0.39	23291589
NR3C2	Corneal structure	4E-8	    .12	[0.061-0.179] unit decrease	rs3931397	T	0.07	23291589
ADAMTS6	Corneal structure	6E-11	    .09	[0.07-0.11] unit increase	rs2307121	T	0.34	23291589
FAM46A, IBTK	Corneal structure	1E-12	    .07	[0.031-0.109] unit decrease	rs1538138	T	0.25	23291589
VKORC1L1	Corneal structure	4E-9	    .07	[0.05-0.09] unit increase	rs11763147	A	0.45	23291589
C7orf42	Corneal structure	3E-10	    .05	[0.03-0.07] unit increase	rs4718428	T	0.65	23291589
MPDZ, NF1B	Corneal structure	8E-9	    .05	[0.011-0.089] unit decrease	rs1324183	A	0.2	23291589
LPAR1	Corneal structure	5E-12	    .07	[0.031-0.109] unit increase	rs1007000	T	0.22	23291589
RXRA, COL5A1	Corneal structure	3E-22	    .12	[0.1-0.14] unit decrease	rs1536482	A	0.34	23291589
COL5A1	Corneal structure	5E-12	    .13	[0.091-0.169] unit decrease	rs7044529	T	0.15	23291589
LCN12, PTGDS	Corneal structure	6E-12	    .09	[0.07-0.11] unit increase	rs11145951	T	0.49	23291589
ARID5B	Corneal structure	6E-10	    .06	[0.04-0.08] unit increase	rs7090871	T	0.59	23291589
ARHGAP20, POU2AF1	Corneal structure	4E-9	    .06	[0.04-0.08] unit increase	rs4938174	A	0.31	23291589
GLT8D2	Corneal structure	2E-10	    .08	[0.041-0.119] unit decrease	rs1564892	A	0.76	23291589
FGF9, SGCG	Corneal structure	4E-9	    .10	[0.061-0.139] unit increase	rs1034200	A	0.23	23291589
FOXO1	Corneal structure	4E-14	    .17	[0.13-0.21] unit decrease	rs2721051	T	0.11	23291589
TJP1	Corneal structure	3E-11	    .14	[0.1-0.18] unit decrease	rs785422	T	0.11	23291589
SMAD3	Corneal structure	5E-10	    .08	[0.041-0.119] unit decrease	rs12913547	T	0.77	23291589
AKAP13	Corneal structure	7E-13	    .11	[0.071-0.149] unit decrease	rs6496932	A	0.2	23291589
LRRK1	Corneal structure	6E-19	    .11	[0.071-0.149] unit decrease	rs930847	T	0.77	23291589
CHSY1	Corneal structure	2E-9	    .08	[0.06-0.1] unit decrease	rs752092	A	0.66	23291589
BANP, ZNF469	Corneal structure	2E-49	    .17	[0.15-0.19] unit increase	rs9938149	A	0.62	23291589
HS3ST3B1, PMP22	Corneal structure	7E-10	    .08	[0.06-0.1] unit increase	rs12940030	T	0.71	23291589
PDGFRA	Corneal curvature	5E-14	    .13	[0.093-0.159] (unit decrease)	rs17084051	A	NR	23401653
ELF5	&beta;2-Glycoprotein I (&beta;2-GPI) plasma levels	5E-8	    .65	 (unit increase)	rs836132	C	0.15	23279374
ATF7IP	Prostate-specific antigen levels	2E-9	    .05	 % increase	rs3213764	G	0.467	23359319
KLK2, KLKP1	Prostate-specific antigen levels	6E-20	    .06	 % increase	rs1354774	G	0.343	23359319
F13A1	End-stage coagulation	3E-186	   1.08	[1-1.15] unit decrease	rs5985	C	0.741	23381943
F13A1	End-stage coagulation	8E-142	    .89	[0.82-0.96] unit decrease	rs3024321	A	0.679	23381943
ABO	End-stage coagulation	5E-57	    .56	[0.49-0.63] unit decrease	rs505922	T	0.68	23381943
ABO	End-stage coagulation	1E-49	    .51	[0.44-0.58] unit decrease	rs643434	G	0.656	23381943
F7/F10	End-stage coagulation	2E-47	    .85	[0.73-0.96] unit increase	rs10665	A	0.878	23381943
F7/F10	End-stage coagulation	1E-46	    .83	[0.72-0.95] unit increase	rs2181540	T	0.876	23381943
F7/F10	End-stage coagulation	2E-45	    .88	[0.76-1] unit increase	rs6041	G	0.892	23381943
CFHR4	End-stage coagulation	2E-30	    .52	[0.43-0.61] unit increase	rs10922162	C	0.839	23381943
CFHR4	End-stage coagulation	5E-30	    .52	[0.43-0.6] unit increase	rs12116643	T	0.84	23381943
ABO	End-stage coagulation	2E-25	    .46	[0.37-0.55] unit decrease	rs651007	C	0.81	23381943
F7/F10	End-stage coagulation	3E-19	    .53	[0.42-0.65] unit increase	rs3211770	G	0.879	23381943
CFHR4	End-stage coagulation	3E-19	    .30	[0.23-0.37] unit increase	rs7410943	A	0.531	23381943
CFHR4	End-stage coagulation	7E-19	    .34	[0.26-0.41] unit increase	rs4915559	T	0.759	23381943
F13A1	End-stage coagulation	5E-18	    .30	[0.23-0.37] unit decrease	rs11243081	C	0.676	23381943
F13A1	End-stage coagulation	1E-17	    .30	[0.23-0.37] unit decrease	rs17142067	A	0.67	23381943
ABO	End-stage coagulation	2E-17	    .58	[0.45-0.72] unit decrease	rs8176743	C	0.939	23381943
F13A1	End-stage coagulation	4E-17	    .27	[0.21-0.34] unit decrease	rs1318606	T	0.569	23381943
F7/F10	End-stage coagulation	1E-15	    .37	[0.28-0.46] unit decrease	rs555212	G	0.768	23381943
ORM1	End-stage coagulation	2E-10	    .46	[0.31-0.6] unit increase	rs10982156	T	0.939	23381943
CFHR4	End-stage coagulation	1E-9	    .20	[0.14-0.27] unit increase	rs1410996	G	0.585	23381943
FLJ33360	End-stage coagulation	2E-9	    .46	[0.31-0.61] unit decrease	rs12518614	A	0.954	23381943
ENOX1	End-stage coagulation	2E-9	    .31	[0.21-0.41] unit decrease	rs9533425	G	0.801	23381943
F3	End-stage coagulation	4E-8	    .24	[0.16-0.33] unit decrease	rs2022309	G	0.701	23381943
SLC45A3, NUCKS1, RAB7L1, SLC41A1, FLJ32569	Prostate-specific antigen levels	2E-19	    .20	[NR] % higher levels	rs12409639	A	0.11	23269536
MSMB	Prostate-specific antigen levels	5E-17	    .12	[NR] % higher levels	rs10993994	T	0.50	23269536
KLK3	Prostate-specific antigen levels	6E-37	    .19	[NR] % higher levels	rs2735839	G	0.58	23269536
TET3, DGUOK	Systemic lupus erythematosus	7E-17	   1.33	 	rs6705628	C	0.78	23273568
TET3, DGUOK	Systemic lupus erythematosus	6E-14	   1.27	 	rs4852324	T	0.76	23273568
CD80	Systemic lupus erythematosus	3E-16	   1.27	 	rs6804441	A	0.61	23273568
ARID5B, RTKN2	Systemic lupus erythematosus	5E-11	   1.18	 	rs4948496	C	0.63	23273568
CREBL2	Systemic lupus erythematosus	2E-8	   1.16	 	rs12822507	A	0.57	23273568
GPR19	Systemic lupus erythematosus	4E-17	   1.27	 	rs10845606	C	0.71	23273568
CDKN1B	Systemic lupus erythematosus	5E-12	   1.19	 	rs34330	C	0.52	23273568
DRAM1	Systemic lupus erythematosus	9E-12	   1.19	 	rs4622329	A	0.56	23273568
BLK	Systemic lupus erythematosus	2E-13	   1.49	 	rs2254546	G	0.73	23273568
HLA-DRB1	Systemic lupus erythematosus	5E-24	   1.73	 	rs9270984	T	0.18	23273568
IRF5	Systemic lupus erythematosus	1E-9	   1.47	 	rs729302	A	0.66	23273568
STAT4	Systemic lupus erythematosus	1E-21	   1.63	 	rs7574865	T	0.34	23273568
TNFAIP3	Systemic lupus erythematosus	1E-13	   2.71	 	rs2230926	G	0.02	23273568
TNFSF4	Systemic lupus erythematosus	3E-12	   1.36	 	rs2205960	T	0.25	23273568
UHRF1BP1	Systemic lupus erythematosus	1E-12	   1.56	 	rs3734266	G	0.13	23273568
WDFY4	Systemic lupus erythematosus	8E-9	   1.46	 	rs877819	A	0.18	23273568
ETS1	Systemic lupus erythematosus	3E-8	   1.51	 	rs6590330	A	0.35	23273568
ABO, LOC653163, ADAMTS13, OBP2B, OBP2A, C9orf96, LOC286310, SURF6, SURF5	Coagulation factor levels	1E-128	    .33	[0.30-0.36] lU/dL increase	rs687289	T	0.751	23267103
ABO, LOC653163, ADAMTS13, OBP2B, OBP2A, C9orf96, LOC286310, SURF6, SURF5	Coagulation factor levels	4E-34	    .34	[NR] lU/dL decrease	rs8176704	A	NR	23267103
VWF	Coagulation factor levels	5E-16	    .12	[0.091-0.149] lU/dL decrease	rs1063856	A	0.395	23267103
ABO	Coagulation factor levels	2E-138	    .34	[NR] lU/dL decrease	rs687289, rs8176704, rs8176749	S	0.720	23267103
ABO	Coagulation factor levels	4E-98	    .36	[NR] lU/dL increase	rs687289, rs8176704, rs8176749	S	0.155	23267103
ABO	Coagulation factor levels	7E-50	    .36	[NR] lU/dL increase	rs687289, rs8176704, rs8176749	S	0.0722	23267103
CCND2, PARP11, FGF23, FGF6, C12orf5, RAD51AP1	Colorectal cancer	3E-8	   1.09	[1.06-1.13] 	rs10774214	T	0.379	23263487
PITX1, CATSPER3, PCBD2, MIR4461 and H2AFY	Colorectal cancer	1E-10	   1.11	[1.08-1.15] 	rs647161	A	0.667	23263487
HAO1, PLCB1	Colorectal cancer	7E-9	   1.10	[1.06-1.14] 	rs2423279	C	0.252	23263487
CCND2, PARP11, FGF23, FGF6, C12orf5, RAD51AP1	Colorectal cancer	5E-10	   1.17	[1.11-1.23] 	rs10774214	T	0.352	23263487
PITX1, CATSPER3, PCBD2, MIR4461 and H2AFY	Colorectal cancer	4E-10	   1.17	[1.11-1.22] 	rs647161	A	0.313	23263487
SLC2A9	Gout	4E-26	    .47	[0.38-0.55] unit decrease	rs4475146	A	0.2237	23263486
ABCG2	Gout	2E-32	    .55	[0.46-0.64] unit decrease	rs1481012	A	0.8903	23263486
ABCG2	Urate levels	1E-134	    .22	[0.20-0.23] mg/dl increase	rs2231142	T	0.11	23263486
SLC17A1, SLC17A3	Urate levels	7E-70	    .09	[0.081-0.101] mg/dl decrease	rs1165151	T	0.47	23263486
GCKR	Urate levels	1E-44	    .07	[0.063-0.084] mg/dl increase	rs1260326	T	0.41	23263486
SLC22A11	Urate levels	9E-38	    .07	[0.061-0.085] mg/dl decrease	rs2078267	T	0.51	23263486
PDZK1	Urate levels	1E-29	    .06	[0.049-0.069] mg/dl increase	rs1471633	A	0.46	23263486
SLC16A9	Urate levels	2E-28	    .08	[0.065-0.093] mg/dl decrease	rs1171614	T	0.22	23263486
INHBC, INHBE	Urate levels	2E-25	    .07	[0.058-0.085] mg/dl decrease	rs3741414	T	0.24	23263486
RREB1	Urate levels	1E-23	    .06	[0.049-0.073] mg/dl increase	rs675209	T	0.27	23263486
TRIM46, PKLR	Urate levels	6E-19	    .05	[0.038-0.062] mg/dl decrease	rs11264341	T	0.43	23263486
HNF4G	Urate levels	4E-17	    .04	[0.034-0.054] mg/dl increase	rs2941484	T	0.44	23263486
HLF	Urate levels	5E-17	    .04	[0.032-0.052] mg/dl decrease	rs7224610	A	0.58	23263486
A1CF, ASAH2	Urate levels	7E-17	    .06	[0.043-0.071] mg/dl increase	rs10821905	A	0.18	23263486
SFMBT1, MUSTN1	Urate levels	3E-16	    .04	[0.034-0.054] mg/dl decrease	rs6770152	T	0.58	23263486
VEGFA	Urate levels	8E-16	    .05	[0.036-0.058] mg/dl decrease	rs729761	T	0.30	23263486
IGF1R	Urate levels	5E-15	    .04	[0.031-0.055] mg/dl increase	rs6598541	A	0.36	23263486
UBE2Q2, NRG4	Urate levels	3E-13	    .04	[0.031-0.055] mg/dl increase	rs1394125	A	0.34	23263486
OVOL1, LTBP3	Urate levels	3E-13	    .04	[0.026-0.045] mg/dl decrease	rs642803	T	0.46	23263486
BAZ1B, MLXIPL	Urate levels	1E-12	    .05	[0.034-0.06] unit increase	rs1178977	A	0.81	23263486
ATXN2, PTPN11	Urate levels	7E-12	    .04	[0.025-0.045] mg/dl decrease	rs653178	T	0.51	23263486
TMEM171	Urate levels	4E-11	    .04	[0.027-0.051] mg/dl decrease	rs17632159	C	0.31	23263486
NRXN2, SLC22A12	Urate levels	4E-11	    .05	[0.033-0.061] mg/dl decrease	rs478607	A	0.84	23263486
INHBB	Urate levels	2E-10	    .04	[0.023-0.047] mg/dl increase	rs17050272	A	0.43	23263486
NFAT5	Urate levels	8E-10	    .05	[0.030-0.062] mg/dl decrease	rs7193778	T	0.86	23263486
MAF	Urate levels	2E-9	    .03	[0.022-0.042] mg/dl decrease	rs7188445	A	0.33	23263486
ACVR1B, ACVRL1	Urate levels	2E-9	    .03	[0.022-0.042] mg/dl increase	rs7976059	T	0.35	23263486
PRKAG2	Urate levels	4E-9	    .04	[0.023-0.047] mg/dl increase	rs10480300	T	0.28	23263486
BCAS3, C17orf82	Urate levels	1E-8	    .04	[0.027-0.059] mg/dl increase	rs2079742	T	0.85	23263486
STC1	Urate levels	1E-8	    .03	[0.019-0.039] mg/dl decrease	rs17786744	A	0.58	23263486
ORC4L, ACVR2A	Urate levels	2E-8	    .03	[0.019-0.039] mg/dl decrease	rs2307394	T	0.68	23263486
B3GNT4	Urate levels	3E-8	    .03	[0.019-0.039] mg/dl decrease	rs7953704	A	0.47	23263486
SLC2A9	Urate levels	1E-700	    .37	[0.36-0.38] mg/dl increase	rs12498742	A	0.77	23263486
MYC	Colorectal cancer	1E-11	   1.13	[1.09-1.18] 	rs6983267	G	0.5	23266556
NABP1	Colorectal cancer	4E-8	   1.16	[1.10-1.22] 	rs11903757	C	0.16	23266556
TBC1D1	Crohn's disease	1E-11	   1.33	[1.22-1.44] 	rs1487630	T	NR	23266558
HLA-DQA2, HLA-DRB1, HLA-DQA1, HLA-DQB1, HLA-DOB, PSMB9	Crohn's disease	9E-59	   1.93	[1.78-2.09] 	rs7765379	G	NR	23266558
TNFSF15, LOC100129633, LOC645266, TNFSF8	Crohn's disease	5E-46	   1.73	[1.60-1.86] 	rs6478106	T	NR	23266558
ELF1, microRNA2276, SLC25A15, WBP4	Crohn's disease	8E-9	   1.27	[1.17-1.38] 	rs7329174	G	NR	23266558
STAT3	Crohn's disease	2E-15	   1.37	[1.27-1.48] 	rs9891119	A	NR	23266558
SOX11	Crohn's disease	4E-9	   1.22	[1.2-1.22] 	rs11894081	T	0.55	23266558
DNER	Pulmonary function (interaction)	3E-9	    .02	[-0.01048-0.04048] unit decrease	rs7594321	T	0.35	23284291
DNER	Pulmonary function (interaction)	5E-11	    .00	[0.00005-0.00035] unit decrease	rs7594321	T	0.35	23284291
HLA-DQB1, HLA-DQA2	Pulmonary function (interaction)	4E-9	    .00	[-0.04016-0.04216] unit decrease	rs7764819	T	0.89	23284291
HLA-DQB1, HLA-DQA2	Pulmonary function (interaction)	4E-9	    .00	[-0.00014-0.00025] unit decrease	rs7764819	T	0.89	23284291
KCNJ2, SOX9	Pulmonary function (interaction)	1E-8	    .02	[-0.00848-0.04248] unit decrease	rs11654749	T	0.39	23284291
HBE1, HBB, HBD, HBBP1, HBG1	Hematology traits	5E-11	    .45	[0.31-0.58] unit decrease	rs2213169	T	0.1362	23263863
Alpha-globin cluster	Hematology traits	2E-8	    .20	[0.13-0.27] unit decrease	rs7203560	G	0.06801	23263863
Alpha-globin cluster	Hematology traits	2E-23	    .15	[0.12-0.17] unit increase	rs7203560	G	0.06801	23263863
MPP1	Hematology traits	1E-11	    .07	[0.053-0.096] unit decrease	rs5987027	T	0.2462	23263863
DARC	Hematology traits	5E-47	    .06	[0.053-0.07] unit increase	rs4657616	G	0.099	23263863
ZBTB12, CFB, STK19 	Hematology traits	2E-8	    .03	[0.017-0.034] unit decrease	rs389884	C	0.0953	23263863
TMPRSS6	Hematology traits	3E-8	    .09	[0.058-0.121] unit decrease	rs855791	T	0.4408	23263863
Alpha-globin cluster	Hematology traits	7E-14	    .04	[0.031-0.053] unit increase	rs1211375	A	NR	23263863
DARC	Hematology traits	2E-23	    .02	[0.018-0.027] unit increase	rs2340727	A	NR	23263863
Alpha-globin cluster	Mean corpuscular hemoglobin	5E-62	   1.26	[1.11-1.4] unit decrease	rs7203560	G	0.06801	23263863
TMPRSS6 	Mean corpuscular hemoglobin	5E-14	    .23	[0.17-0.3] unit decrease	rs855791	T	0.4408	23263863
HBS1L, MYB	Mean corpuscular hemoglobin	4E-13	    .25	[0.19-0.32] unit increase	rs7775698	T	0.2615	23263863
TMPRSS6 	Mean corpuscular hemoglobin	7E-19	    .23	[0.18-0.28] unit decrease	rs855791	T	0.4408	23263863
Alpha-globin cluster	Mean corpuscular hemoglobin	3E-17	    .21	[0.16-0.26] unit decrease	rs1211375	A	NR	23263863
HBS1L, MYB	Mean corpuscular hemoglobin	4E-15	    .25	[0.19-0.31] unit decrease	rs9399137	T	NR	23263863
HFE	Mean corpuscular hemoglobin	7E-9	    .36	[0.24-0.48] unit increase	rs1800562	A	NR	23263863
CITED2	Mean corpuscular hemoglobin	9E-9	    .14	[0.092-0.186] unit decrease	rs668459	T	NR	23263863
Alpha-globin cluster	Mean corpuscular hemoglobin concentration	1E-33	    .53	[0.45-0.62] unit decrease	rs7203560	G	0.06801	23263863
HBE1, HBB, HBD, HBBP1, HBG1	Mean corpuscular hemoglobin concentration	1E-13	    .22	[0.16-0.28] unit increase	rs2213169	T	0.1362	23263863
Alpha-globin cluster	Mean corpuscular hemoglobin concentration	3E-11	    .12	[0.083-0.152] unit decrease	rs2266928	A	NR	23263863
Alpha-globin cluster	Mean corpuscular volume	8E-43	   2.56	[2.19-2.92] unit decrease	rs7203560	G	0.06801	23263863
MPP1	Mean corpuscular volume	4E-10	    .92	[0.63-1.2] unit increase	rs5987027	T	0.2462	23263863
HBS1L, MYB	Mean corpuscular volume	2E-9	    .54	[0.37-0.72] unit increase	rs7775698	T	0.2615	23263863
TMPRSS6 	Mean corpuscular volume	2E-9	    .48	[0.32-0.64] unit decrease	rs855791	T	0.4408	23263863
Alpha-globin cluster	Mean corpuscular volume	1E-16	    .53	[0.4-0.65] unit decrease	rs1211375	A	NR	23263863
TMPRSS6	Mean corpuscular volume	7E-12	    .46	[0.33-0.59] unit decrease	rs855791	T	0.4408	23263863
HBS1L, MYB	Mean corpuscular volume	1E-11	    .55	[0.39-0.71] unit decrease	rs9399137	T	NR	23263863
CITED2	Mean corpuscular volume	4E-8	    .34	[0.22-0.46] unit decrease	rs668459	T	NR	23263863
ARHGEF3	Platelet counts	9E-13	  11.44	[8.31-14.57] unit increase	rs1354034	C	0.27	23263863
BAK1	Platelet counts	2E-8	   8.92	[5.82-12.02] unit decrease	rs210134	A	0.2675	23263863
ARHGEF3 	Platelet counts	4E-9	   9.44	[6.3-12.59] unit decrease	rs1354034	T	0.4092	23263863
COPZ1 	Platelet counts	5E-8	   8.68	[5.57-11.79] unit decrease	rs4326844	A	0.4493	23263863
ARHGEF3	Platelet counts	1E-19	  10.44	[8.18-12.69] unit decrease	rs1354034	T	NR	23263863
BAK1 	Platelet counts	2E-12	   7.75	[5.59-9.92] unit decrease	rs513349	A	NR	23263863
apoB	LDL (oxidized)	3E-47	  10.50	 (U/L increase)	rs676210	G	0.77	23247145
STAT4	Hepatocellular carcinoma (hepatitis B virus related)	2E-10	   1.21	[1.14-1.28] 	rs7574865	G	0.67	23242368
HLA-DQ	Hepatocellular carcinoma (hepatitis B virus related)	3E-17	   1.49	[1.36-1.63] 	rs9275319	A	0.88	23242368
NCOA2, TRAM1	Cardiac Troponin-T levels	9E-9	    .04	[0.027-0.059] ug/L decrease	rs10091374	A	NR	23247143
TNNT2	Cardiac Troponin-T levels	5E-8	   2.33	[1.72-3.16] 	rs12564445	A	NR	23247143
TNNT2	Cardiac Troponin-T levels	5E-8	   2.33	[1.72-3.16] 	rs12564445	A	NR	23247143
Intergenic	Response to antipsychotic treatment	4E-8	NR	NR	rs8050896	T	0.161	23241943
PDE4D	Response to antipsychotic treatment	4E-8	NR	NR	rs17382202	T	0.153	23241943
SLCO1B1	Methotrexate clearance (acute lymphoblastic leukemia)	6E-21	  12.00	[NR] mL/min/m2 decrease	rs4149080	C	0.18	23233662
STAT4	Behcet's disease	6E-9	   1.45	[1.30-1.60] 	rs897200	A	0.529	23001997
STAT4	Behcet's disease	4E-8	   1.44	[1.3-1.6] 	rs897200, rs7572482, rs7574070	S	NR	23001997
STXBP5L, FBXO40	Aging (facial)	2E-8	NR	NR	rs322458	G	NR	23223146
STXBP5L, FBXO40	Aging (facial)	6E-9	NR	NR	rs322458, rs17740066	S	NR	23223146
STXBP5L, FBXO40	Aging (facial)	4E-9	NR	NR	rs322458, rs6782025	S	NR	23223146
STXBP5L, FBXO40, POLQ	Aging (facial)	1E-9	NR	NR	rs322458, rs6775899	S	NR	23223146
HTR1A, IPO11	Alcohol and nictotine co-dependence	1E-9	   1.15	[NR] 	rs7445832	A	NR	23216389
HEYL	Red blood cell traits	3E-10	    .01	[0.0072-0.0088] unit increase	rs3916164	G	0.71	23222517
OR10Z1, OR6Y1, SPTA1	Red blood cell traits	4E-16	    .01	[-0.01556-0.02756] unit decrease	rs857684	C	0.74	23222517
MIR181A1	Red blood cell traits	8E-9	    .01	[0.010-0.018] unit increase	rs7529925	C	0.28	23222517
TRIM58	Red blood cell traits	5E-10	    .02	[0.012-0.024] unit increase	rs3811444	T	0.35	23222517
PRKCE	Red blood cell traits	3E-19	    .15	[0.12-0.19] unit increase	rs4953318	A	0.62	23222517
BCL11A	Red blood cell traits	4E-13	    .18	[0.13-0.23] unit decrease	rs243070	T	0.72	23222517
ACOXL	Red blood cell traits	4E-11	    .13	[0.083-0.181] unit decrease	rs10207392	G	0.44	23222517
THRB	Red blood cell traits	6E-16	    .21	[0.16-0.26] unit decrease	rs9310736	A	0.35	23222517
RASA2	Red blood cell traits	4E-11	    .14	[0.087-0.189] unit decrease	rs6776003	A	0.44	23222517
TFRC	Red blood cell traits	7E-19	    .01	[0.00016-0.01584] unit increase	rs11717368	C	0.52	23222517
KIT	Red blood cell traits	3E-39	    .03	[0.027-0.039] unit increase	rs218238	A	0.78	23222517
SLC17A3, HFE	Red blood cell traits	5E-67	    .03	[0.015-0.051] unit increase	rs1408272	G	0.07	23222517
CCND3	Red blood cell traits	2E-40	    .37	[0.31-0.42] unit decrease	rs9349204	G	0.27	23222517
CCDC162P	Red blood cell traits	6E-26	    .01	[0.0041-0.0159] unit decrease	rs1008084	G	0.56	23222517
HBS1L	Red blood cell traits	3E-19	    .60	[0.55-0.65] unit decrease	rs9389269	T	0.72	23222517
LOC645434, CITED2	Red blood cell traits	5E-36	    .31	[0.26-0.36] unit increase	rs590856	G	0.43	23222517
IKZF1	Red blood cell traits	2E-13	    .20	[0.15-0.26] unit decrease	rs12718598	T	0.51	23222517
ACTL6B, TFR2	Red blood cell traits	2E-20	    .02	[0.016-0.028] unit increase	rs2075672	A	0.39	23222517
PRKAG2	Red blood cell traits	8E-15	    .05	[0.038-0.066] unit increase	rs10480300	C	0.72	23222517
RCL1	Red blood cell traits	1E-19	    .28	[0.22-0.34] unit decrease	rs2236496	C	0.22	23222517
ABO	Red blood cell traits	9E-18	    .02	[0.015-0.027] unit increase	rs579459	T	0.8	23222517
MARCH8	Red blood cell traits	2E-16	    .36	[0.27-0.46] unit increase	rs901683	A	0.08	23222517
HK1	Red blood cell traits	4E-20	    .09	[0.067-0.107] unit increase	rs10159477	A	0.16	23222517
NKX2-3	Red blood cell traits	1E-10	    .01	[0.0032-0.0188] unit decrease	rs11190134	G	0.6	23222517
CACNA1C	Red blood cell traits	3E-9	    .10	[0.067-0.141] unit increase	rs7312105	G	0.36	23222517
CCND2	Red blood cell traits	8E-12	    .01	[-0.00180-0.01780] unit decrease	rs10849023	C	0.79	23222517
KITLG	Red blood cell traits	6E-11	    .01	[0.0091-0.0169] unit increase	rs11104870	C	0.3	23222517
SH2B3, ATXN2	Red blood cell traits	4E-19	    .05	[0.039-0.063] unit increase	rs3184504	T	0.48	23222517
FNTB, MAX	Red blood cell traits	2E-12	    .00	[-0.00584-0.00984] unit increase	rs7155454	A	0.51	23222517
SMOC1	Red blood cell traits	1E-9	    .16	[0.099-0.225] unit increase	rs11627546	C	0.84	23222517
EIF5	Red blood cell traits	8E-11	    .01	[-0.00364-0.03164] unit increase	rs17616316	G	0.07	23222517
LIPC	Red blood cell traits	7E-11	    .03	[0.022-0.046] unit increase	rs1532085	G	0.59	23222517
DENND4A, PTPLAD1	Red blood cell traits	3E-9	    .15	[0.096-0.210] unit increase	rs2572207	C	0.74	23222517
NRG4	Red blood cell traits	3E-10	    .03	[0.016-0.040] unit increase	rs11072566	A	0.48	23222517
NPRL3, KIF22	Red blood cell traits	6E-23	    .01	[-0.00084-0.01484] unit increase	rs11248850	G	0.5	23222517
FAM38A, PIEZO1	Red blood cell traits	2E-22	    .02	[-0.00352-0.04352] unit increase	rs10445033	G	0.37	23222517
SYCE2, CALR, FARSA	Red blood cell traits	8E-20	    .01	[-0.00184-0.01384] unit increase	rs741702	A	0.35	23222517
NUDT19	Red blood cell traits	1E-10	    .18	[0.11-0.24] unit increase	rs3892630	T	0.18	23222517
RBM38	Red blood cell traits	4E-13	    .22	[0.15-0.28] unit increase	rs737092	C	0.49	23222517
ATP5O	Red blood cell traits	8E-10	    .15	[0.087-0.221] unit increase	rs2032314	T	0.08	23222517
UBE2L3, YDJC	Red blood cell traits	9E-10	    .19	[0.13-0.25] unit increase	rs5754217	G	0.83	23222517
FBXO7	Red blood cell traits	3E-13	    .01	[-0.00084-0.01484] unit increase	rs5749446	T	0.62	23222517
TMPRSS6, KCTD17	Red blood cell traits	1E-69	    .01	[0.0042-0.0198] unit increase	rs855791	G	0.57	23222517
ODF3B, TYMP, NCAPH2, SCO2	Red blood cell traits	5E-23	    .29	[0.23-0.35] unit increase	rs140522	C	0.67	23222517
TMEM229B	Obesity-related traits	5E-8	    .04	[NR]  kcal increase	rs17104363	G	0.05	23251661
COL4A1	Obesity-related traits	5E-8	    .05	[NR]  SD/y increase	rs494558	G	0.078	23251661
TSEN34, MBOAT7	Obesity-related traits	3E-8	    .05	[NR]  cm/y increase	rs7595	G	0.389	23251661
MTNR1B, LOC642791	Obesity-related traits	4E-8	    .05	[NR] mg/dL increase	rs10830963	G	0.205	23251661
ABO	Obesity-related traits	2E-8	    .04	[NR] pg/mL increase	rs657152	A	0.254	23251661
DARC, FCER1A, OR10J5, OR10J1	Obesity-related traits	1E-21	    .10	[NR] pg/mL increase	rs12075	A	0.436	23251661
CCR3, CCR2	Obesity-related traits	7E-9	    .05	[NR] pg/mL increase	rs12636651	G	0.403	23251661
DFNB31	Obesity-related traits	2E-8	    .06	[NR]  pg/mL increase	rs79509430	A	0.068	23251661
RASGEF1A	Obesity-related traits	5E-8	    .05	[NR]  pg/mL increase	rs28461806	G	0.049	23251661
C21orf34	Obesity-related traits	5E-8	    .04	[NR]  unit increase	rs2823615	A	0.178	23251661
CTCFL, HMG1L1	Obesity-related traits	4E-8	    .04	[NR]  min/d increase	rs6025590	A	0.308	23251661
ARHGAP11A, SCG5	Obesity-related traits	5E-8	    .04	[NR]  min/d increase	rs8037818	G	0.181	23251661
ZNF259, APOA5	Obesity-related traits	3E-8	    .04	[NR]  mg/dL increase	rs3741298	G	0.48	23251661
XPA, FOXE1	Obesity-related traits	1E-9	    .04	[NR] µIU/mL increase	rs1443438	A	0.253	23251661
MATK	Obesity-related traits	3E-8	    .05	[NR]  kcal/d increase	rs12104221	A	0.381	23251661
TOMM40	Cognitive decline	2E-8	    .20	[0.12-0.28] unit decrease	rs2075650	G	NR	23207651
TCF7L2	Type 2 diabetes	1E-35	   1.51	[1.42-1.62] 	rs7903146	T	0.30	23209189
CCNL1	Birth weight	4E-38	    .07	[0.060-0.084] gram decrease	rs900400	C	0.39	23202124
ADCY5	Birth weight	6E-20	    .06	[0.047-0.071] gram decrease	rs9883204	C	0.76	23202124
HMGA2	Birth weight	1E-19	    .05	[0.037-0.057] gram decrease	rs1042725	T	0.50	23202124
CDKAL1	Birth weight	2E-18	    .05	[0.038-0.062] gram decrease	rs6931514	G	0.29	23202124
Intergenic	Birth weight	5E-8	    .03	[0.022-0.046] gram decrease	rs4432842	C	0.30	23202124
LCORL	Birth weight	5E-11	    .04	[0.030-0.054] gram decrease	rs724577	C	0.73	23202124
ADRB1	Birth weight	4E-9	    .04	[0.027-0.055] gram decrease	rs1801253	G	0.26	23202124
NOS1AP	QT interval	2E-15	   3.14	[2.38-3.90] unit decrease	rs12143842	C	0.80	23166209
ATP1B1	QT interval	2E-10	   2.06	[1.43-2.69] unit decrease	rs1320976	A	0.25	23166209
BMP2	Sagittal craniosynostosis	1E-39	   4.38	[3.51-5.45] 	rs1884302	C	0.30	23160099
BBS9	Sagittal craniosynostosis	6E-20	   4.17	[3.13-5.88] 	rs10262453	A	0.69	23160099
TREM2	Alzheimer's disease	2E-12	   2.90	[2.16-3.91] 	rs75932628	T	0.0063	23150908
TP63	Lung cancer	4E-9	   1.19	[1.12-1.26] 	rs4488809	C	0.42	23143601
TERT, hTERT	Lung cancer	4E-27	   1.38	[1.30-1.47] 	rs2736100	G	0.40	23143601
VTI1A	Lung cancer	4E-18	   1.28	[1.21-.1.35] 	rs7086803	A	0.27	23143601
ROS1, DCBLD1	Lung cancer	4E-10	   1.18	[1.11-1.23] 	rs9387478	C	0.50	23143601
HLA class II	Lung cancer	1E-8	   1.17	[1.11-1.23] 	rs2395185, rs28366298	T	0.35	23143601
PRSS1, PRSS2	Pancreatitis	2E-14	   1.36	[1.30-1.42] 	rs10273639	C	0.576	23143602
CLDN2, MORC4, RIPPLY1, TBC1D8B	Pancreatitis	2E-22	   1.39	[1.28-1.49] 	rs12688220	T	0.261	23143602
SCGB1A1	Chronic obstructive pulmonary disease-related biomarkers	1E-26	NR	NR	rs3741240	A	0.36	23144326
AHNAK	Chronic obstructive pulmonary disease-related biomarkers	2E-14	NR	NR	rs2077224	A	0.38	23144326
ASRGL1	Chronic obstructive pulmonary disease-related biomarkers	1E-10	NR	NR	rs2463822	T	0.12	23144326
AHNAK	Chronic obstructive pulmonary disease-related biomarkers	1E-9	NR	NR	rs17157266	C	0.18	23144326
APIP, EHF	Chronic obstructive pulmonary disease-related biomarkers	7E-9	NR	NR	rs7929679	G	0.49	23144326
SFTPD	Chronic obstructive pulmonary disease-related biomarkers	2E-27	NR	NR	rs3923564	G	0.04	23144326
ATP2C2	Chronic obstructive pulmonary disease-related biomarkers	9E-13	NR	NR	rs8048576	A	0.12	23144326
RP11-369J21.2	Chronic obstructive pulmonary disease-related biomarkers	2E-12	NR	NR	rs728616	T	0.08	23144326
RP11-369J21.4	Chronic obstructive pulmonary disease-related biomarkers	1E-11	NR	NR	rs3851050	C	0.41	23144326
RP11-369J21.5, RP11-369J21.6	Chronic obstructive pulmonary disease-related biomarkers	7E-11	NR	NR	rs12220777	C	0.08	23144326
ANXA11	Chronic obstructive pulmonary disease-related biomarkers	1E-10	NR	NR	rs6585424	G	0.13	23144326
HLA-C	Chronic obstructive pulmonary disease-related biomarkers	2E-10	NR	NR	rs2074488	T	0.13	23144326
FGFR3P	Chronic obstructive pulmonary disease-related biomarkers	4E-10	NR	NR	rs9266629	C	0.21	23144326
SFTPD	Chronic obstructive pulmonary disease-related biomarkers	5E-9	NR	NR	rs7078012	T	0.13	23144326
RP11-479O17.4	Chronic obstructive pulmonary disease-related biomarkers	5E-9	NR	NR	rs1923539	A	0.25	23144326
PSORS1C1, CCHCR1	Chronic obstructive pulmonary disease-related biomarkers	6E-9	NR	NR	rs1265093	A	0.26	23144326
PSORS1C1	Chronic obstructive pulmonary disease-related biomarkers	8E-9	NR	NR	rs3130559	T	0.2	23144326
MEIS1	PR interval	1E-11	   2.13	[1.52-2.74] unit increase	rs3891585	A	0.43	23139255
ITGA9	PR interval	4E-11	   2.73	[1.93-3.53] unit increase	rs267567	A	0.18	23139255
SCN5A	PR interval	5E-43	   4.54	[3.89-5.19] unit decrease	rs3922844	T	0.58	23139255
ARHGAP24	PR interval	3E-9	   2.28	[1.52-3.04] unit increase	rs11732231	C	0.23	23139255
CAV1	PR interval	4E-12	   2.29	[1.64-2.94] unit decrease	rs11773845	A	0.36	23139255
TBX5	PR interval	1E-19	   3.19	[2.50-3.88] unit increase	rs1895585	A	0.30	23139255
SCN5A	PR interval	4E-12	   2.62	[1.88-3.36] unit increase	rs6763048	A	0.73	23139255
SCN10A	PR interval	9E-9	   3.36	[2.22-4.50] unit increase	rs6801957	T	0.27	23139255
HHAT	Schizophrenia	6E-9	   2.63	[1.89-3.66] 	rs7527939	C	NR	23142968
CETP	Lipoprotein-associated phospholipase A2 activity and mass	7E-21	    .02	[0.014-0.030] ng/ml increase	rs3764261	T	0.34	23118302
PLA2G7	Lipoprotein-associated phospholipase A2 activity and mass	3E-19	    .02	[0.016-0.030] ng/ml increase	rs1362931	A	0.19	23118302
MS4A4E	Lipoprotein-associated phospholipase A2 activity and mass	2E-11	    .01	[0.0068-0.0206] ng/ml decrease	rs600550	T	0.38	23118302
APOC1, APOE	Lipoprotein-associated phospholipase A2 activity and mass	1E-56	    .07	[0.049-0.093] ng/ml decrease	rs445925	T	0.11	23118302
SORT1	Lipoprotein-associated phospholipase A2 activity and mass	2E-22	    .03	[0.027-0.042] ng/ml decrease	rs12740374	T	0.22	23118302
SCARB1	Lipoprotein-associated phospholipase A2 activity and mass	6E-14	    .03	[0.019-0.038] ng/ml increase	rs11057841	T	0.15	23118302
TMEM49	Lipoprotein-associated phospholipase A2 activity and mass	3E-9	    .01	[0.0039-0.0145] ng/ml decrease	rs11650106	C	0.48	23118302
ABCG2	Lipoprotein-associated phospholipase A2 activity change in response to statin therapy	2E-10	   2.80	[1.82-3.78] percent decrease	rs2199936	A	0.11	23118302
LPA	Lipoprotein-associated phospholipase A2 activity change in response to statin therapy	2E-16	   4.80	[0.82-2.78] percent increase	rs10455872	G	0.05	23118302
Intergenic	Crohn's disease	3E-9	   1.13	[1.077-1.194] 	rs17391694	C	0.889	23128233
PTPN22,DCLRE1B	Crohn's disease	2E-15	   1.20	[1.129-1.268] 	rs6679677	C	0.907	23128233
ADAM30	Crohn's disease	2E-11	   1.16	[1.101-1.224] 	rs3897478	T	0.891	23128233
FASLG,TNFSF18	Crohn's disease	6E-22	   1.13	[1.083-1.167] 	rs9286879	G	0.249	23128233
UCN	Crohn's disease	5E-16	   1.12	[1.086-1.16] 	rs1728918	A	0.299	23128233
Intergenic	Crohn's disease	1E-9	   1.10	[1.062-1.134] 	rs10865331	A	0.396	23128233
SP140	Crohn's disease	1E-16	   1.13	[1.089-1.18] 	rs6716753	C	0.196	23128233
ATG16L1, INPP5D	Crohn's disease	4E-70	   1.23	[1.193-1.274] 	rs12994997	A	0.523	23128233
TXK,TEC,SLC10A4	Crohn's disease	2E-8	   1.09	[1.049-1.123] 	rs6837335	G	0.647	23128233
Intergenic	Crohn's disease	2E-12	   1.17	[1.10-1.248] 	rs13126505	A	0.096	23128233
IL6ST,IL31RA	Crohn's disease	4E-12	   1.12	[1.079-1.17] 	rs10065637	C	0.773	23128233
Intergenic	Crohn's disease	6E-10	   1.09	[1.05-1.126] 	rs7702331	A	0.621	23128233
CPEB4	Crohn's disease	5E-9	   1.10	[1.055-1.136] 	rs17695092	T	0.703	23128233
Intergenic	Crohn's disease	4E-12	   1.10	[1.06-1.131] 	rs12663356	C	0.533	23128233
HLA-C,PSORS1C1,NFKBIL1,MICB	Crohn's disease	5E-28	   1.15	[1.107-1.184] 	rs9264942	C	0.378	23128233
Intergenic	Crohn's disease	4E-10	   1.08	[1.042-1.112] 	rs9491697	G	0.439	23128233
Intergenic	Crohn's disease	8E-15	   1.17	[1.118-1.23] 	rs13204742	T	0.124	23128233
TAGAP	Crohn's disease	3E-14	   1.11	[1.069-1.141] 	rs212388	C	0.41	23128233
Intergenic	Crohn's disease	3E-8	   1.09	[1.048-1.13] 	rs10486483	A	0.247	23128233
CREB5,JAZF1	Crohn's disease	4E-9	   1.09	[1.052-1.123] 	rs864745	T	0.497	23128233
RIPK2	Crohn's disease	1E-8	   1.08	[1.035-1.116] 	rs7015630	T	0.739	23128233
Intergenic	Crohn's disease	1E-16	   1.19	[1.128-1.246] 	rs6651252	T	0.865	23128233
LACC1	Crohn's disease	2E-21	   1.16	[1.112-1.199] 	rs3764147	G	0.248	23128233
RASGRP1,SPRED1	Crohn's disease	4E-9	   1.09	[1.045-1.132] 	rs16967103	C	0.203	23128233
NOD2,ADCY7	Crohn's disease	6E-209	   3.10	[1.497-1.618] 	rs2066847	T	0.024	23128233
LGALS9,NOS2	Crohn's disease	9E-17	   1.14	[1.10-1.175] 	rs2945412	A	0.587	23128233
GPX4,HMHA1	Crohn's disease	8E-22	   1.16	[1.112-1.201] 	rs2024092	A	0.215	23128233
Intergenic	Crohn's disease	2E-10	   1.10	[1.06-1.139] 	rs4802307	G	0.706	23128233
DBP,SPHK2,IZUMO1,FUT2	Crohn's disease	1E-15	   1.11	[1.071-1.143] 	rs516246	T	0.483	23128233
IFNGR2,IFNAR1,IFNAR2,IL10RB,GART,TMEM50B	Crohn's disease	2E-16	   1.12	[1.086-1.162] 	rs2284553	G	0.599	23128233
TNFRSF18,TNFRSF4	Inflammatory bowel disease	8E-13	   1.10	[1.059-1.139] 	rs12103	A	0.182	23128233
TNFRSF9	Inflammatory bowel disease	1E-15	   1.11	[1.07-1.156] 	rs35675666	G	0.838	23128233
Intergenic	Inflammatory bowel disease	1E-17	   1.10	[1.054-1.138] 	rs12568930	T	0.821	23128233
IL23R,IL12RB2	Inflammatory bowel disease	8E-161	   2.01	[1.885-2.15] 	rs11209026	G	0.933	23128233
Intergenic	Inflammatory bowel disease	2E-8	   1.02	[0.986-1.044] 	rs2651244	G	0.599	23128233
RORC	Inflammatory bowel disease	4E-16	   1.14	[1.098-1.192] 	rs4845604	G	0.857	23128233
UBQLN4,RIT1,MSTO1	Inflammatory bowel disease	6E-11	   1.06	[1.028-1.092] 	rs670523	A	0.324	23128233
CD48,SLAMF1,ITLN1,CD244,F11R,USF1,SLAMF7,ARHGAP30	Inflammatory bowel disease	7E-9	   1.06	[1.029-1.094] 	rs4656958	G	0.686	23128233
FCGR2A,FCGR2B,FCGR3A,HSPA6,FCGR3B,FCRLA	Inflammatory bowel disease	2E-38	   1.12	[1.092-1.157] 	rs1801274	A	0.509	23128233
C1orf53	Inflammatory bowel disease	8E-13	   1.12	[1.077-1.153] 	rs2488389	A	0.22	23128233
KIF21B	Inflammatory bowel disease	1E-32	   1.16	[1.128-1.202] 	rs7554511	C	0.725	23128233
IL10,IL20,IL19,IL24,PIGR,MAPKAPK2,FAIM3,RASSF5	Inflammatory bowel disease	7E-42	   1.21	[1.163-1.254] 	rs3024505	A	0.16	23128233
ADCY3	Inflammatory bowel disease	6E-16	   1.11	[1.077-1.141] 	rs6545800	T	0.445	23128233
FOSL2,BRE	Inflammatory bowel disease	3E-15	   1.09	[1.061-1.124] 	rs925255	C	0.557	23128233
Intergenic	Inflammatory bowel disease	8E-12	   1.09	[1.041-1.131] 	rs10495903	T	0.13	23128233
REL,C2orf74,KIAA1841,AHSA2	Inflammatory bowel disease	9E-32	   1.14	[1.105-1.171] 	rs7608910	G	0.394	23128233
SPRED2	Inflammatory bowel disease	2E-8	   1.08	[1.046-1.116] 	rs6740462	A	0.739	23128233
IL1R2,IL18RAP,IL18R1,IL1R1,IL1RL1,IL1RL2	Inflammatory bowel disease	3E-20	   1.10	[1.067-1.14] 	rs917997	T	0.231	23128233
IFIH1	Inflammatory bowel disease	2E-8	   1.07	[1.035-1.097] 	rs2111485	A	0.404	23128233
STAT1,STAT4	Inflammatory bowel disease	3E-11	   1.08	[1.046-1.109] 	rs1517352	C	0.6	23128233
SLC11A1,CXCR2,CXCR1,PNKD,ARPC2,TMBIM1,CTDSP1	Inflammatory bowel disease	4E-12	   1.07	[1.042-1.104] 	rs2382817	A	0.408	23128233
GPR35	Inflammatory bowel disease	3E-21	   1.14	[1.093-1.177] 	rs3749171	T	0.167	23128233
Intergenic	Inflammatory bowel disease	9E-15	   1.11	[1.063-1.152] 	rs4256159	T	0.14	23128233
MST1,PFKFB4,MST1R,UCN2,GPX1,IP6K2,BSN,IP6K1,USP4	Inflammatory bowel disease	1E-47	   1.18	[1.144-1.216] 	rs3197999	A	0.296	23128233
CXCL5,CXCL1,CXCL3,IL8,CXCL6,PF4,CXCL2,PF4V1	Inflammatory bowel disease	3E-8	   1.10	[1.046-1.146] 	rs2472649	G	0.824	23128233
IL2,IL21	Inflammatory bowel disease	3E-13	   1.12	[1.08-1.154] 	rs7657746	A	0.753	23128233
DAP	Inflammatory bowel disease	1E-8	   1.07	[1.034-1.096] 	rs2930047	C	0.382	23128233
PTGER4	Inflammatory bowel disease	2E-82	   1.20	[1.164-1.234] 	rs11742570	C	0.605	23128233
ERAP2,ERAP1,LNPEP	Inflammatory bowel disease	6E-13	   1.07	[1.037-1.099] 	rs1363907	A	0.411	23128233
Intergenic	Inflammatory bowel disease	4E-10	   1.07	[1.039-1.106] 	rs4836519	T	0.768	23128233
IRF1,IL13,CSF2,SLC22A4,IL4,IL3,IL5,PDLIM4,SLC22A5,ACSL6	Inflammatory bowel disease	1E-52	   1.16	[1.125-1.191] 	rs2188962	T	0.425	23128233
SPRY4,NDFIP1	Inflammatory bowel disease	4E-14	   1.09	[1.057-1.121] 	rs6863411	T	0.63	23128233
TNIP1,IRGM,ZNF300P1	Inflammatory bowel disease	3E-37	   1.25	[1.186-1.314] 	rs11741861	G	0.093	23128233
IL12B	Inflammatory bowel disease	1E-42	   1.18	[1.146-1.216] 	rs6871626	A	0.337	23128233
DOK3	Inflammatory bowel disease	2E-8	   1.07	[1.036-1.10] 	rs12654812	A	0.335	23128233
Intergenic	Inflammatory bowel disease	3E-11	   1.07	[1.032-1.11] 	rs17119	A	0.786	23128233
Intergenic	Inflammatory bowel disease	9E-14	   1.09	[1.057-1.121] 	rs9358372	G	0.379	23128233
Intergenic	Inflammatory bowel disease	2E-10	   1.06	[1.029-1.092] 	rs1847472	C	0.655	23128233
Intergenic	Inflammatory bowel disease	8E-20	   1.11	[1.074-1.142] 	rs6568421	G	0.301	23128233
TRAF3IP2,FYN,REV3L	Inflammatory bowel disease	1E-13	   1.15	[1.089-1.219] 	rs3851228	T	0.073	23128233
TNFAIP3	Inflammatory bowel disease	1E-21	   1.10	[1.064-1.141] 	rs6920220	A	0.206	23128233
PHACTR2	Inflammatory bowel disease	2E-8	   1.13	[1.066-1.195] 	rs12199775	A	0.929	23128233
CCR6,RPS6KA2,RNASET2	Inflammatory bowel disease	7E-21	   1.08	[1.051-1.113] 	rs1819333	T	0.523	23128233
ZPBP,IKZF1	Inflammatory bowel disease	7E-15	   1.09	[1.055-1.123] 	rs1456896	T	0.688	23128233
SMURF1	Inflammatory bowel disease	8E-12	   1.08	[1.047-1.117] 	rs9297145	C	0.265	23128233
EPO	Inflammatory bowel disease	2E-13	   1.11	[1.071-1.158] 	rs1734907	A	0.149	23128233
Intergenic	Inflammatory bowel disease	1E-8	   1.05	[1.025-1.085] 	rs38904	T	0.532	23128233
TRIB1	Inflammatory bowel disease	8E-20	   1.08	[1.049-1.113] 	rs921720	G	0.609	23128233
Intergenic	Inflammatory bowel disease	2E-9	   1.05	[1.024-1.084] 	rs1991866	G	0.422	23128233
JAK2	Inflammatory bowel disease	8E-45	   1.17	[1.139-1.209] 	rs10758669	C	0.349	23128233
NFIL3	Inflammatory bowel disease	4E-9	   1.06	[1.023-1.089] 	rs4743820	T	0.702	23128233
TNFSF8,TNFSF15,TNC	Inflammatory bowel disease	3E-32	   1.14	[1.106-1.178] 	rs4246905	C	0.709	23128233
CARD9,PMPCA,SDCCAG3,INPP5E	Inflammatory bowel disease	4E-56	   1.19	[1.154-1.222] 	rs10781499	A	0.412	23128233
IL2RA,IL15RA	Inflammatory bowel disease	4E-10	   1.10	[1.06-1.147] 	rs12722515	C	0.849	23128233
MAP3K8	Inflammatory bowel disease	6E-11	   1.08	[1.044-1.106] 	rs1042058	C	0.592	23128233
CREM	Inflammatory bowel disease	2E-25	   1.12	[1.082-1.148] 	rs11010067	G	0.346	23128233
CISD1,IPMK	Inflammatory bowel disease	8E-9	   1.07	[1.029-1.104] 	rs2790216	G	0.778	23128233
Intergenic	Inflammatory bowel disease	6E-46	   1.17	[1.134-1.20] 	rs10761659	G	0.543	23128233
Intergenic	Inflammatory bowel disease	7E-10	   1.08	[1.048-1.118] 	rs2227564	C	0.77	23128233
Intergenic	Inflammatory bowel disease	3E-18	   1.10	[1.065-1.128] 	rs1250546	A	0.604	23128233
TSPAN14,C10orf58	Inflammatory bowel disease	9E-16	   1.12	[1.076-1.156] 	rs6586030	G	0.847	23128233
Intergenic	Inflammatory bowel disease	3E-8	   1.07	[1.035-1.097] 	rs7911264	C	0.519	23128233
NKX2-3	Inflammatory bowel disease	1E-54	   1.18	[1.149-1.217] 	rs4409764	T	0.491	23128233
TNNI2,LSP1	Inflammatory bowel disease	3E-10	   1.07	[1.035-1.101] 	rs907611	A	0.315	23128233
CNTF,LPXN	Inflammatory bowel disease	7E-10	   1.08	[1.045-1.116] 	rs10896794	T	0.762	23128233
CD6,CD5,PTGDR2	Inflammatory bowel disease	9E-13	   1.09	[1.053-1.118] 	rs11230563	C	0.654	23128233
C11orf9,FADS1,FADS2	Inflammatory bowel disease	2E-15	   1.08	[1.046-1.112] 	rs4246215	T	0.338	23128233
CCDC88B,RPS6KA4,TRPT1,FLRT1	Inflammatory bowel disease	4E-11	   1.10	[1.061-1.142] 	rs559928	C	0.821	23128233
RELA,FOSL1,CTSW,SNX32	Inflammatory bowel disease	3E-10	   1.08	[1.044-1.122] 	rs2231884	T	0.157	23128233
Intergenic	Inflammatory bowel disease	4E-36	   1.15	[1.119-1.185] 	rs2155219	T	0.509	23128233
Intergenic	Inflammatory bowel disease	2E-8	   1.08	[1.049-1.117] 	rs6592362	A	0.248	23128233
CXCR5	Inflammatory bowel disease	7E-9	   1.07	[1.039-1.11] 	rs630923	C	0.846	23128233
LOH12CR1	Inflammatory bowel disease	1E-8	   1.06	[1.025-1.091] 	rs11612508	G	0.267	23128233
LRRK2,MUC19	Inflammatory bowel disease	6E-29	   1.33	[1.217-1.461] 	rs11564258	A	0.025	23128233
VDR	Inflammatory bowel disease	8E-9	   1.05	[1.024-1.084] 	rs11168249	C	0.467	23128233
IFNG,IL26,IL22	Inflammatory bowel disease	9E-32	   1.10	[1.064-1.128] 	rs7134599	A	0.378	23128233
Intergenic	Inflammatory bowel disease	3E-19	   1.11	[1.065-1.147] 	rs17085007	C	0.183	23128233
Intergenic	Inflammatory bowel disease	2E-14	   1.07	[1.036-1.107] 	rs941823	C	0.758	23128233
GPR183,GPR18	Inflammatory bowel disease	2E-14	   1.11	[1.075-1.151] 	rs9557195	T	0.772	23128233
ZFP36L1	Inflammatory bowel disease	3E-10	   1.08	[1.039-1.111] 	rs194749	C	0.226	23128233
FOS,MLH3	Inflammatory bowel disease	3E-8	   1.08	[1.042-1.125] 	rs4899554	C	0.819	23128233
GPR65,GALC	Inflammatory bowel disease	2E-14	   1.15	[1.097-1.211] 	rs8005161	T	0.089	23128233
SMAD3	Inflammatory bowel disease	6E-16	   1.07	[1.032-1.102] 	rs17293632	T	0.235	23128233
CRTC3	Inflammatory bowel disease	9E-11	   1.13	[1.082-1.189] 	rs7495132	C	0.891	23128233
SOCS1,LITAF,RMI2	Inflammatory bowel disease	2E-16	   1.12	[1.085-1.166] 	rs529866	C	0.803	23128233
PRKCB	Inflammatory bowel disease	1E-9	   1.06	[1.03-1.091] 	rs7404095	C	0.572	23128233
RABEP2,IL27,EIF3C,SULT1A1,SULT1A2,NUPR1	Inflammatory bowel disease	1E-21	   1.10	[1.067-1.13] 	rs26528	C	0.451	23128233
IRF8	Inflammatory bowel disease	1E-9	   1.16	[1.094-1.219] 	rs10521318	C	0.915	23128233
CCL13,CCL2,CCL11	Inflammatory bowel disease	1E-26	   1.12	[1.087-1.158] 	rs3091316	G	0.722	23128233
IKZF3,ZPBP2,GSDMB,ORMDL3,GSDMA	Inflammatory bowel disease	4E-38	   1.16	[1.124-1.19] 	rs12946510	T	0.465	23128233
STAT3,STAT5B,STAT5A	Inflammatory bowel disease	6E-22	   1.10	[1.072-1.136] 	rs12942547	A	0.58	23128233
TUBD1,RPS6KB1	Inflammatory bowel disease	9E-13	   1.08	[1.045-1.106] 	rs1292053	G	0.446	23128233
Intergenic	Inflammatory bowel disease	3E-26	   1.17	[1.127-1.216] 	rs1893217	G	0.157	23128233
SMAD7	Inflammatory bowel disease	1E-9	   1.06	[1.026-1.088] 	rs7240004	A	0.616	23128233
CD226	Inflammatory bowel disease	5E-9	   1.08	[1.046-1.108] 	rs727088	G	0.484	23128233
TYK2,PPAN-P2RY11,ICAM1	Inflammatory bowel disease	2E-18	   1.14	[1.096-1.177] 	rs11879191	G	0.797	23128233
CEBPG	Inflammatory bowel disease	6E-15	   1.10	[1.065-1.135] 	rs17694108	A	0.282	23128233
NLRP7,NLRP2,KIR2DL1,LILRB4	Inflammatory bowel disease	7E-11	   1.09	[1.055-1.119] 	rs11672983	A	0.392	23128233
HCK	Inflammatory bowel disease	6E-10	   1.07	[1.041-1.103] 	rs6142618	G	0.564	23128233
DNMT3B	Inflammatory bowel disease	1E-9	   1.08	[1.044-1.106] 	rs4911259	G	0.383	23128233
CD40,MMP9,PLTP	Inflammatory bowel disease	1E-13	   1.09	[1.056-1.126] 	rs1569723	C	0.259	23128233
CEBPB	Inflammatory bowel disease	5E-8	   1.06	[1.024-1.088] 	rs913678	T	0.662	23128233
ZNF831,CTSZ	Inflammatory bowel disease	1E-12	   1.09	[1.054-1.116] 	rs259964	A	0.464	23128233
TNFRSF6B,LIME1,SLC2A4RG,ZGPAT	Inflammatory bowel disease	1E-23	   1.10	[1.071-1.139] 	rs6062504	G	0.684	23128233
Intergenic	Inflammatory bowel disease	9E-30	   1.16	[1.121-1.194] 	rs2823286	G	0.708	23128233
Intergenic	Inflammatory bowel disease	5E-48	   1.18	[1.142-1.219] 	rs2836878	G	0.733	23128233
ICOSLG	Inflammatory bowel disease	2E-26	   1.11	[1.072-1.138] 	rs7282490	G	0.391	23128233
MAPK1,YDJC,UBE2L3,RIMBP3,CCDC116	Inflammatory bowel disease	1E-16	   1.11	[1.066-1.145] 	rs2266959	T	0.186	23128233
LIF,OSM,MTMR3	Inflammatory bowel disease	3E-14	   1.08	[1.049-1.111] 	rs2412970	G	0.457	23128233
ATF4,TAB1,APOBEC3G	Inflammatory bowel disease	4E-33	   1.21	[1.163-1.257] 	rs2413583	C	0.833	23128233
TNFRSF14,MMEL1,PLCH2	Ulcerative colitis	3E-12	   1.08	[1.041-1.116] 	rs10797432	C	0.522	23128233
Intergenic	Ulcerative colitis	2E-68	   1.27	[1.221-1.31] 	rs6426833	A	0.542	23128233
Intergenic	Ulcerative colitis	2E-17	   1.23	[1.161-1.302] 	rs2816958	G	0.887	23128233
RFTN2,PLCL1	Ulcerative colitis	3E-8	   1.10	[1.051-1.15] 	rs1016883	G	0.817	23128233
Intergenic	Ulcerative colitis	2E-13	   1.12	[1.079-1.157] 	rs17229285	C	0.496	23128233
PRKCD,ITIH4	Ulcerative colitis	1E-8	   1.06	[1.027-1.102] 	rs9847710	C	0.416	23128233
NFKB1,MANBA	Ulcerative colitis	4E-12	   1.12	[1.077-1.159] 	rs3774959	A	0.358	23128233
SLC9A3	Ulcerative colitis	2E-8	   1.07	[1.027-1.117] 	rs11739663	T	0.76	23128233
Intergenic	Ulcerative colitis	3E-9	   1.06	[1.019-1.093] 	rs254560	A	0.397	23128233
HLA-DQB1,HLA-DRB1,HLA-DQA1,HLA-DRA	Ulcerative colitis	5E-133	   1.44	[1.387-1.503] 	rs6927022	A	0.535	23128233
CARD11,GNA12,TTYH3	Ulcerative colitis	6E-17	   1.13	[1.084-1.171] 	rs798502	A	0.709	23128233
Intergenic	Ulcerative colitis	2E-8	   1.09	[1.043-1.14] 	rs4722672	C	0.183	23128233
DLD	Ulcerative colitis	2E-26	   1.14	[1.097-1.177] 	rs4380874	T	0.405	23128233
IRF5,TNPO3,TSPAN33	Ulcerative colitis	4E-14	   1.10	[1.066-1.143] 	rs4728142	A	0.444	23128233
JRKL,MAML2	Ulcerative colitis	1E-8	   1.06	[1.017-1.096] 	rs483905	A	0.292	23128233
NXPE1,NXPE4	Ulcerative colitis	5E-17	   1.12	[1.079-1.163] 	rs561722	C	0.663	23128233
ITPKA,NDUFAF1,NUSAP1	Ulcerative colitis	2E-8	   1.08	[1.04-1.126] 	rs28374715	A	0.738	23128233
ITGAL	Ulcerative colitis	6E-10	   1.09	[1.052-1.128] 	rs11150589	T	0.463	23128233
ZFP90	Ulcerative colitis	4E-8	   1.08	[1.031-1.121] 	rs1728785	C	0.767	23128233
Intergenic	Ulcerative colitis	2E-9	   1.11	[1.062-1.163] 	rs7210086	A	0.797	23128233
CALM3	Ulcerative colitis	2E-9	   1.08	[1.037-1.113] 	rs1126510	G	0.363	23128233
PROCR,UQCC,CEP250	Ulcerative colitis	2E-8	   1.08	[1.041-1.117] 	rs6088765	G	0.437	23128233
ADA,HNF4A	Ulcerative colitis	1E-43	   1.23	[1.185-1.273] 	rs6017342	C	0.53	23128233
HERC2, OCA2	Eye color	2E-20	    .35	[0.28-0.42] unit increase	rs1667394	C	0.28	23118974
TNFSF13	IgM levels	4E-9	NR	NR	rs11552708	G	0.7573	23118916
GLYAT	Body mass (lean)	2E-8	NR	NR	rs2507838	A	0.03	23108985
WNT4	Endometriosis	3E-11	   1.19	[1.13-1.25] 	rs7521902	A	0.238	23104006
GREB1	Endometriosis	6E-9	   1.15	[1.09-1.20] 	rs13394619	G	0.521	23104006
NR	Endometriosis	4E-10	   1.17	[1.11-1.23] 	rs7739264	T	0.515	23104006
Intergenic	Endometriosis	4E-9	   1.18	[1.11-1.25] 	rs12700667	A	0.744	23104006
CDKN2B-ASI, CDKN2B, CDKN2A, ARF 	Endometriosis	2E-9	   1.15	[1.10-1.21] 	rs1537377	C	0.401	23104006
VEZT	Endometriosis	5E-13	   1.20	[1.14-1.26] 	rs10859871	C	0.295	23104006
LRFN2	Multiple cancers (lung cancer, gastric cancer, and squamous cell carcinoma)	5E-9	   1.18	[1.12-1.25] 	rs2494938	A	0.23	23103227
LRFN2	Multiple cancers (lung cancer, gastric cancer, and squamous cell carcinoma)	1E-12	   1.15	[1.10-1.19] 	rs2494938	A	0.23	23103227
SP4, DNAH11	Multiple cancers (lung cancer, gastric cancer, and squamous cell carcinoma)	2E-8	   1.17	[1.11-1.24] 	rs2285947	A	0.26	23103227
SP4, DNAH11	Multiple cancers (lung cancer, gastric cancer, and squamous cell carcinoma)	1E-16	   1.17	[1.12-1.21] 	rs2285947	A	0.27	23103227
ATP5SL, CEACAM21	Prostate cancer	1E-8	   1.11	[1.02-1.20] 	rs11672691	G	NR	23065704
ATP5SL, CEACAM21	Prostate cancer	2E-12	   1.08	[1.04-1.12] 	rs11672691	G	NR	23065704
HBS1L,MYB	HbA2 levels	5E-9	NR	NR	rs9399137	C	0.26	23043469
HBB	HbA2 levels	1E-11	NR	NR	rs7950726	A	0.12	23043469
ABO	Protein biomarker	4E-47	    .07	[0.059-0.078] unit decrease	rs644234	G	0.35	23056639
LGALS3, DLGAP5	Protein biomarker	2E-188	    .19	[0.17-0.20] unit decrease	rs2274273	A	0.41	23056639
IL1RL1, IL18R1, IL18RAP	Atopic dermatitis	8E-18	   1.27	[1.20-1.34] 	rs13015714	G	0.412	23042114
HLA-C	Atopic dermatitis	1E-17	   1.36	[1.27-1.46] 	rs9368677	G	0.798	23042114
GPSM3	Atopic dermatitis	8E-20	   1.40	[1.30-1.51] 	rs176095	T	0.81	23042114
C6orf10	Atopic dermatitis	5E-19	   1.61	[1.44-1.80] 	rs9469099	G	0.909	23042114
OR10A3, NLRP10	Atopic dermatitis	2E-22	   1.31	[1.24-1.38] 	rs878860	G	0.537	23042114
GLB1	Atopic dermatitis	6E-21	   1.29	[1.22-1.36] 	rs7613051	A	0.453	23042114
CCDC80, LOC100630917	Atopic dermatitis	2E-19	   1.29	[1.22-1.37] 	rs12634229	G	0.327	23042114
CARD11	Atopic dermatitis	8E-9	   1.18	[1.12-1.25] 	rs4722404	G	0.326	23042114
ZNF365	Atopic dermatitis	6E-20	   1.28	[1.22-1.36] 	rs10995251	C	0.511	23042114
CYP24A1, PFDN4	Atopic dermatitis	2E-8	   1.19	[1.12-1.26] 	rs16999165	T	0.692	23042114
STAT4	Systemic lupus erythematosus	4E-14	   1.48	[1.335-1.634] 	rs7574865	T	NR	23053960
TNPO3	Systemic lupus erythematosus	6E-13	   1.59	[1.403-1.808] 	rs12531711	A	NR	23053960
BLK	Systemic lupus erythematosus	2E-10	   1.39	[1.256-1.540] 	rs13277113	A	NR	23053960
IRF5	Systemic lupus erythematosus	4E-8	   1.29	[1.41-1.18] 	rs729302	A	NR	23053960
HDAC9	Stroke (ischemic)	2E-16	   1.39	[1.27-1.53] 	rs2107595	A	0.16	23041239
PITX2	Stroke (ischemic)	3E-16	   1.36	[1.27-1.47] 	rs6843082	G	0.21	23041239
ZFHX3	Stroke (ischemic)	2E-8	   1.25	[1.15-1.35] 	rs879324	A	0.19	23041239
Intergenic	Stroke (ischemic)	5E-8	   1.95	[1.53-2.48] 	rs13407662	T	0.04	23041239
DOCK1	Apolipoprotein Levels	4E-8	    .06	[0.038-0.082] unit increase	rs9733352	C	NR	23031429
APOE, APOC1	Apolipoprotein Levels	2E-14	    .15	[0.11-0.19] unit increase	rs445925	G	NR	23031429
APOE/APOC1	Apolipoprotein Levels	4E-11	    .23	[0.16-0.30] unit decrease	rs445925	G	NR	23031429
RAD23B, KLF4	Prostate cancer	5E-14	   1.41	[1.29-1.54] 	rs817826	C	0.084	23023329
LILRA3	Prostate cancer	5E-16	   1.28	[1.21-1.36] 	rs103294	C	0.238	23023329
IL1RL1, IL18R1	Asthma	1E-9	   1.23	[1.15-1.31] 	rs13408661	G	0.84	23028483
BTNL2, HLA-DRA	Asthma	1E-8	   1.15	[1.10-1.21] 	rs9268516	T	0.24	23028483
GCKR, FNDC4	Serum albumin level	3E-14	    .01	[0.0093-0.0155] unit increase	rs1260326	T	0.41	23022100
HPN, SCN1B	Serum albumin level	3E-15	    .03	[0.019-0.032] unit increase	rs4806073	C	0.93	23022100
GCKR, FNDC4	Serum albumin level	2E-8	    .03	[0.017-0.037] unit increase	rs1260326	T	0.56	23022100
SERPINF2, WDR81	Serum albumin level	7E-13	    .02	[0.015-0.026] unit increase	rs11078597	C	0.18	23022100
TNFRSF11A, ZCCHC2	Serum albumin level	1E-8	    .01	[0.0062-0.0124] unit increase	rs694419	T	0.52	23022100
FRMD5, WDR76	Serum albumin level	2E-8	    .02	[0.015-0.031] unit increase	rs16948098	A	0.06	23022100
GCKR-FNDC4	Serum albumin level	4E-19	    .01	[0.011-0.017] unit increase	rs1260326	T	0.41	23022100
HPN, SCN1B	Serum albumin level	4E-18	    .03	[0.021-0.033] unit increase	rs4806073	C	0.93	23022100
SERPINF2, WDR81	Serum albumin level	1E-14	    .02	[0.015-0.026] unit increase	rs11078597	C	0.18	23022100
TNFRSF11A, ZCCHC2	Serum albumin level	4E-9	    .01	[0.0064-0.0126] unit increase	rs694419	T	0.52	23022100
RPS11, FCGRT	Serum albumin level	6E-9	    .01	[0.0089-0.0179] unit increase	rs2280401	A	0.17	23022100
TNFRSF13B	Serum total protein level	1E-9	    .04	[0.024-0.048] unit increase	rs4561508	T	0.11	23022100
Intergenic	Serum total protein level	3E-9	    .03	[0.017-0.033] unit increase	rs204999	A	0.74	23022100
TNFRSF13B	Serum total protein level	2E-11	    .05	[-0.09020-0.18420] unit increase	rs4561508	T	0.37	23022100
TNFRSF13B	Serum total protein level	2E-18	    .04	[0.031-0.049] unit increase	rs4561508	T	0.11	23022100
Intergenic	Serum total protein level	4E-11	    .03	[0.019-0.034] unit increase	rs204999	A	0.74	23022100
ELL2	Serum total protein level	1E-8	    .02	[0.013-0.027] unit increase	rs3777200	T	0.27	23022100
ZNF676	Telomere length	1E-8	    .05	[0.032-0.067] unit increase	rs412658	T	0.3564	23001564
CTC1	Telomere length	2E-8	    .06	[0.036-0.079] unit decrease	rs3027234	T	0.1794	23001564
OBFC1	Telomere length	9E-11	    .08	[0.057-0.108] unit increase	rs9419958	T	0.1353	23001564
TERC	Telomere length	1E-8	    .07	[0.046-0.089] unit increase	rs1317082	G	0.2875	23001564
DARC	Monocyte chemoattractant protein-1 	1E-21	NR	NR	rs12075	A	0.43	23017229
NR	Monocyte chemoattractant protein-1 	5E-8	NR	NR	snp10-4307576	4	NR	23017229
PYGL	Acute lymphoblastic leukemia (childhood)	7E-9	   3.61	[2.34-5.57] 	rs7142143	C	0.01	23007406
RGMA, MCTP2	Type 1 diabetes nephropathy	2E-9	   1.80	[1.48-2.17] 	rs12437854	G	0.04	23028342
AFF3	Type 1 diabetes nephropathy	1E-8	   1.29	[1.18-1.40] 	rs7583877	C	0.29	23028342
Intergenic	Disc degeneration (lumbar)	2E-9	    .23	[0.16-0.30] unit increase	rs17034687	C	0.09	22993228
PSMB9	Disc degeneration (lumbar)	3E-8	    .23	[0.15-0.31] unit increase	rs2187689	C	0.08	22993228
PARK2	Disc degeneration (lumbar)	3E-8	    .13	[0.083-0.177] unit decrease	rs926849	C	0.31	22993228
TNFSF15	Primary biliary cirrhosis	3E-14	   1.56	[1.39-1.76] 	rs4979462	T	0.46	23000144
POU2AF1	Primary biliary cirrhosis	2E-8	   1.39	[1.24-1.56] 	rs4938534	A	0.44	23000144
IL7R	Primary biliary cirrhosis	4E-8	   1.47	[1.28-1.69] 	rs6890853	G	NR	23000144
IKZF3, ZPBP2, GSDMB, ORMDL3	Primary biliary cirrhosis	4E-9	   1.44	[1.28-1.63] 	rs9303277	T	NR	23000144
CD80	Primary biliary cirrhosis	3E-9	   1.48	[1.29-1.68] 	rs2293370	C	NR	23000144
NFKBIE	Rheumatoid arthritis	1E-15	   1.20	[1.15-1.26] 	rs2233434	G	0.215	23028356
RTKN2	Rheumatoid arthritis	5E-9	   1.20	[1.13-1.27] 	rs3125734	T	0.108	23028356
RALY, EIF2S2, ASIP	Breast cancer	1E-8	   1.16	[1.10-1.22] 	rs2284378	T	0.31	22976474
NR	Breast cancer	4E-8	   1.14	[NR] 	rs8100241	G	NR	22976474
NR	Breast cancer	2E-10	   1.28	[NR] 	rs9383938	T	NR	22976474
PON-1	Paraoxonase activity 	1E-303	NR	NR	rs2057681	G	0.29	22982463
PON-1	Paraoxonase activity 	5E-116	NR	NR	rs854572	C	0.46	22982463
CFH, CFHR1, CFHR3	Complement C3 and C4 levels	7E-11	    .05	[0.030-0.070] g/L decrease	rs3753394	C	0.43	23028341
C3	Complement C3 and C4 levels	2E-9	    .09	[0.070-0.110] g/L increase	rs3745567	T	0.06	23028341
HLA-A	Complement C3 and C4 levels	3E-48	    .10	[0.080-0.120] g/L increase	rs1052693	G	0.36	23028341
HLA-C	Complement C3 and C4 levels	1E-54	    .23	[0.21-0.25] g/L decrease	rs11575839	A	0.05	23028341
C4	Complement C3 and C4 levels	6E-97	    .17	[0.15-0.19] g/L decrease	rs2075799	T	0.20	23028341
C4	Complement C3 and C4 levels	1E-22	    .08	[0.060-0.100] g/L increase	rs2857009	G	0.20	23028341
HLA-DRA	Complement C3 and C4 levels	4E-72	    .13	[0.11-0.15] g/L decrease	rs2071278	G	0.27	23028341
HLA-DRB	Complement C3 and C4 levels	9E-66	    .12	[0.10-0.14] g/L increase	rs3763317	C	0.37	23028341
HLA-DQB	Complement C3 and C4 levels	3E-22	    .09	[0.070-0.110] g/L decrease	rs9276606	T	0.15	23028341
HLA-DQB	Complement C3 and C4 levels	9E-83	    .23	[0.21-0.25] g/L increase	rs241428	G	0.08	23028341
FTO	Body mass index	2E-10	    .04	[0.025-0.047] unit increase	rs7202116	G	0.402	22982992
MHC, OR2D12, OR2D13	Barrett's esophagus	4E-9	   1.21	[1.13-1.28] 	rs9257809	A	0.87	22961001
FOXF1, LOC732275	Barrett's esophagus	3E-10	   1.14	[1.10-1.19] 	rs9936833	C	0.37	22961001
HEATR3	Esophageal cancer (squamous cell)	2E-20	   1.24	[1.18-1.29] 	rs4785204	T	0.26	22960999
HAP1	Esophageal cancer (squamous cell)	3E-16	   1.27	[1.20-1.34] 	rs6503659	A	0.13	22960999
XBP1	Esophageal cancer (squamous cell)	4E-15	   1.18	[1.13-1.23] 	rs2239815	T	0.37	22960999
ST6GAL1	Esophageal cancer (squamous cell)	6E-14	   1.21	[1.15-1.27] 	rs2239612	T	0.19	22960999
SMG6	Esophageal cancer (squamous cell)	2E-11	   1.21	[1.14-1.28] 	rs17761864	A	0.14	22960999
PTPN2	Esophageal cancer (squamous cell)	2E-11	   1.20	[1.14-1.26] 	rs2847281	C	0.16	22960999
CHEK2	Esophageal cancer (squamous cell)	2E-22	   1.27	[1.21-1.34] 	rs4822983	T	0.20	22960999
IGHG3, IGHG1, IGHG2	IgG levels	8E-16	    .23	[NR] unit increase	rs10136766	A	0.27	23225573
CDKN2B-AS1	Intracranial aneurysm	4E-8	   1.35	[NR] 	rs6475606	T	0.48	22961961
GRK5	Type 2 diabetes	7E-9	   1.12	[1.08-1.16] 	rs10886471	C	0.778	22961080
RASGRP1	Type 2 diabetes	4E-9	   1.10	[1.06-1.13] 	rs7403531	T	0.346	22961080
GLIS3	Type 2 diabetes	6E-12	   1.11	[1.08-1.15] 	rs10814916	C	0.439	22961080
CDKN2B	Type 2 diabetes	3E-17	   1.22	[1.17-1.28] 	rs2383208	A	0.558	22961080
CDC123	Type 2 diabetes	7E-9	   1.15	[1.10-1.20] 	rs11257655	T	0.564	22961080
HNF1B	Type 2 diabetes	2E-11	   1.19	[1.13-1.25] 	rs4430796	G	0.276	22961080
FAM58A	Type 2 diabetes	2E-9	   1.21	[1.14-1.28] 	rs12010175	G	0.786	22961080
DUSP9	Type 2 diabetes	7E-16	   1.18	[1.13-1.23] 	rs5945326	A	0.606	22961080
CDKAL1	Type 2 diabetes	7E-10	   1.35	[1.23-1.48] 	rs7754840	C	0.411	22961080
PMEL, DGKA, CDK2, RAB5B, SUOX, ZNFN1A4, RPS26, ERBB3, PA2G4	Vitiligo	8E-12	   1.18	[1.13-1.24] 	rs10876864	G	0.24	22951725
CXCR5, DDX6, PHLDB1, TREH, AK021715, 	Vitiligo	2E-9	   1.22	[1.14-1.30] 	rs638893	C	0.11	22951725
UNC13A	Amyotrophic lateral sclerosis	5E-8	   1.37	[1.21-1.56] 	rs12608932	C	0.34	22959728
Intergenic	Epilepsy (generalized)	2E-9	   1.23	[1.15-1.32] 	rs13026414	C	.576	22949513
PNPO, ATAD4, CDK5RAP3, COPZ2, hsa-mir-152, NFE2L1, CBX1, SNX11, SKAP1	Epilepsy (generalized)	9E-9	   1.30	[1.20-1.41] 	rs72823592	G	0.753	22949513
ZEB2	Epilepsy (generalized)	9E-9	   1.47	[1.28-1.67] 	rs10496964	C	0.844	22949513
CHRM3	Epilepsy (generalized)	4E-8	   1.42	[1.26-1.61] 	rs12059546	G	.172	22949513
HACE1	Neuroblastoma	3E-11	   1.26	[1.18-1.35] 	rs4336470	C	0.65	22941191
LIN28B	Neuroblastoma	1E-8	   1.38	[1.23-1.54] 	rs17065417	A	0.89	22941191
BARD1	Neuroblastoma	4E-14	   1.37	[NR] 	rs7587476	T	0.246	22941191
LINC00340, FLJ44180	Neuroblastoma	8E-16	   1.36	[NR] 	rs9295536	A	0.430	22941191
LMO1	Neuroblastoma	1E-13	   1.32	[NR] 	rs110419	A	0.489	22941191
HSD17B12	Neuroblastoma	5E-8	   1.23	[NR] 	rs11037575	C	0.407	22941191
CDC5L, SUPT3H	Stroke (ischemic)	5E-8	   1.21	[1.13-1.30] 	rs556621	A	0.30	22941190
JMJD1C	Androgen levels	1E-8	    .06	[0.038-0.078] unit decrease	rs10822184	T	0.49	22936694
SHBG	Androgen levels	1E-12	    .07	[0.053-0.093] unit decrease	rs727428	T	0.414	22936694
FAM9B	Androgen levels	2E-8	    .09	[0.060-0.122] unit increase	rs5934505	G	0.278	22936694
SHBG	Androgen levels	1E-11	    .10	[0.074-0.132] unit decrease	rs727428	T	0.414	22936694
SHBG	Androgen levels	9E-10	    .16	[0.11-0.22] unit increase	rs72829446	T	0.101	22936694
RBX1, EP300	Crohn's disease	3E-8	   1.27	[1.17-1.38] 	rs4820425	A	0.24	22936669
NOD2	Crohn's disease	3E-10	   1.46	[NR] 	rs2076756	G	NR	22936669
IL23R	Crohn's disease	4E-14	   2.84	[NR] 	rs11209026	G	NR	22936669
ATG16L1	Crohn's disease	5E-9	   1.38	[NR] 	rs3792109	A	NR	22936669
TREM2	C-reactive protein	1E-10	NR	NR	rs7748513	G	0.432	22939635
CRP, APCS, DARC, FCER1A, DUSP23, OR10J1, OR10J5, OR10J3, OLFML2B, IFI16, FCRL6	C-reactive protein	4E-73	    .42	[0.37-0.46] unit increase	rs16827466	T	0.178	22939635
IL1F10, IL1RN	C-reactive protein	9E-10	    .11	[0.073-0.143] unit decrease	rs6734238	G	0.446	22939635
HNF1A	C-reactive protein	1E-10	    .12	[0.082-0.156] unit decrease	rs7979473	A	0.443	22939635
TOMM40	C-reactive protein	4E-13	    .13	[NR] unit decrease	rs1160985	C	0.366	22939635
LEPR	C-reactive protein	2E-9	    .11	[0.064-0.162] unit decrease	rs1805096	A	0.451	22939635
CRP	C-reactive protein	1E-9	    .13	[0.078-0.180] unit increase	rs7553007	G	0.344	22939635
HNF1A, OASL, C12orf43	C-reactive protein	3E-10	    .14	[0.092-0.190] unit increase	rs2259816	T	0.379	22939635
CRP, APCS, DARC, FCER1A, DUSP23, OR10J1, OR10J5, OR10J3, OLFML2B, IFI16, FCRL6	C-reactive protein	1E-37	    .27	[0.23-0.31] (unit decrease)	rs7553007	T	0.228	22939635
CRP, APCS, DARC, FCER1A, DUSP23, OR10J1, OR10J5, OR10J3, OLFML2B, IFI16, FCRL6	C-reactive protein	3E-10	    .15	[0.11-0.20] (unit decrease)	rs2808634	T	0.156	22939635
PLEKHA7	Glaucoma (primary open-angle)	5E-12	   1.22	[NR] 	rs11024102	G	NR	22922875
COL11A1	Glaucoma (primary open-angle)	9E-10	   1.20	[NR] 	rs3753841	G	NR	22922875
PCMTD1-ST18	Glaucoma (primary open-angle)	3E-9	   1.50	[NR] 	rs1015213	A	NR	22922875
NR	Prostate cancer	4E-13	   1.87	[1.58-2.22] 	rs6983561	C	0.18	22923026
NR	Prostate cancer	7E-15	   1.73	NR 	rs10505483	T	NR	22923026
NR	Prostate cancer	4E-10	   1.59	[1.38-1.84] 	rs13254738	C	0.54	22923026
vaspin, serpinA4	Vaspin levels	4E-41	    .04	[NR] unit decrease	rs11160190	G	NR	22907691
FMO3, FMO6P	Lentiform nucleus volume 	5E-8	 112.27	[NR] unit decrease	rs1795240	A	0.43	22903471
ATP2B4	Malaria	2E-10	   1.64	[NR] 	rs10900585	T	0.62	22895189
ABO	Malaria	4E-21	   1.48	[NR] 	rs8176719	G	0.37	22895189
HBB	Malaria	6E-14	   2.17	[NR] 	rs372091	C	0.972	22895189
COL27A1, KIF12, ORM1	Tourette syndrome	3E-8	   1.29	[NR] 	rs7868992	G	0.28	22889924
FSHR	Polycystic ovary syndrome	1E-12	   1.15	[NR] 	rs2268361	C	0.504	22885925
C9orf3	Polycystic ovary syndrome	5E-14	   1.30	[NR] 	rs3802457	G	0.904	22885925
YAP1	Polycystic ovary syndrome	1E-22	   1.27	[NR] 	rs1894116	G	0.194	22885925
RAB5B, SUOX	Polycystic ovary syndrome	9E-26	   1.27	[NR] 	rs705702	G	0.245	22885925
HMGA2	Polycystic ovary syndrome	2E-21	   1.43	[NR] 	rs2272046	A	0.907	22885925
TOX3	Polycystic ovary syndrome	4E-11	   1.15	[NR] 	rs4784165	G	0.325	22885925
INSR	Polycystic ovary syndrome	1E-8	   1.14	[NR] 	rs2059807	G	1.24	22885925
SUMO1P1	Polycystic ovary syndrome	2E-9	   1.13	[NR] 	rs6022786	A	0.339	22885925
LHCGR	Polycystic ovary syndrome	4E-9	   1.35	[NR] 	rs13405728	A	NR	22885925
NR	Polycystic ovary syndrome	4E-13	   1.49	[NR] 	rs13429458	A	NR	22885925
NR	Polycystic ovary syndrome	5E-10	   1.35	[NR] 	rs2479106	G	NR	22885925
TERT	Glioma	4E-9	   1.30	[1.19-1.41] 	rs2736100	G	0.494	22886559
CDKN2BAS	Glioma	1E-8	   1.28	[1.177-1.398] 	rs4977756	G	.423	22886559
RTEL1,TNFRSF6B	Glioma	1E-10	   1.43	[1.28-1.59] 	rs6010620	G	.771	22886559
AHCLY2	Response to fenofibrate	4E-9	   4.41	[2.96-5.86] unit increase	rs11766298	T	NR	22890011
MHC, TRIM26	Schizophrenia	1E-16	   1.25	[1.12-1.39] 	rs2523722	G	0.737	22883433
KCNJ16, KCNJ2	Thyrotoxic hypokalemic periodic paralysis	8E-14	   3.20	[2.40-4.40] 	rs312691	C	0.76	22863731
NR	Orofacial clefts	3E-12	   1.42	[1.243-1.623] 	rs560426	G	NR	22863734
IRF6	Orofacial clefts	3E-12	   1.44	[1.273-1.635] 	rs861020	A	NR	22863734
NR	Orofacial clefts	5E-35	   1.92	[1.66-2.218] 	rs987525	A	NR	22863734
NR	Orofacial clefts	4E-11	   1.38	[1.213-1.576] 	rs7078160	A	NR	22863734
NR	Orofacial clefts	2E-8	   1.23	[1.078-1.400] 	rs227731	C	NR	22863734
NR	Orofacial clefts	6E-9	   1.19	[1.06-1.35] 	rs13041247	T	NR	22863734
PAX7	Orofacial clefts	7E-9	   1.32	[1.126-1.537] 	rs742071	T	NR	22863734
THADA	Orofacial clefts	1E-8	   1.42	[1.225-1.636] 	rs7590268	G	NR	22863734
EPHA3	Orofacial clefts	4E-8	   1.37	[1.20-1.55] 	rs7632427	T	NR	22863734
NR	Orofacial clefts	2E-8	   1.27	[1.106-1.463] 	rs12543318	C	NR	22863734
SPRY2	Orofacial clefts	3E-10	   1.31	[1.13-1.511] 	rs8001641	A	NR	22863734
IRF6	Orofacial clefts	5E-10	NR	NR	rs560426	G	NR	22863734
NR	Orofacial clefts	1E-26	NR	NR	rs987525	A	NR	22863734
NR	Orofacial clefts	6E-10	NR	NR	rs7078160	A	NR	22863734
SPRY2	Orofacial clefts	9E-11	   1.35	[1.141-1.607] 	rs8001641	A	NR	22863734
NR	Orofacial clefts	2E-11	NR	NR	rs987525	A	NR	22863734
RNF7	Hepatitis C induced liver fibrosis	9E-9	NR	NR	rs16851720	C	0.19	22841784
MERTK	Hepatitis C induced liver fibrosis	1E-9	NR	NR	rs4374383	A	0.42	22841784
TYW3, CRYZ	Resistin levels 	6E-12	    .05	[0.030-0.070] unit increase	rs3931020	C	0.69	22843503
NDST4	Resistin levels 	6E-18	    .13	[0.091-0.169] unit increase	rs13144478	T	0.09	22843503
AGPHD1	Airflow obstruction 	3E-9	   1.22	 	rs8031948	T	0.35	22837378
GPR35	Sclerosing cholangitis and ulcerative colitis (combined)	2E-9	   1.38	[1.24-1.53] 	rs4676410	A	0.20	22821403
TCF4	Sclerosing cholangitis and ulcerative colitis (combined)	3E-8	   1.33	[1.20-1.47] 	rs1452787	A	0.72	22821403
ZNF469	Central corneal thickness	1E-12	    .16	[0.12-0.20] SD increase	rs9938149	A	0.62	22814818
RXRA, COL5A1	Central corneal thickness	3E-10	    .15	[0.11-0.19] SD increase	rs3132306	T	0.66	22814818
PRMT6	Sex hormone-binding globulin levels	1E-11	    .03	[0.020-0.036] nmol/L decrease	rs17496332	A	0.67	22829776
GCKR	Sex hormone-binding globulin levels	2E-16	    .03	[0.024-0.040] nmol/L decrease	rs780093	T	0.40	22829776
ZBTB10	Sex hormone-binding globulin levels	3E-9	    .03	[0.019-0.037] umol/L decrease	rs440837	A	0.78	22829776
JMJD1C	Sex hormone-binding globulin levels	6E-35	    .05	[0.040-0.056] umol/L decrease	rs7910927	T	0.51	22829776
SLCO1B1	Sex hormone-binding globulin levels	2E-8	    .03	[0.019-0.039] umol/L increase	rs4149056	T	0.82	22829776
NR2F2	Sex hormone-binding globulin levels	8E-12	    .03	[0.021-0.039] umol/L decrease	rs8023580	T	0.72	22829776
SHBG	Sex hormone-binding globulin levels	2E-106	    .10	[0.094-0.112] umol/L increase	rs12150660	T	0.24	22829776
ZNF652	Sex hormone-binding globulin levels	4E-14	    .03	[0.024-0.042] umol/L increase	rs2411984	A	0.28	22829776
TDGF3	Sex hormone-binding globulin levels	4E-14	    .03	[0.021-0.035] umol/L increase	rs1573036	T	0.031	22829776
BAIAP2L1	Sex hormone-binding globulin levels	3E-8	    .03	[0.018-0.038] umol/L decrease	rs3779195	A	0.17	22829776
GCKR	Sex hormone-binding globulin levels	9E-11	    .04	[0.029-0.053] nmol/L decrease	rs780093	T	0.40	22829776
JMJD1C	Sex hormone-binding globulin levels	1E-25	    .05	[0.041-0.059] umol/L decrease	rs7910927	T	0.51	22829776
JMJD1C	Sex hormone-binding globulin levels	2E-13	    .05	[0.034-0.058] umol/L decrease	rs7910927	T	0.51	22829776
SHBG	Sex hormone-binding globulin levels	4E-80	    .11	[0.099-0.121] umol/L increase	rs12150660	T	0.24	22829776
SHBG	Sex hormone-binding globulin levels	6E-30	    .09	[0.071-0.101] umol/L increase	rs12150660	T	0.24	22829776
ZNF652	Sex hormone-binding globulin levels	2E-10	    .03	[0.023-0.045] umol/L increase	rs2411984	A	0.28	22829776
TDGF3	Sex hormone-binding globulin levels	3E-16	    .04	[0.027-0.043] umol/L increase	rs1573036	T	0.031	22829776
UGT2B15	Sex hormone-binding globulin levels	3E-8	    .03	[0.019-0.039] umol/L decrease	rs293428	A	0.69	22829776
SHBG	Sex hormone-binding globulin levels	2E-55	    .08	[0.072-0.092] unit increase	rs12150660	T	0.24	22829776
SHBG	Sex hormone-binding globulin levels	3E-46	    .27	[0.24-0.31] unit decrease	rs6258	T	0.02	22829776
SHBG	Sex hormone-binding globulin levels	1E-24	    .06	[0.052-0.076] unit decrease	rs1641537	T	0.14	22829776
SHBG	Sex hormone-binding globulin levels	2E-21	    .12	[0.11-0.13] unit decrease	rs1625895	T	0.12	22829776
PTPN22	Myasthenia gravis 	8E-10	   1.71	[1.44-2.02] 	rs2476601	A	0.11	23055271
TNIP1	Myasthenia gravis 	3E-10	   1.73	[1.46-2.06] 	rs4958881	G	0.09	23055271
NR	Myasthenia gravis 	2E-90	   5.64	[4.77-6.67] 	rs3130544	A	0.13	23055271
MTX1, GBA	Renal function-related traits (BUN)	2E-12	    .01	[0.0052-0.0092] mg/dl increase	rs2049805	T	0.17	22797727
PAX8	Renal function-related traits (BUN)	3E-10	    .01	[0.0035-0.0067] mg/dl increase	rs11123170	G	0.35	22797727
MECOM	Renal function-related traits (BUN)	3E-14	    .01	[0.0048-0.0080] mg/dl increase	rs16853722	C	0.29	22797727
UNCX	Renal function-related traits (BUN)	4E-9	    .01	[0.0046-0.0093] mg/dl increase	rs10275044	T	0.34	22797727
MPPED2l, DCDC5	Renal function-related traits (BUN)	5E-16	    .01	[0.0052-0.0084] mg/dl increase	rs10767873	C	0.69	22797727
C12orf51	Renal function-related traits (BUN)	2E-9	    .01	[0.0042-0.0086] mg/dl increase	rs2074356	A	0.23	22797727
WDR72	Renal function-related traits (BUN)	3E-11	    .01	[0.0035-0.0067] mg/dl increase	rs17730281	G	0.58	22797727
BCAS3	Renal function-related traits (BUN)	2E-9	    .01	[0.0039-0.0079] mg/dl increase	rs11868441	G	0.75	22797727
GNAS	Renal function-related traits (BUN)	9E-9	    .01	[0.0034-0.0070] mg/dl increase	rs6026584	T	0.32	22797727
LRIG1, KBTBD8	Renal function-related traits (BUN)	1E-19	    .01	[0.0073-0.0113] mg/dl increase	rs13069000	G	0.17	22797727
BCL6, LPP	Renal function-related traits (BUN)	9E-30	    .01	[0.0082-0.0118] mg/dl increase	rs10937329	T	0.69	22797727
RSPO3	Renal function-related traits (BUN)	1E-11	    .01	[0.0036-0.0068] mg/dl increase	rs1936800	T	0.50	22797727
SLC14A2	Renal function-related traits (BUN)	7E-18	    .01	[0.0063-0.0103] mg/dl increase	rs7227483	G	0.80	22797727
MHC	Renal function-related traits (eGRFcrea)	1E-9	    .01	[0.0054-0.0105] ml/min/1.73m2 decrease	rs3828890	G	0.11	22797727
UNCX	Renal function-related traits (eGRFcrea)	1E-10	    .01	[0.0040-0.0076] ml/min/1.73m2 decrease	rs10277115	T	0.35	22797727
MPPED2, DCDC5	Renal function-related traits (eGRFcrea)	1E-9	    .00	[0.0029-0.0057] ml/min/1.73m2 decrease	rs963837	T	0.64	22797727
SHROOM3	Renal function-related traits (eGRFcrea)	7E-11	    .01	[0.0035-0.0067] ml/min/1.73m2  decrease	rs13146355	A	0.21	22797727
WDR72	Renal function-related traits (eGRFcrea)	6E-13	    .01	[0.0039-0.0071] ml/min/1.73m2  decrease	rs17730436	T	0.60	22797727
UMOD	Renal function-related traits (eGRFcrea)	4E-10	    .01	[0.0039-0.0075] ml/min/1.73m2 decrease	rs11864909	C	0.81	22797727
BCAS3	Renal function-related traits (eGRFcrea)	5E-11	    .01	[0.0035-0.0067] ml/min/1.73m2 decrease	rs9895661	C	0.52	22797727
MPPED2, DCDC5	Renal function-related traits (sCR)	3E-9	    .00	[0.0025-0.0049] mg/dl increase	rs963837	T	0.64	22797727
MHC	Renal function-related traits (sCR)	3E-9	    .01	[0.0046-0.0092] mg/dl increase	rs3828890	G	0.11	22797727
UNCX	Renal function-related traits (sCR)	5E-11	    .01	[0.0036-0.0068] mg/dl increase	rs10277115	T	0.35	22797727
ALDH2	Renal function-related traits (sCR)	3E-10	    .00	[0.0031-0.0059] mg/dl increase	rs671	A	0.27	22797727
SHROOM3	Renal function-related traits (sCR)	9E-12	    .00	[0.0033-0.0061] mg/dl increase	rs13146355	A	0.21	22797727
WDR72	Renal function-related traits (sCR)	1E-13	    .01	[0.0036-0.0064] mg/dl increase	rs17730436	T	0.60	22797727
UMOD	Renal function-related traits (sCR)	1E-10	    .01	[0.0036-0.0068] mg/dl increase	rs11864909	C	0.81	22797727
BCAS3	Renal function-related traits (sCR)	7E-11	    .00	[0.0031-0.0059] mg/dl increase	rs9895661	C	0.52	22797727
MAF	Renal function-related traits (urea)	1E-9	    .07	[0.048-0.094] mg/dl increase	rs889472	C	0.57	22797727
SLC2A9	Renal function-related traits (urea)	2E-65	    .18	[0.16-0.20] mg/dl increase	rs3775948	C	0.59	22797727
ABCG2	Renal function-related traits (urea)	4E-30	    .14	[0.11-0.16] mg/dl increase	rs2725220	C	0.32	22797727
SLC22A12	Renal function-related traits (urea)	3E-63	    .23	[0.20-0.25] mg/dl increase	rs504915	T	0.82	22797727
TERT	Lung adenocarcinoma	3E-40	   1.41	[1.32-1.50] 	rs2853677	C	0.30	22797724
TP63	Lung adenocarcinoma	7E-17	   1.25	[1.19-1.32] 	rs10937405	C	0.67	22797724
BPTF	Lung adenocarcinoma	7E-11	   1.20	[1.13-1.26] 	rs7216064	A	0.707	22797724
BTNL2	Lung adenocarcinoma	3E-10	   1.18	[1.12-1.24] 	rs3817963	G	0.318	22797724
Intergenic	C-reactive protein and white blood cell count	6E-13	    .28	[NR] mg/dl increase	rs2526932	G	0.012	22788528
Intergenic	C-reactive protein and white blood cell count	1E-11	    .22	[NR] mg/dl increase	rs6846071	G	0.016	22788528
DOCK4	C-reactive protein and white blood cell count	7E-11	    .24	[NR] mg/dl increase	rs10255299	G	0.013	22788528
Intergenic	C-reactive protein and white blood cell count	9E-10	    .18	[NR] mg/dl increase	rs6904416	C	0.019	22788528
Intergenic	C-reactive protein and white blood cell count	1E-9	    .22	[NR] mg/dl increase	rs960246	T	0.013	22788528
HNF1A	C-reactive protein and white blood cell count	3E-9	    .05	[NR] mg/dl decrease	rs2393791	C	0.478	22788528
Intergenic	C-reactive protein and white blood cell count	3E-9	    .39	[NR] 10^3/ul decrease	rs7600502	G	0.053	22788528
Intergenic	C-reactive protein and white blood cell count	3E-9	    .16	[NR] 10^3/ul increase	rs8078723	C	0.468	22788528
LOC100506403	C-reactive protein and white blood cell count	2E-8	    .46	[NR] 10^3/ul decrease	rs16993221	A	0.034	22788528
SC4MOL	Insulin-related traits	2E-8	    .18	[0.12-0.24] unit increase	rs17046216	A	0.48	22791750
TCERG1L	Insulin-related traits	3E-8	    .30	[0.20-0.40] unit increase	rs10829848	T	0.13	22791750
SC4MOL	Insulin-related traits	3E-8	    .19	[0.13-0.25] unit increase	rs17046216	A	0.48	22791750
HLA-DQA1, HLA-DRB1	Hepatocellular carcinoma	5E-22	   1.28	[1.22-1.35] 	rs9272105	A	0.45	22807686
GRIK1	Hepatocellular carcinoma	5E-10	   1.19	[1.12-1.25] 	rs455804	C	0.66	22807686
TNFRSF13B	IgG levels	1E-12	NR	NR	rs4792800	G	0.50	22673310
WNT16	Bone mineral density	1E-27	    .15	[NR] unit increase	rs917727	T	0.273	22792070
C7orf58	Bone mineral density	1E-10	    .08	[NR] unit decrease	rs4609139	T	0.355	22792070
CDKN2B, CDKN2BAS, CDK2NA	Glaucoma	5E-11	   2.13	[1.69-2.68] 	rs523096	A	0.825	22792221
WNT16	Bone mineral density	1E-15	    .16	[NR] mg/cm3 decrease	rs2908004	G	0.58	22792071
TNFSF11, RANKL	Cortical thickness	4E-9	    .09	[0.051-0.129] mm decrease	rs9525638	T	NR	22792071
WNT16	Cortical thickness	2E-10	    .11	[0.071-0.149] mm decrease	rs2707466	C	NR	22792071
EMID2	Response to citalopram treatment	3E-8	NR	NR	rs17135437	A	0.019	22760553
GNL3, GLT8D1	Osteoarthritis	5E-9	   1.09	[1.06-1.12] 	rs11177	A	0.38	22763110
TTC32, WDR35	Coronary heart disease	7E-11	   1.12	[1.08-1.16] 	rs2123536	T	0.39	22751097
GUCY1A3	Coronary heart disease	1E-11	   1.14	[1.10-1.19] 	rs1842896	T	0.76	22751097
C6orf10, BTNL2	Coronary heart disease	3E-15	   1.16	[1.12-1.20] 	rs9268402	G	0.59	22751097
ATP2B1	Coronary heart disease	6E-10	   1.11	[1.08-1.15] 	rs7136259	T	0.39	22751097
CDKN2A/B	Coronary heart disease	8E-45	   1.37	[1.31-1.43] 	rs10757274	G	0.46	22751097
C12orf51	Coronary heart disease	2E-11	   1.19	[1.13-1.25] 	rs11066280	A	0.17	22751097
PHACTR1	Coronary heart disease	2E-9	   1.15	[1.10-1.21] 	rs9349379	G	0.74	22751097
PTHLH, LOC100129646	Breast size	1E-8	    .16	[0.11-0.22] cup size decrease	rs12371778	G	0.091	22747683
ZNF703,MRPS7P1,KCNU1	Breast size	2E-14	    .15	[0.11-0.19] cup size decrease	rs7816345	T	0.194	22747683
ZNF365, ALDH7A1P4, ADO	Breast size	3E-9	    .10	[0.065-0.127] cup size increase	rs7089814	C	0.375	22747683
AREG, EREG, EPGN, AREGB	Breast size	5E-8	    .10	[0.064-0.138] cup size decrease	rs62314947	T	0.281	22747683
INHBB, LOC84931, GLI2	Breast size	3E-11	    .17	[0.12-0.22] cup size increase	rs4849887	T	0.113	22747683
ESR1, C6orf97	Breast size	6E-11	    .17	[0.12-0.22] cup size increase	rs12173570	T	0.101	22747683
INHBB	Breast size	5E-10	    .13	[.086-.164] cup size increase	rs17625845	C	.205	22747683
HLA-DPA1	Hepatitis B (viral clearance)	4E-45	   1.82	[1.67-1.96] 	rs3077	C	0.60	22737229
HLA-DPB1	Hepatitis B (viral clearance)	2E-21	   1.64	[1.47-1.82] 	rs9277535	G	0.57	22737229
HLA-DPA1	Hepatitis B (viral clearance)	1E-9	   1.67	[1.43-2.0] 	rs3077	C	0.60	22737229
HLA-DPB1	Hepatitis B (viral clearance)	2E-17	   1.52	[1.37-1.67] 	rs9277535	G	0.57	22737229
PHACTR1	Coronary heart disease	8E-10	   1.34	[1.22-1.47] 	rs9349379	G	0.349	22745674
PHACTR1	Coronary heart disease	6E-12	   1.19	[1.22-1.44] 	rs9349379	G	0.349	22745674
SLC8A1	QT interval	8E-14	    .07	[0.038-0.100] unit decrease	rs13017846	G	0.42	22726844
ARMS2,HTRA1	Age-related macular degeneration (CNV vs. GA)	7E-14	   1.38	[NR] 	rs10490924	T	0.438	22705344
C3	Age-related macular degeneration (CNV)	1E-12	   1.61	[1.40-1.85] 	rs2230199	C	0.193	22705344
CF1	Age-related macular degeneration (CNV)	6E-9	   1.31	[1.19-1.44] 	rs10033900	T	0.463	22705344
ARMS2,HTRA1	Age-related macular degeneration (CNV)	2E-138	   3.67	[3.33-4.05] 	rs10490924	T	0.206	22705344
ARMS2, HTRA1	Age-related macular degeneration (GA)	7E-47	   2.52	[2.24-2.83] 	rs10490924	T	.206	22705344
C3	Age-related macular degeneration (GA)	5E-13	   1.83	[1.56-2.14] 	rs2230199	C	.19	22705344
PNPLA3	Nonalcoholic fatty liver disease	1E-10	   1.66	[1.43-1.94] 	rs738409	G	0.484	22719876
F5, SELP	Activated partial thromboplastin time	3E-9	    .23	[0.14-0.31] unit increase	rs6028	C	NR	22703881
AGBL1	Activated partial thromboplastin time	4E-8	    .16	[0.081-0.243] unit increase	rs2469184	A	NR	22703881
ABO, LOC653163, SURF2, SURF4, ADAMTS13, C9orf7	Activated partial thromboplastin time	9E-100	    .82	[0.73-0.90] unit increase	rs687621	A	NR	22703881
UIMC1, FGFR4, NSD1, PRELID1, MXD3, LMAN2, RGS14, SLC34A1, PRR7, DBN1, F12, GRK6	Activated partial thromboplastin time	6E-88	   1.68	[1.48-1.88] unit decrease	rs2545801	C	NR	22703881
F11	Activated partial thromboplastin time	2E-18	    .54	[0.41-0.66] unit decrease	rs1593	A	NR	22703881
F11	Activated partial thromboplastin time	6E-43	    .48	[0.40-0.57] unit increase	rs2289252	C	NR	22703881
AHSG, FETUB, HRG	Activated partial thromboplastin time	1E-111	   1.00	[0.92-1.08] unit increase	rs9898	C	NR	22703881
KNG1, RFC4, ADIPOQ	Activated partial thromboplastin time	2E-203	   1.18	[1.10-1.26] unit decrease	rs710446	C	NR	22703881
F7	Prothrombin time	4E-56	    .04	[0.029-0.041] unit increase	rs561241	C	NR	22703881
EDEM2, TRPC4AP, PROCR, MYH7B,	Prothrombin time	5E-13	    .02	[0.012-0.028] unit decrease	rs2295888	A	NR	22703881
TNXB	Age-related macular degeneration	1E-9	   1.44	[1.28-1.63] 	rs12153855	C	0.011	22694956
NOTCH4	Age-related macular degeneration	2E-11	   1.30	[1.20-1.41] 	rs2071277	C	0.219	22694956
CFB	Age-related macular degeneration	9E-17	   1.89	[1.61-2.17] 	rs541862	T	0.99	22694956
ARMS2, HTRA1	Age-related macular degeneration	3E-72	   3.00	[2.64-3.40] 	rs10490924	T	0.21	22694956
CFH	Age-related macular degeneration	2E-47	   2.33	[2.08-2.63] 	rs10801555	A	0.40	22694956
SLC25A36	Erectile dysfunction	5E-8	NR	NR	rs9850225	A	0.010	22704111
BAK1	Chronic lymphocytic leukemia	9E-16	   1.40	[1.25-1.57] 	rs210142	C	0.70	22700719
NR	Chronic lymphocytic leukemia	8E-14	   1.47	[1.33-1.63] 	rs872071	G	0.53	22700719
NR	Chronic lymphocytic leukemia	3E-12	   1.52	[1.35-1.72] 	rs735665	A	0.20	22700719
NR	Chronic lymphocytic leukemia	3E-11	   1.42	[1.28-1.58] 	rs7176508	A	0.37	22700719
MEF2D	Migraine	7E-11	   1.20	[1.14-1.27] 	rs3790455	C	0.34	22683712
TGFBR2	Migraine	1E-9	   1.19	[1.13-1.26] 	rs7640543	A	0.32	22683712
ASTN2	Migraine	4E-8	   1.16	[1.10-1.23] 	rs6478241	A	0.38	22683712
ZC3H11B	Myopia (pathological)	3E-10	    .16	[0.12-0.20] mm decrease	rs373767	C	0.30	22685421
F5	Venous thromboembolism	2E-22	   3.57	[2.76-4.60] 	rs6025	T	0.063	22672568
ABO	Venous thromboembolism	3E-16	   1.65	[1.46-1.86] 	rs495828	T	0.272	22672568
NME7	Venous thromboembolism	2E-12	   2.02	[1.66-2.45] 	rs16861990	C	0.099	22672568
ABO	Venous thromboembolism	6E-12	   1.47	[1.32-1.64] 	rs8176719	G	0.419	22672568
ABO	Venous thromboembolism	8E-16	   1.69	[1.48-1.91] 	rs2519093	A	0.243	22672568
FXR2, SHBG, SAT2, ATP1B2	Sex hormone-binding globulin levels	2E-16	    .13	[NR] unit decrease	rs727428	T	0.42	22675492
TARDBP	Male-pattern baldness	9E-11	   1.33	[1.22-1.45] 	rs12565727	A	0.789	22693459
HDAC4	Male-pattern baldness	1E-12	   1.31	[1.21-1.41] 	rs9287638	A	0.562	22693459
HDAC9	Male-pattern baldness	1E-12	   1.29	[1.20-1.38] 	rs2073963	G	0.530	22693459
AUTS2	Male-pattern baldness	2E-9	   1.27	[1.18-1.38] 	rs6945541	C	0.539	22693459
Intergenic	Male-pattern baldness	5E-10	   1.33	[1.21-1.45] 	rs12373124	T	0.438	22693459
SETBP1	Male-pattern baldness	3E-9	   1.28	[1.18-1.39] 	rs10502861	C	0.775	22693459
PAX1, FOXA2	Male-pattern baldness	2E-39	   1.60	[1.49-1.72] 	rs6047844	T	0.460	22693459
AR	Male-pattern baldness	2E-91	   2.20	[2.04-2.37] 	rs2497938	T	0.850	22693459
LAMA1	Type 2 diabetes	8E-9	   1.13	[1.09-1.18] 	rs8090011	G	0.38	22693455
HMG20A	Type 2 diabetes	1E-8	   1.11	[1.07-1.15] 	rs7178572	G	0.70	22693455
TCF7L2	Type 2 diabetes	2E-40	   1.58	[1.47-1.68] 	rs7903146	T	0.29	22693455
CDKAL1	Type 2 diabetes	7E-10	   1.26	[1.17-1.35] 	rs7766070	A	0.27	22693455
SLC30A8	Type 2 diabetes	4E-8	   1.23	[1.15-1.33] 	rs3802177	G	0.68	22693455
TCF7L2	Type 2 diabetes	4E-21	   1.26	[1.20 - 1.32] 	rs7903146	T	0.29	22693455
FTO	Type 2 diabetes	1E-20	   1.25	[1.19-1.30] 	rs9939609	A	0.40	22693455
CDKAL1	Type 2 diabetes	6E-11	   1.21	[1.14-1.28] 	rs7766070	A	0.27	22693455
HHEX	Type 2 diabetes	2E-9	   1.18	[1.11-1.23] 	rs5015480	C	0.57	22693455
IG2BP2	Type 2 diabetes	3E-9	   1.15	[1.10-1.21] 	rs4402960	T	0.31	22693455
CHRNA5	Smoking behavior	2E-8	    .04	[0.026-0.054] unit increase	rs2036527	A	0.22	22832964
WDR92	Immune reponse to smallpox (secreted IFN-alpha)	2E-18	NR	NR	rs4078978	A	NR	22610502
ECSM2, TMEM173	Immune reponse to smallpox (secreted IFN-alpha)	3E-14	NR	NR	rs13181561	G	NR	22610502
LOC100128265	Immune reponse to smallpox (secreted IFN-alpha)	2E-12	NR	NR	rs381365	A	NR	22610502
ZNF827	Immune reponse to smallpox (secreted IFN-alpha)	6E-12	NR	NR	rs2048161	A	NR	22610502
MNAT1	Immune reponse to smallpox (secreted IFN-alpha)	3E-10	NR	NR	rs6573333	A	NR	22610502
MAMLD1	Immune reponse to smallpox (secreted IFN-alpha)	6E-10	NR	NR	rs17252936	G	NR	22610502
TIMELESS	Immune reponse to smallpox (secreted IFN-alpha)	6E-10	NR	NR	rs11171846	A	NR	22610502
KCND3	Immune reponse to smallpox (secreted IFN-alpha)	9E-10	NR	NR	rs12044963	A	NR	22610502
LOC152118	Immune reponse to smallpox (secreted IFN-alpha)	2E-9	NR	NR	rs6778194	C	NR	22610502
COL4A4	Immune reponse to smallpox (secreted IFN-alpha)	3E-9	NR	NR	rs2272205	G	NR	22610502
RAB14	Immune reponse to smallpox (secreted IFN-alpha)	4E-9	NR	NR	rs9408928	G	NR	22610502
ATP10A	Immune reponse to smallpox (secreted IFN-alpha)	6E-9	NR	NR	rs6576443	A	NR	22610502
PHEX	Immune reponse to smallpox (secreted IFN-alpha)	9E-9	NR	NR	rs1540283	G	NR	22610502
LOC728241	Immune reponse to smallpox (secreted IFN-alpha)	1E-8	NR	NR	rs17007761	A	NR	22610502
OR2H1	Immune reponse to smallpox (secreted IFN-alpha)	2E-8	NR	NR	rs4713226	A	NR	22610502
LOC344332	Immune reponse to smallpox (secreted IFN-alpha)	3E-8	NR	NR	rs10195263	G	NR	22610502
CEP110	Immune reponse to smallpox (secreted IFN-alpha)	4E-8	NR	NR	rs9408926	A	NR	22610502
SPOCK3	Immune reponse to smallpox (secreted IL-10)	3E-11	NR	NR	rs13111850	G	NR	22610502
DYNC1I1	Immune reponse to smallpox (secreted IL-10)	5E-9	NR	NR	rs13231718	C	NR	22610502
LOC100129730	Immune reponse to smallpox (secreted IL-10)	2E-8	NR	NR	rs17231212	G	NR	22610502
LOC100131805	Immune reponse to smallpox (secreted IL-12p40)	2E-12	NR	NR	rs7771911	A	NR	22610502
KCND2	Immune reponse to smallpox (secreted IL-12p40)	3E-9	NR	NR	rs17142462	A	NR	22610502
BCO2	Immune reponse to smallpox (secreted IL-12p40)	1E-8	NR	NR	rs7105056	A	NR	22610502
ARHGAP10	Immune reponse to smallpox (secreted IL-12p40)	1E-8	NR	NR	rs7658486	A	NR	22610502
FLJ44385	Immune reponse to smallpox (secreted IL-1beta)	4E-9	NR	NR	rs17000918	A	NR	22610502
MTHFD2L	Immune reponse to smallpox (secreted IL-1beta)	7E-9	NR	NR	rs16850864	A	NR	22610502
EPGN, MTHFD2L	Immune reponse to smallpox (secreted IL-1beta)	7E-9	NR	NR	rs16850885	A	NR	22610502
LOC392008	Immune reponse to smallpox (secreted IL-1beta)	3E-8	NR	NR	rs11564024	C	NR	22610502
SLC15A1	Immune reponse to smallpox (secreted IL-1beta)	3E-8	NR	NR	rs9582259	C	NR	22610502
SUPV3L1, VPS26A	Immune reponse to smallpox (secreted IL-1beta)	1E-9	NR	NR	rs10998624	A	NR	22610502
LOC389936	Immune reponse to smallpox (secreted IL-1beta)	3E-9	NR	NR	rs12247397	G	NR	22610502
GAPDHL19	Immune reponse to smallpox (secreted IL-2)	7E-13	NR	NR	rs9389316	A	NR	22610502
RFT1	Immune reponse to smallpox (secreted IL-2)	3E-11	NR	NR	rs13088281	A	NR	22610502
TOMM20	Immune reponse to smallpox (secreted IL-2)	5E-10	NR	NR	rs908327	C	NR	22610502
ITIH3, ITIH4	Immune reponse to smallpox (secreted IL-2)	2E-9	NR	NR	rs17331151	A	NR	22610502
CNTN5	Immune reponse to smallpox (secreted IL-2)	9E-9	NR	NR	rs11223581	G	NR	22610502
GRIN2B	Immune reponse to smallpox (secreted IL-2)	1E-8	NR	NR	rs2268118	A	NR	22610502
NGFR	Immune reponse to smallpox (secreted IL-2)	2E-8	NR	NR	rs16948200	A	NR	22610502
AUTS2	Immune reponse to smallpox (secreted IL-2)	2E-8	NR	NR	rs1403155	A	NR	22610502
IRAK4, PUS7L	Immune reponse to smallpox (secreted TNF-alpha)	2E-8	NR	NR	rs4251424	A	NR	22610502
MEX3C	Immune response to smallpox vaccine (IL-6)	9E-9	NR	NR	rs8096445	A	NR	22610502
PDE4D	Immune response to smallpox vaccine (IL-6)	2E-8	NR	NR	rs17444059	G	NR	22610502
LTBP1	Immune response to smallpox vaccine (IL-6)	4E-8	NR	NR	rs6728021	G	NR	22610502
APOE	Hippocampal atrophy	2E-33	NR	NR	APOE	E	0.19	22745009
F5, SELP	Hippocampal atrophy	1E-9	NR	NR	rs6703865	A	0.08	22745009
GCFC2	Hippocampal atrophy	5E-8	NR	NR	rs2298948	C	0.29	22745009
LHFP	Hippocampal atrophy	2E-8	NR	NR	rs9315702	A	0.44	22745009
LYPLAL1	Visceral adipose tissue/subcutaneous adipose tissue ratio	3E-9	NR	NR	rs11118316	A	0.44	22589738
THNSL2	Visceral fat	2E-8	NR	NR	rs1659258	A	0.92	22589738
DOT1L	Osteoarthritis	1E-11	    .09	[NR] mm increase	rs12982744	G	0.39	22566624
IFIH1	Vitiligo	5E-15	   1.30	[NR] 	rs2111485	G	0.62	22561518
CD80	Vitiligo	4E-10	   1.34	[NR] 	rs59374417	C	0.13	22561518
CLNK	Vitiligo	2E-8	   1.21	[NR] 	rs16872571	C	0.56	22561518
BACH2	Vitiligo	3E-8	   1.20	[NR] 	rs3757247	A	0.47	22561518
SLA	Vitiligo	2E-8	   1.20	[NR] 	rs853308	G	0.48	22561518
CASP7	Vitiligo	4E-8	   1.23	[NR] 	rs3814231	G	0.75	22561518
CD44	Vitiligo	2E-9	   1.22	[NR] 	rs10768122	G	0.41	22561518
TYR	Vitiligo	2E-13	   1.34	[NR] 	rs4409785	C	0.19	22561518
IKZF4	Vitiligo	3E-14	   1.29	[NR] 	rs2456973	C	0.35	22561518
SH2B3	Vitiligo	4E-18	   1.32	[NR] 	rs4766578	T	0.52	22561518
OCA2, HERC2	Vitiligo	4E-8	   1.22	[NR] 	rs1129038	C	0.27	22561518
MC1R	Vitiligo	2E-13	   1.27	[NR] 	rs9926296	A	0.54	22561518
TOB2	Vitiligo	7E-10	   1.28	[NR] 	rs4822024	G	0.79	22561518
KCNJ6	Electroencephalographic traits in alcoholism	5E-10	    .15	[NR] unit decrease	rs2835872	G	0.681	22554406
PTGER4	Multiple sclerosis	1E-9	   1.19	[1.12-1.25] 	rs9292777	T	NR	22570697
GAS7	Intraocular pressure	1E-8	    .19	[0.12-0.26] mmHg decrease	rs11656696	A	0.43	22570627
TMCO1	Intraocular pressure	2E-8	    .28	[0.18-0.37] mmHg increase	rs7555523	C	0.12	22570627
IL5RA	Asthma (childhood onset)	2E-8	    .17	[NR] unit decrease	rs9815663	T	0.1820	22560479
NR	Asthma (childhood onset)	7E-9	    .16	[NR] unit decrease	rs7927044	A	0.0134	22560479
PRRX1	Atrial fibrillation	8E-14	   1.14	[1.10-1.17] 	rs3903239	G	0.45	22544366
CAV1	Atrial fibrillation	4E-12	   1.11	[1.09-1.15] 	rs3807989	G	0.60	22544366
C9orf3	Atrial fibrillation	4E-11	   1.11	[1.08-1.15] 	rs10821415	A	0.42	22544366
SYNPO2L	Atrial fibrillation	4E-9	   1.15	[1.10-1.20] 	rs10824026	A	0.84	22544366
SYNE2	Atrial fibrillation	6E-13	   1.13	[1.09-1.17] 	rs1152591	A	0.48	22544366
HCN4	Atrial fibrillation	3E-17	   1.19	[1.14-1.24] 	rs7164883	G	0.16	22544366
KCNN3, PMVK	Atrial fibrillation	2E-14	   1.18	[1.13-1.23] 	rs6666258	C	0.30	22544366
PITX2	Atrial fibrillation	2E-74	   1.64	[1.55-1.73] 	rs6817105	C	0.13	22544366
ZFHX3	Atrial fibrillation	3E-16	   1.24	[1.17-1.30] 	rs2106261	T	0.176	22544366
DDX1, MYCN	Wilms tumor	1E-14	   1.45	[1.29-1.64] 	rs3755132	G	0.14	22544364
NR	Wilms tumor	5E-10	   1.43	[1.18-1.73] 	rs1027643	T	0.05	22544364
DLG2	Wilms tumor	4E-15	   1.28	[1.17-1.39] 	rs790356	G	0.5	22544364
NR	Wilms tumor	5E-12	   2.05	[1.57-2.69] 	rs2283873	A	0.02	22544364
NR	Wilms tumor	1E-9	   2.64	[1.74-4.01] 	rs5955543	G	0.01	22544364
DDX1, MYCN	Wilms tumor	1E-14	   1.33	[1.22-1.45] 	rs807624	A	0.35	22544364
UGT1A1, UGT1A10	Cholelithiasis-related traits in sickle cell anemia	5E-25	    .19	[NR] unit increase	rs887829	A	0.45	22558097
TNFRSF13B	Non-albumin protein levels 	1E-14	    .11	[0.080-0.134] unit increase	rs4985726	G	0.375	22558069
GCKR	Non-albumin protein levels 	3E-9	    .08	[0.053-0.107] unit decrease	rs1260326	C	0.445	22558069
TNFRSF13B	Non-albumin protein levels 	7E-24	    .14	[0.11-0.16] unit increase	rs4985726	G	0.375	22558069
TNFSF13	Non-albumin protein levels 	7E-15	    .10	[0.079-0.129] unit increase	rs3803800	A	0.311	22558069
ANXA3	Non-albumin protein levels 	1E-9	    .09	[0.058-0.112] unit increase	rs10007186	C	0.307	22558069
SIX1, SIX6	Glaucoma (primary open-angle)	4E-11	   1.32	[1.21-1.43] 	rs10483727	A	NR	22570617
MTNR1B	Fasting plasma glucose	1E-12	   1.38	[1.01-1.75] mg/dL increase	rs10830963	G	0.27	22508271
PDE8B	Thyroid function	3E-27	    .12	[0.093-0.137] unit decrease	rs2046045	T	0.618	22494929
CAPZB	Thyroid function	2E-8	    .06	[0.038-0.078] unit decrease	rs10917477	A	0.511	22494929
NR3C2	Thyroid function	3E-10	    .08	[0.059-0.109] unit increase	rs10028213	C	0.823	22494929
LOC440389, MAF	Thyroid function	6E-10	    .07	[0.046-0.090] unit increase	rs3813582	T	0.681	22494929
MSRB3	Hippocampal volume	5E-11	 123.80	[86.76-160.84] mm3 decrease	rs17178006	G	0.10	22504421
WIF1	Hippocampal volume	7E-11	  63.30	[44.29-82.31] mm3 decrease	rs6581612	C	0.27	22504421
HRK	Hippocampal volume	3E-11	 107.80	[76.05-139.55] mm3 decrease	rs7294919	T	0.91	22504421
ABCF2	Bone mineral density	7E-9	    .05	[NR] unit increase	rs7812088	A	0.13	22504420
AKAP11	Bone mineral density	5E-68	    .10	[NR] unit decrease	rs9533090	T	0.49	22504420
ANAPC1	Bone mineral density	2E-9	    .04	[NR] unit increase	rs17040773	A	0.76	22504420
ARHGAP1	Bone mineral density	5E-18	    .05	[NR] unit increase	rs7932354	T	0.31	22504420
AXIN1	Bone mineral density	1E-16	    .04	[NR] unit decrease	rs9921222	T	0.48	22504420
C12orf23	Bone mineral density	1E-9	    .03	[NR] unit decrease	rs1053051	T	0.52	22504420
C16orf38	Bone mineral density	1E-16	    .04	[NR] unit decrease	rs13336428	A	0.43	22504420
C17orf53	Bone mineral density	3E-24	    .06	[NR] unit decrease	rs227584	A	0.7	22504420
C18orf19	Bone mineral density	5E-8	    .03	[NR] unit increase	rs4796995	A	0.63	22504420
C6orf97	Bone mineral density	4E-35	    .08	[NR] unit decrease	rs4869742	T	0.31	22504420
C7orf58	Bone mineral density	2E-11	    .05	[NR] unit increase	rs13245690	A	0.65	22504420
CDKAL1	Bone mineral density	3E-13	    .04	[NR] unit decrease	rs9466056	A	0.38	22504420
CPN1	Bone mineral density	9E-10	    .03	[NR] unit increase	rs7084921	T	0.39	22504420
CTNNB1	Bone mineral density	4E-25	    .06	[NR] unit decrease	rs430727	T	0.48	22504420
CYLD	Bone mineral density	2E-10	    .04	[NR] unit decrease	rs1564981	A	0.5	22504420
DCDC5	Bone mineral density	2E-11	    .04	[NR] unit decrease	rs163879	T	0.68	22504420
DHH	Bone mineral density	1E-15	    .05	[NR] unit increase	rs12821008	T	0.39	22504420
DNM3	Bone mineral density	9E-15	    .04	[NR] unit decrease	rs479336	T	0.74	22504420
ERC1	Bone mineral density	6E-12	    .04	[NR] unit decrease	rs2887571	A	0.76	22504420
FOXL1	Bone mineral density	1E-14	    .05	[NR] unit increase	rs10048146	A	0.8	22504420
FUBP3	Bone mineral density	3E-22	    .05	[NR] unit increase	rs7851693	C	0.64	22504420
GALNT3	Bone mineral density	4E-30	    .06	[NR] unit decrease	rs1346004	A	0.5	22504420
GPATCH1	Bone mineral density	7E-11	    .04	[NR] unit decrease	rs10416218	T	0.73	22504420
HOXC6	Bone mineral density	8E-16	    .05	[NR] unit increase	rs736825	C	0.56	22504420
IDUA	Bone mineral density	5E-15	    .06	[NR] unit decrease	rs3755955	A	0.16	22504420
INSIG2	Bone mineral density	1E-10	    .04	[NR] unit increase	rs1878526	A	0.22	22504420
JAG1	Bone mineral density	3E-19	    .05	[NR] unit increase	rs3790160	T	0.5	22504420
KCNMA1	Bone mineral density	5E-19	    .06	[NR] unit decrease	rs7071206	T	0.78	22504420
KIAA2018	Bone mineral density	4E-10	    .03	[NR] unit increase	rs1026364	T	0.37	22504420
KLHDC5	Bone mineral density	2E-12	    .05	[NR] unit increase	rs7953528	A	0.18	22504420
LEKR1	Bone mineral density	4E-12	    .06	[NR] unit increase	rs344081	T	0.87	22504420
LIN7C	Bone mineral density	5E-8	    .03	[NR] unit decrease	rs10835187	T	0.55	22504420
LRP5	Bone mineral density	2E-26	    .08	[NR] unit decrease	rs3736228	T	0.16	22504420
MAPT	Bone mineral density	5E-11	    .04	[NR] unit decrease	rs1864325	T	0.22	22504420
MARK3	Bone mineral density	5E-16	    .04	[NR] unit decrease	rs11623869	T	0.35	22504420
MBL2	Bone mineral density	2E-12	    .06	[NR] unit decrease	rs1373004	T	0.13	22504420
MEF2C	Bone mineral density	4E-61	    .08	[NR] unit increase	rs1366594	A	0.54	22504420
MEPE	Bone mineral density	1E-27	    .06	[NR] unit increase	rs6532023	T	0.34	22504420
MPP7	Bone mineral density	2E-16	    .05	[NR] unit increase	rs3905706	T	0.22	22504420
NTAN1	Bone mineral density	2E-10	    .03	[NR] unit decrease	rs4985155	A	0.67	22504420
PKDCC	Bone mineral density	1E-9	    .04	[NR] unit increase	rs7584262	T	0.23	22504420
RPS6KA5	Bone mineral density	2E-15	    .05	[NR] unit decrease	rs1286083	T	0.81	22504420
RSPO3	Bone mineral density	8E-12	    .04	[NR] unit increase	rs13204965	A	0.76	22504420
SALL1	Bone mineral density	2E-22	    .06	[NR] unit decrease	rs1566045	T	0.8	22504420
SLC25A13	Bone mineral density	8E-48	    .08	[NR] unit increase	rs4727338	C	0.67	22504420
SMG6	Bone mineral density	1E-18	    .05	[NR] unit increase	rs4790881	A	0.69	22504420
SOST	Bone mineral density	2E-11	    .04	[NR] unit increase	rs4792909	T	0.37	22504420
SOX6	Bone mineral density	1E-32	    .08	[NR] unit decrease	rs7108738	T	0.83	22504420
SOX9	Bone mineral density	2E-11	    .03	[NR] unit increase	rs7217932	A	0.46	22504420
SP7	Bone mineral density	3E-20	    .05	[NR] unit decrease	rs2016266	A	0.68	22504420
SPTBN1	Bone mineral density	2E-18	    .05	[NR] unit increase	rs4233949	C	0.38	22504420
STARD3NL	Bone mineral density	4E-38	    .07	[NR] unit decrease	rs6959212	T	0.32	22504420
SUPT3H	Bone mineral density	6E-11	    .04	[NR] unit decrease	rs11755164	T	0.4	22504420
TNFRSF11A	Bone mineral density	2E-17	    .05	[NR] unit decrease	rs884205	A	0.27	22504420
TNFRSF11B	Bone mineral density	3E-39	    .08	[NR] unit decrease	rs2062377	A	0.57	22504420
TXNDC3	Bone mineral density	6E-13	    .06	[NR] unit decrease	rs10226308	A	0.84	22504420
WLS	Bone mineral density	3E-45	    .08	[NR] unit increase	rs12407028	T	0.6	22504420
WNT16	Bone mineral density	3E-51	    .09	[NR] unit decrease	rs3801387	A	0.74	22504420
WNT4	Bone mineral density	1E-10	    .05	[NR] unit decrease	rs7521902	A	0.31	22504420
ZBTB40	Bone mineral density	7E-57	    .11	[NR] unit increase	rs6426749	C	0.17	22504420
RSPO3, RNF146, CENPW	Intracranial volume	2E-13	  12.50	[NR] ml increase	rs4273712	G	0.27	22504418
MAPT, GRN, CRHR1, STH	Intracranial volume	8E-15	  14.90	[NR] ml decrease	rs9303525	G	0.22	22504418
HRK, FBXW8	Brain structure	7E-16	  47.58	[36.04-59.12] mm3 increase	rs7294919	C	0.099	22504417
HMGA2	Brain structure	1E-12	#######	[6525.78-11487.64] mm3 increase	rs10784502	C	0.49	22504417
SBNO1	Head circumference (infant)	8E-9	    .07	[0.049-0.099] SD increase	rs7980687	A	0.20	22504419
HMGA2	Head circumference (infant)	3E-10	    .07	[0.045-0.085] SD decrease	rs1042725	T	0.49	22504419
UGT1A1	Circulating cell-free DNA	2E-23	    .34	[0.27-0.40] ug/ml increase	rs6742078	T	0.60	22511988
ZMIZ1	Crohn's disease and psoriasis	7E-14	   1.16	[NR] 	rs1250544	G	NR	22482804
SOCS1	Crohn's disease and psoriasis	1E-13	   1.16	[NR] 	rs4780355	T	NR	22482804
LOC729792, HCG22, C6orf15, HLA-C, HLA-B, DHFRP2, HCP5	Hypothyroidism	1E-8	   1.16	[1.10-1.22] 	rs2517532	G	0.597	22493691
KRT18P13, FOXE1, C9orf156	Hypothyroidism	2E-19	   1.28	[1.22-1.35] 	rs925489	T	0.668	22493691
VAV3	Hypothyroidism	8E-10	   1.30	[1.20-1.41] 	rs4915077	C	0.084	22493691
SH2B3, ATXN2, LOC100101246, BRAP, NAA25, C12orf51, PTPN11	Hypothyroidism	3E-12	   1.20	[1.14-1.27] 	rs3184504	T	0.502	22493691
PHTF1, RSBN1, PTPN22	Hypothyroidism	3E-13	   1.36	[1.25-1.48] 	rs6679677	A	0.091	22493691
LYPLAL1	Adiponectin levels	4E-8	    .02	[0.012-0.028] unit decrease	rs3001032	T	0.70	22479202
GNL3	Adiponectin levels	1E-13	    .03	[0.022-0.038] unit increase	rs1108842	C	0.50	22479202
ADIPOQ	Adiponectin levels	5E-44	    .06	[NR] unit increase	rs182052	G	NR	22479202
VEGFA	Adiponectin levels	3E-8	    .03	[0.020-0.040] unit increase	rs998584	C	0.5	22479202
TRIB1	Adiponectin levels	7E-9	    .03	[0.020-0.040] unit increase	rs2980879	T	0.70	22479202
PDE3A	Adiponectin levels	4E-8	    .02	[0.012-0.028] unit increase	rs7955516	C	0.40	22479202
ATP6V0A2, GPR109A, DNAH10	Adiponectin levels	3E-10	    .05	[NR] unit decrease	rs6488898	G	NR	22479202
CDH13,CMIP	Adiponectin levels	6E-48	    .26	[NR] unit decrease	rs12051272	T	NR	22479202
PEPD	Adiponectin levels	8E-12	    .03	[0.022-0.038] unit decrease	rs731839	G	0.35	22479202
IRS1	Adiponectin levels	2E-8	    .02	[0.012-0.028] unit decrease	rs925735	G	0.64	22479202
GNL3	Adiponectin levels	2E-13	    .03	[0.022-0.038] unit decrease	rs2590838	G	0.51	22479202
ADIPOQ	Adiponectin levels	2E-42	    .06	[0.052-0.068] unit increase	rs6810075	T	0.93	22479202
TRIB1	Adiponectin levels	1E-9	    .03	[0.022-0.038] unit increase	rs2980879	T	0.69	22479202
CMIP	Adiponectin levels	3E-21	    .04	[0.032-0.048] unit decrease	rs2925979	T	0.30	22479202
CDH13	Adiponectin levels	1E-14	    .26	[0.20-0.32] unit decrease	rs12051272	T	0.03	22479202
PEPD	Adiponectin levels	2E-8	    .03	[0.020-0.040] unit decrease	rs4805885	T	0.39	22479202
C6orf10	Multiple sclerosis	7E-16	   2.34	[1.90-2.87] 	rs3129934	T	0.10	22457343
ERBB4	Breast cancer	9E-14	   1.53	[1.37-1.70] 	rs13393577	T	0.051	22452962
BLK	Kawasaki disease	9E-10	   1.54	[1.338-1.767] 	rs2736340	T	0.722	22446961
CD40	Kawasaki disease	6E-9	   1.42	[1.256-1.594] 	rs1569723	A	0.5480	22446961
B3GNT2	Rheumatoid arthritis	1E-8	   1.11	[1.07-1.15] 	rs11900673	T	0.28	22446963
ANXA3	Rheumatoid arthritis	1E-12	   1.13	[1.09-1.17] 	rs2867461	A	0.44	22446963
CSF2	Rheumatoid arthritis	3E-10	   1.12	[1.08-1.15] 	rs657075	A	0.36	22446963
CD83	Rheumatoid arthritis	2E-8	   1.14	[1.09-1.19] 	rs12529514	C	0.14	22446963
NFKBIE	Rheumatoid arthritis	6E-19	   1.19	[1.15-1.24] 	rs2233434	G	0.21	22446963
ARID5B	Rheumatoid arthritis	6E-18	   1.16	[1.12-1.20] 	rs10821944	G	0.36	22446963
PDE2A, ARAP1	Rheumatoid arthritis	6E-10	   1.12	[1.08-1.16] 	rs3781913	T	0.69	22446963
PLD4	Rheumatoid arthritis	2E-14	   1.15	[1.11-1.19] 	rs2841277	T	0.69	22446963
PTPN2	Rheumatoid arthritis	2E-8	   1.10	[1.07-1.14] 	rs2847297	G	0.33	22446963
FAM167A, BLK	Kawasaki disease	8E-21	   1.85	[1.54-2.23] 	rs2254546	G	0.72	22446962
HLA-DQB2, HLA-DOB	Kawasaki disease	5E-11	   1.47	[1.23-1.77] 	rs2857151	G	0.76	22446962
CD40	Kawasaki disease	5E-8	   1.41	[1.20-1.66] 	rs4813003	C	0.67	22446962
MLF1IP	Kawasaki disease	3E-8	   1.42	[1.23-1.64] 	rs2130392	A	0.358	22446962
NUMBL,MIA	Kawasaki disease	4E-10	   1.52	[1.28-1.81] 	rs2233152	A	0.158	22446962
CDKN2B	Glaucoma (primary open-angle)	5E-11	   1.33	[1.22-1.43] 	rs1063192	T	0.79	22419738
BUD13, ZNF259, APOA5, LOC100128347, SIK3	Response to Vitamin E supplementation	3E-12	    .07	[0.050-0.090] mg/L increase	rs964184	G	0.15	22437554
FRMD4A	Alzheimer's disease	1E-10	   1.68	[1.43-1.96]  (AAC)	rs7081208, rs2446581, rs17314229	S	0.028	22430674
CDKN2B-AS1	Glaucoma (primary open-angle)	9E-11	   1.78	[1.50-2.12] 	rs7865618	A	0.82	22428042
KCNJ2	Thyrotoxic hypokalemic periodic paralysis	4E-12	   5.47	[3.04-9.83] 	rs623011	A	0.45	22399142
IL23R, IL12RB2, C1orf141, SERBP1,SLC35D1	Crohn's disease	1E-18	   2.20	[2.10-2.35] 	rs11209026	G	0.921	22412388
ATG16L1, SAG, DGKD, INPP5D, USP40	Crohn's disease	1E-12	   1.32	[1.24-1.41] 	rs2241880	G	0.601	22412388
TMEM17, EHBP1, CPAMD8, AK3	Crohn's disease	7E-9	   1.16	[1.06-1.27] 	rs6545946	C	0.77	22412388
PTGER4	Crohn's disease	2E-11	   1.37	[1.28-1.48] 	rs9292777	T	0.597	22412388
SLCO6A1	Crohn's disease	2E-8	   1.48	[1.17-1.87] 	rs7705924	G	0.066	22412388
HLA-F, MOG, HLA-G, GABBR1, HLA-H, UBD, HLA-A	Crohn's disease	2E-10	   1.45	[1.21-1.68] 	rs9258260	T	0.104	22412388
C8orf84, TERF1, RPL7, RDH10, KCNB2	Crohn's disease	2E-8	   1.15	[1.04-1.28] 	rs12677663	T	0.659	22412388
TCERG1L	Crohn's disease	3E-8	   1.27	[1.10-1.43] 	rs10734105	G	0.375	22412388
ZNF365, ERG2, ADO	Crohn's disease	7E-9	   1.19	[1.10-1.30] 	rs7076156	G	0.751	22412388
SLC43A3, PRG2, PRG3	Crohn's disease	8E-9	   1.15	[1.10-1.39] 	rs11229030	C	0.305	22412388
NOD2, CYLD, SNX20, NKD1	Crohn's disease	1E-37	   1.66	[1.48-1.88] 	rs2076756	G	0.246	22412388
CCL7, CCL2, CCL11, CCL8, CCL13, CCL1	Crohn's disease	4E-8	   1.14	[1.03-1.27] 	rs3091316	G	0.732	22412388
PUS10, PEX13, REL, KIAA1841, C2orf74, PAPOLG, USP34	Crohn's disease	5E-9	   1.05	[1.00-1.40] 	rs13003464	G	0.487	22412388
IL3, ACSL6, P4HA2, PDLIM4, SLC22A4	Crohn's disease	4E-8	   1.23	[1.08-1.42] 	rs3091338	T	0.328	22412388
LRRC16A	Mean platelet volume	9E-9	   4.39	[2.9-5.88] 10^9 L decrease	rs12526480	T	0.305	22423221
BAK1	Mean platelet volume	2E-15	   6.16	[4.63-7.69] 10^9 L decrease	rs210134	G	0.286	22423221
HBS1L, MYB	Mean platelet volume	3E-9	   8.19	[5.49-10.89] 10^9 L increase	rs9494145	T	0.73	22423221
CD36	Mean platelet volume	3E-9	   4.18	[2.81-5.55] 10^9 L increase	rs13236689	T	0.436	22423221
PIK3CG	Mean platelet volume	2E-8	   4.05	[2.64-5.46] 10^L decrease	rs342293	C	0.386	22423221
JMJD1C	Mean platelet volume	2E-12	   5.18	[3.73-6.63] 10^9 L increase	rs7896518	A	0.324	22423221
BAD	Mean platelet volume	5E-8	   4.19	[2.68-5.7] 10^9 L decrease	rs477895	T	0.453	22423221
ACAD10	Mean platelet volume	5E-9	   4.38	[2.91-5.85] 10^9 L decrease	rs6490294	A	0.337	22423221
TPM4	Mean platelet volume	5E-10	   8.72	[5.98-11.46] 10^9 L decrease	rs8109288	G	0.097	22423221
SLMO2, TUBB1	Mean platelet volume	9E-9	   4.49	[2.96-6.02] 10^9 L increase	rs151361	A	0.257	22423221
PIK3CG	Mean platelet volume	1E-11	    .16	[0.12-0.2] fL increase	rs342296	G	0.372	22423221
TAOK1	Mean platelet volume	4E-8	    .13	[0.091-0.169] fL decrease	rs11653144	T	0.442	22423221
TPM4	Mean platelet volume	3E-9	    .26	[0.18-0.34] fL increase	rs8109288	G	0.084	22423221
G6PC2	Metabolic syndrome	5E-26	    .15	[NR] mmol/l increase	rs560887	G	0.69	22399527
TMEM195, DGKB	Metabolic syndrome	1E-13	    .10	[NR] mmol/l increase	rs6947830	A	0.46	22399527
GCK	Metabolic syndrome	4E-13	    .10	[NR] mmol/l increase	rs3757840	A	0.46	22399527
CAMK2B	Metabolic syndrome	9E-11	    .08	[NR] mmol/l increase	rs1127065	G	0.49	22399527
MTNR1B	Metabolic syndrome	5E-16	    .12	[NR] mmol/l increase	rs10830962	G	0.40	22399527
GALNT2	Metabolic syndrome	4E-8	    .08	[NR] mmol/l decrease	rs4846922	T	0.39	22399527
APOB	Metabolic syndrome	1E-10	    .11	[NR] mmol/l decrease	rs673548	G	0.73	22399527
HCG26, MICB	Metabolic syndrome	2E-8	    .15	[NR] mmol/l decrease	rs3099844	A	0.08	22399527
LPL	Metabolic syndrome	2E-12	    .38	[NR] mmol/l decrease	rs268	G	0.02	22399527
ABCA1	Metabolic syndrome	6E-10	    .10	[NR] mmol/l decrease	rs1883025	T	0.19	22399527
NR1H3	Metabolic syndrome	1E-9	    .08	[NR] mmol/l decrease	rs10838681	G	0.64	22399527
LIPC	Metabolic syndrome	5E-24	    .13	[NR] mmol/l decrease	rs1532085	G	0.57	22399527
CETP	Metabolic syndrome	9E-60	    .25	[NR] mmol/l decrease	rs247617	C	0.72	22399527
EDC4	Metabolic syndrome	2E-10	    .11	[NR] mmol/l decrease	rs8060686	T	0.81	22399527
SMEK2	Metabolic syndrome	4E-8	    .09	[NR] mmHg increase	rs782590	T	0.56	22399527
APOB	Metabolic syndrome	4E-8	    .08	[NR] mmol/l increase	rs6711016	C	0.71	22399527
GCKR	Metabolic syndrome	6E-20	    .13	[NR] mmol/l increase	rs780094	A	0.36	22399527
MLXIPL	Metabolic syndrome	2E-11	    .12	[NR] mmol/l increase	rs13226650	A	0.83	22399527
LPL	Metabolic syndrome	1E-14	    .18	[NR] mmol/l increase	rs7841189	C	0.90	22399527
ZNF259	Metabolic syndrome	3E-31	    .23	[NR] mmol/l increase	rs964184	G	0.15	22399527
TOMM40, APOE	Metabolic syndrome	1E-8	    .10	[NR] mmol/l increase	rs157582	T	0.22	22399527
FTO	Metabolic syndrome	2E-9	    .09	[NR] cm increase	rs9940128	A	0.42	22399527
HP	Haptoglobin levels	8E-59	    .14	[0.12-0.15] g/L decrease (SFS family cohort)	rs2000999	A	NR	22403646
PSCA	Duodenal ulcer 	2E-33	   1.41	[NR] 	rs2294008	C	0.37	22387998
ABO	Duodenal ulcer 	1E-10	   1.32	[NR] 	rs505922	T	0.54	22387998
KIF16B	Intelligence	1E-8	NR	NR	rs6043979, rs932541, rs6044001, rs6044003	S	NR	22449649
PAX5	Intelligence	4E-8	NR	NR	rs3758171, rs1329573, rs3824344, rs7020413	S	NR	22449649
ELSPBP1	Intelligence	3E-8	NR	NR	rs3815908, rs2303690, rs3936340, rs2560966	S	NR	22449649
LPA	Response to statin therapy	1E-9	    .28	[0.20-0.36] mmol/L decrease	rs10455872	A	NR	22368281
TAB2	Breast cancer	4E-12	   1.11	[1.09-1.15] 	rs9485372	G	0.55	22383897
FTO	Body mass index	5E-22	    .07	[0.057-0.089] unit increase	rs12149832	A	0.20	22344221
BDNF	Body mass index	4E-16	    .05	[0.034-0.058] unit increase	rs2030323	C	0.60	22344221
GIPR	Body mass index	7E-14	    .05	[0.034-0.058] unit increase	rs11671664	G	0.45	22344221
CDKAL1	Body mass index	1E-11	    .04	[0.027-0.051] unit increase	rs2206734	C	0.59	22344221
MC4R	Body mass index	2E-11	    .05	[0.032-0.060] unit increase	rs2331841	A	0.25	22344221
KLF9	Body mass index	1E-9	    .04	[0.018-0.062] unit increase	rs11142387	C	0.46	22344221
SEC16B	Body mass index	3E-9	    .05	[0.034-0.066] unit increase	rs516636	A	0.22	22344221
KLF9	Body mass index	2E-8	    .07	[0.042-0.090] unit increase	rs13034723	A	NR	22344221
GIPR, QPCTL	Body mass index	6E-14	   4.22	[2.73-5.71] % increase	rs11671664	G	0.50	22344219
ADCY3, DNAJC27	Body mass index	1E-13	   3.26	[1.77-4.75] % increase	rs6545814	G	0.45	22344219
MAP2K5	Body mass index	2E-9	   2.55	[0.79-4.31] % increase	rs4776970	A	0.22	22344219
CDKAL1	Body mass index	2E-11	   3.39	[1.90-4.88] % increase	rs9356744	T	0.58	22344219
PCSK1	Body mass index	5E-9	   3.77	[2.26-5.28] % increase	rs261967	C	0.41	22344219
GP2	Body mass index	1E-8	   4.09	[2.21-5.97] % increase	rs12597579	C	0.80	22344219
PAX3	Facial morphology	4E-16	    .39	[0.30-0.48] mm increase	rs7559271	G	NR	22341974
KCNJ2	Cardiac repolarization	6E-14	   1.70	 ms decrease	rs7219669	T	0.38	22342860
TARDBP	Ewing sarcoma	1E-20	   2.20	[1.77-2.72] 	rs9430161	G	0.79	22327514
EGR2, ADO, ZNF365	Ewing sarcoma	4E-17	   1.66	[1.42-1.93] 	rs224278	C	0.58	22327514
EIF2AK4, SRP14, BMF	Ewing sarcoma	7E-9	   1.46	[1.23-1.74] 	rs4924410	A	0.27	22327514
HCG27, HLA-C	Coronary heart disease	1E-9	   1.14	[NR] 	rs3869109	G	NR	22319020
HDAC9	Stroke	2E-11	   1.42	[1.28-1.57] 	rs11984041	A	0.09	22306652
MBNL1	Infantile hypertrophic pyloric stenosis	2E-17	   1.61	[1.44-1.79] 	rs11712066	A	0.75	22306654
Intergenic	Infantile hypertrophic pyloric stenosis	4E-12	   1.41	[1.28-1.56] 	rs573872	G	0.23	22306654
BNIP1, NKX2-5	Infantile hypertrophic pyloric stenosis	1E-15	   1.42	[1.30-1.55] 	rs29784	A	0.45	22306654
CDKAL1	Glycated hemoglobin levels	1E-11	    .05	[NR] % decrease	rs7747752	C	0.53	22290723
EDNRA	Intracranial aneurysm	1E-8	   1.25	[1.161-1.343] 	rs6842241	C	0.694	22286173
ABO	Inflammatory biomarkers	9E-25	NR	NR	rs643434	A	0.258	22291609
CR1	Inflammatory biomarkers	9E-14	NR	NR	rs12034598	A	0.408	22291609
DARC	Inflammatory biomarkers	4E-51	NR	NR	rs12075	A	0.49	22291609
CADM3	Inflammatory biomarkers	9E-14	NR	NR	rs3026968	T	0.12	22291609
CRP	Inflammatory biomarkers	2E-20	NR	NR	rs1341665	A	0.963	22291609
DARC	Inflammatory biomarkers	2E-11	NR	NR	rs3845624	C	0.47	22291609
HBB	Inflammatory biomarkers	2E-9	NR	NR	rs4910742	G	0.066	22291609
AFF1	Systemic lupus erythematosus	8E-9	   1.21	[1.14-1.30] 	rs340630	A	0.52	22291604
DIRC3	Thyroid cancer	1E-9	   1.34	[1.22-1.47] 	rs966423	C	0.442	22267200
NRG1	Thyroid cancer	2E-9	   1.36	[1.23-1.50] 	rs2439302	G	0.351	22267200
MBIP	Thyroid cancer	5E-11	   2.09	[1.68-2.60] 	rs116909374	T	0.017	22267200
RHBDL2	Menopause (age at onset)	9E-17	    .24	[0.18-0.3] years increase	rs4246511	T	0.271	22267201
EXO1	Menopause (age at onset)	8E-10	    .16	[0.11-0.22] years decrease	rs1635501	C	0.478	22267201
FNDC4	Menopause (age at onset)	2E-12	    .18	[0.13-0.22] years decrease	rs2303369	T	0.388	22267201
TLK1	Menopause (age at onset)	2E-14	    .20	[0.15-0.25] years decrease	rs10183486	T	0.366	22267201
HELQ	Menopause (age at onset)	2E-19	    .23	[0.18-0.28] years increase	rs4693089	G	0.486	22267201
UIMC1	Menopause (age at onset)	9E-32	    .29	[0.24-0.34] years increase	rs365132	T	0.49	22267201
SYCP2L	Menopause (age at onset)	8E-12	    .17	[0.12-0.21] years increase	rs2153157	A	0.492	22267201
PRRC2A	Menopause (age at onset)	2E-16	    .21	[0.16-0.26] years decrease	rs1046089	A	0.353	22267201
ASH2L	Menopause (age at onset)	9E-15	    .26	[0.2-0.33] years increase	rs2517388	G	0.174	22267201
Intergenic	Menopause (age at onset)	1E-11	    .23	[0.16-0.29] years increase	rs12294104	T	0.172	22267201
PRIM1	Menopause (age at onset)	2E-19	    .38	[0.3-0.46] years decrease	rs2277339	G	0.102	22267201
TDRD3	Menopause (age at onset)	1E-10	    .17	[0.12-0.22] years increase	rs4886238	A	0.334	22267201
POLG	Menopause (age at onset)	4E-13	    .18	[0.14-0.23] years decrease	rs2307449	G	0.405	22267201
Intergenic	Menopause (age at onset)	1E-11	    .17	[0.12-0.22] years increase	rs10852344	C	0.415	22267201
TMEM150B	Menopause (age at onset)	1E-59	    .42	[0.37-0.47] years decrease	rs11668344	G	0.363	22267201
NLRP11	Menopause (age at onset)	9E-10	    .16	[0.11-0.21] years decrease	rs12461110	A	0.356	22267201
MCM8	Menopause (age at onset)	1E-73	    .95	[0.85-1.05] years increase	rs16991615	A	0.069	22267201
F5	Hemostatic factors and hematological phenotypes	4E-80	   1.16	[1.04-1.28] unit decrease	rs2420371	G	0.18	22443383
GSS, EDEM2, PROCR	Hemostatic factors and hematological phenotypes	4E-34	  19.27	[16.174-22.372] iu/ml increase (GCTG)	rs17310467, rs6088735, rs6060278, rs867186	S	0.105	22443383
CDKAL1	Diabetes (gestational)	7E-16	   1.52	[1.372-1.680] 	rs7754840	C	0.445	22233651
MTNR1B	Diabetes (gestational)	2E-13	   1.45	[1.315-1.608] 	rs10830962	G	0.430	22233651
SLC2A9, WDR1	Uric acid levels	2E-19	  28.99	[NR] umol/L decrease	rs13129697	G	0.36	22229870
APOE	Alzheimer's disease	7E-16	NR	NR	NR	E	NR	22245343
APOE	Alzheimer's disease	4E-9	NR	NR	NR	E	NR	22245343
RBM43, RND3	Type 2 diabetes	7E-9	   1.33	[1.19-1.49] 	rs7560163	C	0.86	22238593
PROCR	Anticoagulant levels	4E-9	    .85	[NR]  SD units	rs867186	G	0.077	22216198
OVOL1	Atopic dermatitis	1E-13	   1.14	[1.10-1.18] 	rs479844	G	0.56	22197932
ACTL9	Atopic dermatitis	7E-9	   1.16	[1.10-1.22] 	rs2164983	A	0.15	22197932
KIF3A	Atopic dermatitis	4E-8	   1.11	[1.07-1.15] 	rs2897442	C	0.29	22197932
DEFAs	IgA nephropathy	3E-14	   1.27	[1.19-1.35] 	rs2738048	A	0.68	22197929
TNFSF13	IgA nephropathy	9E-11	   1.21	[1.14-1.28] 	rs3803800	A	0.35	22197929
MPDU1	IgA nephropathy	4E-10	   1.23	[1.16-1.32] 	rs4227	G	0.21	22197929
MTMR3	IgA nephropathy	1E-11	   1.28	[1.19-1.39] 	rs12537	C	0.81	22197929
HLA-A	IgA nephropathy	2E-11	   1.21	[1.15-1.28] 	rs2523946	C	0.50	22197929
HLA-DRB1	IgA nephropathy	4E-20	   1.34	[1.26-1.42] 	rs660895	G	0.24	22197929
HLA-DQA/B	IgA nephropathy	3E-13	   1.30	[1.21-1.39] 	rs1794275	A	0.15	22197929
CDKN2B	Ankle-brachial index 	9E-9	    .00	[0.0029-0.0061] unit decrease	rs10757269	G	0.5	22199011
PTGFR	Bipolar disorder	8E-9	NR	NR	rs4650608	T	NR	22182935
LMAN2L	Bipolar disorder	2E-10	NR	NR	rs2271893	G	NR	22182935
Intergenic	Bipolar disorder	3E-10	NR	NR	rs7618915	G	NR	22182935
TRANK1	Bipolar disorder	1E-12	NR	NR	rs9834970	C	NR	22182935
ANK3	Bipolar disorder	4E-10	NR	NR	rs4948418	T	NR	22182935
MAEA	Type 2 diabetes	2E-20	   1.13	[1.101.16]  	rs6815464	C	0.58	22158537
GLIS3	Type 2 diabetes	2E-14	   1.10	[1.071.13] 	rs7041847	A	0.41	22158537
FITM2,R3HDML,HNF4A	Type 2 diabetes	1E-11	   1.09	[1.071.12] 	rs6017317	G	0.48	22158537
GCC1,PAX4	Type 2 diabetes	5E-11	   1.11	[1.071.14] 	rs6467136	G	0.79	22158537
PSMD6	Type 2 diabetes	8E-11	   1.09	[1.061.12] 	rs831571	c	0.61	22158537
ZFAND3	Type 2 diabetes	2E-10	   1.12	[1.081.16] 	rs9470794	C	0.27	22158537
PEPD	Type 2 diabetes	1E-8	   1.10	[1.071.14] 	rs3786897	A	0.56	22158537
KCNK16	Type 2 diabetes	2E-8	   1.08	[1.051.11] 	rs1535500	T	0.42	22158537
BACH1	Pancreatic cancer	2E-13	   1.27	[1.19-1.33] 	rs372883	T	NR	22158540
DAB2	Pancreatic cancer	4E-10	   1.23	[1.15-1.32] 	rs2255280	T	NR	22158540
PRLHR	Pancreatic cancer	5E-11	   1.23	[1.16-1.31] 	rs12413624	T	0.37	22158540
TFF1	Pancreatic cancer	4E-13	   1.27	[1.19-1.35] 	rs1547374	A	NR	22158540
NR	Pancreatic cancer	5E-13	   1.26	[1.18-1.34] 	rs9573163	G	0.43	22158540
FAM19A5	Pancreatic cancer	1E-10	   1.25	[1.17-1.34] 	rs5768709	G	0.23	22158540
IL17F	Response to gemcitabine in pancreatic cancer 	3E-8	   3.30	[2.10-5.10] 	rs763780	G	NR	22142827
CDKN2B	Coronary artery calcification	3E-24	    .20	[0.16-0.24] % increase	rs1333049	C	NR	22144573
PHACTR1	Coronary artery calcification	4E-22	    .20	[0.16-0.24] % decrease	rs9349379	A	NR	22144573
HAPLN1, EDIL3	Ankylosing spondylitis	9E-10	   1.21	[1.14-1.29] 	rs4552569	C	0.28	22138694
ANO6	Ankylosing spondylitis	2E-8	   1.29	[1.18-1.41] 	rs17095830	G	0.10	22138694
PDGFRA	Corneal astigmatism	8E-9	   1.26	[1.18-1.34] 	rs7677751	T	0.22	22144915
EOMES	Multiple sclerosis	2E-8	   1.17	[NR] 	rs170934	T	0.48	22190364
MLANA	Multiple sclerosis	3E-8	   1.16	[NR] 	rs2150702	G	0.49	22190364
THADA	Multiple sclerosis	3E-8	   1.17	[NR] 	rs6718520	A	0.48	22190364
CD58	Multiple sclerosis	6E-9	   1.37	[NR] 	rs2300747	A	0.91	22190364
HLA-B	Multiple sclerosis	1E-11	   1.21	[NR] 	rs9260489	T	0.45	22190364
HLA-DRB1	Multiple sclerosis	1E-206	   2.97	[NR] 	rs3129889	G	0.20	22190364
IL2RA	Multiple sclerosis	4E-8	   1.23	[NR] 	rs12722489	C	0.85	22190364
STAT3	Multiple sclerosis	4E-8	   1.22	[NR] 	rs2293152	C	0.62	22190364
KIF1B	Mean platelet volume	3E-8	    .01	[0.0041-0.0119] ln(fl) increase	rs17396340	A	NR	22139419
DNM3	Mean platelet volume	1E-24	    .01	[0.012-0.016] ln(fl) increase	rs10914144	C	NR	22139419
TMCC2	Mean platelet volume	4E-27	    .01	[0.009-0.013] ln(fl) increase	rs1172130	G	NR	22139419
EHD3	Mean platelet volume	1E-12	    .01	[0.006-0.01] ln(fl) increase	rs649729	T	NR	22139419
ANKMY1	Mean platelet volume	2E-11	    .01	[0.006-0.01] ln(fl) increase	rs4305276	G	NR	22139419
ARHGEF3	Mean platelet volume	3E-69	    .02	[0.021-0.025] ln(fl) increase	rs1354034	T	NR	22139419
KALRN	Mean platelet volume	5E-10	    .01	[0.004-0.008] ln(fl) increase	rs10512627	C	NR	22139419
KIAA0232	Mean platelet volume	1E-11	    .01	[0.0071-0.0149] ln(fl) increase	rs11734132	G	NR	22139419
F2R	Mean platelet volume	1E-15	    .02	[0.015-0.027] ln(fl) increase	rs2227831	G	NR	22139419
MEF2C	Mean platelet volume	2E-9	    .01	[0.006-0.01] ln(fl) increase	rs4521516	G	NR	22139419
RNF145	Mean platelet volume	4E-8	    .01	[0.005-0.009] ln(fl) increase	rs10076782	A	NR	22139419
FLJ36031,PIK3CG	Mean platelet volume	7E-57	    .02	[0.015-0.019] ln(fl) increase	rs342293	G	NR	22139419
DOCK8	Mean platelet volume	4E-12	    .01	[0.005-0.009] ln(fl) increase	rs10813766	T	NR	22139419
JMJD1C	Mean platelet volume	2E-44	    .01	[0.012-0.016] ln(fl) increase	rs7075195	A	NR	22139419
PSMD13,NLRP6	Mean platelet volume	2E-15	    .01	[0.008-0.012] ln(fl) increase	rs17655730	T	NR	22139419
CD9,VWF	Mean platelet volume	2E-21	    .01	[0.008-0.012] ln(fl) increase	rs1558324	A	NR	22139419
MLSTD1	Mean platelet volume	6E-16	    .01	[0.006-0.01] ln(fl) increase	rs2015599	A	NR	22139419
COPZ1,NFE2,CBX5	Mean platelet volume	2E-14	    .01	[0.006-0.01] ln(fl) increase	rs10876550	G	NR	22139419
PTGES3,BAZ2A	Mean platelet volume	7E-14	    .01	[0.006-0.01] ln(fl) increase	rs2950390	C	NR	22139419
WDR66	Mean platelet volume	1E-103	    .03	[0.028-0.032] ln(fl) increase	rs7961894	T	NR	22139419
GRTP1	Mean platelet volume	8E-12	    .01	[0.004-0.008] ln(fl) increase	rs7317038	C	NR	22139419
C14orf73	Mean platelet volume	5E-11	    .01	[0.006-0.01] ln(fl) increase	rs944002	A	NR	22139419
BRF1	Mean platelet volume	3E-11	    .01	[0.005-0.009] ln(fl) increase	rs3000073	G	NR	22139419
TAOK1	Mean platelet volume	5E-38	    .01	[0.011-0.015] ln(fl) increase	rs8076739	T	NR	22139419
SNORD7,AP2B1	Mean platelet volume	4E-12	    .01	[0.007-0.011] ln(fl) increase	rs16971217	C	NR	22139419
CD226	Mean platelet volume	3E-11	    .01	[0.005-0.009] ln(fl) increase	rs12969657	T	NR	22139419
TPM4	Mean platelet volume	1E-11	    .03	[0.021-0.037] ln(fl) increase	rs8109288	A	NR	22139419
SIRPA	Mean platelet volume	6E-14	    .01	[0.006-0.01] ln(fl) increase	rs13042885	C	NR	22139419
CTSZ,TUBB1	Mean platelet volume	1E-9	    .01	[0.006-0.01] ln(fl) increase	rs4812048	C	NR	22139419
MFN2	Platelet counts	1E-8	   2.17	[1.42-2.92] 10^9/l increase	rs2336384	G	NR	22139419
DNM3	Platelet counts	2E-12	   3.42	[2.46-4.37] 10^9/l increase	rs10914144	T	NR	22139419
TMCC2	Platelet counts	3E-14	   2.80	[2.08-3.53] 10^9/l increase	rs1668871	C	NR	22139419
LOC148824	Platelet counts	3E-11	   3.13	[2.21-4.06] 10^9/l increase	rs7550918	T	NR	22139419
TRIM58	Platelet counts	6E-9	   3.35	[2.22-4.47] 10^9/l increase	rs3811444	C	NR	22139419
GCKR	Platelet counts	9E-10	   2.33	[1.59-3.08] 10^9/l increase	rs1260326	T	NR	22139419
EHD3	Platelet counts	9E-14	   4.24	[3.12-5.35] 10^9/l increase	rs625132	G	NR	22139419
THADA	Platelet counts	1E-10	   3.58	[2.49-4.67] 10^9/l increase	rs17030845	C	NR	22139419
SYN2	Platelet counts	5E-8	   2.00	[1.28-2.71] 10^9/l increase	rs7616006	A	NR	22139419
SATB1	Platelet counts	3E-11	   2.76	[1.94-3.57] 10^9/l increase	rs7641175	A	NR	22139419
ARHGEF3	Platelet counts	3E-54	   6.85	[5.98-7.71] 10^9/l increase	rs1354034	C	NR	22139419
PDIA5	Platelet counts	4E-9	   2.15	[1.44-2.87] 10^9/l increase	rs3792366	G	NR	22139419
HSD17B13	Platelet counts	9E-9	   2.13	[1.4-2.85] 10^9/l increase	rs7694379	A	NR	22139419
F2R	Platelet counts	1E-9	   6.07	[4.13-8.02] 10^9/l increase	rs17568628	T	NR	22139419
MEF2C	Platelet counts	1E-9	   2.70	[1.84-3.57] 10^9/l increase	rs700585	C	NR	22139419
IRF1	Platelet counts	1E-10	   2.39	[1.67-3.12] 10^9/l increase	rs2070729	A	NR	22139419
LRRC16	Platelet counts	9E-18	   3.08	[2.38-3.78] 10^9/l increase	rs441460	G	NR	22139419
HLA-B	Platelet counts	9E-10	   5.05	[3.43-6.66] 10^9/l increase	rs3819299	G	NR	22139419
HLA-DOA	Platelet counts	1E-10	   2.35	[1.63-3.06] 10^9/l increase	rs399604	C	NR	22139419
BAK1	Platelet counts	7E-36	   4.96	[4.18-5.73] 10^9/l increase	rs210134	G	NR	22139419
HBS1L,MYB	Platelet counts	5E-47	   5.90	[5.1-6.7] 10^9/l increase	rs9399137	C	NR	22139419
FLJ36031,PIK3CG	Platelet counts	6E-25	   3.74	[3.03-4.45] 10^9/l increase	rs342275	C	NR	22139419
WASL	Platelet counts	3E-12	   4.14	[2.98-5.3] 10^9/l increase	rs4731120	C	NR	22139419
ZFPM2	Platelet counts	4E-17	   3.67	[2.81-4.52] 10^9/l increase	rs6993770	A	NR	22139419
PLEC1	Platelet counts	5E-10	   2.30	[1.58-3.03] 10^9/l increase	rs6995402	C	NR	22139419
AK3	Platelet counts	3E-49	   5.59	[4.84-6.33] 10^9/l increase	rs409801	C	NR	22139419
RCL1	Platelet counts	1E-29	   5.59	[4.64-6.53] 10^9/l increase	rs13300663	C	NR	22139419
CDKN2A	Platelet counts	6E-14	   3.28	[2.42-4.14] 10^9/l increase	rs3731211	A	NR	22139419
BRD3	Platelet counts	2E-10	   3.01	[2.08-3.95] 10^9/l increase	rs11789898	T	NR	22139419
JMJD1C	Platelet counts	2E-24	   3.85	[3.11-4.59] 10^9/l increase	rs10761731	T	NR	22139419
PSMD13,NLRP6	Platelet counts	7E-25	   4.66	[3.77-5.55] 10^9/l increase	rs505404	G	NR	22139419
FEN1	Platelet counts	3E-10	   2.45	[1.69-3.22] 10^9/l increase	rs4246215	T	NR	22139419
CBL	Platelet counts	8E-11	   4.73	[3.31-6.15] 10^9/l increase	rs4938642	C	NR	22139419
CD9,VWF	Platelet counts	4E-11	   2.53	[1.78-3.28] 10^9/l increase	rs7342306	G	NR	22139419
PTGES3,BAZ2A	Platelet counts	2E-10	   2.75	[1.91-3.6] 10^9/l increase	rs941207	G	NR	22139419
SH2B3	Platelet counts	1E-26	   3.99	[3.26-4.72] 10^9/l increase	rs3184504	T	NR	22139419
RPH3A,PTPN11	Platelet counts	1E-8	   2.46	[1.62-3.3] 10^9/l increase	rs17824620	C	NR	22139419
WDR66	Platelet counts	1E-10	   3.92	[2.73-5.12] 10^9/l increase	rs7961894	C	NR	22139419
ABCC4	Platelet counts	7E-12	   4.12	[2.94-5.29] 10^9/l increase	rs4148441	G	NR	22139419
RAD51L1	Platelet counts	2E-10	   3.20	[2.22-4.18] 10^9/l increase	rs8022206	G	NR	22139419
ITPK1	Platelet counts	1E-10	   3.59	[2.49-4.68] 10^9/l increase	rs8006385	G	NR	22139419
C14orf70,DLK1	Platelet counts	3E-8	   2.14	[1.39-2.9] 10^9/l increase	rs7149242	G	NR	22139419
RCOR1	Platelet counts	2E-10	   2.57	[1.78-3.37] 10^9/l increase	rs11628318	A	NR	22139419
C14orf73	Platelet counts	2E-10	   3.54	[2.45-4.62] 10^9/l increase	rs2297067	T	NR	22139419
TPM1	Platelet counts	4E-10	   2.44	[1.68-3.21] 10^9/l increase	rs3809566	G	NR	22139419
ANKDD1A	Platelet counts	1E-11	   3.41	[2.43-4.4] 10^9/l increase	rs1719271	G	NR	22139419
GP1BA	Platelet counts	3E-11	   4.19	[2.96-5.43] 10^9/l increase	rs6065	T	NR	22139419
AKAP10	Platelet counts	2E-9	   2.13	[1.43-2.83] 10^9/l increase	rs397969	C	NR	22139419
TAOK1	Platelet counts	3E-18	   3.26	[2.53-4] 10^9/l increase	rs559972	T	NR	22139419
SNORD7,AP2B1	Platelet counts	2E-14	   3.64	[2.7-4.57] 10^9/l increase	rs10512472	C	NR	22139419
FAM171A2,ITGA2B	Platelet counts	2E-8	   2.44	[1.59-3.28] 10^9/l increase	rs708382	T	NR	22139419
CABLES1	Platelet counts	5E-11	   2.48	[1.74-3.22] 10^9/l increase	rs11082304	G	NR	22139419
TPM4	Platelet counts	3E-10	  11.95	[8.24-15.65] 10^9/l increase	rs8109288	G	NR	22139419
EXOC3L2	Platelet counts	4E-10	   2.60	[1.79-3.41] 10^9/l increase	rs17356664	C	NR	22139419
ARVCF	Platelet counts	3E-8	   2.13	[1.38-2.88] 10^9/l increase	rs1034566	T	NR	22139419
DNAH11	Multiple myeloma	3E-14	   1.38	[1.28-1.50] 	rs4487645	C	0.65	22120009
ULK4	Multiple myeloma	2E-8	   1.32	[1.20-1.45] 	rs1052501	G	0.16	22120009
TCF7L2	Type 2 diabetes	2E-15	   1.46	[NR] 	rs7903146	T	0.26 (EA+AA)	22101970
UGT1A1	Bilirubin levels	2E-22	    .23	[0.183-0.270] unit increase	rs887829	T	0.45	22085899
HLA-DRB1, HLA-DQB1	Nodular sclerosis Hodgkin lymphoma	8E-18	   2.50	[NR] 	rs204999, rs9268528, rs9268542, rs6903608, rs2858870	S	NR (GAATC)	22086417
FCGR2A	Kawasaki disease	7E-11	   1.32	[1.22-1.44] 	rs1801274	A	0.47	22081228
Intergenic	Serum ceruloplasmin levels	2E-11	   1.50	 mg/dl increase	rs13072552	T	0.079	22075249
FCER1A	IgE levels 	5E-26	    .09	[NR] unit increase	rs2251746	C	NR	22075330
STAT6, NAB2	IgE levels 	2E-12	    .12	[NR] unit decrease	rs1059513	C	NR	22075330
IL13	IgE levels 	3E-18	    .08	[NR] unit increase	rs20541	A	NR	22075330
HLA-G	IgE levels 	4E-8	    .06	[NR] unit increase	rs2523809	T	NR	22075330
HLA-A	IgE levels 	1E-15	    .06	[NR] unit increase	rs2571391	C	NR	22075330
DARC	IgE levels 	2E-11	    .09	[NR] unit decrease	rs13962	A	NR	22075330
HLA-DQA2	IgE levels 	1E-8	    .04	[NR] unit decrease	rs2858331	G	NR	22075330
OR10J3	IgE levels 	2E-16	    .08	[NR] unit increase	rs4656784	G	NR	22075330
LRP1	Abdominal aortic aneurysm	5E-10	   1.15	[1.10-1.21] 	rs1466535	C	0.58	22055160
Intergenic	Gamma gluatamyl transferase levels	4E-8	    .08	[0.051-0.105] unit decrease	rs1497406	T	0.41	22010049
HNF1A	Gamma gluatamyl transferase levels	2E-18	    .13	[0.10-0.16] unit decrease	rs1169288	G	0.31	22010049
C14orf73	Gamma gluatamyl transferase levels	5E-13	    .13	[0.094-0.164] unit increase	rs944002	G	0.22	22010049
RORA	Gamma gluatamyl transferase levels	2E-8	    .08	[0.055-0.113] unit decrease	rs340005	G	0.36	22010049
C11orf30, LRRC32	Allergic rhinitis	4E-8	   1.17	[1.11-1.24] 	rs2155219	T	0.47	22036096
C11orf30, LRRC32	IgE grass sensitization	1E-8	   1.22	[1.14-1.31] 	rs2155219	T	0.47	22036096
TMEM232, SLCA25A46	IgE grass sensitization	1E-8	   1.39	[1.24-1.56] 	rs17513503	G	0.09	22036096
HLA region	IgE grass sensitization	2E-9	   1.33	[1.21-1.45] 	rs7775228	C	0.13	22036096
TERT	Breast cancer	1E-10	   1.18	[1.13-1.25]  	rs10069690	T	0.26	22037553
BRP44, DCAF6	Schizophrenia	1E-8	   1.23	[1.15-1.32]  	rs10489202	A	0.141 	22037555
IL23R	Leprosy	3E-11	   1.45	[1.30-1.61] 	rs3762318	A	0.10	22019778
RAB32	Leprosy	4E-14	   1.30	[1.21-1.39] 	rs2275606	A	0.21	22019778
CYLD	Leprosy	2E-10	   1.56	[1.36-1.79] 	rs16948876	A	0.03	22019778
TMEM100, PCTP	Height	6E-9	    .05	[0.024-0.072] unit decrease	rs1549519	T	0.20	22021425
ARSE	Height	5E-12	    .09	[0.056-0.130] unit increase	rs12393627	G	0.37	22021425
LCORL	Height	3E-14	    .06	[0.036-0.076] unit increase	rs925098	G	0.35	22021425
SERPINH1	Height	2E-9	    .04	[0.023-0.063] unit decrease	rs606452	C	0.64	22021425
HMGA2	Height	4E-10	    .04	[0.025-0.061] unit decrease	rs7968682	T	0.58	22021425
MAP3K3	Height	5E-10	    .05	[0.029-0.069] unit decrease	rs11658329	G	0.30	22021425
PRKCA	Height	3E-8	    .06	[0.029-0.083] unit decrease	rs3889237	C	0.14	22021425
DYM	Height	7E-10	    .04	[0.024-0.064] unit increase	rs1787200	T	0.37	22021425
HSD17B13, MAPK10	Liver enzyme levels (alanine transaminase)	3E-9	   2.60	[1.90-3.40] % increase	rs6834314	A	0.75	22001757
TRIB1	Liver enzyme levels (alanine transaminase)	5E-9	   1.60	[0.60-2.60] % increase	rs2954021	A	0.50	22001757
CPN1	Liver enzyme levels (alanine transaminase)	4E-9	   2.30	[1.40-3.10] % increase	rs10883437	T	0.64	22001757
PNPLA3, SAMM50	Liver enzyme levels (alanine transaminase)	1E-45	   6.00	[5.0-7.0] % increase	rs738409	G	0.23	22001757
ALPL, NBPF3	Liver enzyme levels (alkaline phosphatase)	2E-50	   3.60	[3.0-4.2] % increase	rs1976403	C	0.40	22001757
ABCB11	Liver enzyme levels (alkaline phosphatase)	2E-9	   3.90	[1.20-6.70] % increase	rs16856332	T	0.96	22001757
ALDH5A1, GPLD1	Liver enzyme levels (alkaline phosphatase)	6E-26	   3.10	[2.50-3.70] % increase	rs1883415	C	0.33	22001757
PPP1R3B	Liver enzyme levels (alkaline phosphatase)	2E-10	   2.70	[1.10-4.40] % increase	rs6984305	A	0.11	22001757
TRIB1	Liver enzyme levels (alkaline phosphatase)	2E-13	   1.40	[0.50-2.30] % increase	rs2954021	A	0.50	22001757
ALDOB, C9orf125	Liver enzyme levels (alkaline phosphatase)	1E-9	   2.50	[1.40-3.60] % increase	rs10819937	C	0.17	22001757
ABO	Liver enzyme levels (alkaline phosphatase)	3E-123	   8.80	[7.40-10.2] % increase	rs579459	T	0.80	22001757
JMJD1C, NRBF2	Liver enzyme levels (alkaline phosphatase)	6E-23	   2.20	[1.70-2.70] % increase	rs7923609	G	0.50	22001757
C11orf10, FADS1, FADS2	Liver enzyme levels (alkaline phosphatase)	3E-9	   1.70	[0.80-2.60] % increase	rs174601	T	0.35	22001757
ST3GAL4	Liver enzyme levels (alkaline phosphatase)	2E-9	   1.50	[0.60-2.50] % increase	rs2236653	T	0.42	22001757
HPR, PMFBP1	Liver enzyme levels (alkaline phosphatase)	5E-9	   2.00	[1.10-2.90] % increase	rs7186908	C	0.24	22001757
ASGR1, DLG4	Liver enzyme levels (alkaline phosphatase)	8E-12	   2.10	[1.50-2.80] % increase	rs314253	C	0.33	22001757
FUT2	Liver enzyme levels (alkaline phosphatase)	1E-15	   1.80	[0.80-2.80] % increase	rs281377	T	0.43	22001757
ABHD12,GINS1, PYGB	Liver enzyme levels (alkaline phosphatase)	7E-10	   1.50	[0.90-2.0] % increase	rs7267979	G	0.57	22001757
RSG1, EPHA2	Liver enzyme levels (gamma-glutamyl transferase)	3E-19	   3.80	[2.70-4.80] % increase	rs1497406	G	0.56	22001757
CCBL2, PKN2	Liver enzyme levels (gamma-glutamyl transferase)	4E-11	   2.80	[2.20-3.40] % increase	rs12145922	A	0.61	22001757
CEPT1, DENND2D	Liver enzyme levels (gamma-glutamyl transferase)	7E-9	   4.30	[3.50-5.20] % increase	rs1335645	A	0.88	22001757
DPM3, EFNA1, PKLR	Liver enzyme levels (gamma-glutamyl transferase)	2E-15	   3.70	[3.10-4.20] % increase	rs10908458	T	0.58	22001757
C2orf16, GCKR	Liver enzyme levels (gamma-glutamyl transferase)	4E-13	   3.20	[2.40-4.0] % increase	rs1260326	T	0.38	22001757
MYO1B, STAT4	Liver enzyme levels (gamma-glutamyl transferase)	1E-11	   3.70	[2.80-4.6] % increase	rs13030978	T	0.32	22001757
EFHD1, LOC100129166	Liver enzyme levels (gamma-glutamyl transferase)	1E-9	   2.90	[2.30-3.50] % increase	rs2140773	A	0.61	22001757
SLC2A2	Liver enzyme levels (gamma-glutamyl transferase)	6E-11	   4.90	[4.00-5.70] % increase	rs10513686	A	0.14	22001757
ZNF827	Liver enzyme levels (gamma-glutamyl transferase)	3E-27	   6.40	[5.00-7.90] % increase	rs4547811	C	0.18	22001757
CDH6	Liver enzyme levels (gamma-glutamyl transferase)	1E-9	   2.70	[2.00-3.50] % increase	rs6888304	A	0.74	22001757
ITGA1	Liver enzyme levels (gamma-glutamyl transferase)	3E-10	   5.50	[3.30-7.70] % increase	rs4074793	G	0.07	22001757
MLIP	Liver enzyme levels (gamma-glutamyl transferase)	3E-9	   3.00	[2.10-4.00] % increase	rs9296736	T	0.31	22001757
MLXIPL	Liver enzyme levels (gamma-glutamyl transferase)	3E-9	   4.50	[2.90-6.30] % increase	rs17145750	C	0.86	22001757
DLG5	Liver enzyme levels (gamma-glutamyl transferase)	6E-10	   3.50	[2.20-4.80] % increase	rs754466	T	0.24	22001757
HNF1A, C12orf27	Liver enzyme levels (gamma-glutamyl transferase)	7E-45	   6.80	[5.70-7.80] % increase	rs7310409	G	0.59	22001757
C14orf73	Liver enzyme levels (gamma-glutamyl transferase)	6E-29	   6.30	[4.90-7.70] % increase	rs944002	G	0.21	22001757
RORA	Liver enzyme levels (gamma-glutamyl transferase)	7E-20	   4.50	[3.90-5.10] % increase	rs339969	A	0.62	22001757
CD276	Liver enzyme levels (gamma-glutamyl transferase)	1E-9	   2.40	[1.80-3.00] % increase	rs8038465	T	0.39	22001757
DYNLRB2	Liver enzyme levels (gamma-glutamyl transferase)	3E-9	   3.20	[2.50-3.90] % increase	rs4581712	A	0.27	22001757
FLJ37644, SOX9	Liver enzyme levels (gamma-glutamyl transferase)	1E-9	   2.40	[1.80-3.00] % increase	rs9913711	C	0.65	22001757
ATP8B1	Liver enzyme levels (gamma-glutamyl transferase)	9E-10	   4.80	[2.80-6.70] % increase	rs12968116	C	0.87	22001757
NEDD4L	Liver enzyme levels (gamma-glutamyl transferase)	3E-12	   3.60	[2.50-4.70] % increase	rs4503880	T	0.21	22001757
FUT2	Liver enzyme levels (gamma-glutamyl transferase)	8E-10	   2.30	[1.80-2.90] % increase	rs516246	T	0.47	22001757
MICAL3	Liver enzyme levels (gamma-glutamyl transferase)	1E-16	   4.80	[3.50-6.10] % increase	rs1076540	C	0.78	22001757
DDT, DDTL, GSTT1, GSTT2B, MIF	Liver enzyme levels (gamma-glutamyl transferase)	2E-9	   3.70	[2.70-4.60] % increase	rs2739330	T	0.42	22001757
GGT1, GGTLC2	Liver enzyme levels (gamma-glutamyl transferase)	1E-109	  12.30	[10.90-13.70] % increase	rs2073398	G	0.34	22001757
APOC1	Lipoprotein-associated phospholipase A2 activity and mass	5E-30	    .05	[0.044-0.064] unit decrease	rs4420638	A	0.84	22003152
PLA2G7	Lipoprotein-associated phospholipase A2 activity and mass	2E-23	    .04	[0.035-0.051] unit increase	rs1805017	T	0.26	22003152
PLA2G7	Lipoprotein-associated phospholipase A2 activity and mass	1E-10	    .03	[0.019-0.035] unit decrease	rs7756935	A	0.81	22003152
CELSR2	Lipoprotein-associated phospholipase A2 activity and mass	1E-17	    .04	[0.027-0.043] unit increase	rs7528419	A	0.79	22003152
LDLR	Lipoprotein-associated phospholipase A2 activity and mass	3E-11	    .05	[0.031-0.059] unit decrease	rs6511720	T	0.10	22003152
ZNF259	Lipoprotein-associated phospholipase A2 activity and mass	8E-11	    .03	[0.022-0.042] unit decrease	rs964184	C	0.86	22003152
CETP	Lipoprotein-associated phospholipase A2 activity and mass	3E-8	    .02	[0.015-0.031] unit increase	rs247616	T	0.32	22003152
CASP8	Melanoma	9E-10	   1.14	[1.09-1.19] 	rs13016963	A	0.37	21983787
TERT, CLPTM1L	Melanoma	3E-8	   1.20	[1.12-1.28] 	rs401681	A	0.46	21983787
TYR	Melanoma	2E-13	   1.30	[1.21-1.39] 	rs1393350	A	0.28	21983787
MC1R	Melanoma	3E-27	   1.70	[1.54-1.87] 	rs258322	A	0.11	21983787
ARNT, SETDB1, LASS2, ANXA9, MCL1, CTSK	Melanoma	9E-11	   1.15	[NR] 	rs7412746	T	0.55	21983785
ALDH16A1	Gout	2E-16	   3.12	[2.38-4.17] 	c.1580C>G	G	0.019	21983786
ABCG2	Gout	3E-12	   1.67	[1.43-1.92] 	rs2231142	T	0.101	21983786
Intergenic	Serum uric acid levels	5E-16	    .48	[0.36-0.60] s.d. increase	chr1_142697422	C	0.986	21983786
ALDH16A1	Serum uric acid levels	5E-21	    .36	[0.29-0.44] s.d. increase	c.1580C>G	G	0.019	21983786
SLC2A9	Serum uric acid levels	1E-80	    .24	[0.22-0.27] s.d. increase	rs734553	T	0.79	21983786
ABCG2	Serum uric acid levels	2E-20	    .16	[0.12-0.19] s.d. increase	rs2231142	T	0.101	21983786
CCDC88A	Height	2E-8	    .04	[0.028-0.060] unit increase	rs2589113	T	0.48	21998595
ANTXR1	Height	1E-8	    .06	[0.039-0.079] unit decrease	rs4315565	A	0.20	21998595
ZBTB38	Height	2E-10	    .07	[0.045-0.085] unit increase	rs6440003	A	0.81	21998595
LCORL	Height	1E-15	    .07	[0.051-0.083] unit increase	rs724577	A	0.31	21998595
Intergenic	Height	8E-10	    .05	[0.036-0.072] unit decrease	rs994014	T	0.29	21998595
HMGA1	Height	2E-8	    .05	[0.030-0.066] unit increase	rs1150781	C	0.42	21998595
PPARD	Height	1E-11	    .08	[0.057-0.105] unit decrease	rs9470004	T	0.17	21998595
HMGA2	Height	7E-10	    .06	[0.038-0.078] unit decrease	rs7979673	T	0.32	21998595
ACAN	Height	2E-9	    .06	[0.037-0.077] unit increase	rs2351491	T	0.25	21998595
MAP3K3	Height	6E-10	    .05	[0.035-0.071] unit increase	rs11658329	C	0.70	21998595
Intergenic	Height	5E-8	    .05	[0.033-0.073] unit decrease	rs2854160	T	0.21	21998595
DYM	Height	1E-10	    .05	[0.037-0.069] unit increase	rs1787200	A	0.37	21998595
ARSE	Height	6E-12	    .07	[0.052-0.092] unit decrease	rs12393627	A	0.63	21998595
SHBG	Testosterone levels	1E-41	  31.80	[27.29-36.31] ng/dl increase	rs12150660	T	0.23	21998597
SHBG	Testosterone levels	2E-22	  82.30	[65.64-98.96] ng/dl decrease	rs6258	T	0.02	21998597
CDKN2A, CDKN2B	Coronary heart disease	6E-16	   1.25	[1.18-1.31] 	rs944797	C	0.46	21971053
ALDH2	Coronary heart disease	2E-34	   1.43	[1.35-1.51] 	rs671	A	0.23	21971053
BRIP1	Ovarian cancer	6E-13	   7.95	[NR] 	rs34289250	C	0.0089	21964575
GRIN2A	Hepatitis B	2E-8	   1.68	[1.40-2.02] 	rs11866328	G	NR	22004137
F5, SLC19A2, NME7	Venous thromboembolism	2E-26	   2.52	[NR] 	rs1018827	A	0.12	21980494
FGG, FGA	Venous thromboembolism	2E-13	   1.53	[NR] 	rs7659024	A	0.25	21980494
ABO	Venous thromboembolism	1E-34	   1.92	[NR] 	rs505922	C	0.43	21980494
F11	Venous thromboembolism	6E-11	   1.40	[NR] 	rs3756008	T	0.44	21980494
MFAP2	Pulmonary function	8E-16	    .04	[0.030-0.050] unit decrease	rs2284746	G	0.52	21946350
TGFB2	Pulmonary function	1E-8	    .03	[0.022-0.046] unit increase	rs993925	T	0.31	21946350
RARB	Pulmonary function	4E-14	    .05	[0.036-0.060] unit decrease	rs1529672	C	0.83	21946350
CDC123	Pulmonary function	6E-13	    .03	[0.023-0.043] unit increase	rs7068966	T	0.52	21946350
HDAC4	Pulmonary function	2E-12	    .04	[0.029-0.053] unit increase	rs12477314	T	0.20	21946350
CFDP1	Pulmonary function	2E-11	    .03	[0.021-0.041] unit increase	rs2865531	T	0.42	21946350
CCDC38	Pulmonary function	2E-11	    .04	[0.026-0.050] unit increase	rs1036429	T	0.20	21946350
NCR3	Pulmonary function	2E-10	    .04	[0.025-0.049] unit increase	rs2857595	G	0.81	21946350
ARMC2	Pulmonary function	8E-9	    .04	[0.027-0.055] unit decrease	rs2798641	T	0.18	21946350
LRP1	Pulmonary function	1E-8	    .03	[0.020-0.044] unit decrease	rs11172113	T	0.61	21946350
SPATA9	Pulmonary function	2E-8	    .03	[0.021-0.041] unit decrease	rs153916	T	0.55	21946350
KCNE2	Pulmonary function	3E-8	    .04	[0.027-0.059] unit decrease	rs9978142	T	0.16	21946350
MMP15	Pulmonary function	4E-8	    .04	[0.024-0.052] unit decrease	rs12447804	T	0.21	21946350
CDC123	Pulmonary function	3E-12	    .03	[0.021-0.037] unit increase	rs7068966	T	0.52	21946350
C10orf11	Pulmonary function	3E-12	    .03	[0.021-0.037] unit decrease	rs11001819	G	0.52	21946350
ZKSCAN3, ZNF323	Pulmonary function	2E-10	    .04	[0.025-0.049] unit decrease	rs6903823	G	0.21	21946350
MECOM	Pulmonary function	3E-8	    .03	[0.022-0.046] unit decrease	rs1344555	T	0.21	21946350
TP53	Basal cell carcinoma 	2E-20	   2.16	[1.83-2.54] 	rs78378222	C	NR	21946351
CELSR2	Cardiovascular disease risk factors	2E-22	    .17	[0.14-0.20] mmol/l decrease	rs660240	T	0.22	21943158
APOB	Cardiovascular disease risk factors	8E-15	    .11	[0.083-0.137] mmol/l increase	rs10199768	T	0.47	21943158
BCHE	Cardiovascular disease risk factors	6E-92	    .37	[0.33-0.40] units/l decrease	rs1803274	T	0.21	21943158
WDR1	Cardiovascular disease risk factors	9E-71	    .31	[0.27-0.34] umol/l decrease	rs7671266	T	0.21	21943158
Intergenic	Cardiovascular disease risk factors	2E-52	    .26	[0.22-0.29] umol/l decrease	rs4698036	G	0.22	21943158
LPL	Cardiovascular disease risk factors	6E-12	    .15	[0.11-0.19] mmol/l increase	rs17091905	A	0.124	21943158
LPL	Cardiovascular disease risk factors	5E-15	    .17	[0.13-0.22] mmol/l decrease	rs17091905	A	0.12	21943158
MRC1	Cardiovascular disease risk factors	3E-10	    .10	[0.071-0.133] units/l increase	rs2437258	T	0.23	21943158
OASL	Cardiovascular disease risk factors	4E-15	    .12	[0.092-0.150] units/l decrease	rs3213545	A	0.30	21943158
LIPC	Cardiovascular disease risk factors	3E-12	    .10	[0.075-0.133] mmol/l increase	rs10468017	T	0.33	21943158
CETP	Cardiovascular disease risk factors	3E-65	    .26	[0.23-0.28] mmol/l increase	rs173539	T	0.32	21943158
TOMM40	Cardiovascular disease risk factors	2E-14	    .15	[0.11-0.19] mmol/l increase	rs2075650	G	0.15	21943158
TOMM40	Cardiovascular disease risk factors	4E-8	    .12	[0.075-0.157] unit decrease	rs2075650	G	0.15	21943158
GCKR	Cardiovascular disease risk factors	2E-8	    .08	[0.053-0.111] mmol/l increase	rs1260326	T	0.40	21943158
ABCG2	Cardiovascular disease risk factors	2E-17	    .19	[0.14-0.23] umol/l increase	rs2199936	A	0.12	21943158
SLC17A4	Cardiovascular disease risk factors	4E-9	    .08	[0.057-0.111] umol/l decrease	rs11754288	A	0.43	21943158
HFE	Cardiovascular disease risk factors	5E-12	    .18	[0.13-0.23] mg/l increase	rs1800562	A	0.08	21943158
PCSK7	Cardiovascular disease risk factors	2E-10	    .24	[0.16-0.31] mmol/l increase	rs508487	T	0.04	21943158
LDLR	Cardiovascular disease risk factors	5E-11	    .15	[0.10-0.19] mmol/l decrease	rs6511720	T	0.11	21943158
CNNM2	Schizophrenia	2E-8	   1.22	[1.15-1.29] 	rs7914558	G	0.59	21926974
NT5C2	Schizophrenia	3E-8	   1.20	[1.13-1.26] 	rs11191580	T	0.91	21926974
CCDC68	Schizophrenia	3E-8	   1.40	[1.28-1.52] 	rs12966547	G	0.58	21926974
MIR137	Schizophrenia	2E-11	   1.12	[1.09-1.16] 	rs1625579	T	0.80	21926974
PCGEM1	Schizophrenia	5E-8	   1.20	[1.13-1.26] 	rs17662626	A	0.91	21926974
TRIM26	Schizophrenia	2E-12	   1.15	[1.11-1.19] 	rs2021722	C	0.78	21926974
CSMD1	Schizophrenia	2E-8	   1.16	[1.11-1.21] 	rs10503253	A	0.19	21926974
CANCNA1C	Bipolar disorder	2E-8	   1.14	[NR] 	rs4765913	A	NR	21926972
ODZ4	Bipolar disorder	4E-8	   1.14	[NR] 	rs12576775	G	NR	21926972
TFAP2B	Obesity (extreme)	3E-8	NR	NR	rs734597	A	NR	21935397
TNFRSF10A, LOC389641	Age-related macular degeneration	1E-12	   1.37	[1.25-1.49] 	rs13278062	T	0.35	21909106
REST, C4orf14, POLR2B, IGFBP7	Age-related macular degeneration	2E-8	   1.30	[1.19-1.42] 	rs1713985	G	0.29	21909106
ZHX2	Carotid intima media thickness	2E-11	    .01	[0.01-0.01] unit decrease	rs11781551	A	0.48	21909108
APOC1	Carotid intima media thickness	2E-8	    .02	[0.01-0.03] unit decrease	rs445925	A	0.11	21909108
PINX1	Carotid intima media thickness	2E-8	    .01	[0.01-0.01] unit increase	rs6601530	G	0.45	21909108
PIK3CG	Carotid intima media thickness	2E-12	    .16	[0.11-0.21] unit increase	rs17398575	A	0.25	21909108
EDNRA	Carotid intima media thickness	7E-12	    .20	[0.14-0.26] unit increase	rs1878406	T	0.13	21909108
CYP1A1, ULK3	Diastolic blood pressure	3E-26	    .42	[NR] mmHg increase	rs1378942	C	0.35	21909115
SH2B3	Diastolic blood pressure	4E-25	    .45	[NR] mmHg increase	rs3184504	T	0.47	21909115
FGF5	Diastolic blood pressure	9E-25	    .46	[NR] mmHg increase	rs1458038	T	0.29	21909115
GNAS, EDN3	Diastolic blood pressure	6E-23	    .56	[NR] mmHg increase	rs6015450	G	0.12	21909115
SLC39A8	Diastolic blood pressure	2E-17	    .68	[NR] mmHg decrease	rs13107325	T	0.05	21909115
JAG1	Diastolic blood pressure	1E-15	    .30	[NR] mmHg increase	rs1327235	G	0.46	21909115
HFE	Diastolic blood pressure	2E-15	    .46	[NR] mmHg increase	rs1799945	G	0.14	21909115
FURIN, FES	Diastolic blood pressure	2E-15	    .36	[NR] mmHg increase	rs2521501	T	0.31	21909115
FLJ32810, TMEM133	Diastolic blood pressure	2E-15	    .33	[NR] mmHg decrease	rs633185	G	0.28	21909115
EBF1	Diastolic blood pressure	4E-13	    .28	[NR] mmHg decrease	rs11953630	T	0.37	21909115
MECOM	Diastolic blood pressure	2E-12	    .24	[NR] mmHg increase	rs419076	T	0.47	21909115
NPR3, C5orf23	Diastolic blood pressure	9E-12	    .26	[NR] mmHg increase	rs1173771	G	0.60	21909115
BAT2, BAT5	Diastolic blood pressure	3E-11	    .23	[NR] mmHg increase	rs805303	G	0.61	21909115
GUCY1A3, GUCY1B3	Diastolic blood pressure	2E-10	    .26	[NR] mmHg increase	rs13139571	C	0.76	21909115
CACNB2	Diastolic blood pressure	4E-10	    .22	[NR] mmHg decrease	rs4373814	G	0.55	21909115
MOV10	Diastolic blood pressure	1E-9	    .24	[NR] mmHg increase	rs2932538	G	0.75	21909115
SLC4A7	Diastolic blood pressure	4E-9	    .24	[NR] mmHg decrease	rs13082711	T	0.78	21909115
GNAS, EDN3	Hypertension	4E-14	    .11	[NR] unit increase	rs6015450	G	0.12	21909115
FLJ32810, TMEM133	Hypertension	5E-11	    .07	[NR] unit decrease	rs633185	G	0.28	21909115
BAT2, BAT5	Hypertension	1E-10	    .05	[NR] unit increase	rs805303	G	0.61	21909115
HFE	Hypertension	2E-10	    .10	[NR] unit increase	rs1799945	G	0.14	21909115
NPR3, C5orf23	Hypertension	3E-10	    .06	[NR] unit increase	rs1173771	G	0.60	21909115
PLCE1	Hypertension	9E-9	    .06	[NR] unit increase	rs932764	G	0.44	21909115
CYP17A1, NT5C2	Systolic blood pressure	7E-26	   1.10	[NR] mmHg increase	rs11191548	T	0.91	21909115
FGF5	Systolic blood pressure	2E-23	    .71	[NR] mmHg increase	rs1458038	T	0.29	21909115
GNAS, EDN3	Systolic blood pressure	4E-23	    .90	[NR] mmHg increase	rs6015450	G	0.12	21909115
CYP1A1, ULK3	Systolic blood pressure	6E-23	    .61	[NR] mmHg increase	rs1378942	C	0.35	21909115
FURIN, FES	Systolic blood pressure	5E-19	    .65	[NR] mmHg increase	rs2521501	T	0.31	21909115
FLJ32810, TMEM133	Systolic blood pressure	1E-17	    .57	[NR] mmHg decrease	rs633185	G	0.28	21909115
NPR3, C5orf23	Systolic blood pressure	2E-16	    .50	[NR] mmHg increase	rs1173771	G	0.60	21909115
PLCE1	Systolic blood pressure	7E-16	    .48	[NR] mmHg increase	rs932764	G	0.44	21909115
SLC39A8	Systolic blood pressure	3E-14	    .98	[NR] mmHg decrease	rs13107325	T	0.05	21909115
MECOM	Systolic blood pressure	2E-13	    .41	[NR] mmHg increase	rs419076	T	0.47	21909115
ADM	Systolic blood pressure	3E-12	    .62	[NR] mmHg decrease	rs7129220	G	0.89	21909115
HFE	Systolic blood pressure	8E-12	    .63	[NR] mmHg increase	rs1799945	G	0.14	21909115
BAT2, BAT5	Systolic blood pressure	2E-11	    .38	[NR] mmHg increase	rs805303	G	0.61	21909115
EBF1	Systolic blood pressure	3E-11	    .41	[NR] mmHg decrease	rs11953630	T	0.37	21909115
CACNB2	Systolic blood pressure	5E-11	    .37	[NR] mmHg decrease	rs4373814	G	0.55	21909115
GOSR2	Systolic blood pressure	1E-10	    .56	[NR] mmHg decrease	rs17608766	T	0.86	21909115
MOV10	Systolic blood pressure	1E-9	    .39	[NR] mmHg increase	rs2932538	G	0.75	21909115
JAG1	Systolic blood pressure	2E-8	    .34	[NR] mmHg increase	rs1327235	G	0.46	21909115
ZNF827	Gamma glutamyl transpeptidase	1E-14	    .00	[0.0031-0.0055] IU/L decrease	rs4835265	T	0.42	21909109
TBL2	Gamma glutamyl transpeptidase	6E-10	    .01	[0.0035-0.0067] IU/L increase	rs12539316	C	0.10	21909109
MYL2	Gamma glutamyl transpeptidase	9E-58	    .01	[0.011-0.013] IU/L increase	rs12229654	G	0.14	21909109
C12orf51	Gamma glutamyl transpeptidase	3E-126	    .02	[0.015-0.017] IU/L increase	rs2074356	T	0.15	21909109
Intergenic	Gamma glutamyl transpeptidase	6E-44	    .01	[0.0083-0.0111] IU/L increase	rs11066453	G	0.13	21909109
HNF1A	Gamma glutamyl transpeptidase	7E-30	    .01	[0.0062-0.0090] IU/L increase	rs2393791	G	0.48	21909109
GGT1, C22orf36	Gamma glutamyl transpeptidase	7E-53	    .01	[0.0076-0.0100] IU/L decrease	rs4820599	G	0.24	21909109
MYL2	HDL cholesterol	3E-23	    .03	[0.023-0.033] mg/dL decrease	rs12229654	G	0.14	21909109
C12orf51	HDL cholesterol	7E-37	    .04	[0.030-0.040] mg/dL decrease	rs2074356	T	0.15	21909109
LPL	HDL cholesterol	8E-43	    .04	[0.037-0.049] mg/dL increase	rs10503669	T	0.12	21909109
ABCA1	HDL cholesterol	2E-18	    .02	[0.017-0.027] mg/dL decrease	rs12686004	T	0.21	21909109
Intergenic	HDL cholesterol	3E-34	    .03	[0.027-0.037] mg/dL increase	rs11216126	C	0.20	21909109
Intergenic	HDL cholesterol	1E-24	    .02	[0.018-0.027] mg/dL increase	rs16940212	T	0.34	21909109
CETP	HDL cholesterol	2E-28	    .04	[0.033-0.047] mg/dL decrease	rs12708980	C	0.10	21909109
PVRL2, TOMM40, APOE	HDL cholesterol	8E-11	    .02	[0.012-0.023] mg/dL decrease	rs519113	C	0.15	21909109
ABO	Metabolite levels	6E-9	   2.28	[1.51-3.05] mg/dL increase	rs651007	A	0.26	21909109
CELSR2, PSRC1, SORT1	Metabolite levels	2E-19	   5.23	[4.09-6.37] mg/dL decrease	rs599839	G	0.06	21909109
HMGCR	Metabolite levels	1E-20	   2.71	[2.14-3.28] mg/dL decrease	rs12654264	T	0.48	21909109
LDLR	Metabolite levels	2E-12	   2.95	[2.13-3.77] mg/dL increase	rs2738446	C	0.14	21909109
SIX2, SIX3	Metabolite levels	1E-12	    .04	[0.029-0.050] mg/dL increase	rs895636	A	0.38	21909109
ABCB11	Metabolite levels	2E-15	    .06	[0.042-0.069] mg/dL increase	rs16856247	T	0.35	21909109
GCK	Metabolite levels	2E-19	    .06	[0.049-0.075] mg/dL increase	rs1799884	A	0.19	21909109
MTNR1B	Metabolite levels	1E-16	    .04	[0.034-0.055] mg/dL increase	rs10830962	C	0.45	21909109
RPS11	Metabolite levels	9E-13	    .03	[0.021-0.037] g/dL increase	rs2280401	A	0.17	21909109
GCKR	Metabolite levels	5E-18	    .02	[-0.02972-0.07612] g/dL decrea	rs780092	G	0.33	21909109
RSPO3	Metabolite levels	1E-8	    .01	[0.0059-0.0121] mg/dL decrease	rs6569474	A	0.47	21909109
Intergenic	Metabolite levels	3E-21	    .02	[0.019-0.029] mg/dL decrease	rs4686914	T	0.38	21909109
Intergenic	Metabolite levels	3E-18	    .02	[0.014-0.022] mg/dL increase	rs13069049	T	0.17	21909109
SLC14A2	Metabolite levels	8E-14	    .01	[0.011-0.019] mg/dL decrease	rs7232775	C	0.20	21909109
C12orf51	Metabolite levels	8E-22	    .00	[0.0035-0.0055] IU/L increase	rs11066280	A	0.17	21909109
PNPLA3	Metabolite levels	2E-18	    .00	[0.0031-0.0047] IU/L decrease	rs12483959	A	0.42	21909109
C12orf51	Metabolite levels	3E-63	    .00	[0.0014-0.0018] IU/L increase	rs11066280	A	0.17	21909109
PNPLA3	Metabolite levels	2E-39	    .00	[0.00080-0.00120] IU/L increase	rs12483959	A	0.42	21909109
GCKR	Triglycerides	5E-27	    .05	[0.041-0.059] mg/dL decrease	rs780092	G	0.33	21909109
TBL2, MLXIPL	Triglycerides	1E-15	    .07	[0.049-0.081] mg/dL decrease	rs2286276	T	0.10	21909109
LPL	Triglycerides	7E-39	    .09	[0.073-0.098] mg/dL decrease	rs10503669	T	0.12	21909109
Intergenic	Triglycerides	1E-20	    .04	[0.032-0.049] mg/dL increase	rs2001945	C	0.42	21909109
ZNF259, APOA1, APOC3, APOA4, APOA5, BUD13	Triglycerides	2E-86	    .09	[0.079-0.096] mg/dL decrease	rs603446	T	0.23	21909109
FIGN	Blood pressure	2E-8	    .31	[0.20-0.42] mmHg decrease	rs13002573	G	0.20	21909110
CHIC2	Blood pressure	1E-8	    .43	[0.28-0.58] mmHg increase	rs871606	T	0.85	21909110
PIK3CG	Blood pressure	2E-13	    .42	[0.31-0.53] mmHg decrease	rs17477177	T	0.72	21909110
NOV	Blood pressure	4E-9	    .31	[0.21-0.41] mmHg increase	rs2071518	T	0.17	21909110
ADAMTS-8	Blood pressure	2E-11	    .34	[0.24-0.44] mmHg increase	rs11222084	T	0.38	21909110
PLCE-1	Blood pressure	5E-9	    .27	[0.18-0.36] mmHg decrease	rs9663362	G	0.53	21909110
ATP2B1	Blood pressure	6E-10	    .39	[0.27-0.52] mmHg increase	rs17249754	G	0.89	21909110
GOSR2	Blood pressure	6E-15	    .53	[0.40-0.67] mmHg decrease	rs17608766	T	0.91	21909110
FIGN	Blood pressure	6E-12	    .34	[0.24-0.44] mmHg decrease	rs1446468	T	0.53	21909110
ADRB1	Blood pressure	2E-9	    .34	[0.23-0.45] mmHg decrease	rs2782980	T	0.20	21909110
MTHFR, NPPB	Blood pressure	2E-16	    .53	[0.40-0.66] mmHg decrease	rs17367504	G	0.17	21909110
SLC4A7	Blood pressure	5E-9	    .34	[0.22-0.45] mmHg decrease	rs13082711	T	0.80	21909110
SLC39A8	Blood pressure	1E-10	    .63	[0.44-0.82] mmHg decrease	rs13107325	T	0.12	21909110
NPR3, C5orf23	Blood pressure	4E-9	    .28	[0.19-0.37] mmHg increase	rs1173771	G	0.53	21909110
EBF1	Blood pressure	1E-11	    .34	[0.24-0.44] mmHg decrease	rs9313772	T	0.32	21909110
CACNB2	Blood pressure	2E-16	    .43	[0.33-0.53] mmHg decrease	rs12258967	G	0.36	21909110
C10orf107	Blood pressure	2E-18	    .58	[0.45-0.71] mmHg increase	rs4590817	G	0.83	21909110
CYP17A1, NT5C2	Blood pressure	1E-15	    .66	[0.50-0.82] mmHg increase	rs11191593	T	0.94	21909110
ATP2B1	Blood pressure	1E-17	    .56	[0.43-0.69] mmHg increase	rs17249754	G	0.89	21909110
ATXN2	Blood pressure	7E-20	    .43	[0.34-0.52] mmHg decrease	rs653178	T	0.59	21909110
CSK	Blood pressure	2E-15	    .39	[0.29-0.48] mmHg increase	rs1378942	C	0.33	21909110
FES	Blood pressure	3E-8	    .34	[0.22-0.46] mmHg increase	rs2521501	T	0.37	21909110
JAG1	Blood pressure	4E-8	    .26	[0.17-0.35] mmHg increase	rs1327235	G	0.58	21909110
MAP4	Blood pressure	3E-8	    .30	[0.20-0.40] mmHg increase	rs319690	T	0.51	21909110
HFE	Blood pressure	2E-12	    .48	[0.35-0.61] mmHg decrease	rs198846	G	0.86	21909110
PLEKHA7	Blood pressure	3E-8	    .30	[0.19-0.41] mmHg increase	rs381815	T	0.30	21909110
CYP17A1, NT5C2	Blood pressure	8E-11	    .53	[0.37-0.69] mmHg increase	rs11191548	T	0.94	21909110
NPR3, C5orf23	Blood pressure	5E-9	    .28	[0.18-0.37] mmHg increase	rs1173771	G	0.53	21909110
FGF5	Blood pressure	3E-14	    .40	[0.30-0.51] mmHg increase	rs1458038	T	0.30	21909110
FLJ32810, TMEM133	Blood pressure	7E-10	    .33	[0.22-0.43] mmHg decrease	rs633185	G	0.32	21909110
GNAS, EDN3	Blood pressure	2E-12	    .52	[0.38-0.67] mmHg increase	rs6015450	G	0.07	21909110
MECOM	Blood pressure	8E-13	    .34	[0.25-0.43] mmHg increase	rs419076	T	0.44	21909110
HLA-DQB1	HPV seropositivity	1E-14	NR	NR	rs9357152	G	0.33	21896673
IL6R	Asthma	2E-8	   1.09	[1.06-1.12] 	rs4129267	T	0.37	21907864
LRRC32	Asthma	2E-8	   1.09	[1.06-1.13] 	rs7130588	G	0.34	21907864
ZNF365	Breast cancer	6E-9	   1.12	[1.06-1.18] 	rs10822013	T	0.47	21908515
HMGA2	Permanent tooth development	2E-12	    .11	[0.08-0.14] unit decrease	rs12424086	C	0.18	21931568
TNP1	Permanent tooth development	2E-14	    .10	[0.07-0.13] unit decrease	rs4491709	T	0.71	21931568
CACNA1S	Permanent tooth development	8E-17	    .10	[0.08-0.12] unit decrease	rs2281845	T	0.38	21931568
ADK	Permanent tooth development	6E-18	    .11	[0.08-0.13] unit decrease	rs7924176	G	0.43	21931568
MHC	Graves' disease	2E-22	   1.53	[1.40-1.66] 	rs2273017	A	0.51	21900946
MHC	Graves' disease	2E-20	   1.53	[1.39-1.67] 	rs3893464	G	0.36	21900946
MHC	Graves' disease	2E-15	   1.67	[1.47-1.90] 	rs4313034	T	0.83	21900946
MHC	Graves' disease	1E-13	   1.43	[1.30-1.57] 	rs3132613	C	0.25	21900946
MHC	Graves' disease	1E-13	   1.38	[1.27-1.50] 	rs4248154	C	0.54	21900946
MHC	Graves' disease	4E-12	   1.36	[1.24-1.48] 	rs9394159	T	0.53	21900946
MHC	Graves' disease	7E-13	   1.40	[1.28-1.53] 	rs4713693	T	0.65	21900946
PYROXD2, C10orf33	Metabolite levels	8E-15	   1.19	[0.95-1.43] unit decrease	rs7072216	C	NR	21931564
ALMS1, NAT8, TPRKB, DUSP11	Metabolite levels	1E-11	   1.10	[0.85-1.35] unit increase	rs9309473	G	NR	21931564
SLC22A3	Lp (a) levels	4E-9	    .32	[0.22-0.42] mg/dL increase	rs3120139	A	0.13	21900290
LPAL2	Lp (a) levels	5E-8	    .50	[0.32-0.68] decrease mg/dL	rs12214416	A	0.04	21900290
LPA	Lp (a) levels	5E-39	   1.28	[1.08-1.48] mg/dL increase	rs10455872	G	0.07	21900290
PLG	Lp (a) levels	3E-17	    .30	[0.22-0.38] mg/dL decrease	rs783147	A	0.45	21900290
ACADS	Metabolic traits	4E-305	    .61	[NR] unit increase	rs2066938	G	0.252	21886157
NAT8	Metabolic traits	5E-252	    .37	[NR] unit decrease	rs13391552	A	0.216	21886157
FADS1	Metabolic traits	9E-116	    .18	[NR] unit decrease	rs174547	C	0.32	21886157
UGT1A	Metabolic traits	3E-74	    .29	[NR] unit increase	rs887829	T	0.337	21886157
ACADM	Metabolic traits	2E-71	    .16	[NR] unit decrease	rs211718	T	0.304	21886157
OPLAH	Metabolic traits	2E-59	    .12	[NR] unit decrease	rs6558295	G	0.083	21886157
SCD	Metabolic traits	3E-57	    .12	[NR] unit increase	rs603424	A	0.189	21886157
GCKR	Metabolic traits	6E-53	    .10	[NR] unit increase	rs780094	T	0.399	21886157
NAT2	Metabolic traits	2E-40	    .26	[NR] unit decrease	rs1495743	G	0.188	21886157
CYP3A4	Metabolic traits	9E-40	    .48	[NR] unit decrease	rs17277546	A	0.045	21886157
ABO	Metabolic traits	9E-40	    .20	[NR] unit increase	rs612169	G	0.335	21886157
SLC2A9	Metabolic traits	6E-34	    .07	[NR] unit decrease	rs4481233	T	0.193	21886157
CYP4A	Metabolic traits	5E-32	    .16	[NR] unit decrease	rs9332998	C	0.135	21886157
CPS1	Metabolic traits	2E-27	    .12	[NR] unit increase	rs2216405	G	0.177	21886157
LACTB	Metabolic traits	7E-27	    .09	[NR] unit decrease	rs2652822	C	0.467	21886157
SLC22A1	Metabolic traits	7E-25	    .16	[NR] unit decrease	rs662138	G	0.163	21886157
SLCO1B1	Metabolic traits	3E-22	    .21	[NR] unit decrease	rs4149081	A	0.205	21886157
FUT2	Metabolic traits	4E-20	    .13	[NR] unit increase	rs503279	C	0.464	21886157
ACE	Metabolic traits	8E-20	    .13	[NR] unit decrease	rs4329	G	0.465	21886157
PHGDH	Metabolic traits	3E-14	    .05	[NR] unit decrease	rs477992	A	0.313	21886157
ENPEP	Metabolic traits	7E-13	    .12	[NR] unit decrease	rs2087160	G	0.207	21886157
AKR1C	Metabolic traits	7E-13	    .07	[NR] unit decrease	rs2518049	A	0.175	21886157
NT5E	Metabolic traits	7E-13	    .30	[NR] unit increase	rs494562	G	0.106	21886157
PRODH	Metabolic traits	2E-22	    .11	[NR] unit increase	rs2023634	G	0.091	21886157
HPS5	Metabolic traits	1E-20	    .11	[NR] unit decrease	rs2403254	T	0.525	21886157
ALPL	Metabolic traits	3E-20	    .13	[NR] unit decrease	rs10799701	A	0.435	21886157
SLC7A6	Metabolic traits	1E-18	    .11	[NR] unit increase	rs6499165	A	0.266	21886157
KLKB1	Metabolic traits	7E-18	    .24	[NR] unit decrease	rs4253252	T	0.492	21886157
GLS2	Metabolic traits	3E-17	    .04	[NR] unit decrease	rs2657879	G	0.187	21886157
PDXDC1	Metabolic traits	5E-16	    .07	[NR] unit decrease	rs7200543	G	0.304	21886157
SLC22A4	Metabolic traits	7E-16	    .08	[NR] unit increase	rs272889	A	0.37	21886157
AHR	Metabolic traits	5E-15	    .29	[NR] unit increase	rs12670403	C	0.487	21886157
ETFDH	Metabolic traits	6E-15	    .10	[NR] unit decrease	rs8396	C	0.304	21886157
ELOVL2	Metabolic traits	2E-14	    .06	[NR] unit decrease	rs9393903	A	0.242	21886157
SLC16A9	Metabolic traits	3E-14	    .05	[NR] unit decrease	rs7094971	G	0.147	21886157
IVD	Metabolic traits	1E-13	    .09	[NR] unit increase	rs10518693	T	0.396	21886157
SLC16A10	Metabolic traits	1E-12	    .04	[NR] unit decrease	rs7760535	G	0.401	21886157
CYP1A1, CYP1A2	Coffee consumption	2E-11	    .07	[0.05-0.09] unit increase	rs2470893	T	NR	21876539
CPLX3, ULK3	Coffee consumption	7E-9	    .05	[0.03-0.07] unit decrease	rs6495122	A	NR	21876539
LAMB4, NRCAM	Coffee consumption	4E-9	    .08	[0.05-0.11] unit increase	rs382140	A	NR	21876539
RBP4	Retinol levels	7E-15	    .03	[0.02-0.04] ug/L decrease	rs10882272	C	0.35	21878437
TTR	Retinol levels	6E-14	    .03	[0.02-0.04] ug/L increase	rs1667255	C	0.31	21878437
GRB14	Type 2 diabetes	1E-8	   1.09	[1.06-1.13] 	rs3923113	A	0.74	21874001
ST6GAL1	Type 2 diabetes	3E-8	   1.09	[1.06-1.12] 	rs16861329	G	0.75	21874001
VPS26A	Type 2 diabetes	4E-8	   1.08	[1.05-1.12] 	rs1802295	A	0.26	21874001
HMG20A	Type 2 diabetes	7E-11	   1.09	[1.06-1.12] 	rs7178572	G	0.52	21874001
AP3S2	Type 2 diabetes	2E-11	   1.10	[1.07-1.13] 	rs2028299	C	0.31	21874001
HNF4A	Type 2 diabetes	3E-10	   1.09	[1.06-1.12] 	rs4812829	A	0.29	21874001
ARAP1	Proinsulin levels	3E-102	NR	NR	rs11603334	A	0.15	21873549
MADD	Proinsulin levels	1E-88	NR	NR	rs10501320	G	0.72	21873549
PCSK1	Proinsulin levels	1E-26	NR	NR	rs6235	G	0.28	21873549
TCF7L2	Proinsulin levels	2E-20	NR	NR	rs7903146	T	0.30	21873549
VPS13C, C2CD4A, C2CD4B	Proinsulin levels	4E-20	NR	NR	rs4502156	T	0.58	21873549
SLC30A8	Proinsulin levels	3E-18	NR	NR	rs11558471	A	0.69	21873549
LARP6	Proinsulin levels	2E-10	NR	NR	rs1549318	T	0.61	21873549
SGSM2	Proinsulin levels	3E-9	NR	NR	rs4790333	T	0.45	21873549
MADD	Proinsulin levels	7E-12	NR	NR	rs10838687	T	0.80	21873549
MCF2L	Osteoarthritis	2E-8	   1.17	[1.11-1.23] 	rs11842874	A	0.07	21871595
BCHE	Butyrylcholinesterase levels	6E-262	    .71	[0.67-0.75] SD decrease	rs1803274	T	0.21	21862451
RNPEP	Butyrylcholinesterase levels	9E-16	    .14	[0.10-0.18] SD decrease	rs4950806	T	0.40	21862451
ABI2	Butyrylcholinesterase levels	4E-18	    .15	[0.12-0.18] SD decrease	rs11675251	A	0.45	21862451
ATM	Response to metformin	3E-9	NR	NR	rs11212617	A	0.44	21845381
APOM	Rheumatoid arthritis	3E-10	   1.56	[1.36-1.80] 	rs805297	A	0.36	21844665
FCRL3	Graves' disease	2E-13	   1.23	[1.17-1.30] 	rs3761959	A	0.40	21841780
CD28, CTLA4	Graves' disease	2E-17	   1.30	[1.23-1.38] 	rs1024161	T	0.69	21841780
RHOH, CHRNA9	Graves' disease	1E-13	   1.24	[1.17-1.31] 	rs6832151	G	0.35	21841780
MUC21, C6orf15	Graves' disease	4E-51	   1.77	[1.65-1.91] 	rs4947296	C	0.14	21841780
HLA-B	Graves' disease	2E-65	   1.92	[1.78-2.08] 	rs1521	T	0.79	21841780
HLA, DRB1, DQA1, DQB1	Graves' disease	7E-33	   1.40	[1.32-1.48] 	rs6457617	T	0.45	21841780
HLA, DPB1	Graves' disease	2E-65	   1.64	[1.55-1.74] 	rs2281388	T	0.32	21841780
RNASET2, FGFR1OP	Graves' disease	7E-10	   1.19	[1.13-1.26] 	rs9355610	G	0.47	21841780
TSHR	Graves' disease	7E-24	   1.35	[1.28-1.43] 	rs12101261	T	0.64	21841780
SEMA3A	Iris characteristics	7E-11	    .12	[0.08-0.16] unit increase	rs10235789	C	NR	21835309
TRAF3IP1	Iris characteristics	2E-12	    .25	[0.19-0.31] unit increase	rs3739070	A	NR	21835309
SLC324A4	Iris characteristics	8E-21	    .17	[0.13-0.21] unit increase	rs4900109	G	NR	21835309
AGAP2, CYP27B1	Multiple sclerosis	2E-9	   1.10	[1.09-1.12] 	rs12368653	A	NR	21833088
AHI1	Multiple sclerosis	1E-13	   1.13	[1.11-1.15] 	rs11154801	A	NR	21833088
BACH2	Multiple sclerosis	4E-8	   1.09	[1.08-1.1] 	rs12212193	G	NR	21833088
BATF	Multiple sclerosis	2E-8	   1.11	[1.09-1.12] 	rs2300603	A	NR	21833088
C1orf106, KIF21B	Multiple sclerosis	2E-9	   1.11	[1.1-1.13] 	rs7522462	G	NR	21833088
C3orf1, TMEM39A	Multiple sclerosis	3E-9	   1.13	[1.11-1.15] 	rs2293370	G	NR	21833088
CD5, CD6	Multiple sclerosis	2E-11	   1.12	[1.1-1.13] 	rs650258	G	NR	21833088
CD58	Multiple sclerosis	3E-16	   1.22	[1.19-1.24] 	rs1335532	A	NR	21833088
CD86	Multiple sclerosis	1E-11	   1.21	[1.18-1.24] 	rs9282641	G	NR	21833088
CLEC16A	Multiple sclerosis	9E-17	   1.15	[1.13-1.16] 	rs7200786	A	NR	21833088
CLECL1	Multiple sclerosis	1E-8	   1.09	[1.08-1.11] 	rs10466829	A	NR	21833088
CYP24A1	Multiple sclerosis	3E-11	   1.12	[1.1-1.13] 	rs2248359	G	NR	21833088
DKKL1	Multiple sclerosis	5E-9	   1.11	[1.09-1.13] 	rs2303759	C	NR	21833088
EOMES	Multiple sclerosis	1E-9	   1.11	[1.09-1.12] 	rs11129295	A	NR	21833088
EVI5	Multiple sclerosis	6E-15	   1.15	[1.13-1.16] 	rs11810217	A	NR	21833088
EXTL2	Multiple sclerosis	4E-8	   1.09	[1.08-1.11] 	rs12048904	A	NR	21833088
GPR65	Multiple sclerosis	2E-10	   1.22	[1.19-1.25] 	rs2119704	C	NR	21833088
HHEX	Multiple sclerosis	5E-9	   1.10	[1.08-1.11] 	rs7923837	G	NR	21833088
IL12B	Multiple sclerosis	1E-11	   1.11	[1.1-1.13] 	rs2546890	A	NR	21833088
IL22RA2	Multiple sclerosis	6E-13	   1.14	[1.12-1.15] 	rs17066096	G	NR	21833088
IL2RA	Multiple sclerosis	5E-20	   1.19	[1.17-1.21] 	rs7090512	G	NR	21833088
IL7R	Multiple sclerosis	2E-8	   1.11	[1.09-1.13] 	rs6897932	G	NR	21833088
IRF8	Multiple sclerosis	1E-8	   1.11	[1.1-1.13] 	rs13333054	A	NR	21833088
MALT1	Multiple sclerosis	3E-9	   1.12	[1.1-1.14] 	rs7238078	A	NR	21833088
MAPK1	Multiple sclerosis	5E-9	   1.10	[1.08-1.11] 	rs2283792	C	NR	21833088
MERTK	Multiple sclerosis	1E-8	   1.11	[1.09-1.13] 	rs17174870	G	NR	21833088
MMEL1	Multiple sclerosis	1E-14	   1.14	[1.12-1.16] 	rs4648356	C	NR	21833088
MPV17L2	Multiple sclerosis	1E-8	   1.11	[1.09-1.12] 	rs874628	A	NR	21833088
MYC	Multiple sclerosis	8E-9	   1.11	[1.09-1.12] 	rs4410871	G	NR	21833088
Intergenic	Multiple sclerosis	6E-10	   1.11	[1.1-1.13] 	rs12466022	C	NR	21833088
Intergenic	Multiple sclerosis	2E-15	   1.13	[1.12-1.15] 	rs669607	C	NR	21833088
OLIG3	Multiple sclerosis	1E-8	   1.10	[1.09-1.12] 	rs13192841	A	NR	21833088
NCOA5, CD40	Multiple sclerosis	5E-10	   1.11	[1.1-1.13] 	rs2425752	A	NR	21833088
NFKBIZ	Multiple sclerosis	9E-9	   1.10	[1.09-1.12] 	rs771767	A	NR	21833088
ODF3B, SCO2	Multiple sclerosis	2E-8	   1.10	[1.09-1.12] 	rs140522	A	NR	21833088
PLEK	Multiple sclerosis	5E-11	   1.11	[1.1-1.12] 	rs7595037	A	NR	21833088
PTGER4	Multiple sclerosis	3E-16	   1.20	[1.18-1.22] 	rs4613763	G	NR	21833088
PTPRK, THEMIS	Multiple sclerosis	6E-9	   1.10	[1.09-1.12] 	rs802734	A	NR	21833088
PVT1	Multiple sclerosis	5E-9	   1.12	[1.1-1.13] 	rs2019960	G	NR	21833088
RGS1	Multiple sclerosis	2E-8	   1.12	[1.1-1.14] 	rs1323292	A	NR	21833088
SLC30A7, VCAM1	Multiple sclerosis	3E-10	   1.12	[1.1-1.13] 	rs11581062	G	NR	21833088
SP140	Multiple sclerosis	2E-10	   1.14	[1.12-1.16] 	rs10201872	A	NR	21833088
STAT3	Multiple sclerosis	2E-10	   1.11	[1.09-1.12] 	rs9891119	C	NR	21833088
TAGAP	Multiple sclerosis	7E-15	   1.13	[1.12-1.15] 	rs1738074	G	NR	21833088
TNFRSF1A	Multiple sclerosis	4E-14	   1.12	[1.11-1.14] 	rs1800693	G	NR	21833088
TNFSF14	Multiple sclerosis	9E-14	   1.16	[1.14-1.18] 	rs1077667	G	NR	21833088
ZFP36L1	Multiple sclerosis	9E-12	   1.11	[1.1-1.13] 	rs4902647	G	NR	21833088
ZMIZ1	Multiple sclerosis	6E-9	   1.10	[1.09-1.12] 	rs1250550	A	NR	21833088
ZNF767, ZNF746	Multiple sclerosis	5E-9	   1.11	[1.1-1.13] 	rs354033	G	NR	21833088
EXTL2, VCAM1	Multiple sclerosis	4E-8	   1.09	[1.08-1.11] 	rs12048904	A	NR	21833088
SLC15A2, CD86	Multiple sclerosis	2E-8	   1.10	[1.09-1.12] 	rs4285028	A	NR	21833088
IL2RA	Multiple sclerosis	3E-11	   1.12	[1.1-1.13] 	rs3118470	G	NR	21833088
FCRL3	Type 1 diabetes autoantibodies	1E-11	   1.52	[NR] 	rs7528684	T	NR	21829393
PTPN22	Type 1 diabetes autoantibodies	2E-111	   2.00	[NR] 	rs2476601	A	NR	21829393
IL10	Type 1 diabetes autoantibodies	5E-10	   1.20	[NR] 	rs3024505	G	NR	21829393
IFIH1	Type 1 diabetes autoantibodies	2E-14	   1.20	[NR] 	rs1990760	C	NR	21829393
CTLA4	Type 1 diabetes autoantibodies	2E-17	   1.20	[NR] 	rs3087243	A	NR	21829393
BACH2	Type 1 diabetes autoantibodies	3E-8	   1.10	[NR] 	rs11755527	G	NR	21829393
IL2RA	Type 1 diabetes autoantibodies	1E-38	   1.61	[NR] 	rs12722495	A	NR	21829393
IGF2AS	Type 1 diabetes autoantibodies	3E-23	   1.40	[NR] 	rs1004446	G	NR	21829393
IKZF4	Type 1 diabetes autoantibodies	5E-18	   1.25	[NR] 	rs1701704	T	NR	21829393
ERBB3	Type 1 diabetes autoantibodies	3E-27	   1.30	[NR] 	rs2292239	T	NR	21829393
SH2B3	Type 1 diabetes autoantibodies	2E-38	   1.30	[NR] 	rs3184504	T	NR	21829393
CLEC16A	Type 1 diabetes autoantibodies	5E-14	   1.20	[NR] 	rs12708716	G	NR	21829393
IL27	Type 1 diabetes autoantibodies	1E-8	   1.15	[NR] 	rs4788084	C	NR	21829393
PTPN2	Type 1 diabetes autoantibodies	4E-13	   1.30	[NR] 	rs2542151	G	NR	21829393
CD226	Type 1 diabetes autoantibodies	1E-9	   1.12	[NR] 	rs763361	C	NR	21829393
CCHCR1	Nevirapine-induced rash	1E-8	   4.36	[2.58-7.36] 	rs1265112	G	0.06	21810746
MLLT10	Meningioma 	2E-14	   1.46	[1.32-1.61] 	rs11012732	A	0.32	21804547
LOC729675	Asthma	2E-12	   1.16	[1.11-1.21] 	rs7686660	T	0.27	21804548
TSLP	Asthma	1E-16	   1.17	[1.13-1.22] 	rs1837253	C	0.35	21804548
PBX2	Asthma	2E-15	   1.17	[1.12-1.21] 	rs204993	A	0.58	21804548
NOTCH4	Asthma	4E-23	   1.21	[1.16-1.25] 	rs404860	A	0.50	21804548
C6orf10	Asthma	3E-15	   1.17	[1.12-1.21] 	rs3129943	T	0.62	21804548
BTNL2	Asthma	5E-12	   1.16	[1.11-1.21] 	rs3117098	G	0.25	21804548
HLA-DRA	Asthma	5E-13	   1.15	[1.11-1.20] 	rs3129890	T	0.61	21804548
HLA-DQB1	Asthma	5E-15	   1.17	[1.12-1.21] 	rs7775228	A	0.63	21804548
HLA-DQA2	Asthma	5E-12	   1.18	[1.12-1.24] 	rs9275698	T	0.79	21804548
HLA-DOA	Asthma	4E-9	   1.13	[1.09-1.18] 	rs9500927	T	0.26	21804548
LOC338591	Asthma	2E-15	   1.16	[1.12-1.21] 	rs10508372	C	0.433	21804548
CDK2	Asthma	1E-10	   1.15	[1.10-1.20] 	rs2069408	C	0.23	21804548
IKZF4	Asthma	2E-13	   1.19	[1.14-1.25] 	rs1701704	G	0.18	21804548
POU5F1	Stevens-Johnson syndrome and toxic epidermal necrolysis (SJS-TEN)	2E-8	   1.74	[1.43-2.13] 	rs3130501	G	0.74	21801394
HCP5	Stevens-Johnson syndrome and toxic epidermal necrolysis (SJS-TEN)	2E-9	   1.73	[1.44-2.08] 	rs9469003	C	0.15	21801394
C11orf10	Phospholipid levels (plasma)	7E-64	    .02	[NR] % dcrease	rs102275	T	NR	21829377
C11orf9	Phospholipid levels (plasma)	1E-63	    .02	[NR] % decrease	rs174536	A	NR	21829377
DAGLA	Phospholipid levels (plasma)	1E-8	    .01	[NR] % decrease	rs1692120	A	NR	21829377
FADS1	Phospholipid levels (plasma)	3E-64	    .02	[NR] % decrease	rs174547	T	NR	21829377
FADS2	Phospholipid levels (plasma)	3E-63	    .02	[NR] % decrease	rs1535	A	NR	21829377
FADS3	Phospholipid levels (plasma)	4E-25	    .01	[NR] % decrease	rs174448	A	NR	21829377
FEN1	Phospholipid levels (plasma)	9E-60	    .02	[NR] % increase	rs4246215	T	NR	21829377
RAB3IL1	Phospholipid levels (plasma)	1E-12	    .01	[NR] % decrease	rs174468	A	NR	21829377
C11orf10	Phospholipid levels (plasma)	5E-58	    .08	[NR] % decrease	rs174538	A	NR	21829377
C11orf9	Phospholipid levels (plasma)	6E-58	    .08	[NR] % increase	rs174535	T	NR	21829377
FADS1	Phospholipid levels (plasma)	1E-57	    .08	[NR] % increase	rs174550	T	NR	21829377
FADS2	Phospholipid levels (plasma)	4E-55	    .08	[NR] % decrease	rs174574	A	NR	21829377
FEN1	Phospholipid levels (plasma)	6E-55	    .08	[NR] % decrease	rs4246215	T	NR	21829377
FADS3	Phospholipid levels (plasma)	7E-28	    .05	[NR] % increase	rs174448	A	NR	21829377
RAB3IL1	Phospholipid levels (plasma)	2E-17	    .05	[NR] % increase	rs174468	A	NR	21829377
ELOVL2	Phospholipid levels (plasma)	2E-12	    .04	[NR] % increase	rs3798713	C	NR	21829377
HERV, FRD	Phospholipid levels (plasma)	5E-11	    .04	[NR] % decrease	rs1321535	T	NR	21829377
BEST1	Phospholipid levels (plasma)	5E-9	    .05	[NR] % decrease	rs1109748	A	NR	21829377
FTH1	Phospholipid levels (plasma)	2E-8	    .07	[NR] % increase	rs11230874	T	NR	21829377
SYCP2L	Phospholipid levels (plasma)	3E-8	    .03	[NR] % increase	rs6918936	C	NR	21829377
FADS1	Phospholipid levels (plasma)	4E-154	    .07	[NR] % increase	rs174547	T	NR	21829377
C11orf10	Phospholipid levels (plasma)	8E-153	    .07	[NR] % increase	rs102275	T	NR	21829377
FADS2	Phospholipid levels (plasma)	3E-152	    .07	[NR] % increase	rs1535	A	NR	21829377
C11orf9	Phospholipid levels (plasma)	1E-151	    .07	[NR] % increase	rs174535	T	NR	21829377
FEN1	Phospholipid levels (plasma)	1E-139	    .07	[NR] % decrease	rs4246215	T	NR	21829377
FADS3	Phospholipid levels (plasma)	3E-60	    .05	[NR] % increase	rs174448	A	NR	21829377
ELOVL2	Phospholipid levels (plasma)	1E-43	    .04	[NR] % decrease	rs3734398	T	NR	21829377
HERV, FRD	Phospholipid levels (plasma)	1E-38	    .04	[NR] % decrease	rs1321535	T	NR	21829377
SYCP2L	Phospholipid levels (plasma)	3E-36	    .04	[NR] % increase	rs4713103	T	NR	21829377
RAB3IL1	Phospholipid levels (plasma)	3E-35	    .04	[NR] % increase	rs174468	A	NR	21829377
BEST1	Phospholipid levels (plasma)	2E-9	    .05	[NR] % decrease	rs2521572	T	NR	21829377
DAGLA	Phospholipid levels (plasma)	3E-9	    .02	[NR] % increase	rs198426	T	NR	21829377
GCKR	Phospholipid levels (plasma)	9E-9	    .02	[NR] % increase	rs780094	T	NR	21829377
ELOVL2	Phospholipid levels (plasma)	1E-15	    .11	[NR] % decrease	rs2236212	C	NR	21829377
SYCP2L	Phospholipid levels (plasma)	8E-14	    .11	[NR] % decrease	rs4713103	T	NR	21829377
HERV, FRD	Phospholipid levels (plasma)	5E-13	    .01	[NR] % decrease	rs4711171	T	NR	21829377
MCPH1	Epirubicin-induced leukopenia 	2E-9	   2.74	[1.96-3.83] 	rs2916733	C	0.39	21799462
KCNQ1	Type 2 diabetes	2E-17	   1.28	[NR] 	rs163182	C	0.34	21799836
SLC30A8	Asthma	5E-13	   1.34	[1.24-1.45] 	rs3019885	G	0.31	21814517
HLA, DPB1	Asthma	2E-10	   1.40	[1.26-1.55] 	rs987870	C	0.14	21814517
CDH13	Adiponectin levels	6E-17	    .35	[0.24-0.46] ug/mL increase	rs4783244	T	0.30	21771975
Intergenic	Urate levels	1E-9	    .14	[NR] mg/dl increase	rs9321453	T	0.42	21768215
SLC22A12	Urate levels	3E-16	   1.19	[NR] mg/dl decrease	rs12800450	T	0.01	21768215
MEN1,SF1,MAP4K2,PYGM,RASGRP2,CDC42BPG,NRXN2	Urate levels	6E-11	    .18	[NR] mg/dl decrease	rs606458	T	0.35	21768215
MAP4K2	Urate levels	2E-17	    .80	[NR] mg/dl decrease	rs493573	A	0.03	21768215
MGC45491, MRPL14	Vascular endothelial growth factor levels	1E-584	NR	NR	rs4513773	G	0.47	21757650
ZFPM2, LRP12	Vascular endothelial growth factor levels	5E-23	NR	NR	rs6993770	T	0.32	21757650
KCNV2, VLDLR	Vascular endothelial growth factor levels	1E-39	NR	NR	rs10738760	A	0.49	21757650
MGC45491, VEGF	Vascular endothelial growth factor levels	2E-26	NR	NR	rs9472155	T	0.22	21757650
FGG	Fibrinogen	1E-109	    .29	[0.26-0.32] g/L decrease	rs7681423	T	0.23	21757653
FGA	Fibrinogen	9E-90	    .26	[0.23-0.29] g/L decrease	rs6050	C	0.24	21757653
FGB	Fibrinogen	1E-39	    .19	[0.16-0.22] g/L decrease	rs1800788	T	0.20	21757653
PLRG1	Fibrinogen	2E-36	    .18	[0.15-0.21] g/L decrease	rs12511469	A	0.19	21757653
DCHS2	Fibrinogen	2E-12	    .14	[0.10-0.18] g/L decrease	rs12651106	A	0.17	21757653
MEIS1	Restless legs syndrome	3E-49	   1.68	[1.57-1.81] 	rs2300478	G	0.24	21779176
BTBD9	Restless legs syndrome	8E-22	   1.47	[1.35-1.47] 	rs9357271	T	0.76	21779176
PTPRD	Restless legs syndrome	3E-10	   1.29	[1.19-1.40] 	rs1975197	A	0.16	21779176
MAP2K5, SKOR1	Restless legs syndrome	1E-22	   1.41	[1.32-1.52] 	rs12593813	G	0.68	21779176
Intergenic	Restless legs syndrome	9E-11	   1.23	[1.16-1.31] 	rs6747972	A	0.44	21779176
TOX3, BC034767	Restless legs syndrome	9E-19	   1.35	[1.27-1.43] 	rs3104767	G	0.58	21779176
HLA-DPA1	Hepatitis B	2E-61	   1.87	[1.73-2.01] 	rs3077	G	0.60	21750111
HLA-DPB1	Hepatitis B	3E-54	   1.77	[1.65-1.91] 	rs9277535	G	0.57	21750111
HLA-DQB1	Hepatitis B	4E-37	   1.56	[1.45-1.67] 	rs2856718	A	0.48	21750111
HAL-DQB2	Hepatitis B	6E-28	   1.81	[1.62-2.01] 	rs7453920	G	0.83	21750111
SLC14A1	Bladder cancer	8E-11	   1.17	[1.11-1.22] 	rs17674580	T	0.33	21750109
IL23R	Ankylosing spondylitis	2E-17	NR	NR	rs11209026	G	0.93	21743469
KIF21B	Ankylosing spondylitis	5E-12	NR	NR	rs2297909	G	0.68	21743469
Intergenic	Ankylosing spondylitis	7E-34	NR	NR	rs10865331	A	0.37	21743469
ERAP1	Ankylosing spondylitis	2E-27	NR	NR	rs30187	T	0.33	21743469
HLA-B	Ankylosing spondylitis	1E-200	NR	NR	rs4349859	A	0.04	21743469
Intergenic	Ankylosing spondylitis	2E-11	NR	NR	rs378108	G	0.48	21743469
RUNX3	Ankylosing spondylitis	9E-11	NR	NR	rs11249215	A	0.47	21743469
IL12B	Ankylosing spondylitis	2E-8	NR	NR	rs6556416	C	0.67	21743469
LTBR-TNFRSF1A	Ankylosing spondylitis	4E-12	NR	NR	rs11616188	A	0.43	21743469
TBKBP1	Ankylosing spondylitis	5E-8	NR	NR	rs8070463	C	0.51	21743469
GGCX, VAMP8, VAMP5, RNF181	Prostate cancer	3E-15	   1.09	[1.06-1.12] 	rs10187424	A	0.59	21743467
Intergenic	Prostate cancer	3E-9	   1.06	[1.02-1.09] 	rs7584330	C	0.22	21743467
ZBTB38	Prostate cancer	2E-8	   1.04	[1.01-1.07] 	rs6763931	T	0.45	21743467
CLDN11, SKIL	Prostate cancer	7E-22	   1.11	[1.08-1.14] 	rs10936632	A	0.52	21743467
TERT	Prostate cancer	3E-24	   1.15	[1.11-1.19] 	rs2242652	G	0.81	21743467
FGF10	Prostate cancer	4E-8	   1.05	[1.02-1.08] 	rs2121875	G	0.34	21743467
CCHCR1	Prostate cancer	3E-8	   1.05	[1.02-1.09] 	rs130067	G	0.21	21743467
PRPH	Prostate cancer	7E-12	   1.07	[1.04-1.10] 	rs10875943	C	0.31	21743467
AR	Prostate cancer	1E-8	   1.06	[1.02-1.12] 	rs5919432	A	0.81	21743467
MLPH	Prostate cancer	4E-8	   1.14	[1.09-1.19] 	rs2292884	G	0.25	21743057
KRT8, EIF4B, TENC1	Prostate cancer	5E-9	   1.17	[1.11-1.24] 	rs902774	A	0.17	21743057
SLC22A1	Prostate cancer	2E-10	   1.15	[1.10-1.20] 	rs651164	G	NR	21743057
Intergenic	Prostate cancer	3E-16	   1.56	[1.40-1.73] 	rs4242384	C	NR	21743057
Intergenic	Prostate cancer	9E-9	   1.31	[1.20-1.44] 	rs7130881	G	NR	21743057
Intergenic	Prostate cancer	3E-11	   1.27	[1.18-1.37] 	rs1859962	G	NR	21743057
Intergenic	Prostate cancer	4E-10	   1.31	[1.20-1.42] 	rs1016343	T	NR	21743057
PSORS1C1	Systemic sclerosis	6E-10	   1.25	[1.17-1.35] 	rs3130573	G	0.32	21750679
HLA, DQB1	Systemic sclerosis	2E-37	   1.61	[1.49-1.72] 	rs6457617	T	0.50	21750679
TNIP1	Systemic sclerosis	5E-9	   1.31	[1.15-1.43] 	rs2233287	A	0.10	21750679
STAT4	Systemic sclerosis	2E-13	   1.38	[1.27-1.50] 	rs7574865	T	0.22	21750679
RP11415K20.1, WNT4	Dupuytren's disease	3E-9	   1.28	[1.17-1.41] 	rs7524102	G	0.21	21732829
EPDR1, SFRP4	Dupuytren's disease	6E-39	   1.98	[1.78-2.18] 	rs16879765	A	0.19	21732829
DUXA, ZNF264	Dupuytren's disease	7E-14	   1.34	[1.25-1.45] 	rs11672517	A	0.28	21732829
AL049691.1, MAFB	Dupuytren's disease	8E-10	   1.48	[1.30-1.68] 	rs8124695	A	0.10	21732829
RP11398F12.1, WNT7B	Dupuytren's disease	3E-33	   1.54	[1.44-1.65] 	rs6519955	A	0.47	21732829
BUD13, ZNF259, APOA5	Vitamin E levels	8E-12	    .04	[0.02-0.06] unit increase	rs964184	G	0.15	21729881
CYP4F2	Vitamin E levels	1E-10	    .03	[0.01-0.05] unit increase	rs2108622	T	0.21	21729881
SCARB1	Vitamin E levels	8E-9	    .03	[0.01-0.05] unit increase	rs11057830	A	0.15	21729881
TP63	Lung cancer	7E-26	   1.26	[1.21-1.32] 	rs4488809	C	0.47	21725308
TERT	Lung cancer	1E-27	   1.27	[1.22-1.33] 	rs2736100	C	0.41	21725308
MIPEP	Lung cancer	2E-12	   1.18	[1.13-1.24] 	rs753955	G	0.29	21725308
MTMR3	Lung cancer	6E-13	   1.29	[1.20-1.38] 	rs36600	A	0.09	21725308
DEPDC5	Chronic Hepatitis C infection	1E-13	   1.75	[1.51-2.03] 	rs1012068	G	0.12	21725309
LOC90246,C3orf27,RPN1	White blood cell count	4E-13	    .01	[0.0073-0.0127] unit increase	rs4328821	A	NR	21738480
PSORS1C3,HCG27,HLA-C, HLA-B	White blood cell count	1E-11	    .01	[0.010-0.019] unit increase	rs2524079	A	NR	21738480
C19orf44,EPS15L1,CALR3	White blood cell count	3E-12	    .02	[0.011-0.020] unit increase	rs10411936	A	NR	21738480
ITGA4,CERKL	White blood cell count	3E-23	    .04	[0.029-0.044] unit increase	rs1449263	T	NR	21738480
GATA2,LOC90246,C3orf27,RPN1	White blood cell count	6E-13	    .03	[0.020-0.036] unit decrease	rs9880192	C	NR	21738480
MLZE,FAM49B	White blood cell count	3E-20	    .03	[0.027-0.041] unit decrease	rs10098310	A	NR	21738480
EDG2,OR2K2	White blood cell count	2E-22	    .04	[0.034-0.050] unit decrease	rs10980800	T	NR	21738480
GSDMB,ORMDL3,GSDMA,PSMD3,CSF3,MED24,SNORD124,THRA,NR1D1	White blood cell count	2E-31	    .04	[0.034-0.048] unit decrease	rs8078723	T	NR	21738480
MUC21,HCG22,C6orf15,CDSN,PSORS1C1,PSORS1C2,CCHCR1	White blood cell count	4E-13	    .01	[0.0094-0.0164] unit decrease	rs2517510	T	NR	21738480
CSF3, PSMD3, GSDM1, MED24, GSDMB, ORMDL3, GSDMA, SNORD124, THRA, NR1D1	White blood cell count	9E-35	    .02	[0.018-0.025] unit increase	rs4794822	T	NR	21738480
BAZ2B	Sudden cardiac arrest	2E-10	   1.92	[1.57-2.34] 	rs4665058	A	0.014	21738491
CDK6	White blood cell types	7E-10	    .08	[0.06-0.10] unit increase	rs445	C	0.69	21738478
PSMD3, CSF3	White blood cell types	4E-16	    .09	[0.07-0.11] unit increase	rs4794822	T	0.52	21738478
ITGA4	White blood cell types	2E-14	    .11	[0.08-0.14] unit increase	rs12988934	T	0.27	21738478
MHC	White blood cell types	6E-11	    .07	[0.05-0.09] unit increase	rs3095254	C	0.46	21738478
MLZE	White blood cell types	2E-10	    .07	[0.05-0.09] unit increase	rs10956483	C	0.44	21738478
STXBP6	White blood cell types	1E-8	    .06	[0.04-0.08] unit increase	rs10147992	G	0.47	21738478
SLC45A3, NUKS1	White blood cell types	4E-8	    .06	[0.04-0.08] unit increase	rs12748961	T	0.51	21738478
GATA2	White blood cell types	5E-40	    .16	[0.14-0.18] unit increase	rs4328821	A	0.66	21738478
NAALAD2	White blood cell types	2E-9	    .08	[0.05-0.11] unit increase	rs11018874	G	0.69	21738478
ERG	White blood cell types	2E-18	    .20	[0.16-0.24] unit increase	rs7275212	T	0.08	21738478
GATA2	White blood cell types	3E-17	    .10	[0.08-0.12] unit increase	rs4328821	A	0.66	21738478
MHC	White blood cell types	2E-12	    .11	[0.08-0.14] unit increase	rs2516399	A	0.81	21738478
HBS1L, MYB	White blood cell types	1E-10	    .08	[0.06-0.10] unit increase	rs9373124	T	0.65	21738478
KCNMA1	Obesity	3E-10	   1.26	[1.12-1.41] 	rs2116830	G	0.80	21708048
BDNF	Obesity	5E-17	   1.36	[1.20-1.55] 	rs988712	G	0.75	21708048
IRS1	Adiposity	4E-11	    .03	[NR] % decrease	rs2943650	T	0.64	21706003
FTO	Adiposity	3E-26	    .06	[NR] % decrease	rs8050136	C	0.60	21706003
LRRK2	Parkinson's disease	2E-28	   9.62	[6.43-14.37] 	rs34637584	A	0.002	21738487
GBA	Parkinson's disease	5E-21	   4.05	[3.08-5.32] 	i4000416	C	0.005	21738487
SNCA	Parkinson's disease	2E-19	   1.29	[1.22-1.36] 	rs356220	T	0.375	21738487
MAPT	Parkinson's disease	3E-14	   1.30	[1.22-1.39] 	rs12185268	A	0.79	21738487
MCCC1, LAMP3	Parkinson's disease	3E-10	   1.25	[1.16-1.33] 	rs10513789	T	0.80	21738487
SCARB2	Parkinson's disease	8E-10	   1.19	[1.12-1.27] 	rs6812193	C	0.64	21738487
GAK	Parkinson's disease	4E-8	   1.31	[1.19-1.44] 	rs6599389	A	0.075	21738487
UBAC2	Basal cell carcinoma 	3E-8	   1.26	[1.18-1.34] 	rs7335046	G	0.12	21700618
MC1R	Basal cell carcinoma 	4E-17	   1.55	[1.45-1.66] 	rs1805007	T	0.07	21700618
EXOC2	Basal cell carcinoma 	1E-9	   1.24	[1.17-1.31] 	rs12210050	T	0.17	21700618
FER	Adiponectin levels	5E-8	NR	NR	rs10447248	A	0.34	21700879
ADIPOQ	Adiponectin levels	4E-8	NR	NR	rs822354	A	0.68	21700879
CR1	Erythrocyte sedimentation rate	2E-28	    .13	[NR] unit decrease	rs12034383	G	0.41	21700265
MHC	Inflammatory bowel disease	2E-70	   4.44	[3.74-5.27] 	rs9271366	C	0.21	21699788
MHC	Inflammatory bowel disease	3E-31	   2.41	[2.07-2.81] 	rs9271366	C	0.21	21699788
MHC	Inflammatory bowel disease	8E-11	   1.79	[1.49-2.13] 	rs9271366	T	0.79	21699788
TNFSF15	Inflammatory bowel disease	4E-13	   1.67	[1.47-1.92] 	rs2006996	T	0.47	21699788
TNFSF15	Inflammatory bowel disease	4E-16	   1.75	[1.53-1.99] 	rs2006996	C	0.53	21699788
TRIM65	White matter hyperintensity burden	4E-15	NR	NR	rs3744028	C	0.18	21681796
TRIM47	White matter hyperintensity burden	3E-11	NR	NR	rs1055129	G	0.30	21681796
HLA-DRA	Rheumatoid arthritis	5E-109	   2.40	[2.20-2.60] 	rs9268853	C	NR	21653640
FLG	Atopic dermatitis	6E-12	   1.22	[NR] 	rs3126085	A	0.58	21666691
PRDM16	Migraine	4E-9	   1.11	[1.07-1.15] 	rs2651899	C	0.43	21666692
TRPM8	Migraine	6E-12	   1.18	[1.12-1.22] 	rs10166942	T	0.81	21666692
LRP1	Migraine	4E-9	   1.11	[1.08-1.15] 	rs11172113	T	0.59	21666692
FRAP1	Corneal curvature	4E-13	    .18	[0.11-0.25] unit increase	rs17036350	T	0.20	21665993
PDGFRA	Corneal curvature	1E-9	    .13	[0.07-0.19] unit decrease	rs2114039	C	0.30	21665993
PGM1	Alcohol consumption (transferrin glycosylation)	2E-9	    .12	[0.08-0.16] unit decrease	rs2749097	G	0.19	21665994
TF	Alcohol consumption (transferrin glycosylation)	5E-43	    .29	[0.25-0.33] unit decrease	rs1049296	T	0.17	21665994
TF	Alcohol consumption (transferrin glycosylation)	1E-9	    .40	[0.27-0.53] unit decrease	rs1799899	A	0.06	21665994
SRPRB	Alcohol consumption (transferrin glycosylation)	2E-17	    .29	[0.22-0.36] unit decrease	rs1534166	A	0.30	21665994
TF	Alcohol consumption (transferrin glycosylation)	1E-35	    .36	[0.30-0.42] unit increase	rs3811647	A	0.32	21665994
HFE	Alcohol consumption (transferrin glycosylation)	2E-32	    .63	[0.53-0.73] unit decrease	rs1800562	A	0.045	21665994
VEGFA	Age-related macular degeneration	9E-9	   1.15	[NR] 	rs4711751	T	0.50	21665990
HTRA1	Age-related macular degeneration	4E-322	   2.94	[NR] 	rs10490924	T	0.21	21665990
CFH	Age-related macular degeneration	1E-261	   2.41	[NR] 	rs1061170	C	0.37	21665990
C3	Age-related macular degeneration	5E-29	   1.53	[NR] 	rs2230199	C	0.19	21665990
CFI	Age-related macular degeneration	4E-10	   1.18	[NR] 	rs10033900	T	0.46	21665990
CETP	Age-related macular degeneration	7E-9	   1.15	[NR] 	rs3764261	A	0.33	21665990
DDRGK1	Response to hepatitis C treatment	5E-17	   4.50	[3.10-6.50] 	rs11697186	T	0.15	21659334
ITPA	Response to hepatitis C treatment	1E-15	   3.90	[2.80-5.50] 	rs6139030	C	0.17	21659334
DDRGK1	Response to hepatitis C treatment	9E-25	  33.33	[12.50-100] 	rs11697186	A	0.85	21659334
ITPA	Response to hepatitis C treatment	2E-25	  25.00	[11.11-50.0] 	rs6139030	T	0.83	21659334
CRP	C-reactive protein	1E-9	    .29	[0.20-0.38] unit increase	rs876537	C	0.43	21647738
HNF1A	C-reactive protein	1E-8	    .27	[0.18-0.36] unit increase	rs7305618	T	0.52	21647738
RPL6	Esophageal cancer	2E-15	   1.30	[1.22-1.38] 	rs11066280	A	0.21	21642993
C12orf51	Esophageal cancer	2E-31	   1.56	[1.45-1.68] 	rs2074356	T	0.13	21642993
CSNK1A1	Esophageal cancer	5E-9	   2.04	[1.61-2.56] 	rs10058728	T	0.98	21642993
ANP32A	Esophageal cancer	1E-11	   1.56	[1.37-1.78] 	rs8030672	A	0.03	21642993
PLCE1	Esophageal cancer	4E-20	   1.34	[1.26-1.42] 	rs2274223	G	0.21	21642993
PDE4D	Esophageal cancer	2E-19	   1.49	[1.37-1.61] 	rs10052657	C	0.78	21642993
ACAD10	Esophageal cancer	7E-21	   1.38	[1.29-1.48] 	rs11066015	A	0.19	21642993
RUNX1	Esophageal cancer	8E-22	   1.43	[1.33-1.54] 	rs2014300	G	0.83	21642993
UNC5CL	Esophageal cancer	7E-12	   1.33	[1.23-1.45] 	rs10484761	G	0.09	21642993
MIPEP, C1QTNF9B-AS1, C1QTNF9B	Myopia (pathological)	2E-16	   1.32	[1.19-1.46] 	rs9318086	A	0.44	21640322
CSF1, EPS8LS	Paget's disease	7E-35	   1.72	[1.57-1.87] 	rs10494112	G	0.20	21623375
NUP205	Paget's disease	8E-10	   1.45	[1.29-1.63] 	rs4294134	G	0.84	21623375
TM7SF4	Paget's disease	7E-17	   1.40	[1.29-1.51] 	rs2458413	A	0.58	21623375
OPTN	Paget's disease	4E-38	   1.67	[1.54-1.80] 	rs1561570	T	0.53	21623375
RIN3	Paget's disease	3E-11	   1.44	[1.29-1.60] 	rs10498635	C	0.82	21623375
PML	Paget's disease	2E-14	   1.34	[1.25-1.45] 	rs5742915	C	0.45	21623375
TNFRSF11A	Paget's disease	8E-21	   1.45	[1.34-1.56] 	rs3018362	A	0.36	21623375
Intergenic	Coronary heart disease	4E-14	NR	NR	rs11924705, rs6789378	S	(CA)	21626137
STK32B	Coronary heart disease	2E-11	NR	NR	rs7697839, rs7673097	S	(GG)	21626137
CDKN2B, CDKN2A	Coronary heart disease	7E-14	NR	NR	rs1333048, rs1333049	S	(GG)	21626137
HSP90B1	Coronary heart disease	3E-9	NR	NR	rs1165668, rs1165669	S	(GC)	21626137
Intergenic	Hypertension	2E-9	NR	NR	rs10496288, rs10496289	S	(GC)	21626137
GPR39	Hypertension	1E-10	NR	NR	rs13420028, rs10188442	S	(AA)	21626137
RANBP3L	Hypertension	5E-13	NR	NR	rs7735940, rs12522034	S	(AC)	21626137
MYO6	Hypertension	3E-10	NR	NR	rs3798440, rs9350602	S	(AC)	21626137
NOV	Hypertension	3E-16	NR	NR	rs2469997, rs6469823	S	(GC)	21626137
ZFAT	Hypertension	2E-44	NR	NR	rs7827545, rs1372662	S	(CG)	21626137
MACROD2	Hypertension	7E-9	NR	NR	rs200752, rs200759	S	(TA)	21626137
Intergenic	Coronary heart disease	7E-58	   1.27	[1.23-1.31] 	rs1333049	C	0.49	21606135
MTAP	Coronary heart disease	2E-27	   1.18	[1.14-1.21] 	rs7865618	A	0.59	21606135
LIPA	Coronary heart disease	4E-8	   1.10	[1.07-1.14] 	rs1412444	T	0.32	21606135
APIP, EHF	Cystic fibrosis severity	1E-9	NR	NR	rs12793173	C	0.24	21602797
FIGN, GRB14	Blood pressure	4E-11	    .75	[0.53-0.97] mm Hg increase	rs16849225	C	0.61	21572416
NPR3	Blood pressure	2E-8	    .63	[0.41-0.85] mm Hg increase	rs1173766	C	0.60	21572416
RPL6, PTPN11, ALDH2	Blood pressure	8E-31	   1.56	[1.31-1.81] mm Hg increase	rs11066280	T	0.75	21572416
ATP2B1	Blood pressure	8E-20	   1.17	[0.92-1.42] mm Hg increase	rs17249754	G	0.64	21572416
ST7L, CAPZA1	Blood pressure	1E-8	    .38	[0.24-0.52] mm Hg increase	rs17030613	C	0.49	21572416
ENPEP	Blood pressure	9E-9	    .39	[0.25-0.53] mm Hg increase	rs6825911	C	0.51	21572416
RPL6, PTPN11, ALDH2	Blood pressure	1E-35	   1.01	[0.85-1.17] mm Hg increase	rs11066280	T	0.75	21572416
TBX3	Blood pressure	1E-10	    .50	[0.34-0.66] mm Hg increase	rs35444	A	0.75	21572416
ATP2B1	Blood pressure	2E-13	    .58	[0.42-0.74] mm Hg increase	rs17249754	G	0.64	21572416
CNNM2, NT5C2, CYP17A1	Blood pressure	4E-17	   1.18	[0.91-1.45] mm Hg increase	rs11191548	T	0.74	21572416
CASZ1	Blood pressure	3E-10	    .56	[0.38-0.74] mm Hg increase	rs880315	C	0.65	21572416
CNNM2, NT5C2, CYP17A1	Blood pressure	7E-12	    .58	[0.42-0.74] mm Hg increase	rs11191548	T	0.74	21572416
CDKN2A, CDKN2B	Type 2 diabetes	6E-10	   1.22	[1.15-1.30] 	rs1333051	A	NR	21573907
HNF1A	Type 2 diabetes	2E-8	   1.14	[1.09-1.20] 	rs7305618	C	NR	21573907
AGXT2	Urinary metabolites	2E-182	NR	NR	rs37369	T	0.092	21572414
NAT2	Urinary metabolites	1E-28	NR	NR	rs4921914	C	0.23	21572414
WDR66, HPD	Urinary metabolites	1E-46	NR	NR	rs830124	A	0.152	21572414
SLC7A9	Urinary metabolites	6E-27	NR	NR	rs8101881	C	0.35	21572414
SLC6A20	Urinary metabolites	3E-19	NR	NR	rs17279437	A	0.115	21572414
CAPZB	Thyroid volume	3E-18	    .10	[0.08-0.12] unit decrease	rs12138950	A	0.847	21565293
C15orf33, FGF7	Thyroid volume	1E-12	    .07	[0.05-0.09] unit decrease	rs4338740	T	0.738	21565293
MAF	Thyroid volume	9E-15	    .07	[0.05-0.09] unit increase	rs17767419	T	0.321	21565293
CAPZB	Thyroid volume	1E-14	   1.52	[1.37-1.69] 	rs10917468	C	0.217	21565293
C15orf33, FGF7	Thyroid volume	3E-13	   1.45	[1.32-1.59] 	rs4338740	C	0.261	21565293
MAF	Thyroid volume	4E-10	   1.32	[1.21-1.44] 	rs3813579	A	0.518	21565293
CAPZB	Thyroid volume	3E-14	    .07	[0.05-0.09] unit increase	rs12045440	T	0.664	21565293
CAPZB	Thyroid volume	2E-11	   1.38	[1.26-1.51] 	rs12045440	T	0.664	21565293
TERC	Telomere length	2E-14	    .03	[0.02-0.04] unit decrease	rs12696304	G	0.27	21573004
DMRT1	Testicular cancer	1E-11	   1.70	[1.46-1.99] 	rs7040024	A	NR	21551455
DMRT1	Testicular cancer	9E-10	   1.50	[1.32-1.71] 	rs755383	T	NR	21551455
WSB1, FAM27L	Chronic myeloid leukemia	1E-12	   1.85	[1.56-2.17] 	rs4795519	C	0.48	21540461
TMCO1	Glaucoma	6E-14	   1.51	[1.35-1.68] 	rs4656461	G	0.12	21532571
CDKN2B-AS1	Glaucoma	1E-14	   1.39	[1.28-1.51] 	rs4977756	A	0.60	21532571
SLC6A15	Major depressive disorder	1E-9	   1.40	[1.254-1.557] 	rs1545843	A	NR	21521612
GALNT3	Bone mineral density	5E-10	    .06	[NR] unit decrease	rs6710518	T	NR	21533022
RSPO3	Bone mineral density	3E-8	    .07	[NR] unit decrease	rs13204965	C	NR	21533022
MEF2C	Bone mineral density	8E-10	    .14	[NR] unit increase	rs1366594	C	NR	21533022
ABO	Soluble ICAM-1	3E-91	  17.30	[NR] ng/mL decrease	rs507666	A	0.20	21533024
ICAM1	Soluble ICAM-1	1E-120	  24.90	[NR] ng/mL decrease	rs1799969	A	0.11	21533024
ICAM1	Soluble ICAM-1	6E-89	  13.80	[NR] ng/mL increase	rs5498	G	0.43	21533024
HLA-DQB1	Follicular lymphoma	2E-21	   1.56	[1.43-1.72] 	rs2647012	G	0.56	21533074
F5	D-dimer levels	2E-14	  10.10	[2.7-17.9] % increase	rs6687813	A	0.06	21502573
F3	D-dimer levels	6E-52	  10.40	[6.6-14.3] % increase	rs12029080	G	0.31	21502573
FGA, FGG	D-dimer levels	3E-18	   6.30	[2.3-10.4] % increase	rs13109457	A	0.25	21502573
AIRE, PFKL	Rheumatoid arthritis	4E-9	   1.18	[1.11-1.24] 	rs2075876	A	0.34	21505073
HLA-DQA1, HLA-DRB1	Response to interferon beta therapy	4E-10	    .26	[NR] unit increase	rs9272105	A	0.44	21502966
DENND3, PTK2	Response to interferon beta therapy	3E-8	    .23	[NR] unit increase	rs4961252	G	0.40	21502966
HLA-DQ, HLA-DR	Hepatocellular carcinoma	6E-9	   1.30	[1.19-1.42] 	rs9275572	A	0.36	21499248
MICA	Hepatocellular carcinoma	4E-13	   1.39	[1.27-1.52] 	rs2596542	A	0.33	21499248
HNF1B	Endometrial cancer	7E-10	   1.19	[1.12-1.27] 	rs4430796	A	0.52	21499250
ZKSCAN5	Dehydroepiandrosterone sulphate levels	3E-36	    .16	[0.14-0.18] umol/L decrease	rs11761528	T	0.08	21533175
SULT2A1	Dehydroepiandrosterone sulphate levels	3E-19	    .09	[0.07-0.11] umol/L decrease	rs2637125	A	0.15	21533175
BMF	Dehydroepiandrosterone sulphate levels	5E-11	    .05	 [0.03-0.07 u mol/L increase	rs7181230	G	0.33	21533175
HHEX	Dehydroepiandrosterone sulphate levels	5E-9	    .04	[0.02-0.06] umol/L decrease	rs2497306	C	0.49	21533175
CYP2C9	Dehydroepiandrosterone sulphate levels	2E-8	    .06	[0.04-0.08] u mol/L decrease	rs2185570	C	0.13	21533175
TRIM4, CYP3A43	Dehydroepiandrosterone sulphate levels	2E-11	    .11	[0.07-0.15] umol/L decrease	rs17277546	A	0.05	21533175
BCL2L11	Dehydroepiandrosterone sulphate levels	2E-8	    .04	[0.02-0.06] umol/L decrease	rs6738028	G	0.40	21533175
ARPC1A	Dehydroepiandrosterone sulphate levels	2E-16	    .15	[0.11-0.19] umol/L increase	rs740160	T	0.05	21533175
DISC1	Neuranatomic and neurocognitive phenotypes	4E-36	NR	NR	rs12042938	C	0.48	21483430
AHR	Caffeine consumption	2E-19	    .15	[0.11-0.19] mg/day decrease	rs4410790	T	0.38	21490707
LMAN1L, EDC3, CYP1A2, CYP1A1, CSK	Caffeine consumption	5E-14	    .12	[0.08-0.16] mg/day increase	rs2470893	T	0.31	21490707
C6orf57	Type 2 diabetes	3E-8	   1.54	[1.32-1.80] 	rs1048886	G	0.18	21490949
AUTS2	Alcohol consumption	4E-8	    .01	[-0.003-0.028] unit decrease	rs6943555	A	0.24	21471458
SLK, OBFC1	Uterine fibroids	9E-14	   1.47	[1.23-1.75] 	rs7913069	A	0.07	21460842
TNRC6B	Uterine fibroids	3E-12	   1.23	[1.11-1.37] 	rs12484776	G	0.36	21460842
ODF3, BET1L, RIC8A, SIRT3	Uterine fibroids	4E-12	   1.39	[1.17-1.64] 	rs2280543	G	0.88	21460842
CD2AP	Alzheimer's disease (late onset)	9E-9	   1.11	[1.07-1.15] 	rs9349407	C	0.27	21460841
CR1	Alzheimer's disease (late onset)	5E-10	   1.16	[1.11-1.22] 	rs6701713	A	0.20	21460841
BIN1	Alzheimer's disease (late onset)	4E-14	   1.17	[1.13-1.22] 	rs7561528	A	0.35	21460841
TF	Iron status biomarkers	5E-10	  21.49	[NR] ug/dL increase	rs3811647	A	NR	21483845
HFE	Iron status biomarkers	3E-8	  35.36	[NR] ug/dL decrease	rs1800562	A	NR	21483845
HFE	Iron status biomarkers	6E-10	  44.27	[NR] ug/dL decrease	rs1800562	A	NR	21483845
Intergenic	Suicide attempts in bipolar disorder	5E-8	   1.22	[NR] 	rs300774	A	0.18	21423239
ADH1B	Upper aerodigestive tract cancers	1E-20	   1.56	[1.41-1.69] 	rs1229984	T	0.94	21437268
ADH7	Upper aerodigestive tract cancers	9E-17	   1.33	[1.25-1.43] 	rs971074	G	NR	21437268
HEL308, ADH, FAM175A	Upper aerodigestive tract cancers	1E-8	   1.12	[1.08-1.17] 	rs1494961	C	0.49	21437268
ALDH2	Upper aerodigestive tract cancers	2E-8	   1.13	[1.08-1.18] 	rs4767364	A	0.29	21437268
DENND1B	Primary biliary cirrhosis	2E-14	   1.34	[1.25-1.45] 	rs12134279	T	0.20	21399635
STAT4	Primary biliary cirrhosis	2E-19	   1.50	[1.37-1.64] 	rs10931468	A	0.12	21399635
CD80	Primary biliary cirrhosis	3E-11	   1.35	[1.23-1.47] 	rs2293370	G	0.80	21399635
NFKB1	Primary biliary cirrhosis	4E-12	   1.26	[1.18-1.34] 	rs7665090	C	0.52	21399635
IL7R	Primary biliary cirrhosis	1E-11	   1.30	[1.21-1.40] 	rs860413	A	0.72	21399635
Intergenic	Primary biliary cirrhosis	4E-8	   1.25	[1.16-1.36] 	rs6974491	A	0.17	21399635
CXCR5	Primary biliary cirrhosis	3E-12	   1.37	[1.25-1.50] 	rs6421571	C	0.81	21399635
TNFRSF1A	Primary biliary cirrhosis	2E-9	   1.22	[1.14-1.30] 	rs1800693	C	0.40	21399635
RAD51L1	Primary biliary cirrhosis	2E-11	   1.29	[1.20-1.39] 	rs911263	T	0.71	21399635
CLEC16A	Primary biliary cirrhosis	3E-12	   1.29	[1.20-1.38] 	rs12924729	G	0.68	21399635
Intergenic	Primary biliary cirrhosis	5E-11	   1.31	[1.21-1.43] 	rs11117432	G	0.76	21399635
MAP3K7IP1	Primary biliary cirrhosis	1E-9	   1.27	[1.18-1.38] 	rs968451	T	0.19	21399635
IL12RB2	Primary biliary cirrhosis	9E-20	   1.52	[1.39-1.67] 	rs17129789	C	0.18	21399635
IL12A	Primary biliary cirrhosis	2E-16	   1.38	[1.28-1.50] 	rs485499	T	0.57	21399635
MHC	Primary biliary cirrhosis	4E-34	   1.60	[1.48-1.73] 	rs7774434	C	0.38	21399635
IRF5	Primary biliary cirrhosis	9E-17	   1.58	[1.41-1.76] 	rs12531711	G	0.11	21399635
SPIB	Primary biliary cirrhosis	2E-13	   1.38	[1.32-1.44] 	rs3745516	A	0.23	21399635
PLCL2	Primary biliary cirrhosis	2E-8	   1.20	[1.12-1.27] 	rs1372072	A	0.37	21399635
RPS6KA4	Primary biliary cirrhosis	2E-10	   1.23	[1.15-1.31] 	rs538147	G	0.61	21399635
TNFAIP2	Primary biliary cirrhosis	3E-13	   1.22	[1.16-1.27] 	rs8017161	A	0.40	21399635
PNPLA3	Nonalcoholic fatty liver disease	4E-34	    .26	[0.22-0.30] unit increase (GOLD)	rs738409	G	0.23	21423719
LPL	HDL Cholesterol - Triglycerides (HDLC-TG)	1E-16	    .29	[0.23-0.35] unit increase	rs13702	A	NR	21386085
CETP	HDL Cholesterol - Triglycerides (HDLC-TG)	5E-16	    .26	[0.20-0.32] unit increase	rs173539	C	NR	21386085
BUD13	HDL Cholesterol - Triglycerides (HDLC-TG)	3E-15	    .38	[0.28-0.48] unit increase	rs10790162	A	NR	21386085
ZNF259	HDL Cholesterol - Triglycerides (HDLC-TG)	2E-14	    .39	[0.29-0.49] unit increase	rs2075290	C	NR	21386085
APOA5	HDL Cholesterol - Triglycerides (HDLC-TG)	5E-13	    .39	[0.29-0.49] unit increase	rs2266788	C	NR	21386085
TRIB1	HDL Cholesterol - Triglycerides (HDLC-TG)	8E-9	    .16	[0.10-0.22] unit decrease	rs2954026	G	NR	21386085
LOC100129500	HDL Cholesterol - Triglycerides (HDLC-TG)	1E-8	    .24	[0.16-0.32] unit increase	rs439401	C	NR	21386085
LOC100129150	HDL Cholesterol - Triglycerides (HDLC-TG)	1E-8	    .25	[0.17-0.33] unit increase	rs9987289	A	NR	21386085
LPL	Metabolic syndrome	2E-9	    .17	[0.11-0.23] unit increase	rs295	A	NR	21386085
APOA5	Metabolic syndrome	2E-9	    .26	[0.18-0.34] unit increase	rs2266788	C	NR	21386085
ZNF259	Metabolic syndrome	2E-9	    .26	[0.18-0.34] unit increase	rs2075290	C	NR	21386085
BUD13	Metabolic syndrome	5E-9	    .25	[0.17-0.33] unit increase	rs10790162	A	NR	21386085
CETP	Metabolic syndrome	9E-9	    .16	[0.10-0.22] unit increase	rs173539	C	NR	21386085
LOC100128354	Metabolic syndrome (bivariate traits)	8E-9	    .19	[0.13-0.25] unit decrease	rs1387153	C	NR	21386085
CETP	Metabolic syndrome (bivariate traits)	3E-13	    .29	[0.21-0.37] unit increase	rs3764261	G	NR	21386085
LPL	Metabolic syndrome (bivariate traits)	3E-8	    .18	[0.12-0.24] unit decrease	rs1441756	G	NR	21386085
CETP	Metabolic syndrome (bivariate traits)	7E-12	    .31	[0.21-0.41] unit decrease	rs9939224	G	0.46	21386085
LOC100128354	Metabolic syndrome (bivariate traits)	2E-9	    .21	[0.15-0.27] unit decrease	rs1387153	C	NR	21386085
LIPC	Metabolic syndrome (bivariate traits)	1E-8	    .17	[0.11-0.23] unit decrease	rs2043085	A	NR	21386085
CETP	Metabolic syndrome (bivariate traits)	1E-16	    .29	[0.23-0.35] unit increase	rs173539	C	NR	21386085
LPL	Metabolic syndrome (bivariate traits)	3E-11	    .22	[0.16-0.28] unit decrease	rs301	C	NR	21386085
LOC100129150	Metabolic syndrome (bivariate traits)	4E-8	    .24	[0.16-0.32] unit increase	rs9987289	A	NR	21386085
LOC100128354	Metabolic syndrome (bivariate traits)	5E-11	    .20	[0.14-0.26] unit decrease	rs10830956	C	NR	21386085
LPL	Metabolic syndrome (bivariate traits)	2E-9	    .18	[0.12-0.24] unit increase	rs2197089	C	NR	21386085
BUD13	Metabolic syndrome (bivariate traits)	6E-9	    .32	[0.20-0.44] unit increase	rs11820589	A	NR	21386085
ZNF259	Metabolic syndrome (bivariate traits)	1E-8	    .32	[0.20-0.44] unit decrease	rs12286037	C	NR	21386085
LPL	Triglycerides-Blood Pressure (TG-BP)	1E-10	    .27	[0.19-0.35] unit decrease	rs15285	A	NR	21386085
GCKR	Triglycerides-Blood Pressure (TG-BP)	3E-10	    .18	[0.12-0.24] unit increase	rs780093	A	NR	21386085
ZNF259	Triglycerides-Blood Pressure (TG-BP)	3E-9	    .35	[0.23-0.47] unit increase	rs11823543	A	NR	21386085
BUD13	Triglycerides-Blood Pressure (TG-BP)	3E-9	    .32	[0.22-0.42] unit increase	rs11825181	A	NR	21386085
TRIB1	Triglycerides-Blood Pressure (TG-BP)	9E-9	    .17	[0.11-0.23] unit increase	rs2954033	A	NR	21386085
APOA5	Triglycerides-Blood Pressure (TG-BP)	4E-8	    .37	[0.23-0.51] unit increase	rs2266788	C	NR	21386085
ZNF259	Waist Circumference - Triglycerides (WC-TG)	1E-16	    .41	[0.31-0.51] unit increase	rs2075290	C	NR	21386085
APOA5	Waist Circumference - Triglycerides (WC-TG)	2E-16	    .41	[0.31-0.51] unit increase	rs2266788	A	NR	21386085
BUD13	Waist Circumference - Triglycerides (WC-TG)	7E-16	    .39	[0.29-0.49] unit increase	rs10790162	A	NR	21386085
GCKR	Waist Circumference - Triglycerides (WC-TG)	2E-12	    .19	[0.13-0.25] unit increase	rs780093	A	NR	21386085
CCDC121	Waist Circumference - Triglycerides (WC-TG)	1E-9	    .18	[0.12-0.24] unit decrease	rs3749147	C	NR	21386085
C2orf16	Waist Circumference - Triglycerides (WC-TG)	2E-9	    .18	[0.12-0.24] unit decrease	rs1919128	A	NR	21386085
ZNF512	Waist Circumference - Triglycerides (WC-TG)	5E-9	    .17	[0.11-0.23] unit decrease	rs13022873	A	NR	21386085
CXCL12	Coronary heart disease	3E-10	   1.09	[1.07-1.13] 	rs1746048	C	0.87	21378990
PPAP2B	Coronary heart disease	4E-19	   1.17	[1.13-1.22] 	rs17114036	A	0.91	21378990
ANKS1A	Coronary heart disease	1E-8	   1.07	[1.05-1.10] 	rs17609940	G	0.75	21378990
TCF21	Coronary heart disease	1E-12	   1.08	[1.06-1.10] 	rs12190287	C	0.62	21378990
ZC3HC1	Coronary heart disease	9E-18	   1.09	[1.07-1.12] 	rs11556924	C	0.62	21378990
ABO	Coronary heart disease	4E-14	   1.10	[1.07-1.13] 	rs579459	C	0.21	21378990
CYP17A1, CNNM2, NT5C2	Coronary heart disease	1E-9	   1.12	[1.08-1.16] 	rs12413409	G	0.89	21378990
ZNF259, APOA5, APOA4, APOC3, APOA1	Coronary heart disease	1E-17	   1.13	[1.10-1.16] 	rs964184	G	0.13	21378990
COL4A1, COL4A2	Coronary heart disease	4E-9	   1.07	[1.05-1.09] 	rs4773144	G	0.44	21378990
HHIPL1	Coronary heart disease	1E-10	   1.07	[1.05-1.10] 	rs2895811	C	0.43	21378990
ADAMTS7	Coronary heart disease	1E-12	   1.08	[1.06-1.10] 	rs3825807	A	0.57	21378990
SMG6, SRR	Coronary heart disease	1E-9	   1.07	[1.05-1.09] 	rs216172	C	0.37	21378990
RASD1, SMCR3, PEMT	Coronary heart disease	4E-10	   1.07	[1.05-1.09] 	rs12936587	G	0.56	21378990
UBE2Z, GIP, ATP5G1, SNF8	Coronary heart disease	2E-8	   1.06	[1.04-1.08] 	rs46522	T	0.53	21378990
SORT1	Coronary heart disease	3E-10	   1.11	[1.08-1.15] 	rs599839	A	0.78	21378990
MIA3	Coronary heart disease	1E-8	   1.14	[1.09-1.20] 	rs17465637	C	0.74	21378990
WDR12	Coronary heart disease	1E-9	   1.14	[1.09-1.19] 	rs6725887	C	0.15	21378990
MRAS	Coronary heart disease	3E-8	   1.12	[1.07-1.16] 	rs2306374	C	0.18	21378990
PHACTR1	Coronary heart disease	1E-9	   1.10	[1.06-1.13] 	rs12526453	C	0.67	21378990
LPA	Coronary heart disease	3E-11	   1.51	[1.33-1.70] 	rs3798220	C	0.02	21378990
CDKN2A, CDKN2B	Coronary heart disease	1E-22	   1.29	[1.23-1.36] 	rs4977574	G	0.46	21378990
LDLR	Coronary heart disease	1E-9	   1.14	[1.09-1.18] 	rs1122608	G	0.77	21378990
MRPS6	Coronary heart disease	4E-10	   1.18	[1.12-1.24] 	rs9982601	T	0.15	21378990
Intergenic	Coronary heart disease	9E-10	   1.07	[1.05-1.09] 	rs1231206	A	0.37	21378990
Intergenic	Coronary heart disease	2E-25	   1.20	[1.16-1.25] 	rs4977574	G	NR	21378988
CELSR2, PSRC1, SORT1	Coronary heart disease	6E-10	   1.14	[1.09-1.19] 	rs646776	T	NR	21378988
LIPA	Coronary heart disease	3E-13	   1.09	[1.07-1.12] 	rs1412444	T	0.42	21378988
PDGFD	Coronary heart disease	2E-9	   1.07	[1.04-1.09] 	rs974819	T	0.32	21378988
ADAMTS7, MORF4L1	Coronary heart disease	4E-9	   1.07	[1.05-1.10] 	rs4380028	C	0.65	21378988
Intergenic	Coronary heart disease	3E-8	   1.08	[1.05-1.11] 	rs10953541	C	0.80	21378988
KIAA1462	Coronary heart disease	4E-8	   1.07	[1.04-1.09] 	rs2505083	C	0.38	21378988
TNXB	Systemic lupus erythematosus	6E-29	   2.21	[1.93-2.53] 	rs1150754	A	0.13	21408207
HLA-DR3	Systemic lupus erythematosus	6E-28	   2.23	[1.94-2.57] 	rs2187668	A	0.12	21408207
STAT4	Systemic lupus erythematosus	2E-20	   1.77	[1.57-1.99] 	rs7574865	T	0.23	21408207
IRF5	Systemic lupus erythematosus	7E-18	   1.92	[1.66-2.22] 	rs10488631	C	0.11	21408207
ITGAM	Systemic lupus erythematosus	1E-15	   1.80	[1.56-2.07] 	rs9888739	T	0.13	21408207
HLA-DQA2	Systemic lupus erythematosus	2E-12	   1.47	[1.32-1.63] 	rs2301271	T	0.40	21408207
IRF5	Systemic lupus erythematosus	6E-9	   1.58	[1.36-1.83] 	rs12531711	G	0.11	21408207
SYK	Vascular dementia	7E-11	   2.20	[1.73-2.78] 	rs290227	G	0.40	23480133
CYP1A1, CYP1A2	Coffee consumption	5E-14	    .31	[0.17-0.44] increase in cups per day	rs2472297	T	0.265	21357676
AHR	Coffee consumption	2E-11	    .26	[0.15-0.36] increase in cups per day	rs6968865	T	0.593	21357676
CUBN, RSU1	Urinary albumin excretion	1E-11	    .08	[NR] unit decrease (CKDGen)	rs1801239	T	0.90	21355061
SH2B3	Celiac disease and Rheumatoid arthritis	3E-19	NR	NR	rs653178	C	NR	21383967
PTPN2	Celiac disease and Rheumatoid arthritis	5E-12	NR	NR	rs1893217	G	NR	21383967
TRAF1	Celiac disease and Rheumatoid arthritis	4E-11	NR	NR	rs1953126	T	NR	21383967
STAT4	Celiac disease and Rheumatoid arthritis	4E-10	NR	NR	rs7574865	T	NR	21383967
UBE2L3	Celiac disease and Rheumatoid arthritis	3E-10	NR	NR	rs2298428	T	NR	21383967
UBASH3A	Celiac disease and Rheumatoid arthritis	1E-8	NR	NR	rs11203203	A	NR	21383967
ELMO1	Celiac disease and Rheumatoid arthritis	5E-8	NR	NR	rs11984075	G	NR	21383967
NCAN	Bipolar disorder	2E-9	   1.17	[NR] 	rs1064395	A	0.16	21353194
BCL11A	F-cell distribution	2E-16	   1.98	[1.57-2.39] unit increase	rs10189857, rs6545816, rs6545817, rs1427407, rs7599488, rs1896294, rs766432, rs11886868, rs10195871, rs10172646, rs4671393, rs7584113, rs7557939, rs6706648, rs6738440, rs7565301, rs6729815, rs1896295, rs1896296, rs7606173	S	0.254	21326311
C6orf10, BTNL2	Vitiligo	8E-11	NR	NR	rs7758128	A	0.06	21326295
SLC12A9	Coronary heart disease	3E-8	   1.31	[1.19-1.44] 	rs7801190	C	0.73	21347282
PPP1R3B	Coronary heart disease	1E-8	    .14	[0.09-0.19] SD decrease	rs6601299	T	0.16	21347282
LCAT	Coronary heart disease	2E-11	    .09	[0.06-0.12] SD increase	rs3729639	T	0.44	21347282
CELSR2	Coronary heart disease	9E-29	    .18	[0.15-0.21] SD decrease	rs12740374	T	0.25	21347282
SMARCA4	Coronary heart disease	1E-8	    .17	[0.11-0.23] SD decrease	rs11669133	A	0.06	21347282
SCN5A	PR interval	3E-23	   5.11	[4.11-6.11] msec increase	rs3922844	C	0.41	21347284
CARD10	Optic disc parameters	3E-12	    .05	[0.04-0.06] mm2 increase	rs9607469	A	0.14 (Rotterdam)	21307088
CDC7, TGFBR3	Optic disc parameters	8E-17	    .10	[NR] mm2 increase	rs1192415	G	NR	21307088
ATOH7	Optic disc parameters	2E-15	    .09	[NR] mm2 decrease	rs7916697	A	NR	21307088
Intergenic	Diabetic retinopathy 	3E-15	NR	NR	rs17376456	A	NR	21310492
Intergenic	Diabetic retinopathy 	9E-9	NR	NR	rs12219125	T	NR	21310492
ARHGAP22	Diabetic retinopathy 	2E-9	NR	NR	rs4838605	C	NR	21310492
HS6ST3	Diabetic retinopathy 	5E-11	NR	NR	rs2038823	C	NR	21310492
PTPN2	C-reactive protein	2E-8	    .03	[0.02-0.04] unit increase	rs2847281	A	NR	21300955
GPRC6A	C-reactive protein	5E-8	    .04	[0.03-0.05] unit increase	rs6901250	A	NR	21300955
IRF1	C-reactive protein	1E-8	    .04	[0.03-0.05] unit increase	rs4705952	G	NR	21300955
CRP	C-reactive protein	2E-186	    .16	[0.15-0.17] unit increase	rs2794520	C	NR	21300955
APOC1	C-reactive protein	9E-139	    .24	[0.22-0.26] unit increase	rs4420638	A	NR	21300955
HNF1A	C-reactive protein	2E-124	    .15	[0.14-0.16] unit increase	rs1183910	G	NR	21300955
LEPR	C-reactive protein	4E-62	    .09	[0.08-0.10] unit increase	rs4420065	C	NR	21300955
IL6R	C-reactive protein	2E-48	    .08	[0.07-0.09] unit increase	rs4129267	C	NR	21300955
GCKR	C-reactive protein	5E-40	    .07	[0.06-0.08] unit increase	rs1260326	T	NR	21300955
NLRP3	C-reactive protein	1E-15	    .05	[0.04-0.06] unit increase	rs12239046	C	NR	21300955
IL1F10	C-reactive protein	2E-17	    .05	[0.04-0.06] unit increase	rs6734238	G	NR	21300955
PPP1R3B	C-reactive protein	3E-13	    .07	[0.05-0.09] unit increase	rs9987289	A	NR	21300955
ASCL1	C-reactive protein	2E-11	    .04	[0.03-0.05] unit increase	rs10745954	A	NR	21300955
HNF4A	C-reactive protein	2E-9	    .09	[0.06-0.12] unit increase	rs1800961	C	NR	21300955
RORA	C-reactive protein	4E-9	    .03	[0.02-0.04] unit increase	rs340029	T	NR	21300955
SALL1	C-reactive protein	9E-13	    .10	[0.07-0.13] unit increase	rs10521222	C	NR	21300955
PABPC4	C-reactive protein	6E-11	    .05	[0.03-0.06] unit increase	rs12037222	A	NR	21300955
BCL7B	C-reactive protein	4E-9	    .05	[0.03-0.07] unit increase	rs13233571	C	NR	21300955
Intergenic	Ulcerative colitis	4E-35	   1.30	[1.25-1.35] 	rs6426833	A	0.54	21297633
IL23R	Ulcerative colitis	5E-28	   1.74	[1.57-1.92] 	rs11209026	G	0.94	21297633
FCGR2A, FCGR2B, HSPA6	Ulcerative colitis	2E-20	   1.21	[1.16-1.26] 	rs1801274	A	0.51	21297633
IL10, IL19	Ulcerative colitis	6E-17	   1.25	[1.19-1.32] 	rs3024505	A	0.16	21297633
PUS10	Ulcerative colitis	2E-14	   1.19	[1.14-1.24] 	rs7608910	G	0.39	21297633
GPR35	Ulcerative colitis	8E-11	   1.14	[1.09-1.18] 	rs4676406	T	0.52	21297633
MST1, UBA7, APEH, AMIGO3, GMPPB, BSN	Ulcerative colitis	2E-17	   1.21	[1.16-1.26] 	rs9822268	A	0.30	21297633
EXOC3	Ulcerative colitis	3E-8	   1.15	[1.09-1.21] 	rs11739663	T	0.77	21297633
HLA-DRB5, HLA-DQA1, HLA-DRB1, HLA-DRA, BTNL2	Ulcerative colitis	1E-55	   1.40	[1.34-1.47] 	rs9268853	T	0.66	21297633
Intergenic	Ulcerative colitis	2E-16	   1.20	[1.15-1.26] 	rs4510766	A	0.56	21297633
Intergenic	Ulcerative colitis	8E-21	   1.21	[1.16-1.26] 	rs6584283	T	0.47	21297633
IFNG, IL26	Ulcerative colitis	1E-16	   1.19	[1.19-1.24] 	rs7134599	A	0.39	21297633
ZFP90	Ulcerative colitis	4E-8	   1.14	[1.09-1.20] 	rs6499188	A	0.75	21297633
IKZF3, ORMDL3, IKZF3, PNMT, ZPBP2, GSDML	Ulcerative colitis	5E-11	   1.15	[1.10-1.19] 	rs2872507	A	0.46	21297633
SERINC3	Ulcerative colitis	1E-20	   1.20	[1.15-1.26] 	rs6017342	C	0.54	21297633
Intergenic	Ulcerative colitis	2E-22	   1.25	[1.20-1.32] 	rs2836878	G	0.74	21297633
TNFRSF14, MMEL1, PLCH2, C1orf93	Ulcerative colitis	3E-9	   1.05	[1.01-1.09] 	rs734999	C	0.52	21297633
TNFRSF9, ERFFI1, UTS2, PARK7	Ulcerative colitis	5E-9	   1.08	[1.02-1.15] 	rs35675666	G	0.83	21297633
Intergenic	Ulcerative colitis	2E-13	   1.10	[1.05-1.16] 	rs7524102	A	0.83	21297633
IL1R2	Ulcerative colitis	3E-12	   1.09	[1.05-1.14] 	rs2310173	T	0.46	21297633
IL8RA, SLC11A1, IL8RB, AAMP, ARPC	Ulcerative colitis	1E-10	   1.07	[1.03-1.11] 	rs11676348	T	0.49	21297633
DAP	Ulcerative colitis	6E-12	   1.10	[1.06-1.15] 	rs267939	C	0.37	21297633
IL7R	Ulcerative colitis	4E-8	   1.07	[1.02-1.12] 	rs3194051	G	0.27	21297633
PTGER4	Ulcerative colitis	3E-9	   1.08	[1.04-1.12] 	rs6451493	T	0.61	21297633
Intergenic	Ulcerative colitis	1E-9	   1.07	[1.03-1.12] 	rs254560	A	0.40	21297633
IL12B	Ulcerative colitis	1E-21	   1.17	[1.12-1.22] 	rs6871626	A	0.33	21297633
Intergenic	Ulcerative colitis	2E-10	   1.15	[1.08-1.23] 	rs943072	G	0.09	21297633
PDRM1	Ulcerative colitis	1E-8	   1.08	[1.03-1.13] 	rs6911490	T	0.21	21297633
Intergenic	Ulcerative colitis	8E-17	   1.14	[1.09-1.20] 	rs6920220	A	0.21	21297633
GNA12	Ulcerative colitis	3E-15	   1.13	[1.08-1.18] 	rs798502	A	0.71	21297633
IRF5, TNPO3	Ulcerative colitis	2E-8	   1.07	[1.03-1.11] 	rs4728142	A	0.44	21297633
JAK2	Ulcerative colitis	2E-25	   1.17	[1.12-1.21] 	rs10758669	C	0.35	21297633
TNFSF8, TNFSF15	Ulcerative colitis	6E-12	   1.10	[1.05-1.15] 	rs4246905	C	0.71	21297633
CARD9, INPP5E, SDCCAG3, SEC16A, SNAPC4	Ulcerative colitis	3E-19	   1.12	[1.08-1.17] 	rs10781499	A	0.41	21297633
CCNY	Ulcerative colitis	7E-10	   1.07	[1.03-1.12] 	rs12261843	G	0.29	21297633
LSP1	Ulcerative colitis	1E-10	   1.08	[1.03-1.13] 	rs907611	A	0.32	21297633
Intergenic	Ulcerative colitis	5E-16	   1.13	[1.08-1.17] 	rs2155219	T	0.5	21297633
Intergenic	Ulcerative colitis	5E-14	   1.09	[1.05-1.14] 	rs678170	A	0.66	21297633
Intergenic	Ulcerative colitis	1E-16	   1.16	[1.10-1.21] 	rs17085007	C	0.18	21297633
Intergenic	Ulcerative colitis	4E-12	   1.12	[1.07-1.17] 	rs941823	C	0.76	21297633
Intergenic	Ulcerative colitis	6E-19	   1.15	[1.10-1.21] 	rs16940202	C	0.18	21297633
SLC2A4RG, STMN3, ZBTB46, ZGPAT, RTEL1, TNFRSF6B	Ulcerative colitis	2E-10	   1.09	[1.04-1.15] 	rs2297441	A	0.77	21297633
Intergenic	Ulcerative colitis	7E-13	   1.11	[1.06-1.15] 	rs1297265	A	0.56	21297633
ICOSLG	Ulcerative colitis	6E-11	   1.14	[1.05-1.22] 	rs2838519	G	0.39	21297633
C1orf106	Ulcerative colitis	2E-13	   1.19	[1.14-1.25] 	rs7554511	C	0.72	21297633
SLC2A9	Uric acid levels	1E-9	    .18	[0.12-0.24] unit decrease	rs3775948	G	0.34	21294900
SYT11	Parkinson's disease	4E-12	   1.47	[1.35-1.59] 	rs34372695	T	0.03	21292315
ACMSD	Parkinson's disease	7E-9	   1.10	[1.06-1.14] 	rs6710823	G	0.46	21292315
STK39	Parkinson's disease	4E-10	   1.18	[1.12-1.24] 	rs2102808	C	0.12	21292315
MCCC1, LAMP3	Parkinson's disease	8E-12	   1.19	[1.13-1.25] 	rs11711441	G	0.86	21292315
GAK	Parkinson's disease	4E-12	   1.16	[1.12-1.20] 	rs6599388	T	0.31	21292315
BST1	Parkinson's disease	1E-16	   1.15	[1.11-1.19] 	rs11724635	A	0.56	21292315
SNCA	Parkinson's disease	2E-47	   1.29	[1.25-1.33] 	rs356219	G	0.39	21292315
HLA-DRB5	Parkinson's disease	2E-14	   1.28	[1.22-1.34] 	NR	A	0.76	21292315
LRRK2	Parkinson's disease	6E-14	   1.27	[1.21-1.33] 	rs1491942	G	0.08	21292315
CCDC62, HIP1R	Parkinson's disease	3E-13	   1.14	[1.10-1.18] 	rs12817488	T	0.41	21292315
MAPT	Parkinson's disease	1E-28	   1.27	[1.23-1.31] 	rs2942168	G	0.78	21292315
ZNF365	Mammographic density	1E-9	    .18	[0.12-0.25] % decrease	rs10995190	A	0.15	21278746
CLCN6	Natriuretic peptide levels	4E-16	    .20	[0.16-0.24] unit increase	rs1023252	T	0.26	21273288
PUS10	Crohn's disease and celiac disease	1E-11	NR	NR	rs10188217	C	NR	21298027
TAGAP	Crohn's disease and celiac disease	2E-10	NR	NR	rs212388	C	NR	21298027
C12orf51,ALDH2	Alcohol consumption	9E-59	   1.06	[0.94-1.18] unit decrease	rs2074356	T	0.15	21270382
MYL2	Alcohol consumption	4E-35	    .79	[0.67-0.91] unit decrease	rs12229654	G	0.14	21270382
CCDC63	Alcohol consumption	1E-23	    .55	[0.45-0.65] unit decrease	rs10849915	G	0.18	21270382
OAS3	Alcohol consumption	6E-17	    .61	[0.49-0.73] unit decrease	rs2072134	A	0.11	21270382
Intergenic	Breast cancer	2E-10	   1.16	[1.11-1.22] 	rs13387042	A	0.52	21263130
SLC4A7	Breast cancer	2E-8	   1.14	[1.09-1.19] 	rs4973768	C	0.49	21263130
Intergenic	Breast cancer	8E-11	   1.17	[1.11-1.22] 	rs4415084	T	0.42	21263130
Intergenic	Breast cancer	3E-11	   1.16	[1.11-1.22] 	rs1562430	A	0.60	21263130
TOX3	Breast cancer	4E-10	   1.15	[1.10-1.21] 	rs3112612	T	0.43	21263130
KLF4,RAD23B,ACTL7A	Breast cancer	2E-10	   1.12	[1.09-1.18] 	rs865686	T	0.61	21263130
SLC22A3	Colorectal cancer	8E-9	   1.28	[1.18-1.39] 	rs7758229	T	NR	21242260
Intergenic	Colorectal cancer	2E-8	   1.18	[1.11-1.25] 	rs6983267	G	0.34	21242260
ADAMTS7	Coronary heart disease	5E-13	   1.19	[1.13-1.24] 	rs1994016	C	0.60	21239051
ABO	Coronary heart disease	8E-9	   1.21	[1.13-1.28] 	rs514659	C	0.37	21239051
IL28B	Response to hepatitis C treatment	1E-20	   3.00	[2.4-3.8] 	rs8099917	G	0.083	21228123
IGFBP3	Insulin-like growth factors	3E-101	NR	NR	rs11977526	A	0.41	21216879
TNS3	Insulin-like growth factors	4E-21	NR	NR	rs700752	G	0.65	21216879
TNS3	Insulin-like growth factors	5E-9	NR	NR	rs700752	G	0.65	21216879
SORCS2	Insulin-like growth factors	5E-10	NR	NR	rs4234798	T	0.39	21216879
NUBP2, IGFALS	Insulin-like growth factors	1E-11	NR	NR	rs1065656	G	0.68	21216879
SLC17A1	Iron levels	5E-9	  36.50	[24.27-48.73] ng/ml decrease	rs17342717	C	0.93	21208937
TF	Iron levels	3E-47	  15.34	[13.26-17.42] mg/dl increase	rs3811647	A	0.29	21208937
TMPRSS6	Iron levels	4E-11	   4.24	[2.99-5.49] ug/dl decrease	rs4820268	G	0.47	21208937
HFE	Iron levels	3E-9	   4.95	[3.30-6.60] ug/dl decrease	rs1799945	C	0.83	21208937
CRP	C-reactive protein	4E-21	    .16	[0.13-0.19] unit increase	rs3093059	G	0.12	21196492
IL6	C-reactive protein	4E-11	    .10	[0.07-0.13] unit increase	rs2097677	A	0.19	21196492
HNF1A	C-reactive protein	3E-8	    .07	[0.04-0.10] unit increase	rs7310409	G	0.47	21196492
ATM, C111orf65	Response to metformin in type 2 diabetes (glycemic)	3E-9	   1.35	[1.22-1.49] 	rs11212617	C	0.44	21186350
FUT8	N-glycan levels	3E-18	    .26	[0.20-0.32] unit increase	rs7159888	A	0.44	21203500
HNF1A,C12orf43,OASL	N-glycan levels	4E-8	    .17	[0.11-0.23] unit increase	rs735396	G	0.38	21203500
NRTN,FUT6,FUT3	N-glycan levels	3E-12	    .34	[0.24-0.44] unit decrease	rs3760776	A	0.11	21203500
FUT8	N-glycan levels	1E-8	    .22	[0.14-0.30] unit decrease	rs10483776	G	0.21	21203500
HNF1A,C12orf43,OASL	N-glycan levels	2E-8	    .17	[0.11-0.23] unit decrease	rs7953249	G	0.45	21203500
NRTN,FUT6,FUT3	N-glycan levels	4E-17	    .41	[0.31-0.51] unit decrease	rs3760776	A	0.11	21203500
NRTN,FUT6,FUT3	N-glycan levels	9E-10	    .30	[0.20-0.40] unit decrease	rs3760776	A	0.11	21203500
NRTN,FUT6,FUT3	N-glycan levels	1E-12	    .34	[0.24-0.44] unit decrease	rs3760776	A	0.11	21203500
TERT	Serum prostate-specific antigen levels	1E-10	   7.00	[NR] % increase	rs401681	C	0.55	21160077
FGFR2	Serum prostate-specific antigen levels	5E-15	  10.20	[NR] % increase	rs10788160	A	0.31	21160077
MSMB	Serum prostate-specific antigen levels	7E-13	   9.20	[NR] % increase	rs10993994	T	0.39	21160077
TBX3	Serum prostate-specific antigen levels	2E-11	   8.30	[NR] % increase	rs11067228	A	0.56	21160077
HNF1B	Serum prostate-specific antigen levels	6E-11	   9.40	[NR] % increase	rs4430796	A	0.52	21160077
KLK3	Serum prostate-specific antigen levels	3E-46	  39.10	[NR] % increase	rs17632542	T	0.91	21160077
NR	Serum prostate-specific antigen levels	6E-10	NR	NR	rs266849	A	0.83	21160077
GTF2A1L,LHCGR,FSHR	Polycystic ovary syndrome	8E-21	   1.41	[1.30-1.49] 	rs13405728	A	0.76	21151128
ZFP36L2,LOC100129726,THADA	Polycystic ovary syndrome	3E-23	   1.39	[1.30-1.49] 	rs12478601	C	0.71	21151128
DENND1A	Polycystic ovary syndrome	8E-19	   1.34	[1.26-1.43] 	rs2479106	G	0.22	21151128
ZFP36L2,LOC100129726,THADA	Polycystic ovary syndrome	2E-23	   1.49	[1.39-1.61] 	rs13429458	A	0.91	21151128
DENND1A	Polycystic ovary syndrome	9E-18	   1.51	[1.37-1.65] 	rs10818854	A	0.09	21151128
Intergenic	Endometriosis	1E-9	   1.20	[1.13-1.27] 	rs12700667	A	0.74	21151130
SORT1,CELSR2,PSRC1	Progranulin levels	2E-30	    .18	[0.16-0.20] ng/ml decrease	rs646776	G	0.21	21087763
HFE	Iron status biomarkers	9E-9	    .04	[0.03-0.05] unit increase	rs1408272	T	NR	21149283
PCSK7	Iron status biomarkers	1E-27	    .04	[0.03-0.05] unit increase	rs236918	C	NR	21149283
TMPRSS6	Iron status biomarkers	2E-15	    .02	[0.015-0.023] unit increase	rs855791	A	NR	21149283
HFE	Iron status biomarkers	9E-10	    .09	[0.06-0.12] unit increase	rs17342717	T	NR	21149283
APOA	Iron status biomarkers	4E-25	    .04	[0.03-0.05] unit decrease	rs10047462	T	NR	21149283
HLA-A	Adverse response to carbamapezine	1E-16	   9.50	[5.6-16.3] 	NR	A	0.13	21149285
HLA-DRB5	Chronic lymphocytic leukemia	7E-9	   1.69	[1.41-2.01] 	rs674313	T	0.26	21131588
LMO1	Neuroblastoma	5E-16	   1.34	[1.25-1.44] 	rs110419	A	0.49	21124317
FLJ22536, FLJ44180	Neuroblastoma	8E-17	   1.40	[NR] 	rs4712653	C	0.46	21124317
BARD1	Neuroblastoma	5E-13	   1.39	[NR] 	rs3768716	C	0.23	21124317
DGKK	Hypospadias	3E-21	   2.60	[2.1-3.1] 	rs1934179	A	0.33	21113153
PMAIP, Noxa	Bleomycin sensitivity	3E-8	    .18	[0.12-0.24] more chromatid breaks	rs8093763	A	0.25	21106707
LIN28B	Menarche (age at onset)	5E-60	   6.40	[5.62-7.18] week increase	rs7759938	C	0.32	21102462
TMEM38B	Menarche (age at onset)	2E-33	   4.70	[3.92-5.48] week decrease	rs2090409	A	0.31	21102462
INHBA	Menarche (age at onset)	6E-14	   3.90	[2.92-4.88] week increase	rs1079866	G	0.15	21102462
RXRG	Menarche (age at onset)	1E-13	   4.20	[3.02-5.38] week decrease	rs466639	T	0.13	21102462
Intergenic	Menarche (age at onset)	1E-13	   2.70	[1.92-3.48] week decrease	rs6438424	A	0.50	21102462
FUSSEL18	Menarche (age at onset)	2E-13	   2.70	[1.92-3.48] week decrease	rs1398217	G	0.43	21102462
PLCL1	Menarche (age at onset)	6E-13	   3.00	[2.22-3.78] week decrease	rs12617311	A	0.32	21102462
CA10	Menarche (age at onset)	7E-13	   3.00	[2.22-3.78] week decrease	rs9635759	A	0.32	21102462
BSX	Menarche (age at onset)	2E-12	   2.70	[1.92-3.48] week decrease	rs6589964	A	0.48	21102462
ZNF483	Menarche (age at onset)	4E-11	   2.50	[1.72-3.28] week increase	rs10980926	A	0.36	21102462
CCDC85A	Menarche (age at onset)	1E-10	   3.20	[2.22-4.18] week increase	rs17268785	G	0.17	21102462
PHF15	Menarche (age at onset)	2E-10	   3.00	[2.02-3.98] week increase	rs13187289	G	0.20	21102462
VGLL3	Menarche (age at onset)	4E-10	   2.40	[1.62-3.18] week decrease	rs7642134	A	0.38	21102462
NR4A2	Menarche (age at onset)	1E-9	   4.50	[3.13-5.87] week decrease	rs17188434	C	0.07	21102462
TRA2B, ETV5	Menarche (age at onset)	1E-9	   2.20	[1.42-2.98] week increase	rs2002675	G	0.42	21102462
PXMP3	Menarche (age at onset)	3E-9	   2.40	[1.62-3.18] week decrease	rs7821178	A	0.34	21102462
MKL2	Menarche (age at onset)	4E-9	   2.40	[1.62-3.18] week decrease	rs1659127	A	0.34	21102462
CRTC1	Menarche (age at onset)	6E-9	   2.30	[1.52-3.08] week decrease	rs10423674	A	0.35	21102462
GAB2	Menarche (age at onset)	8E-9	   3.10	[2.12-4.08] week increase	rs10899489	A	0.15	21102462
BEGAIN	Menarche (age at onset)	1E-8	   2.30	[1.52-3.08] week increase	rs6575793	C	0.42	21102462
TRIM66	Menarche (age at onset)	1E-8	   2.30	[1.52-3.08] week increase	rs4929923	T	0.36	21102462
TMEM108, NPHP3	Menarche (age at onset)	1E-8	   2.30	[1.52-3.08] week increase	rs6439371	G	0.34	21102462
ARNTL	Menarche (age at onset)	2E-8	   2.30	[1.52-3.08] week increase	rs900145	C	0.30	21102462
RBM6	Menarche (age at onset)	2E-8	   2.50	[1.72-3.28] week increase	rs6762477	G	0.44	21102462
TMEM18	Menarche (age at onset)	2E-8	   2.80	[1.82-3.78] week increase	rs2947411	A	0.17	21102462
C6orf173, TRMT11	Menarche (age at onset)	2E-8	   2.10	[1.32-2.88] week decrease	rs1361108	T	0.46	21102462
NFAT5	Menarche (age at onset)	2E-8	   2.10	[1.32-2.88] week increase	rs1364063	C	0.43	21102462
SEC16B	Menarche (age at onset)	2E-8	   2.60	[1.62-3.58] week decrease	rs633715	C	0.20	21102462
PRDM13, MCHR2	Menarche (age at onset)	2E-8	   2.10	[1.32-2.88] week decrease	rs4840086	G	0.42	21102462
KLHDC8B	Menarche (age at onset)	3E-8	   2.40	[1.62-3.18] week decrease	rs7617480	A	0.22	21102462
FTO	Menarche (age at onset)	3E-8	   2.10	[1.32-2.88] week decrease	rs9939609	A	0.40	21102462
PCSK2	Menarche (age at onset)	3E-8	   2.10	[1.32-2.88] week decrease	rs852069	A	0.37	21102462
KDM3B	Menarche (age at onset)	5E-8	   2.40	[1.62-3.18] week decrease	rs757647	A	0.22	21102462
ZNF365	Crohn's disease	4E-22	   1.23	[1.18-1.29] 	rs10761659	G	0.538	21102463
ZMIZ1	Crohn's disease	1E-30	   1.19	[1.15-1.23] 	rs1250550	G	0.669	21102463
ZFP36L1	Crohn's disease	2E-10	   1.07	[1.11-1.04] 	rs4902642	G	0.584	21102463
YDJC	Crohn's disease	5E-16	   1.10	[1.06-1.15] 	rs181359	T	0.203	21102463
UBE2D1	Crohn's disease	9E-17	   1.19	[1.13-1.25] 	rs1819658	C	0.774	21102463
TYK2,ICAM1,ICAM3	Crohn's disease	1E-12	   1.12	[1.06-1.19] 	rs12720356	G	0.084	21102463
TNFSF18,TNFSF4,FASLG	Crohn's disease	2E-15	   1.22	[1.16-1.28] 	rs7517810	T	0.246	21102463
TNFSF15,TNFSF8	Crohn's disease	1E-15	   1.21	[1.15-1.27] 	rs3810936	C	0.682	21102463
TNFSF11	Crohn's disease	5E-10	   1.10	[1.05-1.15] 	rs2062305	G	0.346	21102463
THADA	Crohn's disease	2E-14	   1.14	[1.09-1.20] 	rs10495903	T	0.129	21102463
TAGAP	Crohn's disease	2E-11	   1.10	[1.05-1.14] 	rs212388	G	0.393	21102463
SP140	Crohn's disease	3E-13	   1.12	[1.07-1.18] 	rs7423615	T	0.187	21102463
SMAD3	Crohn's disease	3E-19	   1.12	[1.07-1.16] 	rs17293632	T	0.233	21102463
SLC22A4,SLC22A5,IRF1,IL3	Crohn's disease	1E-20	   1.23	[1.18-1.28] 	rs12521868	T	0.422	21102463
SCAMP3,MUC1	Crohn's disease	2E-13	   1.13	[1.06-1.19] 	rs3180018	A	0.25	21102463
RTEL1,TNFRS-F6B,SLC2A4RG	Crohn's disease	3E-15	   1.12	[1.06-1.18] 	rs4809330	G	0.709	21102463
PTPN22	Crohn's disease	4E-9	   1.26	[1.17-1.37] 	rs2476601	G	0.907	21102463
PTPN2	Crohn's disease	1E-14	   1.25	[1.18-1.32] 	rs1893217	G	0.153	21102463
PTGER4	Crohn's disease	7E-36	   1.33	[1.27-1.39] 	rs11742570	C	0.606	21102463
PRDX5,ESRRA	Crohn's disease	6E-10	   1.10	[1.05-1.16] 	rs694739	A	0.626	21102463
PRDM1	Crohn's disease	4E-8	   1.13	[1.07-1.18] 	rs6568421	G	0.301	21102463
PLCL1	Crohn's disease	4E-9	   1.06	[1.02-1.11] 	rs6738825	A	0.473	21102463
NOD2	Crohn's disease	4E-69	   1.53	[1.46-1.60] 	rs2076756	G	0.26	21102463
NKX2-3	Crohn's disease	2E-20	   1.22	[1.17-1.27] 	rs4409764	T	0.492	21102463
NDFIP1	Crohn's disease	2E-9	   1.06	[1.02-1.11] 	rs11167764	C	0.796	21102463
MUC19,LRRK2	Crohn's disease	6E-21	   1.74	[1.55-1.95] 	rs11564258	A	0.025	21102463
MTMR3	Crohn's disease	7E-12	   1.08	[1.04-1.13] 	rs713875	C	0.471	21102463
MST1,GPX1,BSN	Crohn's disease	6E-17	   1.22	[1.16-1.27] 	rs3197999	A	0.297	21102463
MLX,STAT3	Crohn's disease	3E-8	   1.15	[1.10-1.21] 	rs11871801	A	0.756	21102463
MAP3K7IP1	Crohn's disease	1E-26	   1.23	[1.17-1.29] 	rs2413583	C	0.83	21102463
LTA,HLA-DQA2,TNF,LST1,LTB	Crohn's disease	4E-11	   1.19	[1.13-1.25] 	rs1799964	C	0.209	21102463
JAK2	Crohn's disease	1E-13	   1.18	[1.13-1.23] 	rs10758669	C	0.349	21102463
IRGM	Crohn's disease	8E-19	   1.37	[1.28-1.47] 	rs7714584	G	0.088	21102463
IL2RA	Crohn's disease	3E-9	   1.11	[1.05-1.16] 	rs12722489	C	0.852	21102463
IL27,SH2B1,EIF3C,LAT,CD19	Crohn's disease	2E-11	   1.07	[1.03-1.12] 	rs151181	G	0.386	21102463
IL23R	Crohn's disease	1E-64	   2.66	[2.36-3.00] 	rs11209026	G	0.932	21102463
IL18RAP,IL12RL2,IL18R1,IL1RL1	Crohn's disease	2E-12	   1.19	[1.14-1.26] 	rs2058660	G	0.231	21102463
IL12B	Crohn's disease	5E-14	   1.18	[1.13-1.24] 	rs6556412	A	0.332	21102463
VAMP3	Crohn's disease	7E-9	   1.05	[1.01-1.10] 	rs2797685	A	0.19	21102463
IL10,IL19	Crohn's disease	2E-14	   1.12	[1.07-1.17] 	rs3024505	T	0.157	21102463
IKZF1,ZPBP,FIGNL1	Crohn's disease	1E-8	   1.14	[1.09-1.20] 	rs1456896	T	0.69	21102463
ICOSLG	Crohn's disease	2E-14	   1.18	[1.13-1.23] 	rs2838519	G	0.391	21102463
GSMDL,ZPBP2,ORMDL3,IKZF3	Crohn's disease	2E-9	   1.14	[1.09-1.19] 	rs2872507	A	0.458	21102463
GPX4,SBNO2	Crohn's disease	8E-12	   1.16	[1.10-1.21] 	rs740495	G	0.247	21102463
GCKR	Crohn's disease	5E-11	   1.15	[1.10-1.21] 	rs780093	T	0.418	21102463
GALC,GPR65	Crohn's disease	4E-18	   1.23	[1.16-1.31] 	rs8005161	T	0.119	21102463
FUT2,RASIP1	Crohn's disease	7E-12	   1.07	[1.04-1.11] 	rs281379	A	0.487	21102463
FADS1	Crohn's disease	2E-11	   1.08	[1.04-1.12] 	rs102275	C	0.341	21102463
ERAP2,LRAP	Crohn's disease	1E-10	   1.05	[1.02-1.09] 	rs2549794	C	0.409	21102463
DNMT3A	Crohn's disease	9E-10	   1.06	[1.03-1.10] 	rs13428812	G	0.326	21102463
DENND1B	Crohn's disease	9E-9	   1.04	[1.00-1.09] 	rs1998598	G	0.302	21102463
CREM	Crohn's disease	1E-9	   1.15	[1.10-1.20] 	rs12242110	G	0.315	21102463
CPEB4	Crohn's disease	3E-12	   1.08	[1.04-1.12] 	rs359457	T	0.571	21102463
CDKAL1	Crohn's disease	1E-8	   1.17	[1.11-1.23] 	rs6908425	C	0.784	21102463
CCR6	Crohn's disease	3E-12	   1.17	[1.12-1.22] 	rs415890	C	0.522	21102463
CCL2,CCL7	Crohn's disease	2E-13	   1.20	[1.14-1.26] 	rs3091315	A	0.723	21102463
CARD9,SNAPC4	Crohn's disease	1E-36	   1.18	[1.13-1.22] 	rs4077515	T	0.411	21102463
C2orf74,REL	Crohn's disease	7E-9	   1.14	[1.09-1.19] 	rs10181042	T	0.42	21102463
C13orf31	Crohn's disease	1E-10	   1.17	[1.12-1.23] 	rs3764147	G	0.245	21102463
C11orf30	Crohn's disease	6E-13	   1.17	[1.12-1.22] 	rs7927997	T	0.389	21102463
BACH2	Crohn's disease	5E-9	   1.07	[1.03-1.11] 	rs1847472	G	0.658	21102463
ATG16L1	Crohn's disease	7E-41	   1.34	[1.29-1.40] 	rs3792109	A	0.529	21102463
intergenic	Crohn's disease	7E-9	   1.08	[1.03-1.13] 	rs13073817	A	0.322	21102463
intergenic	Crohn's disease	6E-12	   1.12	[1.07-1.17] 	rs7702331	A	0.6	21102463
intergenic	Crohn's disease	7E-9	   1.10	[1.05-1.16] 	rs17309827	T	0.639	21102463
intergenic	Crohn's disease	4E-18	   1.23	[1.17-1.30] 	rs6651252	T	0.865	21102463
intergenic	Crohn's disease	9E-9	   1.06	[1.02-1.11] 	rs736289	T	0.612	21102463
intergenic	Crohn's disease	9E-12	   1.16	[1.11-1.21] 	rs1736020	C	0.579	21102463
intergenic	Crohn's disease	2E-12	   1.17	[1.12-1.23] 	rs4871611	A	0.609	21102463
KIAA1462	Coronary heart disease	1E-11	   1.15	[1.11-1.20] 	rs3739998	C	0.44	21088011
SAA1	Amyloid A serum levels	3E-53	    .31	[0.27-0.35] unit increase	rs4638289	A	0.32	21124955
HPS5, GTF2H1	Amyloid A serum levels	2E-51	    .27	[0.23-0.31] unit increase	rs4353250	T	0.35	21124955
LDHA, LDHC	Amyloid A serum levels	4E-22	    .22	[0.17-0.27] unit increase	rs2896526	G	0.17	21124955
GTF2H1, HPS5, LDHA, LDHC	Amyloid A serum levels	3E-111	    .36	[0.26-0.46] unit increase	rs4150642	G	0.2	21124955
RANKL	Bone mineral density	2E-14	   3.89	[1.91-5.87] mg/cm3 decrease	rs1021188	C	0.18	21124946
SNCA	Parkinson's disease	3E-8	   1.37	[NR] 	rs356220	T	0.35	21084426
SCN10A	QRS duration	1E-28	    .77	[0.63-0.91] ms increase	rs6801957	T	0.41	21076409
SCN5A	QRS duration	1E-16	    .79	[0.59-0.99] ms increase	rs11708996	C	0.16	21076409
CDKN1A	QRS duration	3E-27	    .87	[0.71-1.03] ms increase	rs9470361	A	0.25	21076409
TBX5	QRS duration	1E-10	    .49	[0.33-0.65] ms increase	rs883079	C	0.29	21076409
C1orf185, RNF11, CDKN2C, FAF1	QRS duration	3E-10	   1.35	[0.90-1.80] ms decrease	rs17391905	G	0.05	21076409
IGFBP3	QRS duration	1E-9	    .39	[0.25-0.53] ms increase	rs7784776	G	0.43	21076409
KLF12	QRS duration	1E-8	    .40	[0.26-0.54] ms decrease	rs1886512	A	0.37	21076409
LRIG1,SLC25A26	QRS duration	1E-8	    .37	[0.23-0.51] ms increase	rs2242285	A	0.42	21076409
DKK1	QRS duration	3E-8	    .49	[0.31-0.67] ms increase	rs1733724	A	0.25	21076409
GOSR2	QRS duration	5E-10	    .53	[0.33-0.73] ms increase	rs17608766	C	0.16	21076409
SCN10A, SCN5A	QRS duration	2E-20	    .66	[0.52-0.80] ms decrease	rs9851724	C	0.33	21076409
SCN5A	QRS duration	6E-22	    .84	[0.66-1.02] ms decrease	rs11710077	T	0.21	21076409
PCSK6	Handedness in dyslexia	2E-8	    .35	[0.23-0.47] SD increase	rs11855415	A	0.25	21051773
RNF213	Moyamoya disease	2E-8	   4.82	[2.73-8.49] 	rs6565681	A	0.37	21048783
MICA	HIV-1 control	1E-34	   4.40	[NR] 	rs4418214	C	0.075	21051598
HLA-C	HIV-1 control	3E-35	   2.90	[NR] 	rs9264942	C	0.34	21051598
HLA-B	HIV-1 control	1E-25	   5.30	[NR] 	rs2395029	G	0.032	21051598
PSORS1C3	HIV-1 control	4E-16	   2.10	[NR] 	rs3131018	C	0.625	21051598
HLA-B	HIV-1 control	9E-20	   2.60	[NR] 	rs2523608	G	0.326	21051598
Intergenic	HIV-1 control	4E-14	   2.70	[NR] 	rs2255221	T	0.137	21051598
Intergenic	HIV-1 control	1E-8	   3.10	[NR] 	rs9262632	G	0.10	21051598
HLA-B	HIV-1 control	2E-13	   2.40	[NR] 	rs2523590	C	0.164	21051598
SNCA	Parkinson's disease	9E-16	   1.27	[1.17-1.37] 	rs356220	A	0.36	21044948
ELF1	Systemic lupus erythematosus	1E-8	   1.26	[1.16-1.36] 	rs7329174	G	0.22	21044949
MHC	Ulcerative colitis	1E-16	   3.95	[NR] 	rs17207986	G	NR	20848476
REL	Hodgkin's lymphoma	2E-8	   1.22	[1.14-1.30] 	rs1432295	G	0.40	21037568
HLA-DRA	Hodgkin's lymphoma	3E-50	   1.70	[1.58-1.82] 	rs6903608	G	0.27	21037568
PVT1	Hodgkin's lymphoma	1E-13	   1.33	[1.23-1.44] 	rs2019960	G	0.23	21037568
FTO	Body mass in chronic obstructive pulmonary disease	4E-8	NR	NR	rs8050136	A	0.39	21037115
RASIP1, IZUMO1, FUT1, FUT2, CA11, FGF21, FLJ36070	Retinal vascular caliber	2E-25	   2.10	[1.71-2.49] um decrease	rs2287921	T	0.47	21060863
VTA1, NMBR	Retinal vascular caliber	1E-16	   1.90	[1.45-2.35] um decrease	rs225717	C	0.23	21060863
ATXN2, PTPN11, SH2B3	Retinal vascular caliber	2E-13	   1.50	[1.11-1.89] um increase	rs10774625	A	0.48	21060863
MEF2C	Retinal vascular caliber	7E-16	   3.00	[2.27-3.73] um increase	rs17421627	G	0.08	21060863
PRDM9	Recombination (females)	1E-100	NR	NR	rs2914276	G	0.039	20981099
PRDM9	Recombination (males)	1E-50	NR	NR	rs2914276	G	0.039	20981099
UMOD	Hypertension	4E-11	   1.15	[1.10-1.19] 	rs13333226	A	0.81	21082022
DUSP10	Colorectal cancer	1E-9	   1.06	[1.03-1.09] 	rs6691170	T	NR	20972440
MYNN	Colorectal cancer	3E-8	   1.04	[1.04-1.10] 	rs10936599	C	NR	20972440
DIP2B, ATF1	Colorectal cancer	2E-10	   1.09	[1.05-1.11] 	rs11169552	C	NR	20972440
LAMA5	Colorectal cancer	2E-10	   1.08	[1.05-1.10] 	rs4925386	C	NR	20972440
DUSP10	Colorectal cancer	2E-9	   1.09	[1.06-1.12] 	rs6687758	G	NR	20972440
CCNE1	Bladder cancer	2E-11	   1.13	[1.09-1.17] 	rs8102137	C	0.33	20972438
MYC	Bladder cancer	2E-18	   1.21	[1.16-1.27] 	rs9642880	T	0.45	20972438
PSCA	Bladder cancer	4E-11	   1.13	[1.09-1.17] 	rs2294008	T	0.46	20972438
TMEM129,TACC3,FGFR3	Bladder cancer	4E-13	   1.20	[1.14-1.26] 	rs798766	T	0.19	20972438
TP63	Bladder cancer	2E-10	   1.18	[1.12-1.24] 	rs710521	A	0.73	20972438
IL12B	Psoriasis	1E-20	   1.54	[1.32-1.79] 	rs2546890	A	0.56	20953188
TRAF3IP2	Psoriasis	1E-16	NR	NR	rs33980500	T	0.08	20953188
HLA-C	Psoriatic arthritis	2E-72	   2.37	[2.16-2.61] 	rs13191343	T	0.13	20953186
IL12B	Psoriatic arthritis	7E-17	   1.70	[1.50-1.93] 	rs12188300	T	0.08	20953186
TRAF3IP2	Psoriatic arthritis	1E-20	   1.95	[1.69-2.24] 	rs33980500	T	0.07	20953186
REL	Psoriasis	4E-9	   1.12	[1.04-1.20] 	rs702873	G	0.56	20953190
IFIH1	Psoriasis	1E-13	   1.29	[1.17-1.43] 	rs17716942	A	0.86	20953190
ERAP1	Psoriasis	3E-11	   1.13	[1.05-1.22] 	rs27524	A	0.36	20953190
TRAF3IP2	Psoriasis	5E-20	   1.25	[1.16-1.34] 	rs240993	A	0.25	20953190
NFKBIA	Psoriasis	2E-11	   1.19	[1.11-1.27] 	rs8016947	C	0.57	20953190
TYK2	Psoriasis	4E-11	   1.40	[1.23-1.61] 	rs12720356	A	0.90	20953190
TRAF3IP2	Psoriasis	2E-16	   1.37	[1.22-1.54] 	rs458017,rs465969	G	0.06	20953190
TYK2	Psoriasis	4E-9	   1.13	[1.05-1.21] 	rs280519	A	0.47	20953190
NOS2	Psoriasis	4E-11	   1.19	[NR] 	rs4795067	G	0.35	20953189
FBXL19,POL3S	Psoriasis	9E-10	   1.16	[NR] 	rs10782001	G	0.37	20953189
NFKBIA, PSMA6	Psoriasis	2E-8	   1.15	[NR] 	rs12586317	T	0.75	20953189
RSPO3	Waist-hip ratio	1E-11	    .03	[NR] unit increase	rs9491696	G	0.52	20935629
VEGFA	Waist-hip ratio	2E-26	    .05	[NR] unit increase	rs6905288	A	0.56	20935629
TBX15, WARS2	Waist-hip ratio	9E-25	    .03	[NR] unit increase	rs984222	G	0.37	20935629
NFE2L3	Waist-hip ratio	1E-24	    .04	[NR] unit increase	rs1055144	T	0.21	20935629
GRB14	Waist-hip ratio	4E-34	    .05	[NR] unit increase	rs10195252	T	0.60	20935629
LYPLAL1	Waist-hip ratio	5E-33	    .06	[NR] unit increase	rs4846567	G	0.28	20935629
DNM3, PIGC	Waist-hip ratio	1E-17	    .03	[NR] unit increase	rs1011731	G	0.57	20935629
ITPR2, SSPN	Waist-hip ratio	2E-17	    .04	[NR] unit increase	rs718314	G	0.74	20935629
LY86	Waist-hip ratio	2E-17	    .03	[NR] unit increase	rs1294421	G	0.39	20935629
HOXC13	Waist-hip ratio	6E-16	    .04	[NR] unit increase	rs1443512	A	0.24	20935629
ADAMTS9	Waist-hip ratio	2E-16	    .04	[NR] unit increase	rs6795735	C	0.41	20935629
ZNRF3, KREMEN1	Waist-hip ratio	3E-11	    .03	[NR] unit increase	rs4823006	A	0.57	20935629
NISCH, STAB1	Waist-hip ratio	4E-10	    .04	[NR] unit increase	rs6784615	T	0.94	20935629
CPEB4	Waist-hip ratio	2E-9	    .02	[NR] unit increase	rs6861681	A	0.34	20935629
RSPO3	Waist-hip ratio	2E-32	    .05	[NR] unit increase	rs9491696	G	0.52	20935629
FTO	Body mass index	5E-120	    .39	[0.35-0.43] kg/m2 increase	rs1558902	A	0.42	20935630
TMEM18	Body mass index	3E-49	    .31	[0.25-0.37] kg/m2 increase	rs2867125	C	0.83	20935630
MC4R	Body mass index	6E-42	    .23	[0.17-0.29] kg/m2 increase	rs571312	A	0.24	20935630
GNPDA2	Body mass index	4E-31	    .18	[0.14-0.22] kg/m2 increase	rs10938397	G	0.43	20935630
BDNF	Body mass index	5E-26	    .19	[0.13-0.25] kg/m2 increase	rs10767664	A	0.78	20935630
NEGR1	Body mass index	2E-22	    .13	[0.09-0.17] kg/m2 increase	rs2815752	A	0.61	20935630
SH2B1, APOB48R, SULT1A2, AC138894.2, ATXN2L, TUFM	Body mass index	2E-20	    .15	[0.11-0.19] kg/m2 increase	rs7359397	T	0.40	20935630
ETV5	Body mass index	2E-18	    .14	[0.08-0.20] kg/m2 increase	rs9816226	T	0.82	20935630
MTCH2, NDUFS3, CUGBP1	Body mass index	2E-12	    .06	[0.02-0.10] kg/m2 increase	rs3817334	T	0.41	20935630
KCTD15	Body mass index	3E-9	    .06	[0.02-0.10] kg/m2 increase	rs29941	G	0.67	20935630
SEC16B	Body mass index	4E-23	    .22	[0.16-0.28] kg/m2 increase	rs543874	G	0.19	20935630
TFAP2B	Body mass index	3E-20	    .13	[0.07-0.19] kg/m2 increase	rs987237	G	0.18	20935630
FAIM2	Body mass index	2E-17	    .12	[0.08-0.16] kg/m2 increase	rs7138803	A	0.38	20935630
NRXN3	Body mass index	3E-11	    .13	[0.07-0.19] kg/m2 increase	rs10150332	C	0.21	20935630
RBJ, ADCY3, POMC	Body mass index	6E-22	    .14	[0.10-0.18] kg/m2 increase	rs713586	C	0.47	20935630
GPRC5B, IQCK	Body mass index	3E-21	    .17	[0.11-0.23] kg/m2 increase	rs12444979	C	0.87	20935630
MAP2K5, LBXCOR1	Body mass index	1E-18	    .13	[0.09-0.17] kg/m2 increase	rs2241423	G	0.78	20935630
QPCTL, GIPR	Body mass index	2E-16	    .15	[0.09-0.21] kg/m2 increase	rs2287019	C	0.80	20935630
TNNI3K	Body mass index	8E-14	    .07	[0.03-0.11] kg/m2 increase	rs1514175	A	0.43	20935630
SLC39A8	Body mass index	2E-13	    .19	[0.11-0.27] kg/m2 increase	rs13107325	T	0.07	20935630
FLJ35779, HMGCR	Body mass index	2E-13	    .10	[0.06-0.14] kg/m2 increase	rs2112347	T	0.63	20935630
LRRN6C	Body mass index	3E-13	    .11	[0.07-0.15] kg/m2 increase	rs10968576	G	0.31	20935630
TMEM160, ZC3H4	Body mass index	2E-12	    .09	[0.05-0.13] kg/m2 increase	rs3810291	A	0.67	20935630
FANCL	Body mass index	2E-12	    .10	[0.06-0.14] kg/m2 increase	rs887912	T	0.29	20935630
CADM2	Body mass index	4E-11	    .10	[0.06-0.14] kg/m2 increase	rs13078807	G	0.20	20935630
PRKD1	Body mass index	6E-11	    .17	[0.07-0.27] kg/m2 increase	rs11847697	T	0.04	20935630
LRP1B	Body mass index	1E-10	    .09	[0.03-0.15] kg/m2 increase	rs2890652	C	0.18	20935630
PTBP2	Body mass index	4E-10	    .06	[0.02-0.10] kg/m2 increase	rs1555543	C	0.59	20935630
MTIF3, GTF3A	Body mass index	9E-10	    .09	[0.03-0.15] kg/m2 increase	rs4771122	G	0.24	20935630
ZNF608	Body mass index	2E-9	    .07	[0.03-0.11] kg/m2 increase	rs4836133	A	0.48	20935630
RPL27A, TUB	Body mass index	3E-9	    .06	[0.02-0.10] kg/m2 increase	rs4929949	C	0.52	20935630
NUDT3, HMGA1	Body mass index	3E-8	    .06	[0.02-0.10] kg/m2 increase	rs206936	G	0.21	20935630
CYP19A1	Cerebrospinal AB1-42 levels	2E-9	NR	NR	rs2899472	A	NR	20932310
Intergenic	Cerebrospinal T-tau levels	1E-8	NR	NR	rs1997111	T	NR	20932310
Intergenic	Amyotrophic lateral sclerosis	8E-10	NR	NR	rs3849942,rs10122902	S	0.23 (AG)	20801717
Intergenic	Amyotrophic lateral sclerosis	5E-11	NR	NR	rs3849942,rs10122902	S	0.57 (GG)	20801717
SLC2A9	Urate levels	2E-242	  22.21	[20.90-23.52] umol/l decrease	rs13129697	G	0.27	20884846
ABCG2	Urate levels	1E-75	  18.08	[16.16-20.00] umol/l increase	rs2199936	A	0.11	20884846
SLC22A11	Urate levels	2E-26	   6.80	[5.55-8.05] umol/l increase	rs2078267	C	0.46	20884846
SLC17A1	Urate levels	5E-25	   6.21	[5.03-7.39] umol/l decrease	rs1165196	G	0.46	20884846
GCKR	Urate levels	4E-17	   5.15	[3.95-6.35] umol/l increase	rs780093	T	0.40	20884846
R3HDM2,INHBC	Urate levels	2E-11	   5.16	[3.65-6.67] umol/l decrease	rs1106766	T	0.23	20884846
RREB1	Urate levels	1E-9	   4.39	[2.98-5.80] umol/l increase	rs675209	T	0.26	20884846
PDZK1	Urate levels	4E-8	   3.33	[2.15-4.51] umol/l increase	rs1967017	T	0.47	20884846
SLC2A9	Urate levels	4E-13	   1.52	[1.35-1.69] 	rs13129697	T	0.73	20884846
ABCG2	Urate levels	3E-23	   1.86	[1.64-2.10] 	rs2199936	A	0.11	20884846
ACAN	Height	4E-27	    .13	[NR] unit decrease	rs16942341	T	0.03	20881960
PPARD/FANCE	Height	2E-12	    .10	[NR] unit decrease	rs6457821	A	0.02	20881960
HMGA1	Height	8E-28	    .08	[NR] unit decrease	rs2780226	T	0.92	20881960
HHIP	Height	6E-51	    .07	[NR] unit decrease	rs7689420	T	0.16	20881960
ZBTB38	Height	3E-86	    .07	[NR] unit decrease	rs724016	A	0.56	20881960
GDF5	Height	1E-58	    .06	[NR] unit decrease	rs143384	A	0.58	20881960
MYO9A	Height	3E-8	    .06	[NR] unit decrease	rs12902421	T	0.97	20881960
CDC42EP3	Height	2E-18	    .06	[NR] unit decrease	rs17511102	A	0.91	20881960
SSSCA1	Height	4E-13	    .06	[NR] unit decrease	rs3782089	T	0.06	20881960
DLEU7	Height	1E-45	    .06	[NR] unit decrease	rs3118905	A	0.29	20881960
STAT2	Height	1E-13	    .05	[NR] unit decrease	rs2066807	C	0.93	20881960
EFEMP1	Height	3E-35	    .05	[NR] unit decrease	rs3791675	T	0.23	20881960
DOCK3	Height	4E-10	    .05	[NR] unit decrease	rs13088462	T	0.94	20881960
GSDMC	Height	2E-28	    .05	[NR] unit decrease	rs6470764	T	0.2	20881960
CYP19A1	Height	2E-9	    .05	[NR] unit decrease	rs16964211	A	0.05	20881960
PCSK5	Height	1E-11	    .05	[NR] unit decrease	rs11144688	A	0.11	20881960
GPR126	Height	1E-33	    .05	[NR] unit decrease	rs7763064	A	0.29	20881960
TULP4	Height	2E-9	    .05	[NR] unit decrease	rs9456307	A	0.06	20881960
GNA12	Height	2E-33	    .05	[NR] unit decrease	rs798489	T	0.3	20881960
SF3B4	Height	5E-32	    .05	[NR] unit decrease	rs11205277	A	0.58	20881960
NPPC	Height	6E-22	    .05	[NR] unit decrease	rs2580816	T	0.19	20881960
LIN28B	Height	8E-31	    .05	[NR] unit decrease	rs7759938	T	0.68	20881960
TSEN15	Height	2E-31	    .04	[NR] unit decrease	rs1046934	A	0.64	20881960
ADAMTSL3	Height	2E-35	    .04	[NR] unit decrease	rs11259936	A	0.48	20881960
PRKG2/BMP3	Height	9E-28	    .04	[NR] unit decrease	rs788867	T	0.68	20881960
SENP6	Height	3E-13	    .04	[NR] unit decrease	rs9360921	T	0.89	20881960
CSH1/GH1	Height	5E-25	    .04	[NR] unit decrease	rs2665838	C	0.73	20881960
SPAG17	Height	6E-23	    .04	[NR] unit decrease	rs9428104	A	0.24	20881960
ZNF341	Height	6E-22	    .04	[NR] unit decrease	rs7274811	T	0.23	20881960
MFAP2	Height	4E-29	    .04	[NR] unit decrease	rs2284746	C	0.48	20881960
DNM3	Height	1E-23	    .04	[NR] unit decrease	rs17346452	T	0.73	20881960
FER	Height	3E-8	    .04	[NR] unit decrease	rs13177718	T	0.07	20881960
L3MBTL3	Height	1E-21	    .04	[NR] unit decrease	rs6569648	T	0.76	20881960
BMP2	Height	2E-24	    .04	[NR] unit decrease	rs2145272	A	0.65	20881960
DYM	Height	9E-25	    .04	[NR] unit decrease	rs9967417	C	0.58	20881960
HDAC11	Height	7E-10	    .04	[NR] unit decrease	rs2597513	T	0.9	20881960
SLIT3	Height	7E-16	    .04	[NR] unit decrease	rs4282339	A	0.2	20881960
BMP6	Height	1E-23	    .04	[NR] unit decrease	rs3812163	A	0.54	20881960
SBNO1	Height	4E-15	    .04	[NR] unit decrease	rs11830103	A	0.78	20881960
ATAD5/RNF135	Height	2E-21	    .04	[NR] unit decrease	rs3764419	A	0.39	20881960
C3orf47	Height	9E-15	    .03	[NR] unit decrease	rs6439167	T	0.21	20881960
ESR1	Height	1E-17	    .03	[NR] unit decrease	rs543650	T	0.4	20881960
IGF2BP3	Height	2E-14	    .03	[NR] unit decrease	rs12534093	A	0.22	20881960
NARFL	Height	1E-13	    .03	[NR] unit decrease	rs11648796	A	0.74	20881960
NCKAP5	Height	2E-12	    .03	[NR] unit decrease	rs7567288	T	0.8	20881960
ID4	Height	2E-13	    .03	[NR] unit decrease	rs1047014	T	0.75	20881960
OR2J3	Height	2E-17	    .03	[NR] unit decrease	rs3129109	T	0.39	20881960
SIX6	Height	6E-17	    .03	[NR] unit decrease	rs2093210	T	0.58	20881960
ACBD4	Height	2E-16	    .03	[NR] unit decrease	rs4986172	T	0.35	20881960
RYBP	Height	4E-13	    .03	[NR] unit decrease	rs9863706	T	0.22	20881960
FGFR4/NSD1	Height	1E-12	    .03	[NR] unit decrease	rs422421	T	0.22	20881960
TMEM176A	Height	3E-13	    .03	[NR] unit decrease	rs2110001	C	0.69	20881960
PML	Height	1E-15	    .03	[NR] unit decrease	rs5742915	T	0.54	20881960
ADAMTS10	Height	4E-13	    .03	[NR] unit decrease	rs4072910	C	0.46	20881960
SCMH1	Height	2E-12	    .03	[NR] unit decrease	rs2154319	T	0.75	20881960
FBXW11	Height	4E-12	    .03	[NR] unit decrease	rs12153391	A	0.25	20881960
BOD1	Height	9E-16	    .03	[NR] unit decrease	rs889014	T	0.36	20881960
NOG	Height	7E-15	    .03	[NR] unit decrease	rs227724	A	0.65	20881960
DOT1L	Height	3E-16	    .03	[NR] unit decrease	rs12982744	C	0.6	20881960
SLC22A5	Height	7E-16	    .03	[NR] unit decrease	rs274546	A	0.4	20881960
HLA locus	Height	2E-16	    .03	[NR] unit decrease	rs6457620	C	0.51	20881960
PEX2	Height	7E-13	    .03	[NR] unit decrease	rs6473015	A	0.72	20881960
ETV6	Height	5E-15	    .03	[NR] unit decrease	rs2856321	A	0.64	20881960
INSR	Height	2E-12	    .03	[NR] unit decrease	rs891088	A	0.74	20881960
CLIC4	Height	2E-12	    .03	[NR] unit decrease	rs4601530	T	0.26	20881960
TGFB2	Height	2E-12	    .03	[NR] unit decrease	rs6684205	A	0.71	20881960
EIF2AK3	Height	1E-13	    .03	[NR] unit decrease	rs11684404	T	0.67	20881960
CPN1	Height	2E-13	    .03	[NR] unit decrease	rs11599750	T	0.38	20881960
CCDC53/GNPTAB	Height	8E-14	    .03	[NR] unit decrease	rs7971536	A	0.46	20881960
LTBP2	Height	7E-14	    .03	[NR] unit decrease	rs862034	A	0.36	20881960
ADAMTS17	Height	4E-13	    .03	[NR] unit decrease	rs4965598	T	0.68	20881960
MC4R	Height	4E-11	    .03	[NR] unit decrease	rs17782313	T	0.76	20881960
RTF1	Height	1E-12	    .03	[NR] unit decrease	rs2336725	T	0.55	20881960
SLC38A9	Height	2E-12	    .03	[NR] unit decrease	rs11958779	A	0.7	20881960
PTPRJ/SLC39A13	Height	4E-12	    .03	[NR] unit decrease	rs10838801	A	0.69	20881960
LTBP1	Height	2E-9	    .03	[NR] unit decrease	rs6714546	A	0.28	20881960
C3orf63	Height	5E-13	    .03	[NR] unit decrease	rs9835332	C	0.46	20881960
SUPT3H/RUNX2	Height	2E-9	    .03	[NR] unit decrease	rs9472414	A	0.22	20881960
LPAR1	Height	1E-9	    .03	[NR] unit decrease	rs1468758	T	0.25	20881960
PPIF	Height	4E-13	    .03	[NR] unit decrease	rs2145998	A	0.49	20881960
RAD51L1	Height	8E-9	    .03	[NR] unit decrease	rs1570106	T	0.2	20881960
LYPLAL1	Height	2E-12	    .03	[NR] unit decrease	rs11118346	T	0.47	20881960
PDIA4	Height	3E-8	    .03	[NR] unit decrease	rs822552	C	0.74	20881960
ADAM28	Height	2E-9	    .03	[NR] unit decrease	rs1013209	T	0.25	20881960
RPL5	Height	7E-11	    .02	[NR] unit decrease	rs10874746	T	0.37	20881960
SEPT2	Height	1E-8	    .02	[NR] unit decrease	rs12694997	A	0.24	20881960
PCCB	Height	4E-9	    .02	[NR] unit decrease	rs9844666	A	0.25	20881960
VGLL2	Height	1E-11	    .02	[NR] unit decrease	rs961764	C	0.42	20881960
STARD3NL	Height	2E-9	    .02	[NR] unit decrease	rs6959212	T	0.32	20881960
C9orf64	Height	5E-8	    .02	[NR] unit decrease	rs7853377	A	0.77	20881960
TRIP11	Height	1E-10	    .02	[NR] unit decrease	rs7155279	T	0.36	20881960
WWC2	Height	4E-8	    .02	[NR] unit decrease	rs955748	A	0.24	20881960
CEP120	Height	2E-10	    .02	[NR] unit decrease	rs1582931	A	0.47	20881960
RHOD	Height	9E-10	    .02	[NR] unit decrease	rs7112925	T	0.35	20881960
TEAD1	Height	4E-10	    .02	[NR] unit decrease	rs7926971	A	0.55	20881960
PDS5B/BRCA2	Height	6E-10	    .02	[NR] unit decrease	rs7332115	T	0.62	20881960
PIP4K2B	Height	3E-10	    .02	[NR] unit decrease	rs1043515	A	0.45	20881960
SMOX	Height	3E-9	    .02	[NR] unit decrease	rs1741344	T	0.63	20881960
PAPPA2	Height	1E-9	    .02	[NR] unit decrease	rs1325598	A	0.43	20881960
GFPT2	Height	2E-9	    .02	[NR] unit decrease	rs6879260	T	0.39	20881960
ANKRD13B	Height	7E-9	    .02	[NR] unit decrease	rs3110496	A	0.33	20881960
DTL	Height	2E-9	    .02	[NR] unit decrease	rs10863936	A	0.53	20881960
CCDC3	Height	3E-9	    .02	[NR] unit decrease	rs7909670	T	0.44	20881960
C2CD4A	Height	6E-9	    .02	[NR] unit decrease	rs7178424	T	0.47	20881960
ZBTB24	Height	3E-8	    .02	[NR] unit increase	rs1046943	A	0.58	20881960
TREH	Height	2E-8	    .02	[NR] unit increase	rs494459	T	0.41	20881960
LIN28	Height	3E-8	    .02	[NR] unit increase	rs7532866	A	0.67	20881960
PKN2	Height	5E-9	    .02	[NR] unit increase	rs6699417	T	0.61	20881960
ZNF652	Height	4E-8	    .02	[NR] unit increase	rs2072153	C	0.3	20881960
NME2	Height	3E-8	    .02	[NR] unit increase	rs4605213	C	0.34	20881960
PRKCZ	Height	2E-8	    .02	[NR] unit increase	rs425277	T	0.28	20881960
BNC2	Height	2E-8	    .02	[NR] unit increase	rs7864648	T	0.32	20881960
NUCB2	Height	5E-9	    .02	[NR] unit increase	rs1330	T	0.35	20881960
FOLH1	Height	2E-8	    .02	[NR] unit increase	rs1814175	T	0.34	20881960
SERPINE2	Height	8E-12	    .02	[NR] unit increase	rs2629046	T	0.55	20881960
TET2	Height	4E-11	    .02	[NR] unit increase	rs10010325	A	0.49	20881960
KCNJ12	Height	2E-8	    .02	[NR] unit increase	rs4640244	A	0.61	20881960
HTR1D	Height	3E-12	    .03	[NR] unit increase	rs1738475	C	0.59	20881960
C2orf34	Height	8E-10	    .03	[NR] unit increase	rs2341459	T	0.27	20881960
SLBP/FGFR3	Height	2E-11	    .03	[NR] unit increase	rs2247341	A	0.36	20881960
FLI1	Height	4E-11	    .03	[NR] unit increase	rs654723	A	0.62	20881960
GPC5	Height	1E-11	    .03	[NR] unit increase	rs7319045	A	0.4	20881960
KCNJ16/KCNJ2	Height	2E-10	    .03	[NR] unit increase	rs11867479	T	0.34	20881960
MYO9B	Height	3E-8	    .03	[NR] unit increase	rs2279008	T	0.74	20881960
FAM46A	Height	2E-13	    .03	[NR] unit increase	rs310405	A	0.52	20881960
PAPPA	Height	7E-10	    .03	[NR] unit increase	rs751543	T	0.72	20881960
ZCCHC6	Height	3E-12	    .03	[NR] unit increase	rs8181166	C	0.53	20881960
KCNE2	Height	5E-12	    .03	[NR] unit increase	rs2834442	A	0.65	20881960
OR4A5	Height	3E-8	    .03	[NR] unit increase	rs5017948	A	0.18	20881960
MKL2	Height	1E-11	    .03	[NR] unit increase	rs1659127	A	0.34	20881960
SOCS5	Height	3E-13	    .03	[NR] unit increase	rs12474201	A	0.35	20881960
ADAMTS3	Height	2E-14	    .03	[NR] unit increase	rs7697556	T	0.47	20881960
ZFAT	Height	2E-14	    .03	[NR] unit increase	rs12680655	C	0.6	20881960
LRRC37B	Height	3E-8	    .03	[NR] unit increase	rs17780086	A	0.15	20881960
DNAJC27	Height	7E-16	    .03	[NR] unit increase	rs4665736	T	0.54	20881960
IGF2BP2	Height	2E-14	    .03	[NR] unit increase	rs720390	A	0.39	20881960
TWISTNB	Height	9E-10	    .03	[NR] unit increase	rs4470914	T	0.18	20881960
QSOX2	Height	5E-14	    .03	[NR] unit increase	rs7849585	T	0.33	20881960
CTU2/GALNS	Height	3E-8	    .03	[NR] unit increase	rs8052560	A	0.79	20881960
POLR2B	Height	4E-11	    .03	[NR] unit increase	rs17081935	T	0.2	20881960
PITX1	Height	2E-13	    .03	[NR] unit increase	rs526896	T	0.73	20881960
IPPK	Height	8E-17	    .03	[NR] unit increase	rs9969804	A	0.44	20881960
SPIN1	Height	9E-13	    .03	[NR] unit increase	rs2778031	T	0.24	20881960
ZNF462	Height	2E-13	    .03	[NR] unit increase	rs7027110	A	0.23	20881960
SYN3	Height	3E-10	    .03	[NR] unit increase	rs4821083	T	0.84	20881960
JMJD4	Height	2E-13	    .03	[NR] unit increase	rs10799445	A	0.77	20881960
MEF2C	Height	2E-18	    .03	[NR] unit increase	rs10037512	T	0.56	20881960
FUBP3	Height	3E-17	    .03	[NR] unit increase	rs7466269	A	0.64	20881960
CCDC91	Height	7E-17	    .03	[NR] unit increase	rs2638953	C	0.68	20881960
ATP5SL	Height	5E-16	    .03	[NR] unit increase	rs17318596	A	0.36	20881960
GHSR	Height	3E-18	    .03	[NR] unit increase	rs572169	T	0.31	20881960
SLCO1C1	Height	8E-18	    .03	[NR] unit increase	rs10770705	A	0.33	20881960
TNS1	Height	2E-14	    .03	[NR] unit increase	rs1351164	T	0.79	20881960
NPR3	Height	2E-21	    .03	[NR] unit increase	rs1173727	T	0.4	20881960
C6orf173	Height	4E-21	    .03	[NR] unit increase	rs1490384	T	0.5	20881960
NFATC4	Height	2E-18	    .03	[NR] unit increase	rs1950500	T	0.29	20881960
CASKIN1	Height	9E-17	    .03	[NR] unit increase	rs26868	A	0.46	20881960
SUCLG2	Height	2E-9	    .04	[NR] unit increase	rs17806888	T	0.88	20881960
NFIC	Height	4E-16	    .04	[NR] unit increase	rs7507204	C	0.24	20881960
PDE11A	Height	3E-8	    .04	[NR] unit increase	rs7567851	C	0.08	20881960
FRS2	Height	2E-20	    .04	[NR] unit increase	rs10748128	T	0.35	20881960
SERPINH1	Height	4E-13	    .04	[NR] unit increase	rs634552	T	0.14	20881960
MICA	Height	8E-29	    .04	[NR] unit increase	rs2256183	A	0.45	20881960
JAZF1	Height	6E-25	    .04	[NR] unit increase	rs1708299	A	0.3	20881960
TBX2	Height	2E-24	    .04	[NR] unit increase	rs2079795	T	0.33	20881960
CCDC108/IHH	Height	9E-12	    .04	[NR] unit increase	rs12470505	T	0.9	20881960
TLE3	Height	3E-10	    .04	[NR] unit increase	rs10152591	A	0.91	20881960
ZNFX1	Height	1E-20	    .04	[NR] unit increase	rs237743	A	0.21	20881960
GIPC2	Height	2E-11	    .04	[NR] unit increase	rs17391694	T	0.12	20881960
KCNQ1	Height	2E-13	    .05	[NR] unit increase	rs2237886	T	0.11	20881960
CABLES1	Height	4E-30	    .05	[NR] unit increase	rs4800452	T	0.79	20881960
Histone cluster	Height	1E-39	    .05	[NR] unit increase	rs806794	A	0.7	20881960
SOCS2	Height	1E-34	    .05	[NR] unit increase	rs11107116	T	0.22	20881960
CDK6	Height	8E-47	    .06	[NR] unit increase	rs42235	T	0.31	20881960
IGF1R	Height	3E-21	    .06	[NR] unit increase	rs2871865	C	0.88	20881960
SDR16C5	Height	8E-27	    .06	[NR] unit increase	rs7460090	T	0.87	20881960
HMGA2	Height	2E-65	    .06	[NR] unit increase	rs1351394	T	0.49	20881960
PTCH1/FANCC	Height	2E-17	    .07	[NR] unit increase	rs473902	T	0.92	20881960
PTPDC1	Height	1E-9	    .07	[NR] unit increase	rs1257763	A	0.04	20881960
LCORL	Height	7E-46	    .08	[NR] unit increase	rs6449353	T	0.85	20881960
HBS1L,MYB	Red blood cell traits	1E-14	    .09	[0.07-0.11] unit decrease	rs7775698	T	0.26	20927387
TMPRSS6	Red blood cell traits	5E-9	    .62	[0.41-0.83] unit decrease	rs855791	A	0.44	20927387
TMPRSS6	Red blood cell traits	1E-12	    .29	[0.21-0.37] unit decrease	rs855791	A	0.44	20927387
HBS1L, MYB	Red blood cell traits	1E-15	    .38	[0.29-0.47] unit increase	rs7775698	T	0.24	20927387
HFE	Red blood cell traits	3E-9	    .49	[0.33-0.65] unit increase	rs1800562	A	0.06	20927387
SLC17A1	Red blood cell traits	5E-8	    .38	[0.24-0.52] unit increase	rs17342717	T	0.10	20927387
HBS1L,MYB	Red blood cell traits	6E-9	    .07	[0.05-0.09] unit decrease	rs6569992	A	0.20	20927387
HBS1L, MYB	Red blood cell traits	3E-15	    .98	[0.74-1.22] unit increase	rs9494145	C	0.24	20927387
HBS1L,MYB	Red blood cell traits	3E-8	    .75	[0.48-1.02] unit increase	rs6569992	A	0.20	20927387
HBS1L,MYB	Red blood cell traits	1E-8	    .30	[0.19-0.40] unit increase	rs6569992	A	0.19	20927387
TMPRSS6	Red blood cell traits	1E-12	    .09	[0.07-0.11] unit decrease	rs4820268	G	0.47	20927387
HFE	Red blood cell traits	3E-9	    .49	[NR] unit increase	rs1800562	A	0.06	20927387
C3orf21	Non-small cell lung cancer	2E-8	   1.30	[1.19-1.42] 	rs2131877	G	0.44	20876614
CDH13	Adiponectin levels	4E-30	    .11	[0.09-0.13] unit decrease	rs3865188	T	0.47	20876611
ADIPOQ	Adiponectin levels	1E-19	    .13	[0.10-0.16] unit increase	rs864265	G	0.88	20876611
KNG1	Adiponectin levels	2E-9	    .06	[0.04-0.08] unit decrease	rs11924390	C	0.50	20876611
FGFR2	Breast cancer	2E-13	   1.32	[1.22-1.42] 	rs1219648	G	0.42	20872241
TP63	Lung adenocarcinoma	7E-12	   1.31	[1.22-1.42] 	rs10937405	C	0.67	20871597
TERT	Lung adenocarcinoma	3E-11	   1.27	[1.19-1.37] 	rs2736100	C	0.39	20871597
ARMS2,HTRA1	Age-related macular degeneration	1E-60	   2.75	[NR] 	rs10490924	T	NR	20861866
C3, R102G	Age-related macular degeneration	1E-8	   1.44	[NR] 	rs2230199	C	NR	20861866
IL18R1	Asthma	3E-9	   1.15	[1.10-1.20] 	rs3771166	G	0.62	20860503
HLA-DQ	Asthma	7E-14	   1.18	[1.13-1.24] 	rs9273349	C	0.58	20860503
IL33	Asthma	9E-10	   1.20	[1.13-1.28] 	rs1342326	C	0.16	20860503
SMAD3	Asthma	4E-9	   1.12	[1.09-1.16] 	rs744910	G	0.49	20860503
GSDMA	Asthma	5E-9	   1.17	[1.11-1.23] 	rs3894194	A	0.45	20860503
IL2RB	Asthma	1E-8	   1.12	[1.08-1.16] 	rs2284033	G	0.56	20860503
APOE,TOMM40	Alzheimer's disease (late onset)	5E-36	   2.94	[2.48-3.47] 	rs2075650	G	0.20	20885792
MTHFD1L	Alzheimer's disease (late onset)	2E-10	   2.10	[1.67-2.64] 	rs11754661	A	0.07	20885792
Intergenic	Alzheimer's disease (late onset)	4E-8	   1.76	[1.44-2.15] 	rs4676049	A	0.08	20885792
FADS1	HDL cholesterol	1E-12	    .01	[0.007-0.015] unit decrease	rs174548	G	0.17	20864672
TTC39B	HDL cholesterol	7E-9	    .01	[0.009-0.017] unit decrease	rs643531	C	0.07	20864672
GALNT2	HDL cholesterol	4E-9	    .02	[0.01-0.03] unit increase	rs10489615	G	0.60	20864672
LPL	HDL cholesterol	8E-26	    .05	[0.04-0.06] unit decrease	rs325	T	0.89	20864672
ZNF259, APOA5,APOA4,APOC3,APOA1	HDL cholesterol	2E-11	    .03	[0.02-0.04] unit decrease	rs964184	G	0.12	20864672
LIPC	HDL cholesterol	5E-22	    .03	[0.02-0.04] unit increase	rs261334	G	0.20	20864672
CETP	HDL cholesterol	1E-32	    .04	[0.03-0.05] unit increase	rs9989419	G	0.60	20864672
LIPG	HDL cholesterol	2E-12	    .03	[0.02-0.04] unit increase	rs2156552	T	0.81	20864672
MYLIP,GMPR	LDL cholesterol	2E-8	    .01	[0.007-0.015] unit increase	rs2142672	C	0.74	20864672
PCSK9	LDL cholesterol	1E-10	    .03	[0.02-0.04] unit increase	rs11206510	T	0.77	20864672
CELSR2	LDL cholesterol	1E-26	    .04	[0.03-0.05] unit decrease	rs660240	A	0.21	20864672
APOB	LDL cholesterol	2E-20	    .04	[0.03-0.05] unit decrease	rs515135	A	0.19	20864672
HMGCR	LDL cholesterol	1E-11	    .02	[0.01-0.03] unit decrease	rs12916	T	0.62	20864672
SF4,CILP2	LDL cholesterol	1E-11	    .05	[0.04-0.06] unit increase	rs10401969	T	0.91	20864672
APOE,APOC1,APOC4,APOC2	LDL cholesterol	2E-40	    .06	[0.05-0.07] unit increase	rs4420638	G	0.18	20864672
PPP1R3B	LDL cholesterol	7E-12	    .02	[0.01-0.03] unit decrease	rs2126259	A	0.13	20864672
BUD13,ZNF259,APOA5,APOA4,APOC3,APOA1	Triglycerides	4E-21	    .07	[0.06-0.08] unit decrease	rs4938303	T	0.75	20864672
GCKR	Triglycerides	2E-19	    .05	[0.04-0.06] unit decrease	rs1260333	C	0.55	20864672
BAZ1B, BCL7B, TBL2, MLXIPL	Triglycerides	2E-12	    .05	[0.03-0.07] unit increase	rs1178979	A	0.80	20864672
LPL	Triglycerides	4E-26	    .07	[0.06-0.08] increase	rs10105606	C	0.68	20864672
TRIB1	Triglycerides	2E-11	    .04	[0.03-0.05] unit decrease	rs2954029	T	0.46	20864672
CILP2,ZNF101	Triglycerides	4E-8	    .07	[0.04-0.10] unit decrease	rs2304130	G	0.09	20864672
AFF1	Triglycerides	3E-10	    .02	[0.01-0.03] unit increase	rs442177	A	0.50	20864672
FADS1	Triglycerides	5E-14	    .03	[0.02-0.04] unit increase	rs174548	G	0.17	20864672
SPTA1	Glycated hemoglobin levels	3E-9	    .02	[0.01-0.03] % increase	rs2779116	T	0.27	20858683
G6PC2,ABCB11	Glycated hemoglobin levels	8E-18	    .05	[0.04-0.06] % increase	rs552976	G	0.64	20858683
HFE	Glycated hemoglobin levels	3E-20	    .06	[0.05-0.07] % increase	rs1800562	G	0.94	20858683
GCK	Glycated hemoglobin levels	1E-20	    .04	[0.03-0.05] % increase	rs1799884	T	0.18	20858683
ANK1	Glycated hemoglobin levels	6E-12	    .03	[0.02-0.04] % increase	rs4737009	A	0.24	20858683
HK1	Glycated hemoglobin levels	3E-54	    .09	[0.08-0.10] % increase	rs16926246	C	0.90	20858683
MTNR1B	Glycated hemoglobin levels	4E-11	    .03	[0.02-0.04] % increase	rs1387153	T	0.28	20858683
ATP11A,TUBGCP3	Glycated hemoglobin levels	5E-9	    .03	[0.02-0.04] % increase	rs7998202	G	0.14	20858683
FN3K	Glycated hemoglobin levels	2E-26	    .04	[0.03-0.05] % increase	rs1046896	T	0.31	20858683
TMPRSS6	Glycated hemoglobin levels	3E-14	    .03	[0.02-0.04] % increase	rs855791	A	0.42	20858683
ANK1	Glycated hemoglobin levels	1E-8	    .06	[0.04-0.08] % increase	rs6474359	T	0.97	20858683
ABHD8,ANKLE1,C19orf62	Breast cancer	2E-9	   1.26	[1.17-1.35] 	rs8170	A	0.17	20852631
HOXD1,HOXD3	Ovarian cancer	5E-14	   1.16	[1.12-1.21] 	rs2072590	T	NR	20852632
MYC,THEM75	Ovarian cancer	3E-9	   1.19	[1.12-1.25] 	rs10088218	G	NR	20852632
CDC123,CAMK1D	Type 2 diabetes	1E-8	   1.13	[1.08-1.18] 	rs10906115	A	0.57	20862305
SPRY2	Type 2 diabetes	6E-9	   1.15	[1.10-1.20] 	rs1359790	G	0.71	20862305
RASGRF1	Refractive error	2E-9	    .15	[0.10-0.20] diopter decrease	rs939658	G	0.52	20835236
GJD2,ACTC1,GOLGA8B	Refractive error	2E-14	    .23	[0.228-0.232] diopter increase	rs634990	C	0.47	20835239
CAV1,CAV2	Glaucoma (primary open-angle)	2E-11	   1.27	[1.18-1.36] 	rs4236601	A	0.23	20835238
CYP4F2	Warfarin maintenance dose	3E-8	NR	NR	rs2108622	T	NR	20833655
TCF4	Fuchs's corneal dystrophy	1E-18	   5.47	[3.75-7.99] 	rs613872	G	0.15	20825314
CETP,HERPUD1	Cardiovascular disease risk factors	1E-23	   2.99	[2.42-3.56] % SD increase	rs247616	T	0.33	20838585
APOE	Cardiovascular disease risk factors	9E-19	  11.96	[9.33-14.59] % SD increase	rs445925	G	NR	20838585
MTDH,PGCP	Migraine	2E-11	   1.18	[1.13-1.24] 	rs1835740	A	0.21	20802479
MOBKL2B,IFNK,C9orf72	Amyotrophic lateral sclerosis	9E-11	   2.16	[1.72-2.70] 	rs3849942	A	0.16	20801718
SOD1	Amyotrophic lateral sclerosis	3E-8	   2.02	[1.61-2.53] 	rs13048019	T	0.17	20801718
PROC	Protein C levels	4E-36	    .12	[0.10-0.14] ug/ml decrease	rs1158867	C	0.42	20802025
PROCR	Protein C levels	2E-200	    .47	[0.44-0.50] ug/ml increase	rs867186	C	0.10	20802025
EDEM2	Protein C levels	7E-37	    .14	[0.12-0.16] ug/ml decrease	rs6120849	T	0.23	20802025
BAZ1B	Protein C levels	3E-8	    .06	[0.04-0.08] ug/ml decrease	rs17145713	T	0.20	20802025
PLCE1,NOC3L	Esophageal cancer and gastric cancer	4E-9	   1.36	[1.23-1.50] 	rs3781264	C	0.15	20729852
PLCE1,NOC3L	Esophageal cancer and gastric cancer	2E-9	   1.35	[1.22-1.49] 	rs3765524	T	0.207	20729852
CHEK2,HSCB	Esophageal cancer and gastric cancer	1E-8	   1.30	[1.19-1.43] 	rs738722	T	0.25	20729852
COL5A1	Central corneal thickness	5E-8	    .13	[0.09-0.18] unit decrease	rs7044529	A	NR	20719862
FOXO1	Central corneal thickness	1E-8	    .17	[0.11-0.23] unit increase	rs2755237	A	NR	20719862
ZNF469,BANP	Central corneal thickness	6E-22	    .16	[0.13-0.19] unit decrease	rs12447690	G	0.38	20719862
AVGR8,AL354828.1	Central corneal thickness	4E-9	    .14	[0.10-0.19] unit decrease	rs1034200	C	0.22	20719862
PDE8A,AKAP13	Central corneal thickness	1E-8	    .13	[0.09-0.18] unit increase	rs6496932	C	0.22	20719862
ADM	Schizophrenia, bipolar disorder and depression (combined)	4E-8	NR	NR	rs6484218	A	0.14	20713499
HLA-DRA	Parkinson's disease	2E-10	   1.26	[1.17-1.35] 	rs3129882	G	0.40	20711177
GAK	Parkinson's disease	3E-9	   1.46	[1.29-1.65] 	rs11248051	T	0.09	20711177
SNCA	Parkinson's disease	3E-11	   1.38	[1.25-1.52] 	rs356220	T	0.36	20711177
HLA-DQA2	Narcolepsy	3E-8	   1.79	[1.45-2.17] 	rs2858884	A	0.81	20711174
Intergenic	Keloid	6E-23	   1.77	[1.58-1.99] 	rs873549	C	0.28	20711176
LOC389151, FOXL2	Keloid	2E-13	   1.87	[1.58-2.21] 	rs1511412	A	0.08	20711176
NEDD4	Keloid	6E-13	   1.51	[1.35-1.69] 	rs8032158	C	0.36	20711176
CASR,CSTA,WDR5B,KPNA1,C3orf28,CCDC58	Calcium levels	2E-22	    .06	[0.05-0.07] unit increase	rs17251221	G	0.14	20705733
Intergenic	Non-alcoholic fatty liver disease histology (other)	3E-8	   1.31	[NR] unit increase	rs343064	A	0.40	20708005
HLA-DRB1	Immunoglobulin A 	2E-33	   2.53	[2.17-2.95] 	rs2187668	A	0.13	20694011
GATA6,CTAGE1,RBBP8,CABLES1	Tuberculosis	7E-9	   1.19	[1.10-1.30] 	rs4331426	G	0.48	20694014
CLPTM1L,TERT	Lung adenocarcinoma	2E-22	   1.46	[1.35-1.57] 	rs2736100	G	0.39	20700438
MUC1	Magnesium levels	2E-36	    .01	[0.008-0.012] mmol/L decrease	rs4072037	C	0.46	20700443
SHROOM3	Magnesium levels	6E-13	    .01	[0.003-0.007] mmol/L decrease	rs13146355	G	0.56	20700443
ATP2B1	Magnesium levels	1E-16	    .07	[0.005-0.009] mmol/L decrease	rs7965584	G	0.29	20700443
TRPM6	Magnesium levels	8E-15	    .01	[0.009-0.013] mmol/L decrease	rs11144134	T	0.92	20700443
DCDC5	Magnesium levels	5E-16	    .01	[0.004-0.008] mmol/L decrease	rs3925584	C	0.45	20700443
MDS1	Magnesium levels	1E-8	    .00	[0.002-0.006] mmol/L decrease	rs448378	G	0.47	20700443
CELSR2,PSRC1,SORT1	Cholesterol, total	6E-131	   5.41	[4.94-5.88] mg/dL decrease	rs629301	G	0.22	20686565
APOE,APOC1,APOC2	Cholesterol, total	5E-111	   6.83	[6.2-7.46] mg/dL increase	rs4420638	G	0.17	20686565
LDLR	Cholesterol, total	7E-97	   7.09	[6.42-7.76] mg/dL decrease	rs6511720	T	0.11	20686565
APOB	Cholesterol, total	4E-96	   4.16	[3.73-4.59] mg/dL increase	rs1367117	A	0.3	20686565
APOA1,APOC3,APOA4,APOA5	Cholesterol, total	6E-57	   4.68	[4.11-5.25] mg/dL increase	rs964184	G	0.13	20686565
HMGCR	Cholesterol, total	9E-47	   2.84	[2.45-3.23] mg/dL increase	rs12916	C	0.39	20686565
ABCG5,ABCG8	Cholesterol, total	4E-45	   3.01	[2.58-3.44] mg/dL increase	rs4299376	G	0.3	20686565
ANGPTL3,DOCK7	Cholesterol, total	5E-41	   2.60	[2.21-2.99] mg/dL decrease	rs2131925	G	0.32	20686565
CSPG3,CILP2,PBX4	Cholesterol, total	3E-38	   4.74	[3.92-5.56] mg/dL decrease	rs10401969	C	0.07	20686565
TRIB1	Cholesterol, total	5E-36	   2.30	[1.93-2.67] mg/dL decrease	rs2954029	A	0.46	20686565
TIMD4,HAVCR1	Cholesterol, total	7E-28	   1.98	[1.59-2.37] mg/dL decrease	rs6882076	T	0.35	20686565
ABCA1	Cholesterol, total	3E-27	   2.24	[1.77-2.71] mg/dL decrease	rs1883025	T	0.25	20686565
GCKR	Cholesterol, total	7E-27	   1.91	[1.54-2.28] mg/dL increase	rs1260326	T	0.41	20686565
HP,HPR,DHX38	Cholesterol, total	3E-24	   2.34	[1.87-2.81] mg/dL increase	rs2000999	A	0.2	20686565
PCSK9	Cholesterol, total	4E-24	   1.96	[1.49-2.43] mg/dL increase	rs2479409	G	0.3	20686565
PPP1R3B	Cholesterol, total	9E-24	   3.14	[2.51-3.77] mg/dL decrease	rs9987289	T	0.1	20686565
FADS1,FADS2,FADS3	Cholesterol, total	2E-22	   1.78	[1.39-2.17] mg/dL decrease	rs174546	C	0.34	20686565
ABO	Cholesterol, total	9E-21	   2.30	[1.81-2.79] mg/dL increase	rs635634	T	0.21	20686565
LIPC	Cholesterol, total	9E-20	   1.54	[1.15-1.93] mg/dL increase	rs1532085	A	0.39	20686565
LIPG	Cholesterol, total	2E-19	   1.94	[1.43-2.45] mg/dL decrease	rs7241918	A	0.17	20686565
HLA	Cholesterol, total	4E-19	   2.31	[1.78-2.84] mg/dL increase	rs3177928	A	0.16	20686565
TOP1	Cholesterol, total	3E-17	   1.52	[1.15-1.89] mg/dL increase	rs6029526	C	0.47	20686565
LPA	Cholesterol, total	1E-16	   2.18	[1.65-2.71] mg/dL increase	rs1564348	C	0.17	20686565
HNF1A	Cholesterol, total	1E-14	   1.45	[1.06-1.84] mg/dL increase	rs1169288	C	0.33	20686565
IRF2BP2,TOMM20	Cholesterol, total	5E-14	   1.36	[0.97-1.75] mg/dL decrease	rs514230	A	0.48	20686565
CETP	Cholesterol, total	7E-14	   1.67	[1.22-2.12] mg/dL increase	rs3764261	A	0.32	20686565
MOSC1	Cholesterol, total	5E-13	   1.38	[0.95-1.81] mg/dL decrease	rs2642442	T	0.32	20686565
HNF4A	Cholesterol, total	6E-13	   4.73	[3.44-6.02] mg/dL decrease	rs1800961	T	0.03	20686565
CYP7A1	Cholesterol, total	9E-13	   1.26	[0.87-1.65] mg/dL increase	rs2081687	A	0.35	20686565
BRAP	Cholesterol, total	7E-12	    .96	[0.57-1.35] mg/dL decrease	rs11065987	G	0.42	20686565
ST3GAL4	Cholesterol, total	2E-11	   2.01	[1.36-2.66] mg/dL increase	rs11220462	T	0.11	20686565
NPC1L1	Cholesterol, total	3E-11	   2.01	[1.44-2.58] mg/dL increase	rs2072183	C	0.25	20686565
TMEM57,LDLRAP1	Cholesterol, total	4E-11	   1.22	[0.85-1.59] mg/dL decrease	rs12027135	A	0.47	20686565
C6orf106	Cholesterol, total	5E-11	   1.86	[1.21-2.51] mg/dL decrease	rs2814982	T	0.11	20686565
MAFB	Cholesterol, total	6E-11	   1.38	[0.97-1.79] mg/dL decrease	rs2902940	G	0.29	20686565
UBASH3B	Cholesterol, total	2E-10	    .97	[0.6-1.34] mg/dL increase	rs7941030	C	0.38	20686565
FRK	Cholesterol, total	2E-10	   1.18	[0.79-1.57] mg/dL decrease	rs9488822	T	0.35	20686565
FUT2,FLJ36070	Cholesterol, total	2E-10	   1.27	[0.86-1.68] mg/dL increase	rs492602	G	0.49	20686565
GPAM	Cholesterol, total	2E-10	   1.14	[0.75-1.53] mg/dL increase	rs2255141	A	0.3	20686565
ERGIC3	Cholesterol, total	4E-10	   1.19	[0.66-1.72] mg/dL decrease	rs2277862	T	0.15	20686565
DNAH11	Cholesterol, total	7E-10	   1.70	[1.15-2.25] mg/dL increase	rs12670798	T	0.15	20686565
PLEC1	Cholesterol, total	9E-10	   1.34	[0.87-1.81] mg/dL increase	rs11136341	G	0.4	20686565
NAT2	Cholesterol, total	2E-9	   1.07	[0.66-1.48] mg/dL increase	rs1495741	G	0.32	20686565
IDOL	Cholesterol, total	3E-9	   1.46	[0.99-1.93] mg/dL decrease	rs3757354	T	0.22	20686565
TTC39B	Cholesterol, total	3E-9	   1.57	[1.06-2.08] mg/dL decrease	rs581080	G	0.18	20686565
RAF1	Cholesterol, total	4E-9	   1.42	[0.97-1.87] mg/dL decrease	rs2290159	C	0.22	20686565
OSBPL7	Cholesterol, total	1E-8	   1.01	[0.62-1.4] mg/dL increase	rs7206971	A	0.49	20686565
RAB3GAP1	Cholesterol, total	1E-8	   1.18	[0.75-1.61] mg/dL increase	rs7570971	T	0.31	20686565
TRPS1	Cholesterol, total	2E-8	   1.11	[0.7-1.52] mg/dL decrease	rs2737229	C	0.3	20686565
HFE,HIST1H4C	Cholesterol, total	2E-8	   2.16	[1.32-3] mg/dL decrease	rs1800562	A	0.06	20686565
SPTY2D1	Cholesterol, total	3E-8	   1.06	[0.63-1.49] mg/dL decrease	rs10128711	T	0.29	20686565
GVI1,EVI5	Cholesterol, total	3E-8	   1.18	[0.71-1.65] mg/dL decrease	rs7515577	C	0.21	20686565
LPL	HDL cholesterol	1E-97	   2.25	[2.01-2.49] mg/dL increase	rs12678919	G	0.12	20686565
LIPC	HDL cholesterol	3E-96	   1.45	[1.29-1.61] mg/dL increase	rs1532085	A	0.39	20686565
LIPG	HDL cholesterol	3E-49	   1.31	[1.11-1.51] mg/dL decrease	rs7241918	G	0.17	20686565
APOA1,APOC3,APOA4,APOA5	HDL cholesterol	5E-47	   1.50	[1.28-1.72] mg/dL decrease	rs964184	G	0.13	20686565
ABCA1	HDL cholesterol	2E-33	    .94	[0.76-1.12] mg/dL decrease	rs1883025	T	0.25	20686565
LCAT	HDL cholesterol	8E-33	   1.27	[1.05-1.49] mg/dL increase	rs16942887	A	0.12	20686565
APOB	HDL cholesterol	1E-30	    .90	[0.72-1.08] mg/dL increase	rs1042034	C	0.22	20686565
PPP1R3B	HDL cholesterol	6E-25	   1.21	[0.96-1.46] mg/dL decrease	rs9987289	A	0.09	20686565
FADS1,FADS2,FADS3	HDL cholesterol	2E-22	    .73	[0.57-0.89] mg/dL decrease	rs174546	T	0.36	20686565
PLTP	HDL cholesterol	2E-22	    .93	[0.73-1.13] mg/dL decrease	rs6065906	C	0.18	20686565
GALNT2	HDL cholesterol	4E-21	    .61	[0.47-0.75] mg/dL decrease	rs4846914	G	0.4	20686565
APOE,APOC1,APOC2	HDL cholesterol	4E-21	   1.06	[0.82-1.3] mg/dL decrease	rs4420638	G	0.17	20686565
TRIB1	HDL cholesterol	6E-19	    .61	[0.47-0.75] mg/dL increase	rs2954029	T	0.44	20686565
LRP4,NR1H3	HDL cholesterol	3E-18	    .78	[0.58-0.98] mg/dL increase	rs3136441	C	0.15	20686565
LILRA3,LILRB2	HDL cholesterol	4E-16	    .83	[0.61-1.05] mg/dL increase	rs386000	C	0.2	20686565
HNF4A	HDL cholesterol	1E-15	   1.88	[1.41-2.35] mg/dL decrease	rs1800961	T	0.03	20686565
KLF14	HDL cholesterol	1E-15	    .59	[0.45-0.73] mg/dL increase	rs4731702	T	0.48	20686565
MMAB,MVK	HDL cholesterol	7E-15	    .44	[0.3-0.58] mg/dL decrease	rs7134594	C	0.47	20686565
SCARB1	HDL cholesterol	3E-14	    .61	[0.43-0.79] mg/dL increase	rs838880	C	0.31	20686565
STARD3	HDL cholesterol	3E-14	    .51	[0.35-0.67] mg/dL decrease	rs11869286	C	0.34	20686565
TTC39B	HDL cholesterol	1E-13	    .72	[0.52-0.92] mg/dL decrease	rs581080	C	0.14	20686565
CMIP	HDL cholesterol	2E-11	    .45	[0.29-0.61] mg/dL decrease	rs2925979	T	0.3	20686565
TRPS1	HDL cholesterol	6E-11	    .44	[0.28-0.6] mg/dL decrease	rs2293889	T	0.41	20686565
SLC39A8	HDL cholesterol	7E-11	    .84	[0.53-1.15] mg/dL decrease	rs13107325	T	0.07	20686565
ABCA8	HDL cholesterol	2E-10	    .42	[0.26-0.58] mg/dL decrease	rs4148008	G	0.32	20686565
COBLL1	HDL cholesterol	3E-10	    .68	[0.44-0.92] mg/dL increase	rs12328675	C	0.13	20686565
CCDC92,ZNF664	HDL cholesterol	3E-10	    .44	[0.28-0.6] mg/dL increase	rs4765127	T	0.34	20686565
ZNF648	HDL cholesterol	3E-10	    .47	[0.31-0.63] mg/dL decrease	rs1689800	G	0.35	20686565
MACF1,PABPC4	HDL cholesterol	4E-10	    .48	[0.3-0.66] mg/dL decrease	rs4660293	G	0.23	20686565
MLXIPL	HDL cholesterol	1E-9	    .57	[0.33-0.81] mg/dL increase	rs17145738	T	0.12	20686565
IRS1	HDL cholesterol	2E-9	    .46	[0.3-0.62] mg/dL increase	rs2972146	C	0.37	20686565
DOCK6,LOC55908	HDL cholesterol	3E-9	    .64	[0.37-0.91] mg/dL decrease	rs737337	C	0.08	20686565
C6orf106	HDL cholesterol	4E-9	    .49	[0.29-0.69] mg/dL decrease	rs2814944	A	0.16	20686565
PGS1	HDL cholesterol	5E-9	    .40	[0.24-0.56] mg/dL decrease	rs4129767	G	0.48	20686565
RPS3A,MC4R	HDL cholesterol	7E-9	    .42	[0.24-0.6] mg/dL decrease	rs12967135	A	0.23	20686565
SBNO1	HDL cholesterol	8E-9	    .86	[0.55-1.17] mg/dL increase	rs4759375	T	0.06	20686565
LACTB	HDL cholesterol	9E-9	    .39	[0.19-0.59] mg/dL decrease	rs2652834	A	0.2	20686565
UBE2L3	HDL cholesterol	1E-8	    .46	[0.28-0.64] mg/dL decrease	rs181362	T	0.2	20686565
LRP1	HDL cholesterol	2E-8	    .46	[0.28-0.64] mg/dL increase	rs11613352	T	0.24	20686565
CITED2	HDL cholesterol	3E-8	    .39	[0.23-0.55] mg/dL decrease	rs605066	C	0.42	20686565
UBASH3B	HDL cholesterol	3E-8	    .31	[0.15-0.47] mg/dL increase	rs7941030	G	0.37	20686565
LPA	HDL cholesterol	3E-8	    .56	[0.36-0.76] mg/dL decrease	rs1084651	A	0.16	20686565
ANGPTL4	HDL cholesterol	3E-8	    .45	[0.29-0.61] mg/dL decrease	rs7255436	C	0.47	20686565
PDE3A	HDL cholesterol	4E-8	    .40	[0.24-0.56] mg/dL increase	rs7134375	A	0.42	20686565
ADM,AMPD3	HDL cholesterol	5E-8	    .41	[0.21-0.61] mg/dL decrease	rs2923084	G	0.17	20686565
ARL15	HDL cholesterol	5E-8	    .49	[0.31-0.67] mg/dL decrease	rs6450176	A	0.26	20686565
CETP	HDL cholesterol	7E-380	   3.39	[3.21-3.57] mg/dL increase	rs3764261	A	0.32	20686565
CELSR2,PSRC1,SORT1	LDL cholesterol	1E-170	   5.65	[5.24-6.06] mg/dL decrease	rs629301	G	0.22	20686565
APOE,APOC1,APOC2	LDL cholesterol	9E-147	   7.14	[6.57-7.71] mg/dL increase	rs4420638	G	0.17	20686565
LDLR	LDL cholesterol	4E-117	   6.99	[6.4-7.58] mg/dL decrease	rs6511720	T	0.11	20686565
APOB	LDL cholesterol	4E-114	   4.05	[3.68-4.42] mg/dL increase	rs1367117	A	0.3	20686565
ABCG5,ABCG8	LDL cholesterol	2E-47	   2.75	[2.36-3.14] mg/dL increase	rs4299376	G	0.3	20686565
HMGCR	LDL cholesterol	5E-45	   2.45	[2.1-2.8] mg/dL increase	rs12916	C	0.39	20686565
TRIB1	LDL cholesterol	3E-29	   1.84	[1.51-2.17] mg/dL decrease	rs2954029	A	0.46	20686565
PCSK9	LDL cholesterol	2E-28	   2.01	[1.58-2.44] mg/dL increase	rs2479409	G	0.3	20686565
APOA1,APOC3,APOA4,APOA5	LDL cholesterol	1E-26	   2.85	[2.32-3.38] mg/dL increase	rs964184	G	0.13	20686565
HP,HPR,DHX38	LDL cholesterol	2E-22	   2.00	[1.57-2.43] mg/dL increase	rs2000999	A	0.2	20686565
TIMD4,HAVCR1	LDL cholesterol	2E-22	   1.67	[1.3-2.04] mg/dL decrease	rs6882076	T	0.35	20686565
CSPG3,CILP2,PBX4	LDL cholesterol	7E-22	   3.11	[2.37-3.85] mg/dL decrease	rs10401969	C	0.07	20686565
ABO	LDL cholesterol	8E-22	   2.05	[1.64-2.46] mg/dL increase	rs635634	T	0.22	20686565
FADS1,FADS2,FADS3	LDL cholesterol	1E-21	   1.71	[1.34-2.08] mg/dL decrease	rs174546	T	0.35	20686565
TOP1	LDL cholesterol	3E-19	   1.41	[1.08-1.74] mg/dL increase	rs6029526	T	0.47	20686565
ANGPTL3,DOCK7	LDL cholesterol	3E-18	   1.59	[1.22-1.96] mg/dL decrease	rs2131925	G	0.32	20686565
LPA	LDL cholesterol	2E-17	   1.95	[1.48-2.42] mg/dL increase	rs1564348	C	0.17	20686565
HNF1A	LDL cholesterol	1E-15	   1.42	[1.05-1.79] mg/dL increase	rs1169288	C	0.33	20686565
ST3GAL4	LDL cholesterol	1E-15	   1.95	[1.44-2.46] mg/dL increase	rs11220462	A	0.14	20686565
HLA	LDL cholesterol	2E-15	   1.83	[1.36-2.3] mg/dL increase	rs3177928	A	0.16	20686565
PPP1R3B	LDL cholesterol	7E-15	   2.22	[1.65-2.79] mg/dL decrease	rs9987289	T	0.1	20686565
PLEC1	LDL cholesterol	4E-13	   1.40	[0.99-1.81] mg/dL increase	rs11136341	G	0.4	20686565
CETP	LDL cholesterol	9E-13	   1.45	[1.06-1.84] mg/dL decrease	rs3764261	T	0.32	20686565
IRF2BP2,TOMM20	LDL cholesterol	9E-12	   1.13	[0.78-1.48] mg/dL decrease	rs514230	A	0.48	20686565
IDOL	LDL cholesterol	1E-11	   1.43	[1.02-1.84] mg/dL decrease	rs3757354	T	0.22	20686565
NPC1L1	LDL cholesterol	4E-11	   1.17	[0.8-1.54] mg/dL decrease	rs2072183	A	0.43	20686565
CBLN3,KIAA0323	LDL cholesterol	4E-11	   1.17	[0.8-1.54] mg/dL increase	rs8017377	T	0.48	20686565
MOSC1	LDL cholesterol	6E-11	   1.09	[0.7-1.48] mg/dL decrease	rs2642442	T	0.32	20686565
TMEM57,LDLRAP1	LDL cholesterol	1E-10	   1.10	[0.75-1.45] mg/dL decrease	rs12027135	A	0.47	20686565
HFE,HIST1H4C	LDL cholesterol	6E-10	   2.22	[1.46-2.98] mg/dL decrease	rs1800562	A	0.06	20686565
DNAH11	LDL cholesterol	7E-10	   1.26	[0.87-1.65] mg/dL increase	rs12670798	C	0.23	20686565
BRAP	LDL cholesterol	2E-9	    .97	[0.62-1.32] mg/dL decrease	rs11065987	G	0.42	20686565
GPAM	LDL cholesterol	2E-9	   1.08	[0.69-1.47] mg/dL increase	rs2255141	A	0.29	20686565
FRK	LDL cholesterol	3E-9	    .89	[0.54-1.24] mg/dL decrease	rs9488822	T	0.41	20686565
CYP7A1	LDL cholesterol	4E-9	    .95	[0.6-1.3] mg/dL increase	rs2081687	A	0.35	20686565
OSBPL7	LDL cholesterol	4E-9	    .87	[0.52-1.22] mg/dL decrease	rs7206971	T	0.35	20686565
MAFB	LDL cholesterol	1E-8	    .98	[0.61-1.35] mg/dL decrease	rs2902940	G	0.33	20686565
APOA1,APOC3,APOA4,APOA5	Triglycerides	7E-240	  16.95	[16.01-17.89] mg/dL increase	rs964184	G	0.13	20686565
GCKR	Triglycerides	6E-133	   8.76	[7.98-9.54] mg/dL increase	rs1260326	T	0.41	20686565
LPL	Triglycerides	2E-115	  13.64	[12.37-14.91] mg/dL decrease	rs12678919	G	0.12	20686565
MLXIPL	Triglycerides	9E-59	   7.91	[6.93-8.89] mg/dL decrease	rs17145738	G	0.19	20686565
TRIB1	Triglycerides	3E-55	   5.64	[4.88-6.4] mg/dL decrease	rs2954029	T	0.47	20686565
APOB	Triglycerides	1E-45	   5.99	[5.11-6.87] mg/dL decrease	rs1042034	C	0.22	20686565
ANGPTL3,DOCK7	Triglycerides	9E-43	   4.94	[4.16-5.72] mg/dL decrease	rs2131925	G	0.32	20686565
APOE,APOC1,APOC2	Triglycerides	1E-30	   5.50	[4.64-6.36] mg/dL decrease	rs439401	T	0.36	20686565
CSPG3,CILP2,PBX4	Triglycerides	2E-29	   7.83	[6.22-9.44] mg/dL decrease	rs10401969	C	0.07	20686565
FADS1,FADS2,FADS3	Triglycerides	5E-24	   3.82	[3.08-4.56] mg/dL increase	rs174546	T	0.34	20686565
PLTP	Triglycerides	5E-18	   3.32	[2.5-4.14] mg/dL increase	rs6065906	C	0.24	20686565
HLA	Triglycerides	2E-15	   2.99	[2.17-3.81] mg/dL decrease	rs2247056	T	0.25	20686565
GALNT2	Triglycerides	2E-14	   2.76	[2.02-3.5] mg/dL increase	rs4846914	G	0.39	20686565
NAT2	Triglycerides	4E-14	   2.97	[2.15-3.79] mg/dL increase	rs1495741	G	0.22	20686565
LIPC	Triglycerides	2E-13	   2.99	[2.11-3.87] mg/dL increase	rs1532085	G	0.22	20686565
CETP	Triglycerides	1E-12	   2.88	[2.14-3.62] mg/dL decrease	rs3764261	A	0.45	20686565
JMJD1C	Triglycerides	3E-12	   2.38	[1.64-3.12] mg/dL decrease	rs10761731	T	0.43	20686565
TIMD4,HAVCR1	Triglycerides	4E-12	   2.63	[1.87-3.39] mg/dL decrease	rs6882076	G	0.36	20686565
AFF1,KLHL8	Triglycerides	9E-12	   2.25	[1.51-2.99] mg/dL decrease	rs442177	G	0.41	20686565
FRMD5	Triglycerides	2E-11	   5.13	[3.44-6.82] mg/dL increase	rs2929282	T	0.05	20686565
ANKRD55,MAP3K1	Triglycerides	1E-10	   2.57	[1.61-3.53] mg/dL increase	rs9686661	T	0.2	20686565
COBLL1	Triglycerides	2E-10	   2.01	[1.27-2.75] mg/dL decrease	rs10195252	C	0.4	20686565
LRP1	Triglycerides	4E-10	   2.70	[1.86-3.54] mg/dL decrease	rs11613352	T	0.23	20686565
TYW1B	Triglycerides	1E-9	   7.91	[5.28-10.54] mg/dL decrease	rs13238203	T	0.04	20686565
CCDC92,ZNF664	Triglycerides	1E-8	   2.42	[1.62-3.22] mg/dL decrease	rs4765127	G	0.34	20686565
PINX1,XKR6	Triglycerides	1E-8	   2.01	[1.25-2.77] mg/dL increase	rs11776767	C	0.37	20686565
CAPN3	Triglycerides	2E-8	   7.00	[4.08-9.92] mg/dL increase	rs2412710	A	0.02	20686565
IRS1	Triglycerides	2E-8	   1.89	[1.15-2.63] mg/dL decrease	rs2972146	C	0.37	20686565
CYP26A1	Triglycerides	2E-8	   2.28	[1.54-3.02] mg/dL decrease	rs2068888	A	0.47	20686565
MSL2L1	Triglycerides	3E-8	   2.22	[1.34-3.1] mg/dL decrease	rs645040	G	0.22	20686565
CTF1	Triglycerides	3E-8	   2.13	[1.37-2.89] mg/dL decrease	rs11649653	G	0.4	20686565
PLA2G6	Triglycerides	4E-8	   1.54	[0.8-2.28] mg/dL decrease	rs5756931	C	0.4	20686565
CETP	Metabolic syndrome	1E-48	    .07	[0.06-0.08] mmol/l increase	rs3764261	A	0.36	20694148
LPL	Metabolic syndrome	2E-10	    .04	[0.02-0.05] mmol/l increase	rs2083637	G	0.24	20694148
Intergenic	Prostate cancer	4E-18	   1.26	[1.20-1.33] 	rs12653946	T	0.44	20676098
GPRC6A,RFX6	Prostate cancer	2E-12	   1.22	[1.15-1.28] 	rs339331	T	0.37	20676098
Intergenic	Prostate cancer	3E-9	   1.18	[1.12-1.24] 	rs9600079	T	0.38	20676098
KIF1B,UBE4B,PGD	Hepatocellular carcinoma	2E-18	   1.64	[1.49-1.82] 	rs17401966	A	0.72	20676096
UMOD	Chronic kidney disease and serum creatinine levels	4E-10	   1.25	[1.17-1.35] 	rs4293393	T	0.798	20686651
APOL1, MYH9	Glomerulosclerosis	5E-13	NR	NR	rs2239785	G	0.64	20668430
APOA5	Hypertriglyceridemia	5E-24	   3.28	[2.61-4.14] 	rs964184	G	0.14	20657596
GCKR	Hypertriglyceridemia	7E-9	   1.75	[1.45-2.12] 	rs1260326	T	0.41	20657596
CASR	Calcium levels	6E-37	    .00	[0.0031-0.0042] increase in log(CASR, mmol/L)	rs1801725	T	0.1775	20661308
HLA-DQB1	Follicular lymphoma	1E-29	   1.95	[1.72-2.22] 	rs10484561	G	0.11	20639881
Intergenic	Follicular lymphoma	4E-9	   1.81	[1.50-2.20] 	rs735665	T	0.21	20639881
IRF5,TNPO3	Primary biliary cirrhosis	3E-10	   1.63	[NR] 	rs10488631	C	0.11	20639880
IKZF3,ZPBP2,GSDMB,ORMDL3	Primary biliary cirrhosis	2E-9	   1.38	[NR] 	rs9303277	T	0.51	20639880
SPIB	Primary biliary cirrhosis	8E-11	   1.46	[NR] 	rs3745516	A	0.23	20639880
IL12RB2	Primary biliary cirrhosis	8E-12	   1.48	[NR] 	rs3790567	A	0.232	20639880
IL12A	Primary biliary cirrhosis	8E-12	   1.44	[NR] 	rs6441286	G	0.394	20639880
HLA-DQB1	Primary biliary cirrhosis	3E-26	   1.75	[NR] 	rs7774434	C	0.371	20639880
GJA1	Resting heart rate	4E-15	  12.60	[9.54-15.66] ms decrease	rs9398652	A	0.10	20639392
MYH6	Resting heart rate	4E-14	   7.80	[5.84-9.76] ms decrease	rs452036	A	0.36	20639392
MYH7,NDNG	Resting heart rate	3E-8	   7.40	[4.85-9.95] ms decrease	rs223116	A	0.24	20639392
Intergenic	Resting heart rate	2E-10	   8.60	[6.03-11.17] ms increase	rs17287293	G	0.15	20639392
SLC35F1	Resting heart rate	4E-10	   6.30	[4.36-8.24] ms decrease	rs281868	G	0.50	20639392
SLC12A9	Resting heart rate	6E-10	   7.60	[5.23-9.97] ms decrease	rs314370	C	0.19	20639392
UFSP1	Resting heart rate	2E-8	   7.00	[4.63-9.37] ms decrease	rs12666989	C	0.18	20639392
FADS1	Resting heart rate	2E-9	   6.20	[4.22-8.18] ms decrease	rs174547	C	0.33	20639392
DDRGK1,ITPA	Ribavirin-induced anemia	4E-44	NR	NR	rs1127354	A	NR	20637204
DAB2IP	Abdominal aortic aneurysm	5E-10	   1.21	[1.14-1.28] 	rs7025486	A	0.23	20622881
CDKN2A,CKDN2B	Abdominal aortic aneurysm	2E-8	   1.27	[NR] 	rs2383207	G	0.49	20622881
IL23R,IL12RB2	Behcet's disease	2E-11	   1.35	[1.24-1.47] 	rs1495965	G	0.51	20622879
IL10	Behcet's disease	1E-14	   1.45	[1.32-1.60] 	rs1800871	T	0.31	20622879
CDKN2BAS	Endometriosis	6E-12	   1.44	[1.30-1.59] 	rs10965235	C	0.802	20601957
CTLA4,ICOS	Alopecia areata	4E-13	   1.44	[1.30-1.59] 	rs1024161	A	0.40	20596022
IL2,IL21	Alopecia areata	4E-8	   1.34	[1.21-1.48] 	rs7682241	A	0.33	20596022
ULBP3,ULBP6	Alopecia areata	4E-19	   1.65	[1.48-1.83] 	rs9479482	A	0.57	20596022
IL2RA	Alopecia areata	2E-12	   1.41	[1.27-1.56] 	rs3118470	G	0.30	20596022
IKZF4	Alopecia areata	3E-8	   1.34	[1.21-1.48] 	rs1701704	C	0.33	20596022
HLA-DQA2	Alopecia areata	1E-35	   2.21	[1.98-2.47] 	rs9275572	G	0.59	20596022
DQA1	Multiple sclerosis	4E-17	   2.62	[2.09-3.28] 	rs9271366	G	NR	20598377
C1QTNF7	Conduct disorder (symptom count)	3E-9	    .15	[NR] unit increase	rs16891867	G	0.097	20585324
Intergenic	Conduct disorder (symptom count)	1E-8	    .16	[NR] unit increase	rs7950811	A	0.071	20585324
Intergenic	Conduct disorder (symptom count)	1E-8	    .28	[NR] unit increase	rs11838918	C	0.022	20585324
BCL11A	Type 2 diabetes	3E-15	   1.08	[1.06-1.10] 	rs243021	A	NR	20581827
ZBED3	Type 2 diabetes	3E-12	   1.08	[1.06-1.11] 	rs4457053	G	NR	20581827
KLF14	Type 2 diabetes	2E-10	   1.07	[1.05-1.10] 	rs972283	G	NR	20581827
TP53INP1	Type 2 diabetes	1E-9	   1.06	[1.04-1.09] 	rs896854	T	NR	20581827
CHCHD9	Type 2 diabetes	3E-8	   1.11	[1.07-1.15] 	rs13292136	C	NR	20581827
KCNQ1	Type 2 diabetes	3E-13	   1.08	[1.06-1.10] 	rs231362	G	NR	20581827
CENTD2	Type 2 diabetes	1E-22	   1.14	[1.11-1.17] 	rs1552224	A	NR	20581827
HMGA2	Type 2 diabetes	4E-9	   1.10	[1.07-1.14] 	rs1531343	C	NR	20581827
HNF1A	Type 2 diabetes	2E-8	   1.07	[1.05-1.10] 	rs7957197	T	NR	20581827
ZFAND6	Type 2 diabetes	2E-9	   1.06	[1.04-1.08] 	rs11634397	G	NR	20581827
PRC1	Type 2 diabetes	2E-10	   1.07	[1.05-1.09] 	rs8042680	A	NR	20581827
DUSP9	Type 2 diabetes	3E-10	   1.27	[1.18-1.37] 	rs5945326	A	NR	20581827
IRS1	Type 2 diabetes	5E-20	   1.11	[1.08-1.13] 	rs7578326	A	NR	20581827
MTNR1B	Type 2 diabetes	8E-15	   1.09	[1.06-1.11] 	rs1387153	T	NR	20581827
IGF2BP2	Type 2 diabetes	2E-9	   1.14	[1.09-1.19] 	rs1470579	C	NR	20581827
WFS1	Type 2 diabetes	3E-8	   1.13	[1.08-1.18] 	rs1801214	T	NR	20581827
CDKAL1	Type 2 diabetes	2E-22	   1.25	[1.20-1.31] 	rs10440833	A	NR	20581827
JAZF1	Type 2 diabetes	3E-9	   1.13	[1.09-1.18] 	rs849134	A	NR	20581827
SLC30A8	Type 2 diabetes	1E-8	   1.15	[1.10-1.21] 	rs3802177	G	NR	20581827
CDKN2A,CDKN2B	Type 2 diabetes	1E-10	   1.20	[1.13-1.27] 	rs10965250	G	NR	20581827
HHEX,IDE	Type 2 diabetes	1E-15	   1.18	[1.13-1.23] 	rs5015480	C	NR	20581827
TCF7L2	Type 2 diabetes	2E-51	   1.40	[1.34-1.46] 	rs7903146	T	NR	20581827
FTO	Type 2 diabetes	3E-8	   1.13	[1.08-1.18] 	rs11642841	A	NR	20581827
TCHH	Common traits (Other)	2E-42	    .29	[NR] unit decrease	rs17646946	A	0.20	20585627
LCE3E	Common traits (Other)	1E-10	    .13	[NR] unit increase	rs499697	G	0.29	20585627
WNT10A	Common traits (Other)	3E-14	    .19	[NR] unit increase	rs7349332	T	0.14	20585627
OR2M7	Common traits (Other)	7E-24	   1.67	[NR] 	rs4481887	G	0.74	20585627
Intergenic	Common traits (Other)	1E-11	   1.32	[NR] 	rs10427255	C	0.46	20585627
OCA2	Eye color	1E-300	   2.49	[NR] unit increase	rs12913832	A	0.23	20585627
SLC24A4	Eye color	1E-16	    .34	[NR] unit decrease	rs12896399	T	0.44	20585627
IRF4	Eye color	2E-15	    .42	[NR] unit decrease	rs12203592	T	0.18	20585627
SLC45A2	Eye color	1E-12	    .84	[NR] unit increase	rs16891982	C	0.03	20585627
TYR	Eye color	3E-9	    .28	[NR] unit decrease	rs1393350	A	0.27	20585627
OCA2	Eye color	3E-52	   8.43	[NR] 	rs12913832	A	0.23	20585627
SLC24A4	Eye color	2E-23	   1.73	[NR] 	rs12896399	G	0.44	20585627
TYR	Eye color	1E-15	   1.58	[NR] 	rs1847134	A	0.68	20585627
IRF4	Freckling	2E-91	   1.61	[NR] unit increase	rs12203592	T	0.18	20585627
MC1R	Freckling	8E-62	   1.88	[NR] unit increase	rs12931267	G	0.08	20585627
ASIP	Freckling	5E-14	    .77	[NR] unit increase	rs619865	A	0.10	20585627
BNC2	Freckling	4E-10	    .40	[NR] unit decrease	rs2153271	C	0.41	20585627
OCA2	Hair color	9E-88	    .97	[NR] unit increase	rs12913832	A	0.23	20585627
IRF4	Hair color	2E-28	    .59	[NR] unit increase	rs12203592	T	0.18	20585627
SLC45A2	Hair color	4E-20	   1.10	[NR] unit increase	rs16891982	C	0.03	20585627
MC1R	Hair color	3E-10	    .56	[NR] unit decrease	rs12931267	G	0.08	20585627
MC1R	Hair color	5E-87	    .56	[NR] unit increase	rs12931267	G	0.08	20585627
ASIP	Hair color	2E-15	    .22	[NR] unit increase	rs291671	G	0.10	20585627
SLC24A4	Hair color	5E-13	    .31	[NR] unit decrease	rs12896399	T	0.44	20585627
TOX3	Breast cancer	1E-28	   1.24	[1.20-1.29] 	rs4784227	T	0.24	20585626
FUT2	Crohn's disease	2E-8	NR	NR	rs504963	A	0.431	20570966
ALPL,NBPF3	Phosphorus levels	1E-27	    .05	[NR] mg/dl increase	rs1697421	A	0.49	20558539
CASR,CCDC58	Phosphorus levels	4E-9	    .04	[NR] mg/dl decrease	rs17265703	G	0.15	20558539
ITPR3,LEMD2,MLN	Phosphorus levels	1E-11	    .06	[NR] mg/dl decrease	rs9469578	T	0.08	20558539
PDE7B	Phosphorus levels	3E-12	    .04	[NR] mg/dl increase	rs947583	C	0.29	20558539
FGF6,RAD51AP1,FGF23	Phosphorus levels	4E-9	    .05	[NR] unit increase	rs2970818	A	0.09	20558539
TERT	Testicular germ cell cancer	8E-15	   1.33	[1.18-1.50] 	rs2736100	T	0.49	20543847
TERT, CLPTM1L	Testicular germ cell cancer	1E-23	   1.54	[1.33-1.79] 	rs4635969	T	0.19	20543847
DMRT1	Testicular germ cell cancer	1E-23	   1.37	[1.21-1.55] 	rs755383	T	0.62	20543847
ATF7IP	Testicular germ cell cancer	6E-10	   1.27	[1.12-1.44] 	rs2900333	C	0.62	20543847
RAP1A	Osteoporosis-related phenotypes	4E-8	NR	NR	rs494453	C	0.24	20548944
TNFRSF11B	Osteoporosis-related phenotypes	3E-11	    .14	[NR] g/cm2 increase	rs2062375	G	0.45	20548944
ATOH7,PBLD	Optic disc parameters	3E-35	    .07	[0.06-0.08] mm decrease	rs1900004	T	0.22	20548946
CDC7,TGFBR3	Optic disc parameters	3E-28	    .06	[0.05-0.07] mm increase	rs1192415	G	0.18	20548946
SALL1	Optic disc parameters	5E-9	    .03	[0.02-0.04] mm increase	rs1362756	C	0.28	20548946
CDKN2B	Vertical cup-disc ratio	4E-15	    .01	[0.010-0.018] mm2 decrease	rs1063192	G	0.46	20548946
SIX1	Vertical cup-disc ratio	1E-11	    .01	[0.008-0.016] mm2 increase	rs10483727	T	0.41	20548946
SCYL1	Vertical cup-disc ratio	4E-9	    .01	[0.01-0.02] mm2 decrease	rs17146964	G	0.20	20548946
CHEK2	Vertical cup-disc ratio	1E-8	    .01	[0.007-0.015] mm2 decrease	rs1547014	T	0.29	20548946
ATOH7, PBLD	Vertical cup-disc ratio	2E-8	    .01	[0.009-0.017] mm2 decrease	rs1900004	T	0.22	20548946
DCLK1	Vertical cup-disc ratio	1E-8	    .01	[0.010-0.014] mm2 increase	rs1926320	C	0.24	20548946
BCAS3	Vertical cup-disc ratio	3E-8	    .01	[0.008-0.016] mm2 decrease	rs8068952	G	0.23	20548946
ABCG8	Phytosterol levels	2E-50	  12.00	[NR] % increase	rs4245791	C	0.322	20529992
ABO	Phytosterol levels	9E-13	   8.00	[NR] % increase	rs657152	T	0.383	20529992
ABCG8	Phytosterol levels	6E-25	  14.00	[NR] % decrease	rs41360247	C	0.064	20529992
PEAR1	Platelet aggregation	4E-16	NR	NR	rs12566888	A	0.102	20526338
ADRA2A	Platelet aggregation	3E-12	NR	NR	rs869244	A	0.353	20526338
PEAR1	Platelet aggregation	5E-19	NR	NR	rs12566888	A	0.103	20526338
JMJD1C	Platelet aggregation	5E-8	NR	NR	rs2893923	T	0.336	20526338
GP6	Platelet aggregation	8E-14	NR	NR	rs1671152	T	0.142	20526338
HLA-C,HLA-B	Vitiligo	1E-48	   1.90	[1.74-2.07] 	rs11966200	A	0.06	20526339
RNASET2, FGFR1OP, CCR6	Vitiligo	1E-16	   1.20	[1.15-1.25] 	rs2236313	T	0.38	20526339
TNFRSF19	Nasopharyngeal carcinoma	2E-9	   1.20	[1.10-1.30] 	rs9510787	G	0.37	20512145
NPLOC4,HGS	Eye color traits	9E-14	    .12	[NR] % increase	rs9894429	T	NR	20463881
TTC3,DSCR9	Eye color traits	2E-10	    .10	[NR] % decrease	rs1003719	A	NR	20463881
FOXO1	Central corneal thickness	5E-10	    .24	[0.16-0.32] unit decrease	rs2721051	G	NR	20485516
ZNF469	Central corneal thickness	9E-11	    .16	[0.10-0.22] unit increase	rs12447690	C	NR	20485516
APOE	Alzheimer's disease	1E-295	   2.53	[2.41-2.66] 	rs2075650	G	0.14	20460622
XPNPEP1,ADD3	Biliary atresia	7E-9	   1.77	[1.38-2.26] 	rs17095355	T	0.409	20460270
CCR6	Rheumatoid arthritis	8E-19	   1.19	[1.15-1.24] 	rs3093024	T	0.46	20453841
HLA-DRB1	Rheumatoid arthritis	2E-58	   1.97	[1.82-2.14] 	rs13192471	G	0.22	20453841
CBLB	Multiple sclerosis	2E-10	   1.40	[1.27-1.57] 	rs9657904	T	0.826	20453840
HLA-DRB,HLA-DQB1	Multiple sclerosis	1E-20	   2.05	[NR] 	rs2040406	G	0.26	20453840
SPRED2	Rheumatoid arthritis	5E-10	   1.13	[NR] 	rs934734	G	0.49	20453842
ANKRD55,IL6ST	Rheumatoid arthritis	1E-11	   1.28	[NR] 	rs6859219	C	0.79	20453842
C5orf30	Rheumatoid arthritis	4E-8	   1.14	[NR] 	rs26232	C	0.68	20453842
PXK	Rheumatoid arthritis	5E-8	   1.29	[NR] 	rs13315591	C	0.09	20453842
RBPJ	Rheumatoid arthritis	1E-16	   1.14	[NR] 	rs874040	C	0.30	20453842
CCR6	Rheumatoid arthritis	2E-11	   1.13	[NR] 	rs3093023	A	0.43	20453842
IRF5	Rheumatoid arthritis	4E-11	   1.19	[NR] 	rs10488631	C	0.11	20453842
AFF3	Rheumatoid arthritis	1E-14	   1.12	[NR] 	rs11676922	T	0.46	20453842
CCL21	Rheumatoid arthritis	4E-10	   1.19	[NR] 	rs951005	A	0.84	20453842
IL2RA	Rheumatoid arthritis	1E-11	   1.14	[NR] 	rs706778	T	0.40	20453842
PTPN22	Rheumatoid arthritis	9E-74	   1.94	[1.81-2.08] 	rs2476601	A	0.10	20453842
CTLA4	Rheumatoid arthritis	1E-8	   1.15	[1.10-1.20] 	rs3087243	G	0.56	20453842
TNFAIP3	Rheumatoid arthritis	9E-13	   1.22	[1.16-1.29] 	rs6920220	A	0.22	20453842
CD40	Rheumatoid arthritis	3E-9	   1.18	[1.11-1.25] 	rs4810485	T	0.25	20453842
HLA-DRB1	Rheumatoid arthritis	1E-299	   2.88	[2.73-3.03] 	rs6910071	G	0.22	20453842
FGFR2	Breast cancer	4E-31	   1.43	[1.35-1.53] 	rs2981579	A	0.42	20453838
TOX3	Breast cancer	3E-15	   1.30	[1.22-1.39] 	rs3803662	A	0.26	20453838
MAP3K1	Breast cancer	5E-9	   1.22	[1.14-1.30] 	rs889312	C	0.28	20453838
Intergenic	Breast cancer	2E-10	   1.21	[1.14-1.29] 	rs13387042	A	0.49	20453838
CDKN2A,CDKN2B	Breast cancer	3E-8	   1.09	[1.04-1.14] 	rs1011970	T	0.17	20453838
ZNF365	Breast cancer	5E-15	   1.16	[1.10-1.22] 	rs10995190	G	0.85	20453838
ZMIZ1	Breast cancer	4E-9	   1.07	[1.03-1.11] 	rs704010	A	0.39	20453838
MYEOV,CCND1,ORAOV1,FGF19,FGF4,FGF3	Breast cancer	3E-15	   1.15	[1.10-1.20] 	rs614367	T	0.15	20453838
TNFRSF11A	Paget's disease	2E-11	   1.46	[1.30-1.63] 	rs2957128	A	0.38	20436471
TNFRSF11A	Paget's disease	5E-13	   1.52	[1.36-1.70] 	rs3018362	A	0.34	20436471
Intergenic	Cleft lip	4E-16	   1.78	[1.55-2.05] 	rs987525	A	0.17	20436469
APOC1	Lipoprotein-associated phospholipase A2 activity and mass	6E-24	   8.00	[NR] nmol/ml/min increase	rs4420638	G	0.16	20442857
PSRC1	Lipoprotein-associated phospholipase A2 activity and mass	3E-15	   5.50	[NR] nmol/ml/min decrease	rs599839	G	0.22	20442857
SCARB1	Lipoprotein-associated phospholipase A2 activity and mass	1E-8	   4.60	[NR] nmol/ml/min increase	rs10846744	C	0.15	20442857
ZNF259	Lipoprotein-associated phospholipase A2 activity and mass	4E-8	   6.40	[NR] nmol/ml/min increase	rs12286037	T	0.07	20442857
PLA2G7	Lipoprotein-associated phospholipase A2 activity and mass	6E-14	  11.10	[NR] ng/mL increase	rs1805017	T	0.26	20442857
OBFC1	Telomere length	2E-11	    .10	[0.06-0.14] kb increase	rs4387287	A	NR	20421499
CHRNA5,CHRNA3	Smoking behavior	2E-66	    .08	[0.07-0.09] unit decrease	rs1051730	G	0.66	20418889
CHRNA3	Smoking behavior	3E-73	   1.02	[0.91-1.13] CPD decrease	rs1051730	G	0.65	20418890
LOC100188947	Smoking behavior	6E-10	    .37	[0.25-0.49] CPD decrease	rs1329650	T	0.28	20418890
CYP2A6,EGLN2	Smoking behavior	1E-8	    .33	[0.22-0.44] CPD increase	rs3733829	G	0.36	20418890
BDNF	Smoking behavior	2E-8	   1.06	[1.04-1.08] 	rs6265	C	0.79	20418890
DBH	Smoking behavior	4E-8	   1.12	[1.08-1.18] 	rs3025343	G	0.84	20418890
NR	Smoking behavior	2E-69	    .80	[0.70-0.90] CPD increase	rs1051730	A	0.34	20418888
CHRNB3,CHRNA6	Smoking behavior	1E-8	    .29	[0.19-0.39] CPD increase	rs6474412	T	0.78	20418888
CYP2A6,RAB4D	Smoking behavior	2E-12	    .39	[0.27-0.51] CPD increase	rs4105144	C	0.70	20418888
GC	Vitamin D levels	2E-49	    .38	[0.32-0.44] unit decrease	rs2282679	C	0.26	20418485
NADSYN1,DHCR7	Vitamin D levels	3E-9	    .18	[0.12-0.24] unit decrease	rs3829251,rs11234027	A	0.19	20418485
CYP2R1	Vitamin D levels	3E-17	    .25	[0.15-0.35] unit increase	rs2060793,rs1993116	A	0.41	20418485
FTO	Obesity (early onset extreme)	5E-19	   1.37	[1.26-1.50] 	rs1558902	A	NR	20421936
MC4R	Obesity (early onset extreme)	6E-11	   1.22	[1.09-1.37] 	rs17700144, rs10871777	A	NR	20421936
TNKS, MSRA	Obesity (early onset extreme)	2E-8	   1.18	[1.03-1.35] 	rs17150703, rs473034	A	NR	20421936
RERE	Vitiligo	7E-15	   1.36	[1.26-1.48] 	rs4908760	G	0.37	20410501
HLA-A, HCG9	Vitiligo	9E-23	   1.50	[1.39-1.63] 	rs3823355	T	0.29	20410501
BTNL2, HLA-DRA, HLA-DQA1	Vitiligo	7E-19	   1.42	[1.32-1.54] 	rs3806156	T	0.37	20410501
IL2RA, RBM17, PFKB3	Vitiligo	3E-9	   1.27	[1.17-1.37] 	rs706779	A	0.535	20410501
TYR	Vitiligo	2E-18	   1.53	[1.39-1.68] 	rs1393350	G	0.733	20410501
GZMB	Vitiligo	3E-8	   1.28	[1.17-1.39] 	rs8192917	G	0.236	20410501
UBASH3A	Vitiligo	1E-9	   1.27	[1.18-1.38] 	rs11203203	A	0.373	20410501
C1QTNF6	Vitiligo	2E-16	   1.38	[1.28-1.50] 	rs229527	T	0.419	20410501
LPP	Vitiligo	1E-11	   1.31	[1.21-1.41] 	rs1464510	T	0.44	20410501
PBLD	Optic nerve measurement (disc area)	2E-10	    .31	[0.21-0.42] unit increase	rs12571093	G	NR	20395239
ATOH7	Optic nerve measurement (disc area)	3E-10	    .30	[0.20-0.39] unit increase	rs3858145	A	NR	20395239
TIMP3, SYN3	Age-related macular degeneration	1E-11	   1.41	[1.27-1.57] 	rs9621532	A	0.946	20385819
CFH	Age-related macular degeneration	2E-76	   3.11	[2.76-3.51] 	rs10737680	A	0.566	20385819
ARMS2, HTRA1	Age-related macular degeneration	4E-60	   3.40	[2.94-3.94] 	rs3793917	G	0.164	20385819
C2, CFB	Age-related macular degeneration	3E-21	   2.16	[1.84-2.53] 	rs429608	G	0.842	20385819
C3	Age-related macular degeneration	1E-10	   1.74	[1.47-2.06] 	rs2230199	C	0.163	20385819
CFH	Age-related macular degeneration	6E-16	   1.88	[1.68-2.10] 	rs1329424	T	0.351	20385819
C2, CFB	Age-related macular degeneration	2E-8	   4.31	[2.76-6.87] 	rs9380272	A	0.012	20385819
TIMP3	Age-related macular degeneration	4E-9	   1.61	[1.37-1.89] 	rs9621532	A	0.96	20385826
Intergenic	Age-related macular degeneration	2E-8	   1.16	[1.10-1.22] 	rs493258	C	0.55	20385826
NAT8,NAT8B,ALMS1,DUSP11,TPRKB	Creatinine levels	1E-15	   1.00	[0.7-1.2] % decrease	rs10206899	G	0.22	20383145
SLC22A2	Creatinine levels	7E-10	   1.10	[0.8-1.4] % increase	rs3127573	G	0.13	20383145
TBX2	Creatinine levels	3E-10	    .80	[0.6-1.0] % increase	rs8068318	G	0.27	20383145
SLC7A9	Creatinine levels	5E-11	   1.00	[0.7-1.3] % decrease	rs4805834	A	0.13	20383145
ANXA9,FAM63A,PRUNE,BNIPL,LASS2,SETDB1	Chronic kidney disease	1E-12	    .01	[0.004-0.016] ml/min/1.73m2 increase	rs267734	C	0.20	20383146
GCKR, IFT172, FNDC4	Chronic kidney disease	3E-14	    .01	[0.007-0.011] ml/min/1.73 m2 increase	rs1260326	T	0.41	20383146
NAT8,NAT8B,ALMS1	Chronic kidney disease	5E-14	    .01	[0.005-0.013] ml/min/1.73 m2 increase	rs13538	G	0.23	20383146
TFDP2	Chronic kidney disease	3E-11	   1.09	[0.007-0.011] ml/min/1.73 m2 increase	rs347685	C	0.28	20383146
SLC34A1,GRK6,RGS14,LMAN2,PRR7,F12,PFN3	Chronic kidney disease	1E-14	    .01	[0.007-0.015] ml/min/1.73 m2 decrease	rs6420094	G	0.34	20383146
VEGFA	Chronic kidney disease	9E-14	   1.08	[0.007-0.015] ml/min/1.73 m2 increase	rs881858	G	0.28	20383146
PRKAG2	Chronic kidney disease	4E-12	   1.18	[1.12-1.25] 	rs7805747	A	0.24	20383146
PIP5K1B,FAM122A	Chronic kidney disease	8E-14	    .01	[0.008-0.016] ml/min/1.73 m2 decrease	rs4744712	A	0.39	20383146
ATXN2	Chronic kidney disease	4E-11	    .01	[0.009-0.017] ml/min/1.73 m2 increase	rs653178	T	0.50	20383146
DACH1	Chronic kidney disease	3E-11	    .01	[0.007-0.011] ml/min/1.73 m2 increase	rs626277	C	0.40	20383146
UBE2Q2,FBX022	Chronic kidney disease	3E-17	    .01	[0.007-0.011] ml/min/1.73 m2 decrease	rs1394125	A	0.35	20383146
SLC7A9,CCDC123,ECAT8	Chronic kidney disease	3E-15	    .01	[0.006-0.01] ml/min/1.73 m2 increase	rs12460876	C	0.39	20383146
CPS1	Chronic kidney disease	1E-15	    .01	[0.005-0.013] ml/min/1.73 m2 decrease	rs7422339	A	0.32	20383146
SLC22A2	Chronic kidney disease	6E-12	    .01	[0.009-0.017] ml/min/1.73 m2 decrease	rs2279463	G	0.12	20383146
TMEM60,RSBN1L, PHTF2	Chronic kidney disease	2E-9	    .01	[0.006-0.01] ml/min/1.73 m2 decrease]	rs6465825	C	0.39	20383146
WDR37	Chronic kidney disease	1E-8	    .01	[0.010-0.018] ml/min/1.73 m2 decrease	rs10794720	T	0.08	20383146
SLC6A13, JARID1A, SLC6A12	Chronic kidney disease	1E-9	   1.05	[0.006-0.010] ml/min/1.73 m2 increase	rs10774021	C	0.36	20383146
WDR72	Chronic kidney disease	3E-13	    .01	[0.005-0.013] ml/min/1.73 m2 increase	rs491567	C	0.22	20383146
BCAS3,TBX2,C17orf82	Chronic kidney disease	1E-15	    .01	[0.007-0.015] ml/min/1.73 m2 decrease	rs9895661	C	0.19	20383146
SHROOM3, CCDC158	Chronic kidney disease	1E-19	NR	NR	rs17319721	A	0.43	20383146
STC1	Chronic kidney disease	1E-8	NR	NR	rs10109414	T	0.42	20383146
UMOD,ACSM5,GP2,PDILT	Chronic kidney disease	1E-20	NR	NR	rs12917707	T	0.18	20383146
TNPO, IRF5	Systemic sclerosis	2E-13	   1.50	[1.35-1.67] 	rs10488631	C	NR	20383147
STAT4	Systemic sclerosis	3E-9	   1.30	[1.19-1.41] 	rs3821236	A	0.20	20383147
CCNL1, LEKR1	Birth weight	2E-35	    .09	[0.073-0.10] s.d. decrease	rs900400	C	NR	20372150
ADCY5	Birth weight	7E-15	    .06	[0.047-0.079] s.d. decrease	rs9883204	C	NR	20372150
SOX17	Intracranial aneurysm	1E-12	   1.28	[1.20-1.38] 	rs9298506	A	0.81	20364137
CDKN2A,CDKN2B	Intracranial aneurysm	2E-22	   1.32	[1.25-1.39] 	rs1333040	T	0.56	20364137
CNNM2	Intracranial aneurysm	1E-9	   1.29	[1.19-1.40] 	rs12413409	G	0.91	20364137
STARD13	Intracranial aneurysm	3E-9	   1.20	[1.13-1.28] 	rs9315204	T	0.21	20364137
RBBP8	Intracranial aneurysm	1E-12	   1.22	[1.15-1.28] 	rs11661542	C	0.49	20364137
SRBD1	Glaucoma	3E-9	   2.80	[1.96-3.99] 	rs3213787	A	0.81	20363506
HHIP	Height	1E-9	    .12	[0.07-0.17] SD decrease	rs1812175	C	0.83	20397748
UST	Response to antidepressants	4E-8	  27.00	[NR] % worse outcome	rs2500535	A	0.06	20360315
CACNA1C	Bipolar disorder and major depressive disorder (combined)	3E-8	   1.18	[NR] (bipolar)	rs1006737	A	0.36	20351715
FOXE1, TMOD1, C9orf97, NCBP1, XPA, KRT18P13, C9orf156, HEMGN	Thyroid cancer (Papillary, radiation-related)	5E-12	   1.65	[1.43-1.91] 	rs965513	A	NR	20350937
TACC3,TMEM129,SLBP,FGFR3	Urinary bladder cancer	1E-11	   1.24	[1.17-1.32] 	rs798766	T	0.19	20348956
MYC	Urinary bladder cancer	7E-12	   1.21	[1.15-1.28] 	rs9642880	T	0.44	20348956
CLMN, FLJ45244, DICER1	Response to statin therapy	2E-8	NR	NR	rs8014194	A	0.24	20339536
LOC646909, DUSP4, KIF13B	Response to statin therapy	3E-8	NR	NR	rs10091038	A	0.43	20339536
F12	Activated partial thromboplastin time	2E-30	    .45	[0.37-0.53] unit decrease	rs2731672	A	0.27	20303064
KNG1	Activated partial thromboplastin time	1E-21	    .36	[0.29-0.43] unit decrease	rs710446	G	0.40	20303064
HRG	Activated partial thromboplastin time	1E-11	    .26	[0.19-0.33] unit increase	rs9898	T	0.32	20303064
BTNL2, HLA-DQA2, HLA-DQB1	Knee osteoarthritis	5E-9	   1.31	[1.20-1.44] 	rs10947262	T	0.42	20305777
PROCR	Coagulation factor levels	6E-37	NR	NR	rs867186	G	0.101	20231535
STXBP5	Coagulation factor levels	1E-22	   4.80	[2.1-7.5] % decrease	rs9390459	A	0.442	20231535
SMURF1,KPNA7	Ulcerative colitis	9E-11	   1.56	[1.36-1.78] 	rs7809799	G	0.04	20228798
IL17REL	Ulcerative colitis	4E-8	   1.17	[1.11-1.25] 	rs5771069	G	0.49	20228798
OTUD3	Ulcerative colitis	9E-22	   1.41	[1.30-1.54] 	rs4654925	G	0.52	20228798
IL10	Ulcerative colitis	1E-12	   1.35	[1.22-1.50] 	rs3024493	T	0.16	20228798
HLA-DRA	Ulcerative colitis	4E-15	   1.45	[1.33-1.59] 	rs9268923	C	0.67	20228798
RNF186,OTUD3,PLA2G2E	Ulcerative colitis	2E-10	   1.17	[NR] 	rs1317209	T	NR	20228799
RNF186,OTUD3,PLA2G2E	Ulcerative colitis	2E-21	   1.30	[NR] 	rs6426833	A	NR	20228799
IL23R	Ulcerative colitis	1E-13	   1.27	[NR] 	rs2201841	A	NR	20228799
FCGR2A,FCGR2C	Ulcerative colitis	3E-9	   1.20	[NR] 	rs10800309	A	NR	20228799
IL10,IL19	Ulcerative colitis	1E-8	   1.23	[NR] 	rs3024505	T	NR	20228799
REL,CCDC139,PUS10	Ulcerative colitis	7E-9	   1.13	[NR] 	rs13003464	G	NR	20228799
MST1	Ulcerative colitis	4E-9	   1.20	[NR] 	rs3197999	T	NR	20228799
CEP72,TPPP	Ulcerative colitis	1E-9	   1.30	[NR] 	rs4957048	C	NR	20228799
CARD9	Ulcerative colitis	5E-8	   1.14	[NR] 	rs4077515	C	NR	20228799
NKX2-3	Ulcerative colitis	1E-8	   1.20	[NR] 	rs11190140	T	NR	20228799
IFNG,IL26	Ulcerative colitis	4E-12	   1.16	[NR] 	rs1558744	A	NR	20228799
ORMDL3,ZPBP2M,GSDML	Ulcerative colitis	3E-8	   1.15	[NR] 	rs2305480	A	NR	20228799
C4BPB, C4BPA	C4b binding protein levels	4E-10	NR	NR	rs3813948	C	NR	20212171
REL, AHSA2	Celiac disease	4E-13	   1.15	[1.11-1.20] 	rs13003464	G	0.40	20190752
IL18RAP, IL18R1, IL1RL1, IL1RL2	Celiac disease	1E-15	   1.19	[1.14-1.25] 	rs917997	A	0.24	20190752
ITGA4, UBE2E3	Celiac disease	5E-11	   1.13	[1.09-1.18] 	rs13010713	G	0.45	20190752
CTLA4, ICOS, CD28	Celiac disease	6E-9	   1.14	[1.09-1.19] 	rs4675374	A	0.22	20190752
CCR1, CCR2, CCRL2, CCR3, CCR5, CCR9	Celiac disease	3E-17	   1.30	[1.23-1.39] 	rs13098911	A	0.10	20190752
IL12A	Celiac disease	4E-28	   1.36	[1.29-1.44] 	rs17810546	G	0.13	20190752
LPP	Celiac disease	3E-40	   1.29	[1.25-1.34] 	rs1464510	A	0.49	20190752
HLA-DQA1, HLA-DQB1	Celiac disease	1E-50	   6.23	[5.95-6.52] 	rs2187668	A	0.26	20190752
TNFAIP3	Celiac disease	4E-19	   1.23	[1.17-1.28] 	rs2327832	G	0.22	20190752
TAGAP	Celiac disease	3E-15	   1.16	[1.12-1.21] 	rs1738074	A	0.43	20190752
SH2B3	Celiac disease	7E-21	   1.20	[1.15-1.24] 	rs653178	G	0.50	20190752
PTPN2	Celiac disease	3E-10	   1.17	[1.12-1.23] 	rs1893217	G	0.17	20190752
CCR4	Celiac disease	3E-9	   1.13	[1.08-1.17] 	rs13314993	C	0.46	20190752
CD80, KTELC1	Celiac disease	8E-9	   1.13	[1.08-1.17] 	rs11712165	C	0.39	20190752
BACH2, MAP3K7	Celiac disease	4E-10	   1.13	[1.09-1.17] 	rs10806425	A	0.40	20190752
PTPRK, THEMIS	Celiac disease	3E-14	   1.17	[1.12-1.22] 	rs802734	G	0.31	20190752
ETS1	Celiac disease	5E-16	   1.21	[1.16-1.27] 	rs11221332	A	0.24	20190752
NCAPG, LCORL	Height	8E-15	    .09	[0.07-0.11] cm decrease	rs7678436	A	0.26	20189936
HMGA1	Height	1E-13	    .11	[0.08-0.14] cm increase	rs7742369	G	0.14	20189936
PLAG1	Height	8E-10	    .12	[0.08-0.16] cm decrease	rs7833986	A	0.08	20189936
EFEMP1	Height	6E-9	    .07	[0.05-0.09] cm increase	rs3791679	A	0.25	20189936
ZBTB38	Height	6E-9	    .07	[0.05-0.09] cm increase	rs9825379	A	0.24	20189936
DIS3L2	Height	9E-9	    .06	[0.04-0.08] cm increase	rs7571816	A	0.45	20189936
LHX3, QSOX2	Height	2E-8	    .06	[0.04-0.08] cm increase	rs12338076	C	0.34	20189936
IGF1	Height	4E-8	    .07	[0.05-0.09] cm decrease	rs5742692	G	0.27	20189936
KCNJ2	Primary tooth development (number of teeth)	1E-14	   1.15	[NR] % variance explained	rs8079702	G	0.39	20195514
EDA	Primary tooth development (number of teeth)	5E-11	    .73	[NR] % variance explained	rs4844096	G	0.42	20195514
IGF2BP1	Primary tooth development (number of teeth)	2E-8	    .27	[NR] % variance explained	rs9674544	G	0.46	20195514
RAD51L1	Primary tooth development (number of teeth)	3E-8	    .51	[NR] % variance explained	rs1956529	T	0.38	20195514
KCNJ2	Primary tooth development (time to first tooth eruption)	4E-22	   1.62	[NR] % variance explained	rs8079702	G	0.39	20195514
EDA	Primary tooth development (time to first tooth eruption)	6E-11	    .50	[NR] % variance explained	rs5936487	G	0.39	20195514
MSRB3	Primary tooth development (time to first tooth eruption)	6E-9	    .46	[NR] % variance explained	rs10506525	C	0.27	20195514
ABO	E-selectin levels	2E-82	   9.71	[NR] % variance explained	rs651007	T	0.22	20147318
LEPR	Soluble leptin receptor levels	6E-13	   7.60	[5.64-9.56] % decrease	rs1751492	C	0.30	20167575
PITX2	Atrial fibrillation	3E-28	   2.03	[1.79-2.30] 	rs6843082	G	0.26	20173747
KCNN3	Atrial fibrillation	2E-21	   1.52	[1.40-1.64] 	rs13376333	T	0.30	20173747
ITPA	Chronic Hepatitis C infection	9E-76	NR	NR	rs7270101	C	0.11	20173735
ITPA	Chronic Hepatitis C infection	2E-58	NR	NR	rs1127354	A	0.069	20173735
SRR	Type 2 diabetes	3E-9	   1.28	[1.18-1.39] 	rs391300	G	0.62	20174558
PTPRD	Type 2 diabetes	9E-10	   1.57	[1.36-1.82] 	rs17584499	T	0.06	20174558
KCNQ1	Type 2 diabetes	1E-9	   1.29	[1.19-1.40] 	rs2237895	C	0.33	20174558
SELP	Soluble levels of adhesion molecules	4E-61	  22.60	[19.86-25.34] % increase	rs6136	T	NR	20167578
SELP	Soluble levels of adhesion molecules	4E-16	   7.30	[5.54-9.06] % decrease	rs2235302	T	NR	20167578
ABO	Soluble levels of adhesion molecules	2E-41	  14.00	[12.04-15.96] % increase	rs579459	T	NR	20167578
ICAM-1	Soluble levels of adhesion molecules	4E-23	   4.15	[3.33-4.97] % increase	rs3093030	T	NR	20167578
ABO	Soluble levels of adhesion molecules	1E-15	   3.95	[2.99-4.91] % decrease	rs649129	T	NR	20167578
PSMD3, CSF3	Neutrophil count	6E-10	    .10	[0.07-0.13] unit decrease in log(neutrophil ct)	rs4794822	C	0.48	20172861
PLCB4	Neutrophil count	3E-10	    .11	[0.07-0.15] unit decrease in log(neutrophil ct)	rs2072910	C	0.30	20172861
CPS1	Homocysteine levels	5E-9	    .05	[0.03-0.07] increase in log(Hcy)	rs7422339	A	0.24	20154341
STAT3	Multiple sclerosis	3E-10	   1.15	[1.10-1.20] 	rs744166	G	0.41	20159113
HLA	Multiple sclerosis	2E-25	   3.43	[NR] 	rs3135338	A	0.13	20159113
ETS1	Systemic lupus erythematosus	2E-11	   1.29	[1.20-1.39] 	rs1128334	A	0.35	20169177
WDFY4	Systemic lupus erythematosus	8E-12	   1.30	[1.21-1.40] 	rs7097397	G	0.28	20169177
BCO2	Interleukin-18 levels	4E-9	NR	NR	rs2115763	T	0.33	20150558
BCO2	Interleukin-18 levels	1E-8	NR	NR	rs1834481	G	0.24	20150558
TERC	Telomere length	4E-14	    .11	[0.08-0.14] unit decrease	rs12696304	G	0.30	20139977
GCKR	Hematological and biochemical traits	4E-9	    .09	[0.056-0.114] unit decrease	rs1260326	C	0.44	20139978
ABO	Hematological and biochemical traits	4E-59	    .31	[0.27-0.35] unit decrease	rs495828	T	0.28	20139978
Intergenic	Hematological and biochemical traits	3E-8	    .11	[0.068-0.142] unit decrease	rs7173947	C	0.29	20139978
ALPL	Hematological and biochemical traits	5E-13	    .16	[0.12-0.21] unit increase	rs2242420	T	0.18	20139978
GPLD1	Hematological and biochemical traits	2E-11	    .24	[0.17-0.3] unit decrease	rs6911965	C	0.66	20139978
PNPLA3,SAMM50,PARVB	Hematological and biochemical traits	2E-12	    .09	[0.061-0.109] unit increase	rs2896019	G	0.45	20139978
BRAP,ALDH2	Hematological and biochemical traits	5E-9	    .08	[0.052-0.106] unit decrease	rs3782886	G	0.27	20139978
FAM23A,MRC1L1,FAM23B,MRC1	Hematological and biochemical traits	1E-16	    .10	[0.075-0.123] unit decrease	rs2477664	T	0.44	20139978
PNPLA3,SAMM50,PARVB	Hematological and biochemical traits	2E-12	    .09	[0.061-0.109] unit decrease	rs2896019	G	0.45	20139978
Intergenic	Hematological and biochemical traits	1E-11	    .09	[0.062-0.112] unit decrease	rs9820070	C	0.31	20139978
SLC14A2	Hematological and biochemical traits	2E-10	    .09	[0.06-0.114] unit decrease	rs4890568	G	0.24	20139978
Intergenic	Hematological and biochemical traits	1E-10	    .10	[0.071-0.133] unit increase	rs11709625	A	0.17	20139978
CD163	Hematological and biochemical traits	3E-26	    .17	[0.13-0.2] unit increase	rs7136716	G	0.39	20139978
GGT1	Hematological and biochemical traits	8E-20	    .17	[0.13-0.21] unit decrease	rs5751902	T	0.37	20139978
ALDH2	Hematological and biochemical traits	5E-9	    .12	[0.082-0.164] unit decrease	rs671	A	0.26	20139978
TMPRSS6	Hematological and biochemical traits	2E-10	    .08	[0.052-0.1] unit increase	rs5756504	T	0.45	20139978
ABO	Hematological and biochemical traits	1E-11	    .09	[0.064-0.114] unit decrease	rs495828	T	0.28	20139978
LIPC	Hematological and biochemical traits	1E-14	    .14	[0.1-0.18] unit decrease	rs1077834	T	0.49	20139978
APOA1,APOC3,APOA4,APOA5	Hematological and biochemical traits	9E-10	    .12	[0.085-0.163] unit decrease	rs7350481	T	0.28	20139978
CETP	Hematological and biochemical traits	5E-29	    .25	[0.21-0.3] unit increase	rs3764261	A	0.21	20139978
HBS1L,MYB	Hematological and biochemical traits	1E-10	    .08	[0.056-0.104] unit decrease	rs7775698	T	0.35	20139978
ABO	Hematological and biochemical traits	6E-10	    .08	[0.056-0.106] unit decrease	rs495828	T	0.28	20139978
WDR72	Hematological and biochemical traits	2E-8	    .07	[0.044-0.092] unit decrease	rs10518733	C	0.4	20139978
TNFRSF13B	Hematological and biochemical traits	3E-10	    .09	[0.061-0.115] unit increase	rs4273077	G	0.46	20139978
RPL13A,RPS11,FCGRT,RCN3	Hematological and biochemical traits	3E-8	    .11	[0.07-0.144] unit increase	rs2280401	A	0.16	20139978
HBA2,HBA1,LUC7L,ITFG3,RGS11	Mean corpuscular hemoglobin	3E-9	    .07	[0.045-0.093] unit decrease	rs2858942	A	0.46	20139978
HBS1L,MYB	Mean corpuscular hemoglobin	3E-66	    .21	[0.19-0.23] unit increase	rs7775698	T	0.35	20139978
RCL1	Mean corpuscular hemoglobin	6E-11	    .08	[0.053-0.101] unit decrease	rs2236496	C	0.47	20139978
TFRC,ZDHHC19	Mean corpuscular hemoglobin	4E-11	    .08	[0.054-0.102] unit decrease	rs4916483	C	0.44	20139978
TMPRSS6	Mean corpuscular hemoglobin	5E-25	    .12	[0.098-0.146] unit increase	rs855791	G	0.44	20139978
CITED2	Mean corpuscular hemoglobin	1E-9	    .08	[0.056-0.106] unit decrease	rs632057	G	0.25	20139978
IGDCC4,DPP8,PTPLAD1,C15orf44,SLC24A1,DENND4A	Mean corpuscular hemoglobin	3E-9	    .08	[0.053-0.103] unit increase	rs6494537	C	0.27	20139978
NCAPH2,SCO2,TYMP,KLHDC7B	Mean corpuscular hemoglobin	4E-8	    .07	[0.049-0.099] unit decrease	rs470119	T	0.26	20139978
PDGFRA,HK1	Mean corpuscular hemoglobin	3E-25	    .14	[0.11-0.16] unit increase	rs218237	T	0.27	20139978
THRB	Mean corpuscular hemoglobin	4E-10	    .08	[0.059-0.109] unit decrease	rs9310736	A	0.26	20139978
ATP6V1G3,PTPRC	Mean corpuscular hemoglobin	7E-10	    .09	[0.061-0.119] unit increase	rs12127588	A	0.21	20139978
USP49,MED20,BYSL,CCND3	Mean corpuscular hemoglobin	2E-20	    .14	[0.11-0.17] unit decrease	rs3218097	A	0.19	20139978
MSMB,NCOA4,TIMM23	Mean corpuscular hemoglobin	6E-10	    .10	[0.071-0.133] unit increase	rs7085433	A	0.15	20139978
ALOX5,MARCH8,ANUBL1,FAM21C,AGAP4	Mean corpuscular hemoglobin	4E-12	    .13	[0.093-0.163] unit increase	rs2279434	T	0.12	20139978
C6orf182,CD164	Mean corpuscular hemoglobin	1E-8	    .11	[0.072-0.15] unit increase	rs11966072	G	0.1	20139978
HBS1L,MYB	Mean corpuscular volume	3E-56	    .19	[0.17-0.22] unit increase	rs7775698	T	0.35	20139978
HIC2,UBE2L3	Mean corpuscular volume	1E-8	    .07	[0.043-0.091] unit decrease	rs4821112	A	0.47	20139978
RBM38	Mean corpuscular volume	1E-8	    .07	[0.044-0.092] unit decrease	rs6092477	G	0.42	20139978
RCL1	Mean corpuscular volume	3E-14	    .09	[0.066-0.114] unit decrease	rs2236496	C	0.47	20139978
TFRC,ZDHHC19	Mean corpuscular volume	2E-8	    .07	[0.043-0.091] unit decrease	rs4916483	C	0.44	20139978
TMPRSS6	Mean corpuscular volume	1E-15	    .10	[0.071-0.119] unit increase	rs855791	G	0.44	20139978
CITED2	Mean corpuscular volume	1E-9	    .08	[0.057-0.107] unit decrease	rs632057	G	0.25	20139978
DOK2,XPO7	Mean corpuscular volume	3E-8	    .07	[0.047-0.097] unit increase	rs7843479	A	0.29	20139978
PDGFRA,HK1	Mean corpuscular volume	2E-29	    .15	[0.12-0.17] unit increase	rs218237	T	0.27	20139978
THRB	Mean corpuscular volume	3E-8	    .07	[0.049-0.099] unit decrease	rs9310736	A	0.26	20139978
USP49,MED20,BYSL,CCND3	Mean corpuscular volume	4E-27	    .16	[0.13-0.19] unit decrease	rs3218097	A	0.19	20139978
MSMB,NCOA4,TIMM23	Mean corpuscular volume	7E-9	    .10	[0.064-0.126] unit increase	rs7085433	A	0.15	20139978
TRIM58	Mean corpuscular volume	2E-8	    .09	[0.060-0.122] unit decrease	rs11204538	C	0.16	20139978
ALOX5,MARCH8,ANUBL1,FAM21C,AGAP4	Mean corpuscular volume	3E-11	    .12	[0.088-0.158] unit increase	rs2279434	T	0.12	20139978
C6orf182,CD164	Mean corpuscular volume	3E-8	    .11	[0.071-0.149] unit increase	rs11966072	G	0.1	20139978
KIT	Mean corpuscular volume	1E-27	    .70	[0.573-0.824] unit decrease	rs172629	C	0.74	20139978
AK3	Platelet counts	3E-13	   5.93	[4.344-7.507] unit increase	rs385893	C	0.76	20139978
HBS1L,MYB	Platelet counts	3E-14	    .09	[0.069-0.117] unit increase	rs7775698	T	0.34	20139978
THPO,CHRD	Platelet counts	5E-11	    .08	[0.052-0.100] unit increase	rs6141	T	0.45	20139978
BAK1	Platelet counts	7E-11	    .09	[0.063-0.117] unit increase	rs5745568	T	0.23	20139978
RCL1	Platelet counts	3E-13	    .10	[0.072-0.126] unit decrease	rs385893	T	0.25	20139978
SH2B3	Platelet counts	5E-19	    .14	[0.11-0.17] unit decrease	rs739496	A	0.16	20139978
GP1BA	Platelet counts	2E-12	    .12	[0.089-0.159] unit increase	rs6065	T	0.12	20139978
CCND2	Red blood cell count	6E-9	    .07	[0.047-0.095] unit decrease	rs11611647	C	0.37	20139978
HBS1L,MYB	Red blood cell count	7E-48	    .18	[0.16-0.20] unit decrease	rs7775698	T	0.35	20139978
TERT	Red blood cell count	3E-8	    .07	[0.043-0.091] unit increase	rs2736100	G	0.4	20139978
ABO	Red blood cell count	3E-12	    .09	[0.066-0.116] unit decrease	rs495828	T	0.28	20139978
PDGFRA,HK1	Red blood cell count	2E-17	    .11	[0.086-0.136] unit decrease	rs218237	T	0.27	20139978
USP49,MED20,BYSL,CCND3	Red blood cell count	1E-10	    .10	[0.068-0.126] unit increase	rs3218097	T	0.19	20139978
PRKCE	Red blood cell count	4E-8	    .09	[0.056-0.118] unit decrease	rs10495928	G	0.17	20139978
C6orf182,CD164	Red blood cell count	7E-9	    .11	[0.075-0.153] unit decrease	rs11966072	G	0.1	20139978
GCKR	Triglycerides	1E-11	    .10	[0.072-0.13] unit decrease	rs1260326	C	0.45	20139978
APOA1,APOC3,APOA4,APOA5	Triglycerides	1E-49	    .24	[0.21-0.27] unit increase	rs7350481	G	0.43	20139978
ANGPTL3	Triglycerides	2E-9	    .13	[0.085-0.167] unit decrease	rs10889353	C	0.14	20139978
LPL	Triglycerides	9E-14	    .17	[0.12-0.21] unit decrease	rs10096633	T	0.12	20139978
LRP2	Urate levels	4E-8	    .08	[0.053-0.111] unit decrease	rs2544390	C	0.49	20139978
ABCG2	Urate levels	1E-13	    .12	[0.09-0.152] unit increase	rs4148155	G	0.3	20139978
SLC2A9	Urate levels	7E-24	    .16	[0.13-0.2] unit increase	rs11722228	T	0.45	20139978
SLC22A12	Urate levels	2E-31	    .23	[0.19-0.27] unit decrease	rs506338	C	0.17	20139978
CDSN,PSORS1C1	White blood cell count	7E-9	    .07	[0.046-0.094] unit increase	rs3094212	C	0.35	20139978
GSDMA,PSMD3,CSF3,MED24	White blood cell count	3E-14	    .09	[0.070-0.118] unit decrease	rs4065321	T	0.32	20139978
HBS1L,MYB	White blood cell count	2E-9	    .07	[0.049-0.097] unit decrease	rs4895441	G	0.37	20139978
RAP1B,NUP107,SLC35E3	White blood cell count	3E-8	    .07	[0.041-0.089] unit increase	rs12313946	C	0.47	20139978
CDK6	White blood cell count	2E-8	    .07	[0.045-0.095] unit decrease	rs445	T	0.32	20139978
CDT1	mean corpuscular hemoglobin concentration	4E-13	    .09	[0.064-0.112] unit increase	rs837763	C	0.38	20139978
HBS1L,MYB	mean corpuscular hemoglobin concentration	6E-12	    .09	[0.061-0.109] unit increase	rs7775698	T	0.35	20139978
TMPRSS6	mean corpuscular hemoglobin concentration	8E-14	    .09	[0.065-0.113] unit increase	rs855791	G	0.44	20139978
ALDH2	mean corpuscular hemoglobin concentration	7E-10	    .08	[0.058-0.108] unit decrease	rs671	A	0.26	20139978
SLC12A7	mean corpuscular hemoglobin concentration	5E-10	    .08	[0.058-0.108] unit decrease	rs4580814	T	0.26	20139978
ABO	mean corpuscular hemoglobin concentration	4E-8	    .08	[0.055-0.113] unit increase	rs8176746	T	0.18	20139978
BGLAP,PAQR6,SMG5,TMEM79,C1orf85,VHLL,CCT3,C1orf182	mean corpuscular hemoglobin concentration	3E-9	    .09	[0.057-0.115] unit decrease	rs6684514	A	0.21	20139978
KLF5, KLF12	Pancreatic cancer	3E-11	   1.26	[1.18-1.35] 	rs9543325	C	0.37	20101243
NR5A2	Pancreatic cancer	2E-10	   1.30	[1.19-1.41] 	rs3790844	T	0.76	20101243
JAG1	Bone mineral density	5E-8	    .07	[NR] s.d. increase	rs2273061	A	0.31	20096396
G6PC2	Fasting glucose-related traits	9E-218	NR	NR	rs560887	C	0.70	20081858
MTNR1B	Fasting glucose-related traits	6E-175	NR	NR	rs10830963	G	0.30	20081858
GCK	Fasting glucose-related traits	7E-92	NR	NR	rs4607517	A	0.16	20081858
DGKB, TMEM195	Fasting glucose-related traits	3E-44	NR	NR	rs2191349	T	0.52	20081858
GCKR	Fasting glucose-related traits	6E-38	NR	NR	rs780094	C	0.62	20081858
ADCY5	Fasting glucose-related traits	7E-22	NR	NR	rs11708067	A	0.78	20081858
MADD	Fasting glucose-related traits	2E-18	NR	NR	rs7944584	A	0.75	20081858
ADRA2A	Fasting glucose-related traits	3E-16	NR	NR	rs10885122	G	0.87	20081858
FADS1	Fasting glucose-related traits	2E-15	NR	NR	rs174550	T	0.64	20081858
CRY2	Fasting glucose-related traits	1E-14	NR	NR	rs11605924	A	0.49	20081858
SLC2A2	Fasting glucose-related traits	8E-13	NR	NR	rs11920090	T	0.87	20081858
GLIS3	Fasting glucose-related traits	1E-12	NR	NR	rs7034200	A	0.49	20081858
PROX1	Fasting glucose-related traits	7E-12	NR	NR	rs340874	C	0.52	20081858
C2CD4B	Fasting glucose-related traits	4E-8	NR	NR	rs11071657	A	0.63	20081858
G6PC2	Fasting glucose-related traits	2E-66	NR	NR	rs560887	C	0.70	20081858
MTNR1B	Fasting glucose-related traits	3E-43	NR	NR	rs10830963	G	0.30	20081858
GCK	Fasting glucose-related traits	2E-16	NR	NR	rs4607517	A	0.16	20081858
DGKB, TMEM195	Fasting glucose-related traits	3E-17	NR	NR	rs2191349	T	0.52	20081858
ADCY5	Fasting glucose-related traits	3E-12	NR	NR	rs11708067	A	0.78	20081858
FADS1	Fasting glucose-related traits	5E-13	NR	NR	rs174550	T	0.64	20081858
GLIS3	Fasting glucose-related traits	1E-13	NR	NR	rs7034200	A	0.49	20081858
SLC30A8	Fasting glucose-related traits	3E-11	NR	NR	rs11558471	A	0.31	20081858
TCF7L2	Fasting glucose-related traits	1E-8	NR	NR	rs4506565	T	0.31	20081858
GCKR	Fasting glucose-related traits	4E-20	NR	NR	rs780094	C	0.62	20081858
GCKR	Fasting glucose-related traits	3E-24	NR	NR	rs780094	C	0.62	20081858
IGF1	Fasting glucose-related traits	3E-8	NR	NR	rs35767	G	0.85	20081858
IGF1	Fasting glucose-related traits	2E-9	NR	NR	rs35767	G	0.85	20081858
GCKR	Fasting insulin-related traits	4E-20	NR	NR	rs780094	C	0.62	20081858
GCKR	Fasting insulin-related traits	3E-24	NR	NR	rs780094	C	0.62	20081858
IGF1	Fasting insulin-related traits	3E-8	NR	NR	rs35767	G	0.85	20081858
IGF1	Fasting insulin-related traits	2E-9	NR	NR	rs35767	G	0.85	20081858
GCKR	Two-hour glucose challenge	3E-10	    .07	[0.05-0.09] mmol/L increase	rs1260326	T	NR	20081857
ADCY5	Two-hour glucose challenge	7E-16	    .09	[0.07-0.11] mmol/L increase	rs2877716	C	NR	20081857
GIPR	Two-hour glucose challenge	3E-12	    .09	[0.07-0.11] mmol/L increase	rs10423928	A	NR	20081857
ACE	Angiotensin-converting enzyme activity	3E-25	  16.20	[NR] % variance	rs4343	G	0.31	20066004
ABO	Angiotensin-converting enzyme activity	3E-8	   4.90	[NR] % variance	rs495828	A	0.17	20066004
SCN10A	Electrocardiographic traits	3E-15	   3.33	[2.51-4.15] ms increase	rs6795970	A	0.36	20062061
NOS1AP	Electrocardiographic traits	7E-10	   2.53	[1.73-3.33] ms decrease	rs1415259	A	0.39	20062061
SCN10A	Electrocardiographic traits	1E-58	  14.81	[13.01-16.60] % s.d. increase	rs6795970	A	0.36	20062063
ARHGAP24	Electrocardiographic traits	3E-17	   8.46	[6.50-10.42] % s.d. increase	rs7660702	T	0.74	20062063
SCN10A	Electrocardiographic traits	4E-9	   5.17	[3.46-6.89] % s.d. increase	rs6795970	A	0.36	20062063
CDKN1A	Electrocardiographic traits	3E-10	   6.52	[4.50-8.55] % s.d. increase	rs1321311	T	0.21	20062063
CAV1	Electrocardiographic traits	7E-13	   6.40	[4.65-8.15] % s.d. increase	rs3807989	A	0.40	20062063
TBX5	Electrocardiographic traits	3E-13	   7.35	[5.37-9.33] % s.d. increase	rs3825214	G	0.22	20062063
MYH6	Electrocardiographic traits	9E-11	   5.25	[3.66-6.83] % s.d. increase	rs365990	G	0.34	20062063
TBX5	Electrocardiographic traits	3E-12	   7.36	[5.29-9.43] % s.d. increase	rs3825214	G	0.22	20062063
NOS1AP	Electrocardiographic traits	5E-22	  12.20	[9.72-14.68] % s.d. increase	rs10494366	G	0.39	20062063
SCN5A	Electrocardiographic traits	5E-10	   8.24	[5.64-10.83] % s.d. decrease	rs11129795	G	0.77	20062063
KCNH2	Electrocardiographic traits	5E-11	  11.95	[8.39-15.51] % s.d. increase	rs3807375	T	0.35	20062063
KCNQ1	Electrocardiographic traits	8E-11	  13.16	[9.19-17.12] % s.d. increase	rs12296050	T	0.15	20062063
KCNE1	Electrocardiographic traits	2E-12	  11.70	[8.46-14.94] % s.d. increase	rs727957	T	0.19	20062063
MEIS1	PR interval	5E-11	   1.36	[0.95-1.77] ms increase	rs11897119	C	0.39	20062060
SCN5A	PR interval	6E-26	   3.04	[2.47-3.61] ms increase	rs11708996	C	0.15	20062060
SCN10A	PR interval	2E-74	   3.77	[3.37-4.17] ms increase	rs6800541	C	0.40	20062060
ARHGAP24	PR interval	6E-20	   2.01	[1.58-2.44] ms decrease	rs7692808	A	0.31	20062060
NKX2-5, C5orf41	PR interval	9E-13	   1.49	[1.08-1.90] ms decrease	rs251253	C	0.40	20062060
CAV1, CAV2	PR interval	4E-28	   2.30	[1.89-2.71] ms increase	rs3807989	A	0.40	20062060
WNT11	PR interval	3E-8	   1.19	[0.77-1.61] ms decrease	rs4944092	G	0.32	20062060
SOX5, C12orf67	PR interval	3E-13	   2.09	[1.53-2.65] ms decrease	rs11047543	A	0.15	20062060
TBX5, TBX3	PR interval	3E-17	   1.95	[1.50-2.40] ms increase	rs1896312	C	0.28	20062060
B3GNT2	Ankylosing spondylitis	2E-19	   1.27	[1.18-1.37] 	rs10865331	A	0.40	20062062
ERAP1	Ankylosing spondylitis	5E-12	   1.19	[1.10-1.30] 	rs27434	A	0.23	20062062
ALDH7A1	Osteoporosis	2E-9	   2.25	[1.72-2.94] 	rs13182402	G	0.05	20072603
IL28B, IL28A, IL29	Chronic Hepatitis C infection	6E-9	   2.31	[1.74-3.06] 	rs8099917	G	0.24	20060832
RYR3	Carotid atherosclerosis in HIV infection	3E-8	NR	NR	rs2229116	G	0.18	20009918
HLA-B	CD4:CD8 lymphocyte ratio	2E-28	    .37	[0.31-0.43] SD increase	rs2524054	A	0.32	20045101
HLA-B	CD4:CD8 lymphocyte ratio	6E-21	    .31	[0.25-0.37] SD decrease	rs2524054	A	0.32	20045101
FADS1	Metabolite levels	7E-179	  36.30	[NR] % variance explained	rs174547	C	0.30	20037589
ACADS	Metabolite levels	5E-96	  21.50	[NR] % variance explained	rs2014355	T	0.28	20037589
ACADM	Metabolite levels	1E-63	  14.60	[NR] % variance explained	rs211718	C	0.31	20037589
ACADL	Metabolite levels	3E-60	  13.80	[NR] % variance explained	rs2286963	T	0.37	20037589
ETFDH	Metabolite levels	4E-24	   5.60	[NR] % variance explained	rs8396	T	0.30	20037589
HCP5, HLA-B	HIV-1 control	5E-35	   5.80	[NR] % increase	rs2395029	G	0.048	20041166
HLA-C	HIV-1 control	6E-32	   5.30	[NR] % increase	rs9264942	C	0.412	20041166
NOG	Orofacial clefts	1E-8	   1.38	[1.21-1.56] 	rs227731	C	0.42	20023658
KIAA1598, VAX1	Orofacial clefts	2E-8	   1.36	[1.21-1.53] 	rs7078160	A	0.16	20023658
BCL11A	Fetal hemoglobin levels	1E-29	    .23	[NR] unit increase	rs766432	C	0.33	20018918
OR51B5,OR51B6	Fetal hemoglobin levels	3E-8	    .16	[NR] unit increase	rs5006884	A	0.25	20018918
HLA-DR-DQ	Leprosy	5E-27	   1.61	[1.39-1.61] 	rs602875	A	0.68	20018961
RIPK2	Leprosy	1E-16	   1.32	[1.23-1.41] 	rs42490	G	0.58	20018961
TNFSF15	Leprosy	3E-21	   1.37	[1.28-1.46] 	rs6478108	A	0.46	20018961
C13orf31	Leprosy	4E-54	   1.68	[1.57-1.80] 	rs3764147	G	0.31	20018961
NOD2	Leprosy	4E-40	   1.59	[1.49-1.71] 	rs9302752	G	0.29	20018961
RIPK2	Leprosy	1E-12	   1.30	[1.20-1.39] 	rs40457	A	0.28	20018961
HHIP	Pulmonary function	3E-20	    .52	[NR] % increase	rs1980057	T	0.40	20010835
GPR126	Pulmonary function	1E-9	    .42	[NR] % decrease	rs3817928	A	0.78	20010835
ADAM19	Pulmonary function	1E-10	    .38	[NR] % increase	rs2277027	A	0.71	20010835
AGER, PPT2	Pulmonary function	3E-14	   1.00	[NR] % increase	rs2070600	T	0.04	20010835
HTR4	Pulmonary function	1E-11	    .40	[NR] % decrease	rs11168048	T	0.58	20010835
INTS12, NPNT, FLJ20184, GSTCD	Pulmonary function	5E-17	  64.70	[NR] ml increase	rs11727189	T	0.06	20010835
TNS1	Pulmonary function	1E-12	    .07	[NR] % variance explained	rs2571445	G	0.60	20010834
GSTCD	Pulmonary function	2E-23	    .14	[NR] % variance explained	rs10516526	G	0.06	20010834
HHIP	Pulmonary function	6E-13	    .27	[NR] % variance explained	rs12504628	T	0.56	20010834
HTR4	Pulmonary function	4E-9	    .07	[NR] % variance explained	rs3995090	C	0.41	20010834
AGER	Pulmonary function	3E-15	    .09	[NR] % variance explained	rs2070600	T	0.06	20010834
THSD4	Pulmonary function	7E-15	    .09	[NR] % variance explained	rs12899618	G	0.85	20010834
TYK2	Type 1 diabetes	4E-9	   1.16	[1.11-1.22] 	rs2304256	C	0.71	19966805
DLK1, MEG3, RTL1, DIO3	Type 1 diabetes	1E-10	   1.11	[1.06-1.16] 	rs941576	A	0.57	19966805
ARL15	Adiponectin levels	3E-8	    .96	[NR] ug/ml increase	rs4311394	G	0.41	20011104
ADIPOQ	Adiponectin levels	9E-19	   1.07	[NR] ug/ml increase	rs266717	C	0.48	20011104
ADIPOQ	Adiponectin levels	3E-12	    .94	[NR] ug/ml increase	rs1648707	C	0.07	20011104
ADIPOQ	Adiponectin levels	1E-41	    .13	[NR] log(ug/ml) increase	rs17366568	G	0.89	20018283
HLA	Ulcerative colitis	4E-67	   2.73	[2.43-3.07] 	rs9263739	T	0.15	19915573
Intergenic	Ulcerative colitis	5E-22	   1.92	[1.68-2.19] 	rs2395185	G	0.61	19915573
LAMB1	Ulcerative colitis	3E-8	   1.11	[1.03-1.19] 	rs886774	G	0.41	19915572
CDH1	Ulcerative colitis	3E-8	   1.17	[1.07-1.27] 	rs1728785	G	0.76	19915572
HNF4A	Ulcerative colitis	9E-17	   1.17	[1.09-1.26] 	rs6017342	C	0.52	19915572
IL27, CCDC101, CLN3, EIF3C, NUPR1, SULT1A1, SULT1A2	Inflammatory bowel disease (early onset)	2E-9	   1.14	[1.00-1.30] 	rs8049439	G	0.37	19915574
MAPT,  C17orf69, KIAA1267, LOC644246	Parkinson's disease	2E-16	   1.30	[NR] 	rs393152	A	0.82	19915575
SNCA	Parkinson's disease	2E-16	   1.23	[NR] 	rs2736990	C	0.51	19915575
NSF	Parkinson's disease	1E-14	   1.28	[NR] 	rs199533	C	0.83	19915575
SLCO1B1	Methotrexate phramacokinetics (acute lymphoblastic leukemia)	8E-11	   1.80	[7.6-14.0] mL/min/m2 increase	rs11045879	T	0.16	19901119
HMGA1, C6orf1, NUDT3	Height	2E-8	    .55	[NR] cm increase	rs6918981	G	0.21	19893584
GLT6D1	Periodontitis	6E-9	   1.59	[1.36-1.86] 	rs1537415	G	0.38	19897590
TCHH	Hair morphology	3E-31	   6.11	[NR] % variance	rs11803731	A	0.82	19896111
AL450992.4	Hair morphology	2E-8	NR	NR	rs10788819	T	NR	19896111
TMPRSS6	Iron levels	5E-9	   4.39	[2.90-5.88] ug/dL increase	rs4820268	A	0.54	19880490
HBS1L,MYB	Hematology traits	8E-18	    .19	[0.15-0.23] s.d. decrease	rs7775698	C	0.74	19853236
TMPRSS6	Hematology traits	4E-12	    .13	[0.09-0.17] s.d. increase	rs4820268	A	0.53	19853236
HBS1L,MYB	Hematology traits	5E-13	    .19	[0.13-0.25] s.d. decrease	rs7775698	C	0.74	19853236
TMPRSS6	Hematology traits	3E-10	    .15	[0.11-0.19] s.d. increase	rs4820268	A	0.53	19853236
HFE	Hematology traits	1E-11	    .32	[0.22-0.42] s.d. decrease	rs1408272	T	0.94	19853236
HBS1L,MYB	Hematology traits	1E-9	    .16	[0.10-0.22] s.d. decrease	rs9399137	T	0.74	19853236
TNFSF4	Systemic lupus erythematosus	3E-32	   1.46	[1.37-1.56] 	rs2205960	A	0.27	19838193
RASGRP3	Systemic lupus erythematosus	1E-15	   1.43	[1.32-1.56] 	rs13385731	A	0.85	19838193
STAT4	Systemic lupus erythematosus	5E-42	   1.51	[1.43-1.61] 	rs7574865	A	0.33	19838193
TNIP1	Systemic lupus erythematosus	2E-9	   1.23	[1.15-1.33] 	rs10036748	A	0.76	19838193
PRDM1, ATG5	Systemic lupus erythematosus	5E-12	   1.25	[1.17-1.33] 	rs548234	G	0.26	19838193
TNFAIP3	Systemic lupus erythematosus	1E-17	   1.72	[1.52-1.94] 	rs2230926	C	0.04	19838193
IKZF1	Systemic lupus erythematosus	3E-23	   1.39	[1.30-1.47] 	rs4917014	A	0.68	19838193
NR	Systemic lupus erythematosus	2E-8	   1.20	[1.12-1.28] 	rs1167796	G	0.71	19838193
IRF5	Systemic lupus erythematosus	8E-19	   1.43	[1.32-1.54] 	rs4728142	A	0.13	19838193
BLK	Systemic lupus erythematosus	2E-24	   1.45	[1.35-1.56] 	rs7812879	G	0.76	19838193
LRRC18, WDFY4	Systemic lupus erythematosus	7E-12	   1.24	[1.17-1.32] 	rs1913517	A	0.29	19838193
NR	Systemic lupus erythematosus	1E-16	   1.29	[1.22-1.37] 	rs4639966	G	0.30	19838193
ETS1	Systemic lupus erythematosus	2E-25	   1.37	 [1.29-1.45)	rs6590330	A	0.34	19838193
SLC15A4	Systemic lupus erythematosus	2E-11	   1.26	[1.18-1.35] 	rs1385374	A	0.20	19838193
NR	Systemic lupus erythematosus	3E-8	   1.31	[1.20-1.46] 	rs7197475	A	0.08	19838193
HIC2, UBE2L3	Systemic lupus erythematosus	1E-16	   1.28	[1.20-1.35] 	rs131654	A	0.48	19838193
TERT	Lung adenocarcinoma	2E-10	   1.12	[1.08-1.16] 	rs2736100	G	0.50	19836008
CHRNA3, CHRNA5	Lung adenocarcinoma	2E-51	   1.31	[1.27-1.36] 	rs1051730	T	0.35	19836008
CLPTM1L	Lung adenocarcinoma	2E-10	   1.12	[1.09-1.16] 	rs31489	C	0.59	19836008
BAT3, APOM	Lung adenocarcinoma	5E-12	   1.22	[1.15-1.29] 	rs3117582	C	0.10	19836008
TRNAA-UGC	Lung adenocarcinoma	2E-8	   1.16	[1.09-1.24] 	rs4324798	A	0.09	19836008
TMPRSS6	Iron status biomarkers	1E-10	    .13	[0.09-0.17] s.d. decrease	rs855791	T	0.42	19820699
HFE	Iron status biomarkers	2E-8	    .22	[0.14-0.30] s.d. increase	rs1800562	A	0.08	19820699
TMPRSS6	Hemoglobin	2E-13	    .13	[0.09-0.17] g/dl decrease	rs855791	A	0.53	19820698
HFE	Hemoglobin	1E-8	NR	NR	rs198846	A	NR	19820698
HFE	Hematocrit	2E-9	    .31	[0.21-0.41] % increase	rs1800562	A	NR	19862010
HBS1L, MYB	Hematocrit	3E-15	    .22	[0.16-0.28] % increase	rs9483788	C	NR	19862010
TFR2	Hematocrit	4E-10	    .15	[0.10-0.20] % decrease	rs7385804	C	NR	19862010
PRKAG2	Hematocrit	6E-15	    .20	[0.15-0.25] % increase	rs10224002	G	NR	19862010
HK1	Hematocrit	1E-13	    .33	[0.24-0.42] % increase	rs16926246	T	NR	19862010
SH2B3, ATXN2	Hematocrit	1E-12	    .17	[0.12-0.22] % decrease	rs11065987	G	NR	19862010
TMPRSS6	Hematocrit	2E-13	    .17	[0.13-0.22] % decrease	rs2413450	T	NR	19862010
PRKCE	Hematocrit	4E-15	    .19	[0.14-0.23] % increase	rs10168349	C	NR	19862010
PRKCE	Hemoglobin	7E-13	    .06	[0.05-0.08] g/dl increase	rs10495928	G	NR	19862010
HFE	Hemoglobin	6E-19	    .16	[0.13-0.20] g/dl increase	rs1800562	A	NR	19862010
PRKAG2	Hemoglobin	3E-15	    .07	[0.05-0.09] g/dl increase	rs10224002	G	NR	19862010
HK1	Hemoglobin	2E-11	    .11	[0.08-0.14] g/dl increase	rs16926246	T	NR	19862010
TRAFD1	Hemoglobin	1E-11	    .06	[0.04-0.08] g/dl increase	rs11065987	A	NR	19862010
TSHZ2	Hemoglobin	1E-10	    .06	[0.05-0.08] g/dl decrease	rs6013509	A	NR	19862010
TMPRSS6	Hemoglobin	3E-25	    .09	[0.07-0.11] g/dl decrease	rs855791	A	NR	19862010
TFRC	Mean corpuscular hemoglobin	8E-13	    .00	[0.003-0.005] pg increase	rs11915082	A	NR	19862010
SLC17A3	Mean corpuscular hemoglobin	4E-39	    .02	[0.01-0.02] pg decrease	rs1408272	G	NR	19862010
CCND3, BYSL	Mean corpuscular hemoglobin	8E-20	    .01	[0.004-0.006] pg decrease	rs9349205	A	NR	19862010
HBS1L, MYB	Mean corpuscular hemoglobin	7E-69	    .01	[0.009-0.0111] pg decrease	rs7776054	G	NR	19862010
CITED2	Mean corpuscular hemoglobin	1E-17	    .00	[0.003-0.005] pg decrease	rs628751	C	NR	19862010
RCL1	Mean corpuscular hemoglobin	2E-14	    .00	[0.004-0.006] pg decrease	rs10758658	A	NR	19862010
ITFG3	Mean corpuscular hemoglobin	3E-10	    .00	[0.003-0.006] pg increase	rs1122794	A	NR	19862010
GCDH	Mean corpuscular hemoglobin	1E-11	    .00	[0.003-0.005] pg decrease	rs11085824	G	NR	19862010
TMPRSS6	Mean corpuscular hemoglobin	9E-34	    .01	[0.0005-0.007] pg decrease	rs2413450	T	NR	19862010
BCL11A	Mean corpuscular volume	1E-14	    .00	[0.002-0.004] fl decrease	rs2540917	C	NR	19862010
TFRC	Mean corpuscular volume	8E-14	    .00	[0.002-0.004] fl increase	rs9859260	C	NR	19862010
KIT	Mean corpuscular volume	1E-15	    .00	[0.003-0.006] fl decrease	rs172629	G	NR	19862010
HFE	Mean corpuscular volume	1E-46	    .01	[0.010-0.014] fl increase	rs1800562	A	NR	19862010
CCND3, BYSL	Mean corpuscular volume	1E-31	    .01	[0.004-0.006] fl decrease	rs9349205	A	NR	19862010
CD164	Mean corpuscular volume	4E-10	    .00	[0.002-0.003] fl decrease	rs9374080	C	NR	19862010
HBS1L, MYB	Mean corpuscular volume	7E-86	    .01	[0.007-0.009] fl decrease	rs4895441	G	NR	19862010
CITED2	Mean corpuscular volume	5E-25	    .00	[0.003-0.005] fl decrease	rs643381	A	NR	19862010
IKZF1	Mean corpuscular volume	5E-13	    .00	[0.002-0.004] fl increase	rs12718597	A	NR	19862010
TFR2	Mean corpuscular volume	3E-11	    .00	[0.002-0.004] fl increase	rs7786877	G	NR	19862010
RCL1	Mean corpuscular volume	3E-20	    .00	[0.003-0.005] fl decrease	rs10758658	A	NR	19862010
MARCH8	Mean corpuscular volume	1E-10	    .00	[0.002-0.003] fl decrease	rs11239550	G	NR	19862010
FNTB	Mean corpuscular volume	5E-8	    .00	[0.001-0.003] fl increase	rs4466998	A	NR	19862010
ITFG3	Mean corpuscular volume	2E-12	    .00	[0.002-0.004] fl decrease	rs7189020	T	NR	19862010
RTBDN	Mean corpuscular volume	2E-12	    .00	[0.002-0.004] fl decrease	rs7255045	A	NR	19862010
TMPRSS6	Mean corpuscular volume	3E-41	    .01	[0.004-0.006] fl decrease	rs2413450	T	NR	19862010
ECGF1	Mean corpuscular volume	1E-15	    .00	[0.003-0.005] fl decrease	rs131794	A	NR	19862010
SPTA1	Other erythrocyte phenotypes	1E-10	    .00	[0.001-0.002] g/dl decrease	rs857721	A	NR	19862010
HBS1L, MYB	Other erythrocyte phenotypes	7E-14	    .00	[0.002-0.003] g/dl decrease	rs9373124	C	NR	19862010
HBS1L, MYB	Other erythrocyte phenotypes	1E-47	    .00	[0.012-0.016] 1 M cells/mm^3 increase	rs9483788	G	NR	19862010
EPO	Other erythrocyte phenotypes	1E-9	    .00	[0.005-0.009] 1 M cell/mm^3 increase	rs2075671	A	NR	19862010
TMPRSS6	Hematological parameters	1E-9	    .14	[0.10-0.18] pg increase	rs5756506	C	NR	19820697
BYSL, CCND3	Hematological parameters	7E-19	    .58	[0.44-0.70] fl increase	rs11970772	T	NR	19820697
HFE	Hematological parameters	1E-23	   1.41	[1.13-1.69] fl increase	rs1800562	A	NR	19820697
FBX07	Hematological parameters	4E-10	    .37	[0.25-0.49] fl increase	rs9609565	G	NR	19820697
HBS1L, MYB	Hematological parameters	7E-42	    .82	[0.70-0.94] fl increase	rs9402686	A	NR	19820697
TFR2	Hematological parameters	5E-10	    .01	[0.004-0.008] 10^12/l increase	rs7385804	C	NR	19820697
PTPN11	Hematological parameters	8E-12	   4.65	[3.32-5.98] 10^9/l increase	rs11066301	G	NR	19820697
BAK1	Hematological parameters	4E-10	   5.44	[3.74-7.14] 10^9/l increase	rs210135	A	NR	19820697
AK3	Hematological parameters	9E-17	   6.26	[4.78-7.74] 10^9/l increase	rs385893	C	NR	19820697
GSDMA, ORMDL3	Hematological parameters	9E-9	    .02	[0.01-0.03] 10^9/l increase	rs17609240	G	NR	19820697
DNM3	Mean platelet volume	2E-14	    .01	[0.009-0.017] fl increase	rs10914144	C	NR	19820697
TPM1	Mean platelet volume	2E-8	    .01	[0.007-0.015] fl increase	rs11071720	T	NR	19820697
BET1L	Mean platelet volume	1E-14	    .01	[0.009-0.017] fl increase	rs11602954	G	NR	19820697
ARHGEF3	Mean platelet volume	6E-31	    .02	[0.013-0.017] fl increase	rs12485738	A	NR	19820697
TMCC2	Mean platelet volume	1E-20	    .01	[0.01-0.014] fl increase	rs1668873	G	NR	19820697
TAOK1	Mean platelet volume	1E-22	    .02	[0.012-0.020] fl increase	rs2138852	T	NR	19820697
JMJD1C	Mean platelet volume	3E-21	    .01	[0.01-0.018] fl increase	rs2393967	A	NR	19820697
PIK3CG	Mean platelet volume	2E-33	    .02	[0.013-0.017] fl increase	rs342293	G	NR	19820697
SIRPA	Mean platelet volume	8E-11	    .01	[0.006-0.014] fl increase	rs6136489	T	NR	19820697
EHD3	Mean platelet volume	3E-11	    .01	[0.006-0.014] fl increase	rs647316	A	NR	19820697
WDR66	Mean platelet volume	3E-44	    .03	[0.027-0.035] fl increase	rs7961894	T	NR	19820697
CD226	Mean platelet volume	1E-10	    .01	[0.007-0.015] fl increase	rs893001	C	NR	19820697
GPR177	Bone mineral density (hip)	2E-12	    .10	[0.07-0.13] s.d. increase	rs2566755	C	0.21	19801982
CTNNB1	Bone mineral density (hip)	8E-10	    .07	[0.05-0.09] s.d. decrease	rs87938	A	0.45	19801982
MEF2C	Bone mineral density (hip)	1E-13	    .09	[0.07-0.11] s.d. decrease	rs1366594	C	0.45	19801982
FLJ42280	Bone mineral density (hip)	5E-12	    .08	[0.06-0.10] s.d. decrease	rs7781370	T	0.34	19801982
SOX6	Bone mineral density (hip)	6E-10	    .09	[0.06-0.12] s.d. increase	rs7117858	G	0.20	19801982
ARHGAP1	Bone mineral density (hip)	4E-9	    .07	[0.05-0.09] s.d. increase	rs7932354	T	0.29	19801982
HDAC5	Bone mineral density (hip)	2E-8	    .08	[0.05-0.11] s.d. increase	rs228769	G	0.20	19801982
ESR1	Bone mineral density (hip)	2E-10	    .07	[0.05-0.09] s.d. increase	rs2941740	G	0.43	19801982
TNFRSF11B	Bone mineral density (hip)	7E-9	    .07	[0.05-0.09] s.d. decrease	rs11995824	G	0.55	19801982
GPR177	Bone mineral density (spine)	3E-13	    .11	[0.07-0.14] s.d. increase	rs1430742	C	0.21	19801982
STARD3NL	Bone mineral density (spine)	1E-9	    .07	[0.05-0.09] s.d. decrease	rs1524058	T	0.40	19801982
FLJ42280	Bone mineral density (spine)	2E-10	    .08	[0.05-0.11] s.d. decrease	rs4729260	G	0.32	19801982
DCDC5	Bone mineral density (spine)	2E-9	    .08	[0.05-0.11] s.d. increase	rs16921914	A	0.27	19801982
FOXL1	Bone mineral density (spine)	2E-8	    .09	[0.06-0.12] s.d. decrease	rs10048146	G	0.19	19801982
CRHR1	Bone mineral density (spine)	1E-8	    .07	[0.05-0.09] s.d. decrease	rs9303521	T	0.46	19801982
SPTBN1	Bone mineral density (spine)	2E-8	    .07	[0.05-0.09] s.d. increase	rs11898505	A	0.34	19801982
MEPE	Bone mineral density (spine)	2E-8	    .07	[0.05-0.09] s.d. increase	rs1471403	T	0.34	19801982
ZBTB40	Bone mineral density (spine)	3E-10	    .09	[0.06-0.12] s.d. increase	rs7524102	G	0.17	19801982
ESR1	Bone mineral density (spine)	6E-11	    .08	[0.06-0.10] s.d. decrease	rs2504063	A	0.40	19801982
TNFRSF11B	Bone mineral density (spine)	4E-16	    .09	[0.07-0.11] s.d. increase	rs2062377	T	0.44	19801982
LRP5	Bone mineral density (spine)	5E-8	    .07	[0.05-0.09] s.d. decrease	rs599083	G	0.31	19801982
SP7	Bone mineral density (spine)	1E-8	    .07	[0.05-0.09] s.d. increase	rs2016266	G	0.32	19801982
AKAP11	Bone mineral density (spine)	5E-25	    .12	[0.10-0.14] s.d. decrease	rs9533090	T	0.50	19801982
TNFRSF11A	Bone mineral density (spine)	9E-9	    .08	[0.05-0.11] s.d. decrease	rs884205	A	0.27	19801982
ATP10D	Sphingolipid levels	8E-19	    .06	[0.04-0.07] unit increase	rs10938494	A	0.23	19798445
FADS3	Sphingolipid levels	7E-13	    .62	[0.45-0.78] unit decrease	rs1000778	A	0.32	19798445
LASS4	Sphingolipid levels	2E-27	    .00	[0.0007-0.001] mol % increase	rs7258249	G	0.48	19798445
SPTLC3	Sphingolipid levels	8E-15	    .10	[0.08-0.13] mol % increase	rs680379	A	0.34	19798445
SGPP1	Sphingolipid levels	9E-66	    .00	[0.001-0.002] mol % increase	rs7157785	A	0.19	19798445
CTSO, TDO2, PDGFC	Speech perception in dyslexia	5E-8	NR	NR	rs4234898	T	NR	19786962
Intergenic	Prostate cancer	3E-10	   1.12	[1.08-1.16] 	rs10934853	A	0.28	19767754
Intergenic	Prostate cancer	5E-10	   1.14	[1.10-1.19] 	rs445114	T	0.64	19767754
Intergenic	Prostate cancer	2E-11	   1.12	[1.08-1.15] 	rs8102476	C	0.54	19767754
Intergenic	Prostate cancer	7E-12	   1.23	[1.16-1.31] 	rs11228565	A	0.20	19767754
Intergenic	Prostate cancer	3E-14	   1.80	[1.55-2.09] 	rs16901979	A	0.04	19767754
Intergenic	Prostate cancer	6E-15	   1.21	[1.15-1.26] 	rs16902094	G	0.15	19767754
Intergenic	Prostate cancer	2E-19	   1.58	[1.43-1.74] 	rs1447295	A	0.11	19767754
IL28A, IL28B	Response to hepatitis C treatment	9E-9	   1.98	[1.57-2.52] 	rs8099917	G	NR	19749758
IL28B	Response to hepatitis C treatment	3E-32	  27.10	[14.6-50.3] 	rs8099917	G	0.12	19749757
CLU	Alzheimer's disease	6E-10	   1.22	[1.14-1.29] 	rs2279590, rs11136000, rs9331888	S	0.26	19734903
CR1	Alzheimer's disease	3E-10	   1.22	[1.15-1.30] 	rs6656401, rs3818361	S	0.18	19734903
LOC64673, IRS1	Type 2 diabetes and other traits	9E-12	   1.19	[1.13-1.25] 	rs2943641	C	0.63	19734900
WFS1, PPP2R2C	Type 2 diabetes and other traits	1E-8	   1.16	[1.10-1.21] 	rs4689388	T	0.57	19734900
CDKAL1	Type 2 diabetes and other traits	2E-12	   1.20	[1.14-1.26] 	rs4712523	G	0.32	19734900
TCF7L2	Type 2 diabetes and other traits	1E-30	   1.48	[1.39-1.57] 	rs7903146	T	0.27	19734900
ABO	Soluble E-selectin levels	1E-29	NR	NR	rs579459	C	0.20	19729612
BRAP, ALDH2	Esophageal cancer	3E-24	   1.67	[1.58-1.76] 	rs671	A	NR	19698717
ADH6, ADH1B	Esophageal cancer	8E-24	   1.79	[1.69-1.88] 	rs1229984	G	NR	19698717
IL28B	Response to hepatitis C treatment	1E-28	   2.00	[1.8-2.3] (European-Americans)	rs12979860	C	0.72	19684573
IKZF1	Acute lymphoblastic leukemia (childhood)	1E-19	   1.69	[1.58-1.81] 	rs4132601	C	0.28	19684604
ARID5B	Acute lymphoblastic leukemia (childhood)	7E-19	   1.65	[1.54-1.76] 	rs7089424	C	0.34	19684604
ARID5B	Acute lymphoblastic leukemia (childhood)	1E-15	   1.91	[1.60-2.20] 	rs10821936	C	0.34	19684603
IKZF1, DDC	Acute lymphoblastic leukemia (childhood)	8E-11	   1.69	[1.40-1.90] 	rs11978267	G	0.27	19684603
HLA-A	Nasopharyngeal carcinoma	4E-20	   1.88	[1.65-2.15] 	rs2517713	A	0.62	19664746
GABBR1	Nasopharyngeal carcinoma	9E-17	   1.67	[1.48-1.88] 	rs29232	A	0.46	19664746
HLA-F	Nasopharyngeal carcinoma	7E-11	   1.51	[1.34-1.71] 	rs3129055	G	0.31	19664746
MTNR1B	Fasting plasma glucose	2E-9	    .07	 (0.04-0.09) mmol/L increase	rs2166706	G	0.46	19651812
ABO	Pancreatic cancer	5E-8	   1.20	[1.12-1.28] 	rs505922	C	0.35	19648918
BNC2, LOC648570, CNTLN	Ovarian cancer	5E-19	   1.22	[1.16-1.27] 	rs3814113	T	0.68	19648919
PSCA	Bladder cancer	2E-10	   1.15	[1.10-1.20] 	rs2294008	T	0.46	19648920
MMP	Matrix metalloproteinase levels	6E-34	    .44	[NR] unit decrease in ln(MMP-1)	rs495366	A	0.36	20031604
MMP-1	Matrix metalloproteinase levels	9E-29	    .39	[NR] unit increase in ln(MMP-1)	rs11225434	C	0.38	20031604
MMP-1, MMP-3	Matrix metalloproteinase levels	2E-18	    .44	[NR] unit increase in ln(MMP-1)	rs11226373	G	0.15	20031604
NOS1AP	QT interval	2E-10	    .19	[0.13-0.25] unit increase	rs2880058	G	0.32	20031603
Intergenic	QT interval	4E-8	    .17	[0.11-0.23] unit increase	rs2478333	A	0.33	20031603
GPR133	RR interval (heart rate)	4E-8	    .17	[0.11-0.23] unit decrease	rs885389	A	0.30	20031603
STG, PSORS1	Follicular lymphoma	5E-11	   1.69	[1.43-2.00] 	rs6457327	C	0.62	19620980
PITX2	Atrial fibrillation	4E-63	   1.65	 	rs17042171	A	0.12	19597492
ZFHX3	Atrial fibrillation	2E-15	   1.25	 	rs2106261	T	0.174	19597492
ZFHX3	Atrial fibrillation	1E-10	   1.21	[1.14-1.29] 	rs7193343	T	NR	19597491
OLFML2B, NOS1AP	QT interval	1E-83	    .18	[NR] unit increase	rs12143842	T	0.25	19587794
SLC35F1, C6orf204, PLN	QT interval	2E-29	    .09	[NR] unit increase	rs11153730	C	0.50	19587794
SMG6, SRR, TSR1, SGSM2	Aortic root size	2E-11	    .03	[0.02-0.04] cm increase	rs10852932	T	0.36	19584346
CCDC100, PPIC	Aortic root size	1E-11	    .03	[0.02-0.04] cm increase	rs17470137	A	0.29	19584346
HMGA2	Aortic root size	2E-9	    .03	[0.02-0.04] cm decrease	rs4026608	C	0.38	19584346
PDE3A	Aortic root size	2E-8	    .03	[0.02-0.04] cm increase	rs10770612	G	0.19	19584346
SLC35F1, C6orf204, PLN	Cardiac structure and function	1E-9	    .03	[0.02-0.04] cm decrease	rs89107	G	0.50	19584346
TYR	Melanoma	2E-14	   1.29	[1.21-1.38] 	rs1393350	A	0.27	19578364
MC1R	Melanoma	3E-27	   1.67	[1.52-1.83] 	rs258322	A	0.09	19578364
MC1R	Melanoma	6E-22	   1.36	[1.28-1.45] 	rs4785763	A	0.32	19578364
MTAP	Cutaneous nevi	3E-15	    .20	[0.13-0.27] increase in log nevus count	rs4636294	A	0.48	19578365
PLA2G6	Cutaneous nevi	3E-8	    .08	[-0.002-0.16] decrease in log nevus count	rs2284063	G	0.35	19578365
TERT	Glioma	2E-17	   1.27	[1.19-1.37] 	rs2736100	G	0.49	19578367
TERT	Glioma	4E-14	   1.26	[1.20-1.32] 	rs2853676	A	0.73	19578367
CCDC26	Glioma	8E-11	   1.24	[1.17-1.30] 	rs891835	G	0.79	19578367
CCDC26	Glioma	2E-18	   1.36	[1.29-1.43] 	rs4295627	G	0.83	19578367
CDKN2A, CDKN2B	Glioma	7E-15	   1.24	[1.19-1.30] 	rs4977756	G	0.60	19578367
PHLDB1	Glioma	1E-8	   1.18	[1.13-1.24] 	rs498872	T	0.69	19578367
RTEL1	Glioma	3E-12	   1.28	[1.21-1.35] 	rs6010620	G	0.23	19578367
Intergenic	Glioma (high-grade)	2E-10	   1.42	[1.27-1.58] 	rs1412829	C	0.39	19578366
RTEL1	Glioma (high-grade)	3E-9	   1.52	[1.32-1.75] 	rs6010620	G	0.77	19578366
RTEL1	Glioma (high-grade)	2E-9	   1.60	[1.37-1.87] 	rs4809324	C	0.10	19578366
LEPR	C-reactive protein	3E-14	  14.80	[12.0-17.6] % decrease	rs6700896	T	NR	19567438
IL6R	C-reactive protein	2E-14	  11.50	[8.5-14.4] % decrease	rs4537545	T	NR	19567438
CRP	C-reactive protein	8E-44	  20.70	[18.9-23.4] % decrease	rs7553007	A	NR	19567438
HNF1A	C-reactive protein	1E-30	  13.80	[10.9-16.6] % decrease	rs1183910	T	NR	19567438
APOE, APOC1, APOCII	C-reactive protein	5E-27	  21.80	[18.1-25.3] % decrease	rs4420638	G	NR	19567438
DIS3L2, ALPP, NPPC	Height	3E-9	    .44	[0.20-0.68] cm increase	rs6717918	T	0.78	19570815
MHC	Schizophrenia	1E-8	   1.22	 	rs13194053	T	0.86	19571811
SLC17A1, SLC17A3, BTN3A2, BTN2A2, BTN3A1, HIST1H2AG, HIST1H2BJ, PRSS16, POM121L2, ZNF184	Schizophrenia	1E-8	   1.28	[NR] 	rs13194053	T	0.82	19571809
MHC, PRSS16	Schizophrenia	1E-12	   1.16	[NR] 	rs6932590	T	0.78	19571808
NRGN	Schizophrenia	2E-9	   1.15	[NR] 	rs12807809	T	0.83	19571808
TCF4	Schizophrenia	4E-9	   1.23	[NR] 	rs9960767	C	0.06	19571808
MHC, NOTCH4	Schizophrenia	2E-10	   1.19	[NR] 	rs3131296	G	0.87	19571808
PECR	Alcohol dependence	1E-8	   1.35	[1.22-1.49] 	rs7590720	G	0.29	19581569
CLDN14	Kidney stones	4E-12	   1.25	[1.17-1.33] 	rs219780	C	0.79	19561606
NRXN3	Waist circumference	5E-8	    .65	[NR] cm increase	rs10146997	G	NR	19557197
TFAP2B	Adiposity	2E-11	    .04	[0.03-0.05] z-score unit increase	rs987237	G	0.164	19557161
MSRA	Adiposity	9E-9	    .04	[0.03-0.05] z-score unit increase	rs7826222	G	0.183	19557161
LYPLAL1	Adiposity	3E-8	    .04	[0.03-0.05] z-score unit increase	rs2605100	G	0.692	19557161
FTO	Obesity (extreme)	6E-12	   1.48	[1.33-1.66] 	rs9941349	T	0.43	19553259
METTL1, CYP27B1	Multiple sclerosis	5E-11	   1.23	[NR] 	rs703842	A	0.67	19525955
HLA-DRB1	Multiple sclerosis	7E-184	   2.78	[NR] 	rs9271366	G	0.15	19525955
HLA-DRB1	Multiple sclerosis	4E-225	   2.75	[2.46-3.07] 	rs3135388	A	0.22	19525953
HLA-B	Multiple sclerosis	1E-17	   1.28	[1.18-1.39] 	rs2523393	A	0.59	19525953
CD58	Multiple sclerosis	3E-10	   1.30	[1.14-1.47] 	rs2300747	A	0.88	19525953
IRF8	Multiple sclerosis	4E-9	   1.25	[1.12-1.39] 	rs17445836	G	0.81	19525953
CD6	Multiple sclerosis	4E-9	   1.18	[1.07-1.30] 	rs17824933	G	0.25	19525953
TNFRSF1A	Multiple sclerosis	2E-11	   1.20	[1.10-1.31] 	rs1800693	C	0.45	19525953
REL	Rheumatoid arthritis	2E-12	   1.21	[1.15-1.28] 	rs13017599	A	0.34	19503088
CTLA4	Rheumatoid arthritis	6E-9	   1.17	[1.11-1.23] 	rs231735	T	0.51	19503088
BLK	Rheumatoid arthritis	6E-9	   1.19	[1.13-1.27] 	rs2736340	A	0.24	19503088
PDZK1	Uric acid levels	3E-9	    .06	[0.042-0.083] mg/dl decrease	rs12129861	A	0.46	19503597
GCKR	Uric acid levels	1E-9	    .05	[0.035-0.068] mg/dl increase	rs780094	T	0.42	19503597
SLC2A9	Uric acid levels	1E-41	    .22	[0.188-0.252] mg/dl increase	rs734553	T	0.77	19503597
ABCG2	Uric acid levels	2E-18	    .22	[0.171-0.270] mg/dl increase	rs2231142	T	0.11	19503597
LRRC16A, SCGN	Uric acid levels	9E-9	    .05	[0.036-0.072] mg/dl increase	rs742132	A	0.70	19503597
SLC17A1	Uric acid levels	3E-14	    .06	[0.459-0.078] mg/dl decrease	rs1183201	A	0.48	19503597
SLC16A9	Uric acid levels	1E-8	    .08	[0.051-0.105] mg/dl increase	rs12356193	A	0.83	19503597
SLC22A11	Uric acid levels	7E-14	    .06	[0.046-0.078] mg/dl increase	rs17300741	A	0.51	19503597
SLC22A12	Uric acid levels	2E-9	    .06	[0.038-0.074] mg/dl decrease	rs505802	T	0.70	19503597
SLC2A9	Uric acid levels	1E-192	    .40	[0.371-0.423] mg/dl increase	rs734553	T	0.77	19503597
ABCG2	Uric acid levels	1E-10	    .14	[0.096-0.181] mg/dl increase	rs2231142	T	0.11	19503597
KITLG	Testicular cancer	6E-15	   3.07	[2.29-4.13] 	rs4474514	A	NR	19483682
SPRY4	Testicular germ cell tumor	3E-13	   1.37	[1.19-1.58] 	rs4624820	A	0.54	19483681
BAK1	Testicular germ cell tumor	1E-13	   1.50	[1.28-1.75] 	rs210138	G	0.20	19483681
KITLG	Testicular germ cell tumor	1E-31	   2.55	[2.05-3.19] 	rs995030	G	0.80	19483681
KITLG	Testicular germ cell tumor	3E-30	   2.69	[2.10-3.44] 	rs995030	G	0.83	19483681
IL12A	Primary biliary cirrhosis	2E-14	   1.54	[1.38-1.72] 	rs6441286	G	0.39	19458352
IL12RB2	Primary biliary cirrhosis	3E-11	   1.51	[1.33-1.70] 	rs3790567	A	0.24	19458352
c6orf10, BTNL2, HLA-DQB1	Primary biliary cirrhosis	1E-10	NR	NR	rs2395148, rs3135363, rs2856683, rs9357152	S	0.01	19458352
c6orf10, BTNL2, HLA-DQB1	Primary biliary cirrhosis	7E-10	NR	NR	rs2395148, rs3135363, rs2856683, rs9357152	S	0.20	19458352
KIFAP3	Amyotrophic lateral sclerosis	2E-8	    .58	[0.38-0.78] years older	rs1541160	C	NR	19451621
ZNF746	Amyotrophic lateral sclerosis	4E-8	   1.08	[0.70-1.46] years older	rs855913	A	NR	19451621
LIN28B	Menarche and menopause (age at onset)	3E-13	    .16	[0.12-0.20] years older	rs314277	A	0.14	19448621
Intergenic	Menarche and menopause (age at onset)	3E-9	    .09	[0.06-0.12] years younger	rs7861820	C	0.48	19448621
TRMT6, MCM8	Menarche and menopause (age at onset)	1E-21	   1.07	[0.85-1.29] years older	rs16991615	A	0.06	19448621
BRSK1	Menarche and menopause (age at onset)	2E-19	    .49	[0.38-0.60] years younger	rs1172822	T	0.37	19448621
UIMC1	Menarche and menopause (age at onset)	8E-14	    .39	[0.29-0.49] years older	rs365132	T	0.49	19448621
GCM2, SYCP2L	Menarche and menopause (age at onset)	5E-8	    .29	[0.19-0.39] years older	rs2153157	T	0.49	19448621
LIN28B	Menarche (age at onset)	4E-16	    .14	[0.11-0.17] years younger	rs314276	C	0.67	19448623
TMEM38B, SLC44A1, FKTN, FSD1L, TAL2, ZNF462	Menarche (age at onset)	2E-9	    .10	[0.06-0.14] years younger	rs2090409	A	0.31	19448620
LIN28B	Menarche (age at onset)	7E-9	    .09	[0.05-0.13] years older	rs7759938	C	0.33	19448620
BRSK1, TMEM224, SUV420H2	Menopause (age at onset)	6E-11	    .39	[0.27-0.51] years younger	rs1172822	T	0.39	19448619
MCM8	Menopause (age at onset)	1E-10	    .50	[0.34-0.65] years older	rs236114	A	0.21	19448619
LOC121793, ARHGEF7	Menopause (age at onset)	3E-8	    .52	[0.34-0.70] years older	rs7333181	A	0.12	19448619
LIN28B, HACE1, E3 ubiquitin protein ligase 1, BVES, POPDC3	Menarche (age at onset)	2E-14	   1.20	[0.9-1.5] months older	rs314280	T	0.48	19448622
Intergenic	Type 1 diabetes	5E-10	   1.09	[1.02-1.17] 	rs10517086	A	0.30	19430480
C6orf173	Type 1 diabetes	4E-13	   1.17	[1.10-1.24] 	rs9388489	G	0.45	19430480
CD69	Type 1 diabetes	2E-11	   1.09	[1.02-1.16] 	rs4763879	A	0.37	19430480
Intergenic	Type 1 diabetes	4E-9	   1.09	[1.02-1.16] 	rs4900384	G	0.29	19430480
IL27	Type 1 diabetes	3E-13	   1.09	[1.02-1.16] 	rs4788084	G	0.42	19430480
Intergenic	Type 1 diabetes	3E-15	   1.28	[1.17-1.41] 	rs7202877	G	0.10	19430480
Intergenic	Type 1 diabetes	3E-16	   1.10	[1.04-1.17] 	rs5753037	T	0.39	19430480
Intergenic	Type 1 diabetes	8E-9	   1.16	[1.07-1.24] 	rs2664170	G	0.32	19430480
UMOD	Renal function and chronic kidney disease	2E-12	   1.25	[1.18-1.33] 	rs12917707	G	0.82	19430482
SHROOM3	Renal function and chronic kidney disease	1E-12	    .01	[0.008-0.016] ml/min/1.73m2 decrease	rs17319721	A	0.44	19430482
SPATA5L1, GATM	Renal function and chronic kidney disease	6E-14	    .01	[0.009-0.017] ml/min/1.73m2 decrease	rs2467853	G	0.38	19430482
UMOD	Renal function and chronic kidney disease	5E-16	    .02	[0.014-0.022] ml/min/1.73m2 increase	rs12917707	T	0.18	19430482
ULK4	Diastolic blood pressure	3E-9	    .49	[0.33-0.65] mm Hg increase	rs9815354	A	0.17	19430479
CACNB2	Diastolic blood pressure	1E-8	    .37	[0.25-0.49] mm Hg increase	rs11014166	A	0.66	19430479
ATP2B1	Diastolic blood pressure	1E-9	    .50	[0.34-0.66] mm Hg increase	rs2681472	A	0.83	19430479
SH2B3	Diastolic blood pressure	3E-14	    .48	[0.36-0.60] mm Hg increase	rs3184504	T	0.48	19430479
TBX3, TBX5	Diastolic blood pressure	4E-8	    .35	[0.23-0.47] mm Hg decrease	rs2384550	A	0.35	19430479
CSK, ULK3	Diastolic blood pressure	2E-10	    .40	[0.28-0.52] mm Hg increase	rs6495122	A	0.42	19430479
ATP2B1	Hypertension	2E-11	    .15	[0.11-0.19] increase in log odds	rs2681472	A	0.83	19430479
CYP17A1	Systolic blood pressure	1E-10	   1.05	[0.74-1.36] mm Hg increase	rs1004467	A	0.90	19430479
PLEKHA7	Systolic blood pressure	2E-9	    .65	[0.43-0.87] mm Hg increase	rs381815	T	0.26	19430479
ATP2B1	Systolic blood pressure	4E-11	    .85	[0.60-1.10] mm Hg increase	rs2681492	T	0.80	19430479
SH2B3	Systolic blood pressure	5E-9	    .58	[0.38-0.78] mm Hg increase	rs3184504	T	0.48	19430479
FGF5, PRDM8, c4orf22	Diastolic blood pressure	1E-21	    .50	[0.40-0.60] mm Hg increase	rs16998073	T	0.21	19430483
c10orf107, TMEM26, RTKN2, RHOBTB1, ARID5B	Diastolic blood pressure	1E-9	    .39	[0.27-0.51] mm Hg decrease	rs1530440	T	0.19	19430483
ATXN2, SH2B3	Diastolic blood pressure	3E-18	    .46	[0.36-0.56] mm Hg decrease	rs653178	T	0.53	19430483
CYP1A1, CYP1A2, CSK, LMAN1L, CPLX3, ARID3B	Diastolic blood pressure	1E-23	    .43	[0.35-0.51] mm Hg increase	rs1378942	C	0.36	19430483
ZNF652, PHB	Diastolic blood pressure	5E-9	    .31	[0.21-0.41] mm Hg increase	rs16948048	G	0.39	19430483
MTHFR, NPPA, CLCN6, NPPB, AGTRAP	Systolic blood pressure	2E-13	    .85	[0.63-1.07] mm Hg decrease	rs17367504	G	0.14	19430483
CYP17A1, AS3MT, CNNM2, NT5C2	Systolic blood pressure	7E-24	   1.16	[0.92-1.40] mm Hg increase	rs11191548	T	0.91	19430483
PLCD3, ACBD4, HEXIM1, HEXIM2	Systolic blood pressure	1E-8	    .57	[0.37-0.77] mm Hg increase	rs12946454	T	0.28	19430483
PDE4D	Asthma	3E-8	   1.18	[1.08-1.30] 	rs1588265	C	0.29	19426955
LOC344371, MYADML, FAM98A, RASGRP3	Hypertension (young onset)	3E-10	NR	NR	rs9308945,rs6711736,rs6729869,rs10495809	S	NR	19421330
SLCO1B3	Bilirubin levels	3E-14	    .13	[0.08-0.18] s.d. increase	rs2117032	C	0.47	19419973
UGT1A1	Bilirubin levels	1E-69	    .57	[0.50-0.63] s.d. decrease	rs887829	T	0.30	19419973
G6PD	Bilirubin levels	9E-9	    .18	[0.12-0.24] s.d. decrease	rs766420	G	0.18	19419973
UGT1A1	Bilirubin levels	5E-324	    .23	[0.21-0.25] umol/l increase in log(tbil)	rs6742078	T	0.32	19414484
SLCO1B1,LST-3TM12,SLCO1A2	Bilirubin levels	7E-13	    .05	[0.03-0.07] umol/l increase in log(tbil)	rs4149056	C	0.15	19414484
BARD1	Neuroblastoma (high-risk)	9E-18	   1.68	[1.49-1.90] 	rs6435862	G	0.29	19412175
TRA-alpha, TRAJ10	Narcolepsy	3E-22	   1.69	[1.52-1.88] 	rs1154155	C	0.14	19412176
CDKAL1	Type 2 diabetes	7E-20	   1.27	[1.21-1.33] 	rs4712523	G	0.41	19401414
CDKN2A, CDKN2B	Type 2 diabetes	2E-29	   1.34	[1.27-1.41] 	rs2383208	A	0.55	19401414
KCNQ1	Type 2 diabetes	1E-26	   1.33	[1.27-1.41] 	rs2237892	C	0.59	19401414
SLC30A8	Type 2 diabetes	2E-14	   1.22	[1.16-1.28] 	rs13266634	C	0.57	19401414
HHEX	Type 2 diabetes	7E-12	   1.21	[1.15-1.28] 	rs1111875	C	0.28	19401414
TCF7L2	Type 2 diabetes	8E-12	   1.54	[1.36-1.74] 	rs7903146	T	0.04	19401414
CDH10,CDH9	Autism	2E-10	   1.19	[NR] 	rs4307059	T	0.61	19404256
C12orf51	Biomedical quantitative traits	8E-12	    .01	[0.004-0.008] decrease	rs2074356	T	0.15	19396169
CD46, LOC148696	Biomedical quantitative traits	3E-9	   1.09	[0.72-1.44] beats per minute increase	rs12731740	T	0.10	19396169
LOC644502	Biomedical quantitative traits	2E-9	    .66	[0.45-0.87] beats per minute increase	rs12110693	A	0.49	19396169
FAM3C	Biomedical quantitative traits	1E-11	NR	NR	rs7776725	C	0.13	19396169
HMGA1	Height	3E-8	    .40	[0.26-0.54] cm increase	rs6918981	G	0.21	19396169
ZBTB38	Height	6E-12	    .46	[0.33-0.59] cm increase	rs10513137	A	0.26	19396169
PLAG1	Height	1E-9	    .71	[0.48-0.94] cm decrease	rs13273123	G	0.07	19396169
EFEMP1	Height	2E-9	    .42	[0.28-0.56] cm increase	rs3791675	G	0.22	19396169
NINJ2	Stroke	1E-9	   1.29	[1.19-1.41] 	rs12425791	A	0.19	19369658
CETP	HDL cholesterol	3E-12	   6.20	 mg/dl increase	rs3764261	A	0.20	19359809
C11orf30	Atopic dermatitis	8E-10	   1.22	[1.15-1.30] 	rs7927894	A	0.36	19349984
HLA-DPB1	Hepatitis B	6E-39	   1.75	[1.61-1.92] 	rs9277535	G	NR	19349983
MATP	Tanning	3E-10	    .44	[0.30-0.58] decrease in tanning ability score	rs35391	T	NR	19340012
EXOC2	Tanning	5E-14	    .22	[0.16-0.28] increase in tanning ability score	rs12210050	T	NR	19340012
GRM5	Tanning	5E-9	    .14	[0.10-0.18] decrease in tanning ability score	rs10831496	G	NR	19340012
TYR	Tanning	2E-13	    .19	[0.13-0.25] increase in tanning ability score	rs1393350	A	NR	19340012
MC1R	Tanning	3E-9	    .14	[0.10-0.18] decrease in tanning ability score	rs11648785	T	NR	19340012
IL6R	Fibrinogen	2E-11	   5.30	[NR] mg/dl decrease	rs8192284	C	0.40	20031577
CPS1	Fibrinogen	9E-9	   4.84	[NR] mg/dl decrease	rs7422339	A	0.31	20031577
FGB, FGA, FGG	Fibrinogen	8E-39	  12.94	[NR] mg/dl increase	rs6056	A	0.18	20031577
SLC22A5, SLC22A4, IRF1	Fibrinogen	1E-12	   6.84	[NR] mg/dl decrease	rs1016988	G	0.20	20031577
CD300LF, SLC9A3R1, NAT9	Fibrinogen	8E-11	   6.45	[NR] mg/dl decrease	rs10512597	A	0.18	20031577
FGB	Fibrinogen	2E-30	    .09	[0.07-0.11] g/L increase	rs1800789	A	0.22	20031576
IRF1	Fibrinogen	1E-15	    .06	[0.04-0.08] g/L decrease	rs2522056	A	0.21	20031576
PCCB	Fibrinogen	6E-10	    .05	[0.03-0.06] g/L increase	rs511154	A	0.22	20031576
NLRP3	Fibrinogen	1E-8	    .04	[0.03-0.05] g/L decrease	rs1539019	A	0.37	20031576
MTHFR	Homocysteine levels	8E-35	    .05	[NR] unit increase in log(homocysteine)	rs1801133	A	0.33	20031578
COL4A1	Arterial stiffness	5E-8	  21.00	[11.79-30.21] cm/s increase	rs3742207	C	0.44	20031579
FGFR2	Breast cancer	2E-10	   1.17	[1.07-1.27] 	rs2981579	T	0.41	19330030
TOX3	Breast cancer	1E-9	   1.16	[1.07-1.27] 	rs3803662	T	0.27	19330030
Intergenic	Breast cancer	2E-8	   1.25	[1.15-1.37] 	rs13387042	A	0.51	19330030
Intergenic	Breast cancer	7E-10	   1.16	[1.09-1.24] 	rs11249433	C	0.39	19330030
NOS1AP	QT interval	2E-78	   3.15	[2.81-3.49] msec increase	rs12143842	T	0.26	19305408
NOS1AP	QT interval	3E-45	   2.98	[2.63-3.32] msec increase	rs12029454	A	0.15	19305408
NOS1AP	QT interval	1E-34	   2.63	[2.28-2.97] msec increase	rs16857031	G	0.14	19305408
KCNQ1	QT interval	3E-17	   7.88	[6.16-9.59] msec decrease	rs2074238	T	0.06	19305408
CNOT1,GINS3, NDRG4, SLC38A7, GOT2	QT interval	3E-25	   1.75	[1.41-2.09] msec decrease	rs37062	G	0.24	19305408
c6orf204,SLC35F1, PLN, ASF1A	QT interval	5E-22	   1.40	[1.06-1.74] msec increase	rs11756438	A	0.47	19305408
KCNQ1	QT interval	1E-15	   1.75	[1.41-2.09] msec increase	rs12576239	T	0.13	19305408
RNF207,NPHP4, CHDS, ACOT7, PLEKHG5, KLH21	QT interval	1E-16	   1.75	[1.41-2.09] msec increase	rs846111	C	0.28	19305408
KCNH2	QT interval	5E-16	   1.58	[1.23-1.92] msec increase	rs4725982	T	0.22	19305408
LITAF,CLEC16A, SNN, ZC3H7A, TNFRSF17	QT interval	5E-15	   1.23	[0.88-1.57] msec increase	rs8049607	T	0.49	19305408
SCN5A	QT interval	1E-14	   1.23	[0.88-1.57] msec decrease	rs12053903	C	0.34	19305408
LIG3,RFFL	QT interval	6E-12	   1.05	[0.71-1.39] msec decrease	rs2074518	T	0.46	19305408
KCNH2	QT interval	8E-16	   1.40	[1.06-1.74] msec decrease	rs2968864	C	0.25	19305408
RNF207	QT interval	4E-16	   1.49	[1.00-1.98] ms increase	rs846111	C	0.29	19305409
NOS1AP	QT interval	2E-78	   2.88	[2.43-3.33] ms increase	rs12143842	T	0.24	19305409
ATP1B1	QT interval	1E-15	   2.05	[1.48-2.62] ms increase	rs10919071	A	0.87	19305409
SCN5A	QT interval	5E-14	   1.27	[0.82-1.72] ms decrease	rs11129795	A	0.23	19305409
PLN	QT interval	2E-24	   1.64	[1.25-2.03] ms increase	rs11970286	T	0.44	19305409
KCNH2	QT interval	2E-15	   1.35	[0.90-1.80] ms decrease	rs2968863	T	0.29	19305409
KCNQ1	QT interval	3E-17	   1.44	[0.95-1.93] ms increase	rs12296050	T	0.20	19305409
LITAF	QT interval	6E-15	   1.25	[0.81-1.69] ms increase	rs8049607	T	0.46	19305409
KCNJ2	QT interval	6E-12	   1.02	[0.53-1.51] ms decrease	rs17779747	T	0.35	19305409
NDRG4	QT interval	7E-25	   1.66	[1.20-2.12] ms increase	rs7188697	A	0.74	19305409
NOS1AP	QT interval	7E-33	   2.19	[1.76-2.62] ms increase	rs4657178	T	0.33	19305409
PLN	QT interval	2E-17	   3.13	[2.29-3.97] ms decrease	rs12210810	C	0.06	19305409
CHRNA3,CHRNA4,CHRNA5, LOC123688	Chronic obstructive pulmonary disease	1E-10	   1.40	[1.18-1.67] 	rs8034191	C	0.33	19300482
VKORC1	Warfarin maintenance dose	3E-181	    .97	[0.91-1.02] mg/week decrease	rs9923231	T	0.40	19300499
HHIP	Pulmonary function	8E-11	    .10	[NR] % increase in FEV1/FVC ratio	rs13147758	G	0.39	19300500
ALPL	Folate pathway vitamin levels	8E-18	   1.45	[0.90-2.00] ng/ml decrease	rs4654748	C	0.50	19303062
FUT2	Folate pathway vitamin levels	3E-20	  49.77	[37.09-62.45] pg/ml increase	rs602662	A	0.53	19303062
ABO	Venous thromboembolism	4E-15	   1.81	[1.56-2.11] 	rs505922	C	0.35	19278955
PVT1, GSDMC	Orofacial clefts	3E-24	   2.57	[2.02-3.26] 	rs987525	A	0.20	19270707
TRHR	Body mass (lean)	4E-10	    .10	[0.04-0.16] kg increase	rs7832552	T	0.32	19268274
ADAMTS18	Bone mineral density	2E-8	   1.00	% [NR] of variance explained	rs11864477	C	0.12	19249006
ESR1, C6orf97	Breast cancer	2E-15	   1.29	[1.21-1.37] 	rs2046210	A	0.37	19219042
Intergenic	Mean platelet volume	1E-24	    .02	[0.014-0.018] log fl increase	rs342293	G	0.45	19221038
MRAS	Coronary heart disease	7E-13	   1.15	[1.11-1.19] 	rs9818870	T	0.15	19198612
IL1RL1	Eosinophil counts	5E-14	   6.40	[4.7-8.1] % standard unit increase	rs1420101	A	0.41	19198610
IKZF2	Eosinophil counts	5E-10	   6.30	[4.3-8.3] % standard unit increase	rs12619285	G	0.74	19198610
GATA2	Eosinophil counts	9E-17	   9.40	[7.2-11.6] % standard unit increase	rs4857855	T	0.82	19198610
SH2B3	Eosinophil counts	7E-19	   7.60	[5.9-9.3] % standard unit increase	rs3184504	T	0.38	19198610
IL5	Eosinophil counts	1E-10	   7.10	[4.9-9.2] % standard unit increase	rs4143832	C	0.16	19198610
CDKN2A, CDKN2B	Myocardial infarction (early onset)	3E-44	   1.29	[1.25-1.34] 	rs4977574	G	0.56	19198609
CELSR2, PSRC1, SORT1	Myocardial infarction (early onset)	8E-12	   1.19	[1.13-1.26] 	rs646776	T	0.81	19198609
MIA3	Myocardial infarction (early onset)	1E-9	   1.14	[1.10-1.19] 	rs17465637	C	0.72	19198609
CXCL12	Myocardial infarction (early onset)	7E-9	   1.17	[1.11-1.24] 	rs1746048	C	0.84	19198609
SLC5A3, MRPS6, KCNE2	Myocardial infarction (early onset)	6E-11	   1.20	[1.14-1.27] 	rs9982601	T	0.13	19198609
PHACTR1	Myocardial infarction (early onset)	1E-9	   1.12	[1.08-1.17] 	rs12526453	C	0.65	19198609
WDR12	Myocardial infarction (early onset)	1E-8	   1.17	[1.11-1.23] 	rs6725887	C	0.14	19198609
LDLR	Myocardial infarction (early onset)	2E-9	   1.15	[1.10-1.20] 	rs1122608	G	0.75	19198609
PCSK9	Myocardial infarction (early onset)	1E-8	   1.15	[1.10-1.21] 	rs11206510	T	0.81	19198609
SLC22A3,LPAL2,LPA	Coronary heart disease	1E-9	   1.20	[1.13-1.28] 	rs2048327,rs3127599,rs7767084,rs10755578	S	0.16	19198611
SLC22A3,LPAL2,LPA	Coronary heart disease	4E-15	   1.82	[1.57-2.12] 	rs2048327,rs3127599,rs7767084,rs10755578	S	0.02	19198611
FOXE1	Thyroid cancer	2E-27	   1.75	[1.59-1.94] 	rs965513	A	0.34	19198613
NKX2-1	Thyroid cancer	2E-9	   1.37	[1.24-1.52] 	rs944289	T	0.57	19198613
Intergenic	Quantitative traits	1E-9	    .23	[NR] mg/dL increase	rs7396835	T	0.32	19197348
RET, GALNACT-2, RASGEF1A	Hirschsprung's disease	4E-18	NR	NR	rs2742234	T	NR	19196962
NRG1	Hirschsprung's disease	2E-8	   1.68	[1.40-2.00] 	rs16879552	G	0.61	19196962
CETP, NUP93, SLC12A3, HERPUD1	HDL cholesterol	4E-93	   3.09	 mg/dL increase	rs1800775	A	0.49	20031564
LINGO1	Essential tremor	1E-9	   1.55	[1.35-1.79] 	rs9652490	G	0.23	19182806
SLC2A9	Biochemical measures	1E-9	    .29	[0.21-0.37] umol/l decrease	rs13129697	C	0.25	19260141
BCMO1	Carotenoid and tocopherol levels	2E-24	    .15	[0.120-0.177] umol/L increase	rs6564851	G	0.39	19185284
APOA5	Carotenoid and tocopherol levels	8E-10	    .07	[0.049-0.095] umol/L increase	rs12272004	A	0.07	19185284
HLA-C	Psoriasis	1E-100	   2.64	[NR] 	rs12191877	T	0.15	19169254
IL12B	Psoriasis	2E-28	   1.44	[NR] 	rs2082412	G	0.80	19169254
TNIP1	Psoriasis	1E-20	   1.59	[NR] 	rs17728338	A	0.054	19169254
IL13	Psoriasis	5E-15	   1.27	[NR] 	rs20541	G	0.79	19169254
TNFAIP3	Psoriasis	9E-12	   1.19	[NR] 	rs610604	G	0.32	19169254
IL23A, STAT2	Psoriasis	1E-9	   1.34	[NR] 	rs2066808	A	0.93	19169254
IL23R	Psoriasis	3E-8	   1.13	[NR] 	rs2201841	G	0.30	19169254
LCE3D, LCE3A	Psoriasis	7E-30	   1.32	[1.25-1.39] 	rs4085613	A	0.43	19169255
IL12B	Psoriasis	3E-26	   1.28	[1.23-1.35] 	rs3213094	A	0.45	19169255
ADIPOQ	Adiponectin levels	5E-8	NR	NR	rs6773957	A	0.37	19165155
FTO	Obesity	1E-28	   1.39	[1.27-1.51] 	rs1421085	C	0.40	19151714
MC4R	Obesity	5E-15	   1.22	[1.05-1.40] 	rs17782313	C	0.18	19151714
MAF	Obesity	4E-13	   1.12	[1.00-1.24] 	rs1424233	A	0.43	19151714
CLPTM1L, TERT	Basal cell carcinoma 	4E-12	   1.25	[1.18-1.34] 	rs401681	C	0.56	19151717
OTUD3, PLA2G2E	Ulcerative colitis	5E-13	   1.37	 	rs6426833	G	0.54	19122664
IL23R	Ulcerative colitis	1E-8	   1.29	 	rs10889677	A	0.30	19122664
IFNG, IL26, IL22	Ulcerative colitis	3E-12	   1.35	 	rs1558744	A	0.38	19122664
HCP5, MICB, MCCD1, BAT1, LTB, TNF	AIDS progression	3E-19	   3.47	[2.39-5.04] 	rs2395029	G	0.03	19115949
ARHGEF3	Mean platelet volume	4E-27	    .02	[0.01-0.02] per log fl increase	rs12485738	A	0.30	19110211
WDR66	Mean platelet volume	7E-48	    .03	[0.03-0.04] per log fl increase	rs7961894	A	0.11	19110211
TAOK1	Mean platelet volume	7E-28	    .02	[0.01-0.02] per log fl decrease	rs2138852	C	0.47	19110211
HK1	Glycated hemoglobin levels	2E-25	    .05	[NR] % increase	rs7072268	A	0.50	19096518
G6PC2	Glycated hemoglobin levels	5E-10	    .02	[NR] % increase	rs1402837	A	0.23	19096518
GCK	Glycated hemoglobin levels	6E-12	    .03	[NR] % increase	rs730497	A	0.17	19096518
SLC30A8	Glycated hemoglobin levels	5E-8	    .02	[NR] % decrease	rs13266634	A	0.30	19096518
TF	Iron status biomarkers	1E-9	    .43	[NR] s.d. increase	rs1830084	A	0.36	19084217
APOA1, APOC3, APOA4, APOA5, DSCAML1	Triglycerides	3E-29	NR	NR	rs10892151	A	0.028	19074352
Intergenic	Bone mineral density (hip)	1E-16	    .15	[0.11-0.18] s.d. decrease	rs7524102	A	0.82	19079262
ESR1	Bone mineral density (hip)	4E-10	    .08	[0.06-0.11] s.d. decrease	rs1038304	G	0.47	19079262
SOST	Bone mineral density (hip)	2E-8	    .08	[0.05-0.10] s.d. decrease	rs1513670	A	0.37	19079262
RANKL	Bone mineral density (spine)	2E-17	    .12	[0.09-0.15] s.d. decrease	rs9594759	T	0.62	19079262
Intergenic	Bone mineral density (spine)	2E-8	    .12	[0.08-0.16] s.d. decrease	rs6696981	G	0.86	19079262
C6orf97, ESR1	Bone mineral density (spine)	2E-10	    .10	[0.07-0.13] s.d. decrease	rs6929137	A	0.30	19079262
NEGR1	Body mass index	1E-11	   3.77	[2.67-4.87] % SD	rs2568958	A	0.58	19079260
TMEM18	Body mass index	4E-17	   6.12	[4.69-7.55] % SD	rs7561317	G	0.84	19079260
SFRS10, ETV5, DGKG	Body mass index	7E-11	   4.42	[3.09-5.75] % SD	rs7647305	C	0.77	19079260
BDNF	Body mass index	9E-10	   3.85	[2.62-5.08] % SD	rs925946	T	0.34	19079260
BDNF	Body mass index	5E-10	   4.58	[3.07-6.09] % SD	rs6265	G	0.85	19079260
SH2B1, ATP2A1	Body mass index	3E-10	   3.63	[2.49-4.77] % SD	rs7498665	G	0.44	19079260
FTO	Body mass index	4E-13	   5.25	[3.82-6.68] % SD	rs6499640	A	0.41	19079260
FTO	Body mass index	1E-47	   8.04	[6.96-9.12] % SD	rs8050136	A	0.41	19079260
MC4R	Body mass index	1E-12	   4.38	[3.16-5.60] % SD	rs12970134	A	0.30	19079260
KCTD15, CHST8	Body mass index	7E-12	   4.18	[2.98-5.38] % SD	rs29941	C	0.69	19079260
NEGR1	Weight	2E-8	   3.37	[2.19-4.55] % SD	rs2568958	A	0.58	19079260
SEC16B, RASAL2	Weight	1E-8	   3.82	[2.51-5.13] % SD	rs10913469	C	0.20	19079260
TMEM18	Weight	2E-18	   6.47	[5.02-7.92] % SD	rs7561317	G	0.84	19079260
SFRS10, ETV5, DGKG	Weight	4E-9	   4.00	[2.67-5.33] % SD	rs7647305	C	0.77	19079260
AIF1, NCR3	Weight	2E-8	   3.58	[2.33-4.83] % SD	rs2844479	T	0.68	19079260
BDNF	Weight	4E-9	   3.80	[2.55-5.05] % SD	rs925946	T	0.34	19079260
SH2B1, ATP2A1	Weight	1E-9	   3.69	[2.51-4.87] % SD	rs7498665	G	0.44	19079260
FTO	Weight	6E-14	   5.50	[4.07-6.93] % SD	rs6499640	A	0.65	19079260
FTO	Weight	5E-36	   7.05	[5.95-8.15] % SD	rs8050136	A	0.41	19079260
MC4R	Weight	5E-13	   4.66	[3.41-5.91] % SD	rs12970134	A	0.30	19079260
KCTD15, CHST8	Weight	5E-9	   3.73	[2.48-4.98] % SD	rs29941	C	0.69	19079260
FTO	Body mass index	4E-51	    .33	[0.27-0.39] kg/m2 increase	rs9939609	A	0.41	19079261
TMEM18	Body mass index	1E-18	    .26	[0.19-0.34] kg/m2 increase	rs6548238	C	0.84	19079261
MC4R	Body mass index	5E-18	    .20	[0.12-0.28] kg/m2 increase	rs17782313	C	0.21	19079261
GNPDA2	Body mass index	3E-16	    .19	[0.13-0.25] kg/m2	rs10938397	G	0.45	19079261
SH2B1	Body mass index	5E-11	    .15	[0.08-0.21] kg/m2 increase	rs7498665	G	0.41	19079261
MTCH2	Body mass index	5E-9	    .07	[0.01-0.13] kg/m2 increase	rs10838738	G	0.34	19079261
KCTD15	Body mass index	2E-8	    .06	[-0.01-0.13] kg/m2 increase	rs11084753	G	0.67	19079261
PRNP	Creutzfeldt-Jakob disease	2E-21	NR	NR	rs1799990	A	NR	19081515
TMEM57	Cholesterol, total	5E-10	    .06	[NR] s.d. increase	rs10903129	G	0.54	19060911
ABCG5	Cholesterol, total	2E-11	    .15	[NR] s.d. increase	rs6756629	G	0.92	19060911
DOCK7	Cholesterol, total	4E-12	    .08	[NR] s.d. decrease	rs10889353	C	0.32	19060911
CELSR2	Cholesterol, total	9E-22	    .13	[NR] s.d. decrease	rs646776	G	0.22	19060911
FADS2, FADS3	Cholesterol, total	2E-10	    .09	[NR] s.d. increase	rs174570	G	0.83	19060911
APOB	Cholesterol, total	9E-23	    .10	[NR] s.d. decrease	rs693	G	0.52	19060911
HMGCR	Cholesterol, total	3E-19	    .09	[NR] s.d. increase	rs3846662	G	0.44	19060911
TRIB1	Cholesterol, total	3E-9	    .07	[NR] s.d. increase	rs6987702	G	0.29	19060911
LIPG	Cholesterol, total	2E-11	    .07	[NR] s.d. increase	rs4939883	G	0.83	19060911
LDLR	Cholesterol, total	9E-24	    .16	[NR] s.d. increase	rs2228671	G	0.88	19060911
NCAN	Cholesterol, total	2E-15	    .15	[NR] s.d. decrease	rs2304130	G	0.07	19060911
TOMM40, APOE	Cholesterol, total	3E-19	    .14	[NR] s.d. increase	rs2075650	G	0.15	19060911
MADD, FOLH1	HDL cholesterol	6E-11	    .07	[NR] s.d. decrease	rs7395662	G	0.61	19060911
CTCF, PRMT8	HDL cholesterol	8E-16	    .13	[NR] s.d. decrease	rs2271293	G	0.87	19060911
APOB	HDL cholesterol	4E-8	    .07	[NR] s.d. increase	rs6754295	C	0.25	19060911
LPL	HDL cholesterol	6E-18	    .11	[NR] s.d. increase	rs2083637	G	0.26	19060911
ABCA1	HDL cholesterol	9E-13	    .11	[NR] s.d. increase	rs3905000	G	0.86	19060911
LIPC	HDL cholesterol	1E-35	    .13	[NR] s.d. decrease	rs1532085	G	0.59	19060911
CETP	HDL cholesterol	9E-94	    .21	[NR] s.d. decrease	rs1532624	C	0.57	19060911
LIPG	HDL cholesterol	2E-11	    .10	[NR] s.d. increase	rs4939883	G	0.83	19060911
DNAH11	LDL cholesterol	6E-9	    .09	[NR] s.d. increase	rs12670798	G	0.24	19060911
ABCG5	LDL cholesterol	3E-10	    .16	[NR] s.d. increase	rs6756629	G	0.92	19060911
FADS2, FADS3	LDL cholesterol	4E-13	    .11	[NR] s.d. increase	rs174570	G	0.83	19060911
CELSR2	LDL cholesterol	8E-23	    .16	[NR] s.d. decrease	rs646776	G	0.22	19060911
APOB	LDL cholesterol	4E-17	    .10	[NR] s.d. decrease	rs693	G	0.52	19060911
HMGCR	LDL cholesterol	2E-11	    .08	[NR] s.d. increase	rs3846662	G	0.44	19060911
APOA1, APOA4, APOA5, APOC3	LDL cholesterol	5E-13	    .18	[NR] s.d. decrease	rs12272004	C	0.93	19060911
LDLR	LDL cholesterol	4E-14	    .14	[NR] s.d. increase	rs2228671	G	0.88	19060911
TOMM40, APOE	LDL cholesterol	2E-19	    .11	[NR] s.d. decrease	rs157580	G	0.33	19060911
DOCK7	Triglycerides	2E-12	    .09	[NR] s.d. decrease	rs1167998	C	0.32	19060911
APOB	Triglycerides	3E-8	    .08	[NR] s.d. decrease	rs6754295	C	0.25	19060911
GCKR	Triglycerides	3E-20	    .10	[NR] s.d. decrease	rs780094	G	0.63	19060911
LPL	Triglycerides	2E-18	    .17	[NR] s.d. increase	rs10096633	G	0.88	19060911
TOMM40, APOE	Triglycerides	2E-9	    .09	[NR] s.d. increase	rs439401	G	0.68	19060911
MLXIPL	Triglycerides	1E-12	    .14	[NR] s.d. increase	rs2240466	G	0.87	19060911
APOA1, APOA4, APOA5, APOC3	Triglycerides	5E-13	    .18	[NR] s.d. decrease	rs12272004	C	0.93	19060911
MTNR1B	Fasting plasma glucose	2E-36	    .07	[0.05-0.08] mmol/l increase	rs1387153	T	0.29	19060909
FADS1, FADS2, FADS3	HDL cholesterol	2E-12	    .09	[0.05-0.13] s.d. decrease	rs174547	C	0.33	19060906
LCAT	HDL cholesterol	9E-13	    .07	[0.01-0.13] s.d. increase	rs2271293	A	0.11	19060906
TTC39B	HDL cholesterol	3E-10	    .08	[0.02-0.14] s.d. decrease	rs471364	C	0.12	19060906
HNF4A	HDL cholesterol	8E-10	    .19	[0.09-0.29] s.d. decrease	rs1800961	T	0.03	19060906
PLTP	HDL cholesterol	4E-9	    .07	[0.03-0.11] s.d. decrease	rs7679	C	0.19	19060906
ANGPTL4	HDL cholesterol	1E-8	    .12	[0.04-0.20] s.d. decrease	rs2967605	T	0.16	19060906
CETP	HDL cholesterol	4E-75	    .25	[0.21-0.29] s.d. increase	rs173539	T	0.32	19060906
LPL	HDL cholesterol	2E-34	    .23	[0.17-0.29] s.d. increase	rs12678919	G	0.10	19060906
LIPC	HDL cholesterol	8E-23	    .10	[0.06-0.14] s.d. increase	rs10468017	T	0.30	19060906
LIPG	HDL cholesterol	7E-15	    .14	[0.10-0.18] s.d. decrease	rs4939883	T	0.17	19060906
APOA1, APOC3, APOA4, APOA5	HDL cholesterol	1E-12	    .17	[0.11-0.23] s.d. decrease	rs964184	G	0.14	19060906
MMAB,MVK	HDL cholesterol	1E-10	    .07	[0.03-0.11] s.d. decrease	rs2338104	C	0.45	19060906
ABCA1	HDL cholesterol	1E-9	    .08	[0.04-0.12] s.d. decrease	rs1883025	T	0.26	19060906
GALNT2	HDL cholesterol	4E-8	    .05	[0.01-0.09] s.d. decrease	rs4846914	G	0.40	19060906
ABCG8	LDL cholesterol	2E-20	    .15	[0.11-0.19] s.d. increase	rs6544713	T	0.32	19060906
TIMD4, HAVCR1	LDL cholesterol	1E-11	    .07	[0.03-0.11] s.d. decrease	rs1501908	G	0.37	19060906
MAFB	LDL cholesterol	4E-9	    .06	[0.03-0.10] s.d. decrease	rs6102059	T	0.32	19060906
HNF1A	LDL cholesterol	2E-8	    .07	[0.03-0.11] s.d. increase	rs2650000	A	0.36	19060906
CELSR2, PSRC1, SORT1	LDL cholesterol	2E-42	    .23	[0.19-0.27] s.d. decrease	rs12740374	T	0.21	19060906
APOB	LDL cholesterol	5E-29	    .16	[0.12-0.20] s.d. decrease	rs515135	T	0.20	19060906
APOE, APOC1, APOC4, APOC2	LDL cholesterol	4E-27	    .29	[0.17-0.41] s.d. increase	rs4420638	G	0.16	19060906
LDLR	LDL cholesterol	2E-26	    .26	[0.18-0.34] s.d. increase	rs6511720	T	0.10	19060906
HMGCR	LDL cholesterol	8E-12	    .07	[0.03-0.11] s.d.  increase	rs3846663	T	0.38	19060906
NCAN, CILP2, PBX4	LDL cholesterol	2E-8	    .05	[-0.03-0.13] s.d. decrease	rs10401969	C	0.06	19060906
PCSK9	LDL cholesterol	4E-8	    .09	[0.05-0.13] s.d. decrease	rs11206510	C	0.19	19060906
FADS1, FADS2, FADS3	Triglycerides	2E-14	    .06	[0.02-0.10] s.d. increase	rs174547	C	0.33	19060906
PLTP	Triglycerides	7E-11	    .07	[0.03-0.11] s.d. increase	rs7679	C	0.19	19060906
XKR6, AMAC1L2	Triglycerides	3E-8	    .04	[0.001-0.08] s.d. decrease	rs7819412	G	0.48	19060906
APOA1, APOC3, APOA4, APOA5	Triglycerides	4E-62	    .30	[0.24-0.36] s.d. increase	rs964184	G	0.14	19060906
LPL	Triglycerides	2E-41	    .25	[0.19-0.31] s.d. decrease	rs12678919	G	0.10	19060906
GCKR	Triglycerides	2E-31	    .12	[0.08-0.16] s.d. increase	rs1260326	T	0.45	19060906
TRIB1	Triglycerides	3E-19	    .11	[0.07-0.15] s.d. decrease	rs2954029	T	0.44	19060906
MLXIPL	Triglycerides	3E-15	    .16	[0.10-0.22] s.d. decrease	rs714052	G	0.12	19060906
APOB	Triglycerides	9E-12	    .08	[0.04-0.12] s.d. decrease	rs7557067	G	0.22	19060906
NCAN,CILP2,PBX4	Triglycerides	4E-11	    .11	[0.05-0.17] s.d. decrease	rs17216525	T	0.07	19060906
NR1H3	HDL cholesterol	4E-8	    .04	[0.03-0.05] mmol/l increase	rs7120118	G	0.42	19060910
LIPC	HDL cholesterol	2E-10	    .05	[0.03-0.06] mmol/l increase	rs1532085	A	0.44	19060910
CETP	HDL cholesterol	7E-29	    .09	[0.08-0.11] mmol/l increase	rs3764261	A	0.28	19060910
LCAT	HDL cholesterol	3E-8	    .05	[0.03-0.07] mmol/l increase	rs255049	G	0.22	19060910
CELSR2, PSRC1, SORT1	LDL cholesterol	2E-12	    .16	[0.11-0.20] mmol/l decrease	rs646776	G	0.21	19060910
APOB	LDL cholesterol	3E-11	    .12	[0.09-0.16] mmol/l increase	rs693	A	0.41	19060910
APO cluster	LDL cholesterol	5E-8	    .11	[0.07-0.15] mmol/l decrease	rs157580	G	0.29	19060910
APOB	Metabolic traits	2E-8	    .08	[0.05-0.11] mmol/l decrease	rs673548	A	0.27	19060910
GCKR	Metabolic traits	4E-10	    .09	[0.06-0.12] mmol/l increase	rs1260326	A	0.35	19060910
LPL	Metabolic traits	5E-8	    .12	[0.07-0.17] mmol/l decrease	rs10096633	A	0.098	19060910
CRP	Metabolic traits	3E-22	    .47	[0.32-0.62] mmol/l decrease	rs2794520	A	0.36	19060910
LEF1	Metabolic traits	3E-11	    .40	[0.25-0.55] mmol/l decrease	rs2650000	A	0.45	19060910
G6PC2, ABCB11	Metabolic traits	6E-10	    .06	[0.04-0.07] mmol/l decrease	rs560887	A	0.31	19060910
MTNR1B	Fasting plasma glucose	3E-50	    .07	[0.06-0.08] mmol/l increase	rs10830963	G	0.28	19060907
G6PC2	Fasting plasma glucose	1E-57	    .06	[0.05-0.07] mmol/l increase	rs560887	C	0.70	19060907
GCK	Fasting plasma glucose	1E-25	    .06	[0.05-0.07] mmol/l increase	rs4607517	A	0.18	19060907
RHPN2	Colorectal cancer	5E-9	   1.15	[1.10-1.20] 	rs10411210	C	0.90	19011631
Intergenic	Colorectal cancer	2E-10	   1.12	[1.08-1.16] 	rs961253	A	0.36	19011631
CDH1	Colorectal cancer	1E-8	   1.10	[1.06-1.12] 	rs9929218	G	0.29	19011631
BMP4	Colorectal cancer	8E-10	   1.11	[1.08-1.15] 	rs4444235	C	0.46	19011631
KIF1B	Multiple sclerosis	3E-10	   1.34	[1.23-1.48] 	rs10492972	C	0.27	18997785
BOLL, PLCL1	Intracranial aneurysm	4E-8	   1.24	[1.15-1.34] 	rs700651	G	0.35	18997786
SOX17	Intracranial aneurysm	1E-10	   1.36	[1.24-1.49] 	rs10958409	A	0.15	18997786
SOX17	Intracranial aneurysm	2E-9	   1.35	[1.22-1.49] 	rs9298506	A	0.81	18997786
CDKN2A, CDKN2B	Intracranial aneurysm	1E-10	   1.29	[1.19-1.40] 	rs1333040	T	0.55	18997786
BACH2	Type 1 diabetes	5E-12	   1.13	[1.08-1.19] 	rs11755527	G	0.47	18978792
PRKCQ	Type 1 diabetes	4E-9	   1.10	[1.03-1.18] 	rs947474	G	0.19	18978792
CTSH	Type 1 diabetes	3E-15	   1.16	[1.10-1.22] 	rs3825932	T	0.68	18978792
C1QTNF6	Type 1 diabetes	2E-8	   1.11	[1.05-1.16] 	rs229541	T	0.43	18978792
PTPN22	Type 1 diabetes	1E-40	NR	NR	rs6679677	A	NR	18978792
CTLA4	Type 1 diabetes	8E-11	NR	NR	rs3087243	A	NR	18978792
HLA	Type 1 diabetes	6E-129	NR	NR	rs9272346	G	NR	18978792
C12orf30	Type 1 diabetes	6E-18	NR	NR	rs17696736	G	NR	18978792
ERBB3	Type 1 diabetes	3E-16	NR	NR	rs2292239	A	NR	18978792
CLEC16A	Type 1 diabetes	7E-13	NR	NR	rs12708716	G	NR	18978792
Intergenic	Lung cancer	1E-15	   1.35	[1.25-1.45] 	rs1051730	A	NR	18978790
BAT3,MSH5	Lung cancer	5E-10	   1.24	[1.16-1.33] 	rs3117582	C	NR	18978787
CLPTM1L	Lung cancer	8E-9	   1.15	[1.09-1.19] 	rs401681	G	NR	18978787
JAZF1	Height	9E-10	    .25	 [0.17-0.33] cm taller	rs1635852	A	NR	18952825
HLA-DRB1	Multiple sclerosis	9E-11	   3.30	[2.3-4.9] 	rs3129934	T	NR	18941528
PAX1, BQ013595, BE789145	Male-pattern baldness	3E-15	   1.82	[1.45-2.30] 	rs2180439	C	0.43	18849994
PAX1	Male-pattern baldness	1E-14	   1.60	[1.42-1.80] (males)	rs1160312	A	0.43	18849991
AR	Male-pattern baldness	5E-11	   3.30	[2.31-4.71] 	rs6625163	A	NR	18849991
PADI4, PADI6,RCC2, ARHGEF10L	Basal cell carcinoma 	4E-12	   1.28	[1.19-1.37] 	rs7538876	A	0.35	18849993
RHOU	Basal cell carcinoma 	6E-12	   1.28	[1.19-1.37] 	rs801114	G	0.33	18849993
CPN1, CHUK, ERLIN1	Liver enzyme levels	2E-8	    .04	[0.025-0.053] U/L decrease	rs11597390	A	0.36	18940312
HNF1A, C12orf27, C12orf43	Liver enzyme levels	2E-10	    .01	[0.003-0.007] U/L decrease	rs1169313	C	0.38	18940312
JMJD1C	Liver enzyme levels	5E-10	    .03	[0.017-0.033] U/L increase	rs12355784	A	0.48	18940312
REEP3	Liver enzyme levels	7E-10	    .03	[0.017-0.033] U/L increase	rs10761779	G	0.49	18940312
ADAMTS13	Liver enzyme levels	8E-21	    .06	[0.048-0.072] U/L decrease	rs4962153	A	NR	18940312
PNPLA3, SAMM50	Liver enzyme levels	8E-16	    .06	[0.046-0.074] U/L increase	rs2281135	T	0.18	18940312
NBPF3, ALPL, RAP1GAP	Liver enzyme levels	7E-15	    .03	[0.023-0.039] U/L increase	rs1780324	T	0.43	18940312
ABO	Liver enzyme levels	2E-30	    .05	[0.039-0.055] U/L decrease	rs657152	T	0.39	18940312
GPLD1	Liver enzyme levels	1E-11	    .03	[0.024-0.044] U/L increase	rs9467160	A	0.24	18940312
GGT1, C22orf36	Liver enzyme levels	4E-11	    .01	[0.005-0.009] U/L increase	rs4820599	G	0.31	18940312
UBASH3A	Type 1 diabetes	2E-8	   1.16	[1.10-1.22] 	rs9976767	C	NR	18840781
HLA-DRA, BTNL2	Ulcerative colitis	6E-18	   1.45	[1.33-1.58] 	rs9268877	T	0.45	18836448
IL10	Ulcerative colitis	1E-12	   1.46	[1.31-1.62] 	rs3024505	T	0.15	18836448
SLC2A9	Urate levels	7E-168	    .34	[0.30-0.38] SD decrease in serum uric acid level	rs16890979	T	0.23	18834626
NR	Stroke (ischemic)	2E-10	   1.26	[1.17-1.35] 	rs2200733	T	0.11	18991354
CETP	HDL cholesterol	9E-27	   2.66	[NR] mg/dl decrease	rs9989419	A	0.38	20031538
LPL	HDL cholesterol	3E-11	   2.02	[NR] mg/dl increase	rs17482753	T	0.11	20031538
LIPG	HDL cholesterol	5E-10	   2.27	[NR] mg/dl decrease	rs7240405	A	0.15	20031538
TERT	Idiopathic pulmonary fibrosis	3E-8	   2.11	[1.61-2.78] 	rs2736100	A	0.41	18835860
PVRL2, TOMM40, APOE	Alzheimer's disease	6E-14	NR	NR	rs6859	A	NR	18823527
HMGCR	LDL cholesterol	1E-8	  18.00	[NR] % s.d. increase	rs7703051	A	0.41	18802019
LOC123688, PSMA4, CHRNA3, CHRNA5, CHRNB4	Lung cancer	1E-8	   1.38	[1.17-1.64] 	rs8034191	G	NR	18780872
MYC, BC042052	Urinary bladder cancer	9E-12	   1.22	[1.15-1.29] 	rs9642880	T	0.45	18794855
CCL21	Rheumatoid arthritis	3E-8	   1.12	[NR] 	rs2812378	G	0.34	18794853
CD40	Rheumatoid arthritis	8E-9	   1.15	[NR] 	rs4810485	G	0.75	18794853
FUT2	Vitamin B12 levels	5E-17	    .09	[0.07-0.11] pg/ml decrease	rs492602	G	0.49	18776911
IRF4	Chronic lymphocytic leukemia	2E-20	   1.54	[1.41- 1.69] 	rs872071	G	0.54	18758461
Intergenic	Chronic lymphocytic leukemia	5E-12	   1.37	[1.26-1.50] 	rs7176508	A	0.37	18758461
SP140, SP110	Chronic lymphocytic leukemia	6E-10	   1.41	[1.26-1.57] 	rs13397985	G	0.19	18758461
GRAMD1B	Chronic lymphocytic leukemia	4E-12	   1.45	[1.31-1.61] 	rs735665	A	0.21	18758461
ACOXL,BCL2L11	Chronic lymphocytic leukemia	2E-10	   1.39	[1.25-1.53] 	rs17483466	G	0.20	18758461
PRKD2,STRN4	Chronic lymphocytic leukemia	4E-9	   1.35	[1.22-1.49] 	rs11083846	A	0.22	18758461
TNFRSF6B	Inflammatory bowel disease	9E-15	   1.36	[1.05-1.76] 	rs2315008	G	0.69	18758464
NOD2	Inflammatory bowel disease	4E-10	   1.46	[1.29-1.64] 	rs5743289	T	0.17	18758464
FCER1A	IgE levels 	2E-20	  19.20	[NR] % decrease	rs2251746	C	0.26	18846228
ANK3	Bipolar disorder	9E-9	   1.45	[NR] 	rs10994336	T	0.05	18711365
CDKAL1	Type 2 diabetes	3E-10	   1.22	[1.15-1.31] 	rs4712524	G	0.42	18711366
IGF2BP2	Type 2 diabetes	1E-9	   1.23	[1.15-1.31] 	rs6769511	C	0.32	18711366
KCNQ1	Type 2 diabetes	1E-16	   1.33	[1.24-1.41] 	rs2237897	C	0.34	18711366
KCNQ1	Type 2 diabetes	2E-42	   1.40	[1.34-1.47] 	rs2237892	C	0.61	18711367
PTPRD	Restless legs syndrome	6E-9	   1.31	[1.20-1.44] 	rs1975197	T	0.16	18660810
PTPRD	Restless legs syndrome	6E-10	   1.44	[1.31-1.59] 	rs4626664	A	0.12	18660810
SLCO1B1	Response to statin therapy	2E-9	   4.50	[2.60-7.70] 	rs4149056	C	0.13	18650507
ABO	Soluble ICAM-1	5E-29	  17.73	[NR] umol/L decrease	rs507666	G	0.20	18604267
ICAM1	Soluble ICAM-1	4E-47	  28.19	[NR] umol/L decrease	rs1799969	A	0.12	18604267
ICAM1	Soluble ICAM-1	5E-25	  13.22	[NR] umol/L increase	rs5498	A	0.43	18604267
Unknown	Crohn's disease	2E-13	   1.25	[NR] 	rs3764147	G	0.22	18587394
IL12B	Crohn's disease	4E-13	   1.11	[NR] 	rs10045431	C	0.71	18587394
CCR6	Crohn's disease	1E-12	   1.21	[NR] 	rs2301436	T	0.46	18587394
STAT3	Crohn's disease	7E-12	   1.18	[NR] 	rs744166	A	0.57	18587394
Unknown	Crohn's disease	2E-10	   1.17	[NR] 	rs7746082	C	0.29	18587394
PTPN22	Crohn's disease	1E-8	   1.31	[NR] 	rs2476601	G	0.90	18587394
ITLN1	Crohn's disease	1E-9	   1.14	[NR] 	rs2274910	C	0.68	18587394
Intergenic	Crohn's disease	2E-9	   1.19	[NR] 	rs9286879	G	0.24	18587394
Intergenic	Crohn's disease	1E-11	   1.18	[NR] 	rs11584383	T	0.70	18587394
CDKAL1	Crohn's disease	9E-10	   1.21	[NR] 	rs6908425	C	0.78	18587394
Intergenic	Crohn's disease	5E-9	   1.20	[NR] 	rs1456893	A	0.68	18587394
Intergenic	Crohn's disease	5E-9	   1.08	[NR] 	rs1551398	A	0.62	18587394
JAK2	Crohn's disease	3E-9	   1.12	[NR] 	rs10758669	C	0.35	18587394
Intergenic	Crohn's disease	2E-9	   1.16	[NR] 	rs17582416	G	0.35	18587394
C11orf30	Crohn's disease	1E-9	   1.16	[NR] 	rs7927894	T	0.39	18587394
LRRK2, MUC19	Crohn's disease	3E-10	   1.54	[NR] 	rs11175593	T	0.02	18587394
ORMDL3	Crohn's disease	5E-9	   1.12	[NR] 	rs2872507	A	0.47	18587394
Intergenic	Crohn's disease	7E-9	   1.18	[NR] 	rs1736135	T	0.57	18587394
ICOSLG	Crohn's disease	1E-9	   1.13	[NR] 	rs762421	G	0.39	18587394
IL23R	Crohn's disease	7E-63	   2.50	[NR] 	rs11465804	T	0.93	18587394
ATG16L1	Crohn's disease	2E-32	   1.25	[NR] 	rs3828309	G	0.53	18587394
MST1	Crohn's disease	1E-12	   1.20	[NR] 	rs3197999	A	0.27	18587394
PTGER4	Crohn's disease	7E-27	   1.32	[NR] 	rs4613763	C	0.13	18587394
Intergenic	Crohn's disease	2E-18	   1.25	[NR] 	rs2188962	T	0.43	18587394
IRGM	Crohn's disease	3E-16	   1.33	[NR] 	rs11747270	G	0.09	18587394
TNFSF15	Crohn's disease	3E-10	   1.22	[NR] 	rs4263839	G	0.68	18587394
NKX2-3	Crohn's disease	3E-16	   1.20	[NR] 	rs11190140	T	0.48	18587394
NOD2	Crohn's disease	3E-24	   3.99	[NR] 	rs2066847	C	0.02	18587394
PTPN2	Crohn's disease	5E-17	   1.35	[NR] 	rs2542151	G	0.15	18587394
ZNF365	Crohn's disease	4E-20	   1.25	[NR] 	rs10995271	C	0.39	18587394
G6PC2	Fasting plasma glucose	4E-23	    .06	[0.05-0.08] mmol/l decrease	rs560887	A	0.30	18451265
PDE8B	Thyroid stimulating hormone	2E-20	    .25	[0.17-0.33] uIU/ml increase	rs4704397	A	0.44	18514160
CDC91L1	Melanoma	1E-15	   1.75	[1.53-2.01] 	rs910873	T	0.09	18488026
TPCN2	Blond vs. brown hair color	4E-30	   2.49	[1.96-3.15] 	rs35264875	T	0.22	18488028
TYRP1	Blue vs. green eyes	6E-17	   1.40	[1.25-1.57] 	rs1408799	C	0.75	18488028
ASIP	Burning and freckling	6E-37	   2.56	[2.06-3.18] 	rs1015362, rs4911414	G	0.08	18488028
ASIP	Freckles	8E-29	   1.95	[1.65-2.32] 	rs1015362, rs4911414	G	0.08	18488028
ASIP	Red vs. non-red hair color	3E-9	   1.76	[1.34-2.31] 	rs1015362, rs4911414	G	0.08	18488028
ASIP	Skin sensitivity to sun	2E-24	   1.76	[1.49-2.08] 	rs1015362, rs4911414	G	0.08	18488028
IRF4	Black vs. blond hair color	7E-127	    .35	[0.33-0.37] decrease in hair color score	rs12203592	T	NR	18483556
MATP	Black vs. blond hair color	1E-17	    .46	[0.36-0.56] decrease in hair color score	rs28777	C	NR	18483556
HERC2	Black vs. blond hair color	4E-103	    .44	[0.40-0.48] decrease in hair color score	rs12913832	A	NR	18483556
Intergenic	Black vs. blond hair color	5E-11	    .12	[0.08-0.16] increase in hair color score	rs8033165	T	NR	18483556
SLC24A4	Black vs. blond hair color	8E-21	    .18	[0.14-0.22] increase in hair color score	rs12896399	G	NR	18483556
OCA2	Black vs. blond hair color	2E-24	    .28	[0.22-0.34] decrease in hair color score	rs11855019	G	NR	18483556
IRF4	Black vs. red hair color	9E-28	    .31	[0.25-0.36] decrease in hair color score	rs12203592	T	NR	18483556
MATP	Black vs. red hair color	9E-14	    .46	[0.34-0.58] decrease in hair color score	rs28777	C	NR	18483556
HERC2	Black vs. red hair color	1E-77	    .44	[0.40-0.48] decrease in hair color score	rs12913832	A	NR	18483556
Intergenic	Black vs. red hair color	2E-12	    .15	[0.11-0.19] increase in hair color score	rs8033165	T	NR	18483556
OCA2	Black vs. red hair color	6E-20	    .29	[0.23-0.35] decrease in hair color score	rs11855019	G	NR	18483556
MC1R	Black vs. red hair color	2E-23	    .36	[0.28-0.44] increase in hair color score	rs258322	T	NR	18483556
FLJ22536, FLJ44180	Neuroblastoma	9E-15	   1.37	[1.27-1.49] 	rs6939340	G	0.50	18463370
MC4R	Waist circumference and related phenotypes	2E-9	    .88	[0.59-1.17] cm increase	rs12970134	A	0.36	18454146
MC4R	Body mass index	3E-15	    .05	[0.04-0.06] unit increase in log(BMI)	rs17782313	C	0.24	18454148
TNFRSF11B	Bone mineral density	8E-10	    .09	[NR] SD decrease	rs4355801	A	0.53	18455228
LRP5	Bone mineral density	6E-12	    .13	[NR] SD decrease	rs3736228	T	0.14	18455228
ZBTB40	Bone mineral density (hip)	5E-16	    .15	[0.11-0.19] s.d. decrease	rs7524102	A	0.82	18445777
ESR1	Bone mineral density (hip)	5E-9	    .08	[0.06-0.11] s.d. decrease	rs1038304	G	0.47	18445777
OPG	Bone mineral density (hip)	3E-11	    .09	[0.07-0.12] s.d. decrease	rs6993813	C	0.50	18445777
RANKL	Bone mineral density (hip)	2E-8	    .10	[0.06-0.13] s.d. decrease	rs9594738	T	0.56	18445777
ZBTB40	Bone mineral density (spine)	9E-9	    .11	[0.07-0.15] s.d. decrease	rs7524102	A	0.82	18445777
ESR1	Bone mineral density (spine)	2E-11	    .11	[0.08-0.14] s.d. decrease	rs4870044	T	0.28	18445777
OPG	Bone mineral density (spine)	7E-15	    .12	[0.09-0.15] s.d. decrease	rs6469804	A	0.51	18445777
RANKL	Bone mineral density (spine)	2E-21	    .17	[0.14-0.21] s.d. decrease	rs9594759	T	0.62	18445777
ESR1, C6orf97	Bone mineral density (spine)	4E-11	    .10	[0.07-0.13] s.d. decrease	rs1038304	G	0.47	18445777
ESR1, C6orf97	Bone mineral density (spine)	2E-8	    .09	[0.06-0.12] s.d. decrease	rs1999805	C	0.44	18445777
HNF1A	C-reactive protein	2E-8	    .13	[0.08-0.17] mg/l decrease in log(CRP) level	rs1169310	A	0.38	18439552
LEPR	C-reactive protein	7E-21	    .17	[NR] mg/dl decrease	rs1892534	A	NR	18439548
HNF1A	C-reactive protein	7E-17	    .15	[NR] mg/dl decrease	rs7310409	A	NR	18439548
GCKR	C-reactive protein	7E-15	    .14	[NR] mg/dl increase	rs780094	A	NR	18439548
Unknown	C-reactive protein	1E-10	    .12	[NR] mg/dl decrease	rs10778213	G	NR	18439548
CHI3L1	YKL-40 levels	1E-13	    .30	[NR] ng/ml decrease	rs4950928	G	0.29	18403759
ZBTB38	Height	1E-27	   7.40	[6.03-8.77] % s.d. taller	rs6763931	A	0.45	18391951
GNA12	Height	7E-15	   5.90	[6.03-8.77] % s.d. taller	rs798544	G	0.72	18391951
GPR126	Height	5E-14	   6.50	[5.44-9.36] % s.d. taller	rs3748069	A	0.74	18391951
HHIP	Height	1E-11	   8.30	[5.95-10.65] % s.d. taller	rs1812175	C	0.86	18391951
BMP6	Height	2E-11	   6.80	[4.84-8.76] % s.d. taller	rs12198986	A	0.50	18391951
Histone class 2A,MTMR11, SV2A, SF3B4	Height	1E-10	   5.10	[3.53-6.67] % s.d. taller	rs11205277	G	0.44	18391951
DNM3	Height	3E-8	   5.40	[3.44-7.36] % s.d. taller	rs678962	G	0.22	18391951
C1orf19,GLT25D2	Height	8E-9	   5.30	[3.54-7.06] % s.d. taller	rs2274432	T	0.37	18391951
EFEMP1, PNPT1	Height	6E-11	   5.80	[4.04-7.56] % s.d. taller	rs3791679	T	0.81	18391951
LCORL, NCAPG	Height	1E-10	   6.30	[4.34-8.26] % s.d. taller	rs6830062	T	0.89	18391951
Histone class 1, Butyrophilin genes	Height	6E-10	   5.60	[3.84-7.36] % s.d. taller	rs10946808	A	0.70	18391951
HLA class III	Height	3E-8	   5.20	[3.44-6.96] % s.d. taller	rs185819	T	0.52	18391951
HMGA1, LBH	Height	1E-8	   8.80	[5.66-11.94] % s.d. taller	rs1776897	C	0.07	18391951
ANKS1A, TCP11, ZNF76, DEF6,SCUBE3	Height	4E-8	   6.80	[4.45-9.15] % s.d. taller	rs4713858	G	0.86	18391951
CDK6, PEX1, GATAD1, ERVWE1	Height	1E-8	   5.80	[3.84-7.76] % s.d. taller	rs2282978	C	0.29	18391951
PXMP3, ZFHX4	Height	5E-8	   5.00	[3.24-6.76] % s.d. taller	rs7846385	C	0.27	18391951
ZNF462	Height	2E-8	   5.30	[3.54-7.06] % s.d. taller	rs4743034	A	0.23	18391951
HMGA2	Height	2E-16	   6.60	[5.03-8.17] % s.d. taller	rs8756	C	0.52	18391951
ADAMTS17	Height	3E-8	   5.60	[3.64-7.56] % s.d. taller	rs4533267	A	0.28	18391951
CRLF3, ATAD5, CENTA2, RNF135	Height	2E-9	   6.00	[4.04-7.96] % s.d. taller	rs3760318	C	0.63	18391951
CABLES1, RBBP8, C18orf45	Height	4E-9	   6.40	[4.24-8.56] % s.d. taller	rs4800148	A	0.79	18391951
BMP2	Height	2E-8	   4.30	[2.73-5.87] % s.d. taller	rs967417	C	0.53	18391951
TRIP11, FBLN5, ATXN3, CPSF2	Height	1E-10	   5.70	[3.94-7.46] % s.d. taller	rs7153027	A	0.52	18391951
ZBTB38	Height	8E-22	    .37	[0.29-0.45] cm taller	rs724016	G	0.48	18391950
GPR126	Height	2E-18	    .38	[0.28-0.48] cm shorter	rs4896582	A	0.27	18391950
HIST1H1D	Height	4E-17	    .36	[0.26-0.46] cm shorter	rs10946808	G	0.28	18391950
HHIP	Height	1E-11	    .29	[0.21-0.37] cm shorter	rs1492820	G	0.48	18391950
TRIP11,ATXN3	Height	6E-10	    .42	[0.30-0.54] cm shorter	rs8007661	T	0.30	18391950
LIN28B	Height	1E-8	    .41	[0.26-0.59] cm taller	rs314277	A	0.13	18391950
DOT1L	Height	3E-8	    .31	[0.21-0.46] cm taller	rs12986413	T	0.45	18391950
HMGA2	Height	3E-20	    .48	[0.58-1.09] cm shorter	rs1042725	T	0.49	18391950
GDF5,UQCC	Height	1E-16	    .44	[0.34-0.72] cm taller	rs6060369	C	0.36	18391950
ZBTB38	Height	2E-24	    .07	[0.04-0.09] s.d. taller - among males	rs6440003	A	0.44	18391952
CDK6	Height	8E-23	    .09	[0.06-0.12] s.d. taller - among males	rs2282978	C	0.33	18391952
HMGA2	Height	3E-18	    .05	[0.03-0.08] s.d. taller - among males	rs1042725	C	0.49	18391952
GDF5	Height	2E-17	    .08	[0.05-0.11] s.d. shorter - among males	rs6060373	A	0.62	18391952
LCORL	Height	2E-13	    .07	[0.03-0.11] s.d. shorter - among males	rs16896068	A	0.16	18391952
LOC387103	Height	5E-13	    .06	[0.03-0.08] s.d. taller - among males	rs4549631	C	0.50	18391952
EFEMP1	Height	2E-12	    .09	[0.05-0.12] s.d. taller - among males	rs3791675	C	0.77	18391952
C6orf106	Height	4E-12	    .09	[0.05-0.13] s.d. taller - among males	rs2814993	A	0.15	18391952
PTCH1	Height	4E-11	    .05	[0.02-0.07] s.d. taller - among males	rs10512248	G	0.31	18391952
SPAG17	Height	4E-11	    .08	[0.05-0.11] s.d. shorter - among males	rs12735613	A	0.24	18391952
SOCS2	Height	6E-10	    .04	[0.01-0.07] s.d. shorter - among males	rs11107116	G	0.77	18391952
HHIP	Height	2E-9	    .06	[0.03-0.08] s.d. taller - among males	rs6854783	A	0.43	18391952
ZNF678	Height	5E-9	    .04	[0.01-0.08] s.d. taller - among males	rs1390401	A	0.82	18391952
DLEU7	Height	7E-9	    .04	[0.00-0.07] s.d. shorter - among males	rs3116602	G	0.21	18391952
SCMH1	Height	2E-8	    .05	[0.02-0.08] s.d. shorter - among males	rs6686842	C	0.56	18391952
ADAMTSL3	Height	2E-8	    .05	[0.02-0.07] s.d. taller - among males	rs10906982	A	0.52	18391952
IHH	Height	2E-8	    .06	[0.02-0.10] s.d. shorter - among males	rs6724465	A	0.10	18391952
HLA-C	Psoriasis	2E-39	   2.80	[2.40-3.30] 	rs10484554	T	0.15	18369459
HLA-C	Psoriasis	2E-26	   4.10	[3.10-5.30] 	rs2395029	C	0.03	18369459
CHRNA3, CHRNA5, PSMA4, LOC123688	Lung cancer	3E-18	   1.30	[1.15-1.47] 	rs8034191	G	NR	18385676
CHRNA3,CHRNA5, CHRNB4, PSMA4, LOC123688	Lung cancer	5E-20	   1.30	[1.23-1.37] 	rs8034191	C	0.34	18385738
CHRNA3,CHRNA5,CHRNB4	Nicotine dependence	6E-20	    .10	[0.08-0.12] increase in cigarettes per day	rs1051730	T	0.35	18385739
POU5FIP1, HsG57825, DQ515897	Colorectal cancer	9E-26	   1.19	[1.15-1.23] 	rs7014346	A	0.18	18372901
Intergenic	Colorectal cancer	6E-10	   1.11	[1.08-1.15] 	rs3802842	C	0.43	18372901
SMAD7	Colorectal cancer	8E-28	   1.20	[1.16-1.24] 	rs4939827	T	0.52	18372901
Intergenic	Colorectal cancer	3E-13	   1.12	[1.10-1.16] 	rs10795668	A	0.67	18372905
EIF3H	Colorectal cancer	3E-18	   1.27	[1.20-1.34] 	rs16892766	A	0.07	18372905
JAZF1	Type 2 diabetes	5E-14	   1.10	[1.07-1.13] 	rs864745	T	0.50	18372903
CDC123,CAMK1D	Type 2 diabetes	1E-10	   1.11	[1.07-1.14] 	rs12779790	G	0.18	18372903
TSPAN8,LGR5	Type 2 diabetes	1E-9	   1.09	[1.06-1.12] 	rs7961581	C	0.27	18372903
THADA	Type 2 diabetes	1E-9	   1.15	[1.10-1.20] 	rs7578597	T	0.90	18372903
ADAMTS9	Type 2 diabetes	1E-8	   1.09	[1.06-1.12] 	rs4607103	C	0.76	18372903
NOTCH2, ADAM30	Type 2 diabetes	4E-8	   1.13	[1.08-1.17] 	rs10923931	T	0.11	18372903
CDKAL1	Type 2 diabetes	1E-11	   1.25	[1.17-1.33] 	rs6931514	G	NR	18372903
TCF7L2	Type 2 diabetes	3E-23	   1.37	[1.28-1.47] 	rs7903146	T	NR	18372903
ECHDC1,RNF146	Breast cancer	3E-8	   1.41	[1.25-1.59] 	rs2180341	G	0.21	18326623
SLC2A9	Urate levels	3E-70	    .35	[NR] mg/dl decrease in uric acid	rs7442295	C	0.40	18327256
SLC2A9	Urate levels	3E-9	    .88	[NR] uM decrease in uric acid [females only]	rs737267	C	0.31	18327257
RGS1	Celiac disease	3E-11	   1.39	[1.26-1.53] 	rs2816316	C	NR	18311140
IL1RL1,IL18R1,IL18RAP, SLC9A4	Celiac disease	4E-9	   1.28	[1.18-1.39] 	rs13015714	C	NR	18311140
IL12A, SCHIP1	Celiac disease	1E-9	   1.35	[1.23-1.49] 	rs17810546	G	NR	18311140
LPP	Celiac disease	5E-9	   1.23	[1.15-1.32] 	rs1464510	A	NR	18311140
KIAA1109, ADAD1, IL2, IL21	Celiac disease	3E-13	   1.44	[1.30-1.58] 	rs6822844	C	0.81	18311140
MSMB	Prostate cancer	9E-29	   1.25	[1.17-1.34] 	rs10993994	T	0.40	18264097
KLK3	Prostate cancer	2E-18	   1.20	[1.10-1.33] 	rs2735839	G	0.85	18264097
Intergenic	Prostate cancer	2E-12	   1.19	[1.11-1.27] 	rs7931342	G	0.51	18264097
SLC22A3	Prostate cancer	6E-10	   1.17	[1.08-1.26] 	rs9364554	T	0.29	18264097
LMTK2	Prostate cancer	1E-9	   1.12	[1.05-1.20] 	rs6465657	C	0.46	18264097
Intergenic	Prostate cancer	3E-8	   1.18	[1.06-1.31] 	rs2660753	T	0.11	18264097
NUDT10, NUDT11	Prostate cancer	2E-9	   1.19	[1.07-1.31] 	rs5945619	C	0.36	18264097
Intergenic	Prostate cancer	9E-13	   1.42	[NR] 	rs6983267	G	0.49	18264097
Intergenic	Prostate cancer	3E-16	   1.88	[NR] 	rs4242384	C	0.09	18264097
HNF1B	Prostate cancer	9E-12	   1.41	[NR] 	rs7501939	C	0.57	18264097
NUDT10, NUDT11, LOC340602	Prostate cancer	4E-13	   1.23	[1.16-1.30] 	rs5945572	A	0.35	18264098
EHBP1	Prostate cancer	8E-9	   1.15	[1.10-1.21] 	rs721048	A	0.19	18264098
MSMB	Prostate cancer	7E-13	   1.16	[1.04-1.29] 	rs10993994	T	0.40	18264096
Intergenic	Prostate cancer	2E-9	   1.10	[0.98-1.23] 	rs10896449	G	0.52	18264096
Intergenic	Prostate cancer	7E-12	   1.28	[1.15-1.45] 	rs6983267	G	0.53	18264096
Intergenic	Prostate cancer	3E-19	   1.66	[1.47-1.87] 	rs4242382	A	0.12	18264096
HNF1B	Prostate cancer	1E-9	   1.18	[1.04-1.32] 	rs4430796	A	0.54	18264096
CELSR2,PSRC1	LDL cholesterol	1E-33	    .16	[0.14-0.18] mmol/L decrease	rs599839	G	0.19	18262040
APOC1	LDL cholesterol	1E-20	    .06	[0.04-0.08] mmol/L increase	rs4420638	G	0.18	18262040
APOB	LDL cholesterol	1E-9	    .04	[0.02-0.06] mmol/L decrease	rs562338	T	0.20	18262040
HBB	Fetal hemoglobin levels	1E-21	    .58	[NR] s.d. decrease in HbF	rs4910742	A	0.93	18245381
BCL11A	Fetal hemoglobin levels	7E-35	    .48	[NR] s.d. decrease in HbF	rs11886868	T	0.80	18245381
RNF212,SPON2	Recombination rate (females)	2E-12	  88.20	[63.7-112.7] cM increase	rs1670533	C	0.23 (men and women combined)	18239089
RNF212,SPON2	Recombination rate (males)	3E-24	  70.70	[57.1-84.3] cM  decrease	rs3796619	T	0.33 (men and women combined)	18239089
ITGAM	Systemic lupus erythematosus	2E-23	   1.62	[1.47-1.78] 	rs9888739	T	0.13	18204446
PXK	Systemic lupus erythematosus	7E-9	   1.25	[1.16-1.35] 	rs6445975	C	0.28	18204446
IRF5, TNPO3	Systemic lupus erythematosus	4E-19	   1.54	[1.40-1.70] 	rs12537284	A	0.13	18204446
HLA region	Systemic lupus erythematosus	2E-52	   2.36	[2.11-2.64] 	rs3131379	A	0.1	18204446
C8orf13, BLK	Systemic lupus erythematosus	1E-10	   1.39	[1.28-1.51] 	rs13277113	A	0.23	18204098
ITGAM, ITGAX	Systemic lupus erythematosus	3E-11	   1.33	[1.22-1.46] 	rs11574637	C	0.19	18204098
HLA-DQA1	Systemic lupus erythematosus	3E-21	NR	NR	rs2187668	A	0.11	18204098
IRF5, TNPO3	Systemic lupus erythematosus	2E-11	NR	NR	rs10488631	C	0.12	18204098
STAT4	Systemic lupus erythematosus	9E-14	NR	NR	rs7574865	T	0.23	18204098
BANK1	Systemic lupus erythematosus	4E-10	   1.38	[1.25-1.53] 	rs10516487	G	0.77	18204447
RAB5B, SUOX, IKZF4, ERBB3, CDK2	Type 1 diabetes	9E-10	   1.25	[1.12-1.40] 	rs1701704	C	0.35	18198356
GALNT2	HDL cholesterol	2E-13	    .07	[0.05-0.09] % SD lower	rs4846914	G	0.40	18193044
ABCA1	HDL cholesterol	3E-10	    .10	[0.06-0.14] % SD lower	rs3890182	A	0.13	18193044
CETP	HDL cholesterol	1E-73	    .18	[0.16-0.20] % SD lower	rs1800775	C	0.51	18193044
LIPC	HDL cholesterol	2E-32	    .14	[0.12-0.16] % SD higher	rs1800588	T	0.21	18193044
LPL	HDL cholesterol	9E-23	    .17	[0.13-0.21] % SD higher	rs328	G	0.09	18193044
CELSR2,PSRC1,SORT1	LDL cholesterol	3E-29	    .16	[0.14-0.18] % SD lower	rs646776	C	0.24	18193044
CILP2, PBX4	LDL cholesterol	3E-8	    .10	[0.06-0.14] % SD lower	rs16996148	T	0.10	18193044
APOB	LDL cholesterol	1E-21	    .12	[0.10-0.14] % SD higher	rs693	A	0.48	18193044
APOE, APOC1, APOC4, APOC2	LDL cholesterol	1E-60	    .19	[0.15-0.23] % SD higher	rs4420638	G	0.20	18193044
HMGCR	LDL cholesterol	1E-20	    .10	[0.08-0.12] % SD higher	rs12654264	T	0.39	18193044
LDLR	LDL cholesterol	2E-51	    .26	[0.22-0.30] % SD lower	rs6511720	T	0.10	18193044
PCSK9	LDL cholesterol	2E-44	    .47	[0.41-0.53] % SD lower	rs11591147	T	0.01	18193044
BCL7B, TBL2, MLXIPL	Triglycerides	7E-22	    .14	[0.25-0.53] % SD lower	rs17145738	T	0.13	18193044
TRIB1	Triglycerides	4E-17	    .08	[0.06-0.10] % SD lower	rs17321515	G	0.49	18193044
GALNT2	Triglycerides	7E-15	    .08	[0.06-0.10] % SD higher	rs4846914	G	0.40	18193044
CILP2, PBX4	Triglycerides	4E-9	    .10	[0.06-0.14] % SD lower	rs16996148	T	0.10	18193044
ANGPTL3, DOCK7, ATG4C	Triglycerides	2E-8	    .11	[0.07-0.15] % SD lower	rs12130333	T	0.22	18193044
APOA1, APOC3, APOA4, APOA5, ZNF259, BUD13	Triglycerides	2E-17	    .26	[0.20-0.32] % SD higher	rs28927680	G	0.07	18193044
GCKR	Triglycerides	3E-14	    .13	[0.09-0.17] % SD higher	rs780094	T	0.34	18193044
LPL	Triglycerides	2E-28	    .19	[0.15-0.23] % SD lower	rs328	G	0.09	18193044
MLXIPL	Triglycerides	1E-10	  10.50	[5.3-17.7] % higher	rs3812316	C	0.95	18193046
LOC440069, MGC13125	Triglycerides	2E-26	  17.00	[13.28-20.72] % higher	rs1558861	C	0.18	18193046
LPL, C8orf35, SLC18A1	Triglycerides	5E-12	   6.60	[3.66-9.54] % higher	rs326	A	0.78	18193046
APOA1,KIAA0999,LOC645044	Triglycerides	5E-8	   8.70	[5.76-11.64] % higher	rs2075292	G	0.24	18193046
BFZB	Height	2E-16	    .44	[NR] cm taller	rs6060369	C	0.44	18193045
MVK,MMAB	HDL cholesterol	3E-8	    .48	[NR] mg/dl higher	rs2338104	G	0.45	18193043
LIPG	HDL cholesterol	6E-12	   1.20	[NR] mg/dl higher	rs2156552	T	0.84	18193043
CETP	HDL cholesterol	2E-57	   3.47	[NR] mg/dl higher	rs3764261	A	0.31	18193043
CETP	HDL cholesterol	7E-39	   4.12	[NR] mg/dl higher	rs1864163	G	0.80	18193043
CETP	HDL cholesterol	3E-31	   1.72	[NR] mg/dl higher	rs9989419	G	0.65	18193043
LIPC	HDL cholesterol	3E-20	   1.38	[NR] mg/dl higher	rs4775041	C	0.33	18193043
LPL	HDL cholesterol	4E-19	   2.09	[NR] mg/dl higher	rs10503669	A	0.10	18193043
GALNT2	HDL cholesterol	3E-14	   1.11	[NR] mg/dl higher	rs2144300	T	0.60	18193043
ABCA1	HDL cholesterol	1E-10	    .82	[NR] mg/dl higher	rs4149268	C	0.64	18193043
CELSR2,PSRC1,SORT1	LDL cholesterol	6E-33	   5.48	[NR] mg/dl higher	rs599839	A	0.77	18193043
B3GALT4	LDL cholesterol	5E-8	   1.91	[NR] mg/dl higher	rs2254287	G	0.38	18193043
LDLR	LDL cholesterol	4E-26	   9.17	[NR] mg/dl higher	rs6511720	G	0.90	18193043
PCSK9	LDL cholesterol	4E-11	   3.04	[NR] mg/dl higher	rs11206510	T	0.81	18193043
APOE,APOC1,APOC4	LDL cholesterol	3E-43	   6.61	[NR] mg/dl higher	rs4420638	G	0.18	18193043
APOB	LDL cholesterol	6E-22	   4.89	[NR] mg/dl higher	rs562338	G	0.82	18193043
NCAN,CILP2	LDL cholesterol	3E-9	   3.32	[NR] mg/dl higher	rs16996148	G	0.89	18193043
GCKR	Triglycerides	6E-32	   8.59	[NR] mg/dl higher	rs780094	T	0.39	18193043
TRIB1	Triglycerides	7E-13	   6.42	[NR] mg/dl higher	rs17321515	A	0.56	18193043
MLXIPL	Triglycerides	2E-12	   8.21	[NR] mg/dl higher	rs17145738	C	0.84	18193043
ANGPTL3	Triglycerides	2E-10	   7.12	[NR] mg/dl higher	rs1748195	C	0.70	18193043
NCAN,CILP2	Triglycerides	3E-9	   6.10	[NR] mg/dl higher	rs16996148	G	0.92	18193043
LIPC	Triglycerides	2E-8	   3.62	[NR] mg/dl higher	rs4775041	C	0.33	18193043
APOA5, APOA4, APOC3, APOA1	Triglycerides	1E-26	  25.82	[NR] mg/dl higher	rs12286037	T	0.06	18193043
LPL	Triglycerides	4E-22	  11.57	[NR] mg/dl higher	rs10503669	C	0.90	18193043
APOA1,APOC3,APOA5	LDL cholesterol	3E-11	NR	NR	rs6589566	G	0.06	18179892
SLC2A9,WDR1	Urate levels	2E-15	    .02	[0.02-0.03] mMol/L higher	rs7442295	A	0.79	18179892
DPP6	Amyotrophic lateral sclerosis	5E-8	   1.30	[1.18-1.43] 	rs10260404	C	0.35	18084291
GLUT9	Urate levels	2E-16	    .32	[NR] mg/dl higher	rs6855911	A	0.74	17997608
TNFAIP3, OLIG3	Rheumatoid arthritis	1E-9	   1.33	[1.15-1.52] 	rs10499194	C	0.71	17982456
KITLG	Blond vs. brown hair color	4E-30	   2.32	[1.86-2.92] 	rs12821256	C	0.14	17952075
SLC24A4	Blond vs. brown hair color	1E-48	   2.56	[2.12-3.09] 	rs12896399	T	0.44	17952075
MC1R	Blond vs. brown hair color	2E-13	   2.34	[1.69-3.24] 	rs1805007	T	0.08	17952075
OCA2	Blond vs. brown hair color	6E-35	   4.94	[3.16-7.71] 	rs1667394	A	0.88	17952075
OCA2	Blue vs. brown eyes	1E-241	  29.43	[21.47-40.35] 	rs1667394	A	0.88	17952075
SLC24A4	Blue vs. green eyes	4E-38	   2.06	[1.76-2.42] 	rs12896399	T	0.40	17952075
TYR	Blue vs. green eyes	3E-12	   1.52	[1.28-1.81] 	rs1393350	A	0.23	17952075
OCA2	Blue vs. green eyes	2E-53	   6.74	[4.61-9.83] 	rs1667394	A	0.98	17952075
SEC5L1,IRF4	Freckles	4E-18	   1.40	[1.26-1.57] 	rs1540771	A	0.42	17952075
TYR	Freckles	2E-11	   1.32	[1.17-1.49] 	rs1042602	C	0.67	17952075
MC1R	Freckles	1E-96	   4.37	[3.56-5.37] 	rs1805007	T	0.05	17952075
MC1R	Red vs non-red hair color	2E-142	  12.47	[9.37-16.60] 	rs1805007	T	NR	17952075
MC1R	Skin sensitivity to sun	2E-55	   2.94	[2.42-3.58] 	rs1805007	T	0.06	17952075
SLC24A5	Skin pigmentation	1E-50	  12.50	[8.33-20.0] 	rs1834640	G	0.08	17999355
TYR	Skin pigmentation	4E-10	   4.36	[2.64-7.20] 	rs1042602	C	0.84	17999355
SLC45A2	Skin pigmentation	3E-11	   4.86	[2.88-8.21] 	rs16891982	C	0.83	17999355
SMAD7	Colorectal cancer	1E-12	   1.16	[1.09-1.27] 	rs4939827	T	0.52	17934461
TRAF1-C5	Rheumatoid arthritis	4E-14	   1.32	[1.23-1.42] 	rs3761847	G	0.41	17804836
IL23R	Crohn's disease	1E-8	   1.38	[1.23-1.53] 	rs11209003,rs11209002,rs2064689,rs1004819,rs2902440,rs11465802,rs2201841,rs11465804,rs11209026,rs1343151,rs10889676,rs10889677,rs9988642,rs12567232,rs6669582,rs10789230	1	0.23	17804789
HMGA2	Height	6E-16	    .40	[NR] cm per copy in adult height	rs1042725	C	0.51	17767157
LOXL1	Glaucoma (exfoliation)	3E-21	  20.10	[10.80-37.41] 	rs3825942	G	0.85	17690259
IL2RA	Multiple sclerosis	3E-8	   1.25	[1.11-1.36] 	rs12722489	C	0.85	17660530
HLA-DRA	Multiple sclerosis	9E-81	   1.99	[1.84-2.15] 	rs3135388	A	0.23	17660530
ORMDL3	Asthma	9E-11	   1.45	[1.17-1.81] 	rs7216389	T	0.52	17611496
FTO	Obesity-related traits	3E-8	    .16	[NR] SD lower (hip)	rs9930506	A	0.54	17658951
BTBD9	Restless legs syndrome	1E-17	   1.90	[1.50-2.20] 	rs3923809	A	0.66	17634447
MTHFD1L	Coronary heart disease	3E-8	   1.23	[1.15-1.33] 	rs6922269	A	0.25	17634449
Intergenic	Coronary heart disease	3E-19	   1.36	[1.27-1.46] 	rs1333049	C	0.47	17634449
PSRC1	Coronary heart disease	4E-9	   1.29	[1.18-1.40] 	rs599839	A	0.77	17634449
MEIS1	Restless legs syndrome	3E-28	   1.74	[1.57-1.92] 	rs2300478	G	0.24	17637780
BTBD9	Restless legs syndrome	4E-18	   1.67	[1.49-1.89] 	rs9296249	T	0.76	17637780
MAP2K5, LBXCOR1	Restless legs syndrome	1E-15	   1.50	[1.36-1.66] 	rs12593813	G	0.67	17637780
ABCG8	Gallstones	1E-14	   2.20	[1.80-2.60] 	rs11887534	C	0.10	17632509
KIAA0350	Type 1 diabetes	7E-11	   1.54	[1.32-1.79] 	rs2903692	G	0.62	17632545
HLA-DRB1	Type 1 diabetes	1E-16	   8.30	[6.97-9.89] 	rs2647044	A	0.13	17632545
INS	Type 1 diabetes	4E-9	   1.61	[1.37-1.89] 	rs1004446	C	0.65	17632545
Intergenic	Colorectal cancer	1E-14	   1.27	[1.16-1.39] 	rs6983267	G	0.49	17618284
ORF DQ515897	Colorectal cancer	3E-11	   1.17	[1.12-1.23] 	rs10505477	A	0.50	17618283
PITX2,ENPEP	Atrial fibrillation/atrial flutter	3E-41	   1.72	[1.59-1.86] 	rs2200733	T	0.11	17603472
PITX2,ENPEP	Atrial fibrillation/atrial flutter	7E-11	   1.39	[1.26-1.53] 	rs10033464	T	0.08	17603472
TCF2	Prostate cancer	1E-11	   1.22	[1.15-1.30] 	rs4430796	A	0.49	17603485
Intergenic	Prostate cancer	3E-10	   1.20	[1.14-1.27] 	rs1859962	G	0.46	17603485
TCF7L2	Type 2 diabetes	5E-8	   1.71	[1.41-2.08] 	rs7903146	A	NR	17668382
KIAA1109,TENR,IL2,IL21	Celiac disease	1E-14	   1.59	[1.41-1.75] 	rs6822844	G	0.82	17558408
HLA-DQA1	Celiac disease	1E-19	   7.04	[6.08-8.15] 	rs2187668	A	0.14	17558408
GAB2	Alzheimer's disease (late onset)	1E-10	   4.06	[2.81-14.69] 	rs2373115	G	0.70	17553421
CDKN2A,CDKN2B	Coronary heart disease	1E-13	   1.47	[1.27-1.70] 	rs1333049	C	0.47	17554300
BSN, MST1	Crohn's disease	4E-8	   1.09	[0.96-1.24] 	rs9858542	A	0.28	17554300
NOD2	Crohn's disease	4E-11	   1.29	[1.13-1.46] 	rs17221417	G	0.29	17554300
IL23R	Crohn's disease	6E-12	   1.39	[1.22-1.58] 	rs11805303	T	0.32	17554300
ATG16L1	Crohn's disease	5E-14	   1.19	[1.01-1.41] 	rs10210302	T	0.48	17554300
Intergenic	Crohn's disease	2E-12	   1.54	[1.34-1.76] 	rs17234657	G	0.13	17554300
PTPN22	Rheumatoid arthritis	6E-25	   1.98	[1.72-2.27] 	rs6679677	A	0.10	17554300
MHC	Rheumatoid arthritis	5E-75	   2.36	[1.97-2.84] 	rs6457617	T	0.49	17554300
ERBB3	Type 1 diabetes	1E-11	   1.34	[1.17-1.54] 	rs11171739	C	0.42	17554300
SH2B3,LNK,TRAFD1,PTPN11	Type 1 diabetes	2E-14	   1.34	[1.16-1.53] 	rs17696736	G	0.42	17554300
NR	Type 1 diabetes	5E-8	   1.57	[1.38-1.79] 	rs3764021	C	0.47	17554300
PTPN22	Type 1 diabetes	5E-26	   1.82	[1.59-2.09] 	rs6679677	A	0.10	17554300
MHC	Type 1 diabetes	5E-134	   5.49	[4.83-6.24] 	rs9272346	G	0.61	17554300
TCF7L2	Type 2 diabetes	5E-12	   1.36	[1.20-1.54] 	rs4506565	T	0.32	17554300
C12orf30	Type 1 diabetes	2E-16	   1.22	[1.15-1.28] 	rs17696736	G	0.42	17554260
ERBB3	Type 1 diabetes	2E-20	   1.28	[1.21-1.35] 	rs2292239	A	0.34	17554260
KIAA0350	Type 1 diabetes	3E-18	   1.23	[1.16-1.30] 	rs12708716	A	0.68	17554260
PTPN2	Type 1 diabetes	1E-14	   1.30	[1.22-1.40] 	rs2542151	C	0.16	17554260
CD226	Type 1 diabetes	1E-8	   1.16	[1.10-1.22] 	rs763361	A	0.47	17554260
PHTF1, PTPN22	Type 1 diabetes	8E-24	   1.89	[1.67-2.13] 	rs6679677	A	0.10	17554260
PTPN22	Type 1 diabetes	2E-80	   1.98	[1.82-2.15] 	rs2476601	T	0.09	17554260
IFIH1	Type 1 diabetes	2E-11	   1.18	[1.11-1.23] 	rs1990760	A	0.60	17554260
FGFR2	Breast cancer	2E-76	   1.26	[1.23-1.30] 	rs2981582	A	0.38	17529967
TNRC9, LOC643714	Breast cancer	1E-36	   1.20	[1.16-1.24] 	rs3803662	T	0.25	17529967
MAP3K1	Breast cancer	7E-20	   1.13	[1.10-1.16] 	rs889312	C	0.28	17529967
Intergenic	Breast cancer	5E-12	   1.08	[1.05-1.11] 	rs13281615	C	0.40	17529967
LSP1	Breast cancer	3E-9	   1.07	[1.04-1.11] 	rs3817198	C	0.30	17529967
FGFR2	Breast cancer	1E-10	   1.20	[1.07-1.42] 	rs1219648	G	0.40	17529973
Intergenic	Breast cancer	1E-13	   1.20	[1.14-1.26] 	rs13387042	A	0.50	17529974
TNRC9	Breast cancer	6E-19	   1.28	[1.21-1.35] 	rs3803662	T	0.27	17529974
DGKH	Bipolar disorder	2E-8	   1.59	[1.35-1.87] 	rs1012053	A	0.84	17486107
CDKN2A,CDKN2B	Myocardial infarction	1E-20	   1.28	[1.22-1.35] 	rs10757278	G	0.45	17478679
APOE cluster	Triglycerides	3E-13	   2.40	% [NR] of variance explained	rs4420638	G	0.22	17463246
CETP	Triglycerides	3E-13	   2.10	% [NR] of variance explained	rs1800775	C	0.47	17463246
CDKAL1	Type 2 diabetes	4E-11	   1.12	[1.08-1.16] 	rs7754840	C	0.31	17463246
HHEX	Type 2 diabetes	6E-10	   1.13	[1.08-1.17] 	rs1111875	C	0.53	17463246
SLC30A8	Type 2 diabetes	5E-8	   1.12	[1.07-1.16] 	rs13266634	C	0.65	17463246
CDKN2A,CDKN2B	Type 2 diabetes	5E-8	   1.20	[1.12-1.28] 	rs10811661	T	0.83	17463246
IGF2BP2	Type 2 diabetes	2E-9	   1.17	[1.11-1.23] 	rs4402960	T	0.29	17463246
TCF7L2	Type 2 diabetes	2E-31	   1.38	[1.31-1.46] 	rs7903146	T	0.26	17463246
TCF7L2	Type 2 diabetes	1E-8	   1.34	[1.21-1.49] 	rs7903146	T	0.18	17463248
IGF2BP2	Type 2 diabetes	9E-16	   1.14	[1.11-1.18] 	rs4402960	T	0.30	17463248
CDKAL1	Type 2 diabetes	4E-11	   1.12	[1.08-1.16] 	rs7754840	C	0.36	17463248
CDKN2A,CDKN2B	Type 2 diabetes	8E-15	   1.20	[1.14-1.25] 	rs10811661	T	0.85	17463248
FTO	Type 2 diabetes	1E-12	   1.17	[1.12-1.22] 	rs8050136	A	0.38	17463248
SLC30A8	Type 2 diabetes	5E-8	   1.12	[1.07-1.16] 	rs13266634	C	0.61	17463248
HHEX	Type 2 diabetes	6E-10	   1.13	[1.09-1.17] 	rs1111875	C	0.52	17463248
KCNJ11	Type 2 diabetes	7E-11	   1.14	[1.10-1.19] 	rs5219	T	0.46	17463248
CDKAL1	Type 2 diabetes	8E-9	   1.20	[1.13-1.27] 	rs7756992	G	0.26	17460697
KCNJ11	Type 2 diabetes	5E-11	   1.14	[1.10-1.19] 	rs5215	C	NR	17463249
FTO	Type 2 diabetes	7E-14	   1.23	[1.18-1.32] 	rs8050136	A	0.40	17463249
CDKAL1	Type 2 diabetes	1E-8	   1.16	[1.10-1.22] 	rs10946398	C	0.32	17463249
IGF2BP2	Type 2 diabetes	9E-16	   1.14	[1.11-1.18] 	rs4402960	T	0.32	17463249
SLC30A8	Type 2 diabetes	5E-8	   1.12	[1.07-1.16] 	rs13266634	C	0.69	17463249
TCF7L2	Type 2 diabetes	1E-48	   1.37	[1.31-1.43] 	rs7901695	C	NR	17463249
ATG16L1	Crohn's disease	1E-13	   1.45	[1.27-1.64] 	rs2241880	G	0.55	17435756
FTO	Body mass index	2E-20	    .36	[NR] kg/m2 per copy in adults	rs9939609	A	0.39	17434869
Intergenic	Prostate cancer	1E-12	   1.79	[1.53-2.11] (EA)	rs16901979	A	0.03 (EA)	17401366
Intergenic	Prostate cancer	6E-18	   1.60	[1.43-1.77] 	rs1447295	A	0.09	17401366
Intergenic	Prostate cancer	9E-13	   1.26	[1.13-1.41] 	rs6983267	G	0.50	17401363
Intergenic	Prostate cancer	2E-14	   1.43	[1.29-1.59] 	rs1447295	A	0.11	17401363
TCF7L2	Type 2 diabetes	2E-34	   1.65	[1.28, 2.02] 	rs7903146	T	0.30	17293876
IL23R	Inflammatory bowel disease	4E-11	   3.84	[2.33-6.66] 	rs11209026	G	0.93	17068223
IL23R	Inflammatory bowel disease	4E-13	   1.61	[1.35-1.92] 	rs7517847	C	0.56	17068223
HTRA1	Age-related macular degeneration (wet)	8E-12	   1.60	[0.71-3.61] 	rs11200638	A	NR	17053108
CFH	Age-related macular degeneration	4E-8	   4.60	[2.0-11] 	rs380390	C	0.70 (HapMap CEU)	15761122
